US  	US  	 PRP	O
20070005094  	20070005094  	 CD	O
A1  	A1  	 CD	O
20070104  	20070104  	 CD	O
US  	US  	 NNP	O
11398342  	11398342  	 CD	O
20060404  	20060404  	 CD	O
11  	11  	 CD	O
20060101  	20060101  	 CD	O
A  	A  	 DT	O
A  	A  	 NNP	O
61  	61  	 CD	O
B  	B  	 NNP	O
17  	17  	 CD	O
24  	24  	 CD	O
F  	F  	 NN	O
I  	I  	 PRP	O
20070104  	20070104  	 CD	O
US  	US  	 NNP	O
B  	B  	 NNP	B-NP
H  	H  	 NNP	I-NP
20060101  	20060101  	 CD	O
A  	A  	 DT	O
A  	A  	 NNP	O
61  	61  	 CD	O
F  	F  	 NN	O
2  	2  	 CD	O
18  	18  	 CD	O
L  	L  	 NNP	O
I  	I  	 NNP	O
20070104  	20070104  	 CD	O
US  	US  	 NNP	O
B  	B  	 NNP	B-NP
H  	H  	 NNP	I-NP
US  	US  	 NNP	O
606199000  	606199000  	 CD	O
623023700  	623023700  	 CD	O
Device  	Device  	 NN	O
and  	and  	 CC	O
methods  	methods  	 NNS	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
conditions  	conditions  	 NNS	I-NP
US  	US  	 NNP	O
60668569  	60668569  	 CD	O
20050404  	20050404  	 CD	O
Eaton  	Eaton  	 NNP	B-NP
Donald  	Donald  	 NNP	I-NP
J 	J 	 NNP	I-NP
.  	.  	 .	I-NP
Woodside  	Woodside  	 NNP	O
CA  	CA  	 NNP	O
US  	US  	 NNP	O
Indian  	Indian  	 NNP	O
Springs  	Springs  	 NNP	O
AL  	AL  	 NNP	O
US  	US  	 NNP	O
Cupertino  	Cupertino  	 NNP	B-NP
CA  	CA  	 NNP	I-NP
US  	US  	 NNP	O
Palo  	Palo  	 NNP	B-NP
Alto  	Alto  	 NNP	I-NP
CA  	CA  	 NNP	I-NP
US  	US  	 NNP	O
San  	San  	 NNP	B-NP
Juan  	Juan  	 NNP	I-NP
Capistrano  	Capistrano  	 NNP	I-NP
CA  	CA  	 NNP	I-NP
US  	US  	 NNP	O
Hoover  	Hoover  	 NNP	O
AL  	AL  	 NNP	O
US  	US  	 NNP	O
755  	755  	 CD	O
PAGE  	PAGE  	 NNP	B-NP
MILL  	MILL  	 NNP	I-NP
RD  	RD  	 NNP	I-NP
PALO  	PALO  	 NNP	I-NP
ALTO  	ALTO  	 NNP	I-NP
CA  	CA  	 NNP	I-NP
94304-1018  	94304-1018  	 NNP	O
US  	US  	 NNP	O
Described  	Described  	 VBN	O
here  	here  	 RB	O
are  	are  	 VBP	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
for  	for  	 IN	O
treating  	treating  	 VBG	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
include  	include  	 VBP	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
One  	One  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
may  	may  	 MD	O
deliver  	deliver  	 VB	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
for  	for  	 IN	O
sustained  	sustained  	 JJ	O
release  	release  	 NN	O
to  	to  	 TO	O
treat  	treat  	 VB	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition 	condition 	 NN	I-NP
.  	.  	 .	O
Exemplary  	Exemplary  	 JJ	B-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
conditions  	conditions  	 NNS	I-NP
are  	are  	 VBP	O
sinus  	sinus  	 JJ	B-NP
inflammation  	inflammation  	 JJ	I-NP
due  	due  	 JJ	O
to  	to  	 TO	O
functional  	functional  	 VB	B-NP
endoscopic  	endoscopic  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
surgery  	surgery  	 NN	I-NP
( 	( 	 -LRB-	O
FESS 	FESS 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
rhinosinusitis 	rhinosinusitis 	 NN	B-NP
.  	.  	 .	O
This  	This  	 DT	O
application  	application  	 NN	O
claims  	claims  	 NNS	O
priority  	priority  	 NN	O
to  	to  	 TO	O
U.S.  	U.S.  	 NNP	O
Provisional  	Provisional  	 NNP	O
Application  	Application  	 NNP	O
Ser 	Ser 	 NNP	O
.  	.  	 .	O
No.  	No.  	 NNP	O
60 	60 	 CD	O
/ 	/ 	 CD	O
668,569 	668,569 	 CD	O
,  	,  	 ,	O
filed  	filed  	 VBD	O
Apr.  	Apr.  	 CD	O
4 	4 	 CD	O
,  	,  	 ,	O
2005 	2005 	 CD	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
hereby  	hereby  	 VBN	O
incorporated  	incorporated  	 VBN	O
by  	by  	 IN	O
reference  	reference  	 NN	O
in  	in  	 IN	O
its  	its  	 PRP$	O
entirety 	entirety 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
devices 	devices 	 NNS	O
,  	,  	 ,	O
systems 	systems 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
methods  	methods  	 NNS	O
described  	described  	 VBD	O
here  	here  	 RB	O
are  	are  	 VBP	O
in  	in  	 IN	O
the  	the  	 DT	O
field  	field  	 NN	O
of  	of  	 IN	O
local  	local  	 JJ	O
drug  	drug  	 NN	B-NP
delivery  	delivery  	 NN	I-NP
to  	to  	 TO	O
treat  	treat  	 VB	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
More  	More  	 RBR	O
specifically 	specifically 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
inflammation  	inflammation  	 NN	I-NP
and  	and  	 CC	O
rhinosinusitis  	rhinosinusitis  	 NN	B-NP
is  	is  	 VBZ	O
described 	described 	 VBN	O
.  	.  	 .	O
Rhinosinusitis  	Rhinosinusitis  	 NNP	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
common  	common  	 JJ	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
generally  	generally  	 RB	O
understood  	understood  	 VBN	O
as  	as  	 IN	O
encompassing  	encompassing  	 JJ	O
sinusitis  	sinusitis  	 NN	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
rhinitis 	rhinitis 	 NN	B-NP
.  	.  	 .	O
Typically 	Typically 	 RB	O
,  	,  	 ,	O
rhinosinusitis  	rhinosinusitis  	 NN	B-NP
is  	is  	 VBZ	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
such  	such  	 JJ	O
major  	major  	 JJ	O
symptoms  	symptoms  	 NNS	B-NP
such  	such  	 JJ	O
as  	as  	 IN	O
nasal  	nasal  	 JJ	B-NP
discharge 	discharge 	 NN	I-NP
,  	,  	 ,	O
nasal  	nasal  	 JJ	B-NP
obstruction 	obstruction 	 NN	I-NP
,  	,  	 ,	O
facial  	facial  	 JJ	B-NP
congestion 	congestion 	 NN	I-NP
,  	,  	 ,	O
facial  	facial  	 JJ	B-NP
pain 	pain 	 NN	I-NP
/ 	/ 	 CD	I-NP
pressure 	pressure 	 NN	I-NP
,  	,  	 ,	O
loss  	loss  	 NN	O
of  	of  	 IN	O
smell 	smell 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
fever 	fever 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
such  	such  	 JJ	O
minor  	minor  	 JJ	O
symptoms  	symptoms  	 NNS	B-NP
as  	as  	 IN	O
headache 	headache 	 NN	O
,  	,  	 ,	O
ear  	ear  	 JJ	B-NP
pain 	pain 	 NN	I-NP
/ 	/ 	 CD	I-NP
pressure 	pressure 	 NN	I-NP
,  	,  	 ,	O
halitosis 	halitosis 	 NN	O
,  	,  	 ,	O
dental  	dental  	 JJ	B-NP
pain 	pain 	 NN	I-NP
,  	,  	 ,	O
cough 	cough 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
fatigue 	fatigue 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinuses  	sinuses  	 NNS	I-NP
are  	are  	 VBP	O
air-filled  	air-filled  	 JJ	O
cavities  	cavities  	 NN	O
within  	within  	 IN	O
the  	the  	 DT	O
facial  	facial  	 JJ	B-NP
skeleton 	skeleton 	 NN	I-NP
.  	.  	 .	O
Each  	Each  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 NN	I-NP
is  	is  	 VBZ	O
contiguous  	contiguous  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
and  	and  	 CC	O
opens  	opens  	 VBZ	O
into  	into  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
through  	through  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
key  	key  	 JJ	O
to  	to  	 TO	O
normal  	normal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
function  	function  	 NN	I-NP
is  	is  	 VBZ	O
its  	its  	 PRP$	O
mucociliary  	mucociliary  	 JJ	B-NP
transport  	transport  	 NN	I-NP
system  	system  	 NN	I-NP
which  	which  	 WDT	O
is  	is  	 VBZ	O
comprised  	comprised  	 VBN	O
of  	of  	 IN	O
epithelial  	epithelial  	 JJ	B-NP
goblet  	goblet  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
submucosal  	submucosal  	 JJ	B-NP
seromucous  	seromucous  	 JJ	I-NP
glands  	glands  	 NN	I-NP
that  	that  	 WDT	O
produce  	produce  	 VBP	O
nearly  	nearly  	 RB	O
a  	a  	 DT	O
quart  	quart  	 NN	O
of  	of  	 IN	O
mucus  	mucus  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
a  	a  	 DT	O
day 	day 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
ciliated 	ciliated 	 NN	O
,  	,  	 ,	O
pseudostratified 	pseudostratified 	 NN	B-NP
,  	,  	 ,	O
columnar  	columnar  	 JJ	B-NP
epithelium  	epithelium  	 NN	I-NP
that  	that  	 IN	O
lines  	lines  	 NNS	O
the  	the  	 DT	O
sinuses  	sinuses  	 NN	O
and  	and  	 CC	O
which  	which  	 WDT	O
moves  	moves  	 VBZ	O
the  	the  	 DT	O
mucous  	mucous  	 NN	O
toward  	toward  	 IN	O
the  	the  	 DT	O
natural  	natural  	 JJ	O
sinus  	sinus  	 JJ	B-NP
ostia 	ostia 	 NN	I-NP
.  	.  	 .	O
Any  	Any  	 DT	O
alteration  	alteration  	 NN	O
in  	in  	 IN	O
sinus  	sinus  	 JJ	B-NP
ostia  	ostia  	 JJ	I-NP
patency 	patency 	 NN	I-NP
,  	,  	 ,	O
ciliary  	ciliary  	 JJ	B-NP
function 	function 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
the  	the  	 DT	O
quality  	quality  	 NN	O
of  	of  	 IN	O
mucous  	mucous  	 NNS	O
may  	may  	 MD	O
disrupt  	disrupt  	 VB	O
the  	the  	 DT	O
system  	system  	 NN	O
and  	and  	 CC	O
lead  	lead  	 VB	O
to  	to  	 TO	O
rhinosinusitis 	rhinosinusitis 	 VB	O
.  	.  	 .	O
One  	One  	 CD	O
important  	important  	 JJ	O
factor  	factor  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	I-NP
rhinosinusitis  	rhinosinusitis  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
patency  	patency  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
sinus  	sinus  	 JJ	I-NP
ostia 	ostia 	 NN	I-NP
.  	.  	 .	O
Partial  	Partial  	 JJ	B-NP
obstruction  	obstruction  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
sinus  	sinus  	 JJ	I-NP
ostia  	ostia  	 NNS	I-NP
often  	often  	 RB	O
results  	results  	 NNS	O
in  	in  	 IN	O
stagnation  	stagnation  	 NN	O
of  	of  	 IN	O
mucous  	mucous  	 JJ	B-NP
secretions 	secretions 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
pH  	pH  	 JJ	O
and  	and  	 CC	O
oxygen  	oxygen  	 JJ	B-NP
tension  	tension  	 NN	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
These  	These  	 DT	O
physiologic  	physiologic  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
are  	are  	 VBP	O
thought  	thought  	 VBN	O
to  	to  	 TO	O
create  	create  	 VB	O
a  	a  	 DT	O
favorable  	favorable  	 JJ	O
environment  	environment  	 NN	O
for  	for  	 IN	O
microbial  	microbial  	 JJ	B-NP
infection 	infection 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
microbial  	microbial  	 JJ	B-NP
infection  	infection  	 NN	I-NP
subsequently  	subsequently  	 NN	O
causes  	causes  	 NNS	O
or  	or  	 CC	O
enhances  	enhances  	 VBZ	O
mucosal  	mucosal  	 JJ	B-NP
inflammation  	inflammation  	 NN	I-NP
that  	that  	 WDT	O
may  	may  	 MD	O
further  	further  	 RB	O
reduce  	reduce  	 VB	O
ostial  	ostial  	 JJ	B-NP
patency  	patency  	 NN	I-NP
or  	or  	 CC	O
completely  	completely  	 RB	O
obstruct  	obstruct  	 VBP	O
the  	the  	 DT	O
ostia 	ostia 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
medical  	medical  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
for  	for  	 IN	O
rhinosinusitis  	rhinosinusitis  	 VBG	O
typically  	typically  	 RB	O
includes  	includes  	 VBZ	O
a  	a  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
oral  	oral  	 JJ	B-NP
antibiotics 	antibiotics 	 NN	I-NP
,  	,  	 ,	O
topical  	topical  	 NN	O
or  	or  	 CC	O
oral  	oral  	 JJ	B-NP
decongestants 	decongestants 	 NN	I-NP
,  	,  	 ,	O
steroid  	steroid  	 JJ	B-NP
nasal  	nasal  	 JJ	I-NP
sprays 	sprays 	 NNS	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
oral  	oral  	 JJ	B-NP
steroids  	steroids  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
prednisone 	prednisone 	 NN	B-NP
.  	.  	 .	O
When  	When  	 WRB	O
medical  	medical  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
fails 	fails 	 VBZ	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
often  	often  	 RB	O
the  	the  	 DT	O
case  	case  	 NN	O
with  	with  	 IN	O
rhinosinusitis 	rhinosinusitis 	 NN	B-NP
,  	,  	 ,	O
sinus  	sinus  	 JJ	B-NP
surgery  	surgery  	 NN	I-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
alternative 	alternative 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
surgery  	surgery  	 NN	O
performed  	performed  	 VBN	O
today  	today  	 NN	O
is  	is  	 VBZ	O
functional  	functional  	 JJ	B-NP
endoscopic  	endoscopic  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
surgery  	surgery  	 NN	I-NP
( 	( 	 -LRB-	O
FESS 	FESS 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
goal  	goal  	 NN	O
of  	of  	 IN	O
FESS  	FESS  	 NNP	B-NP
is  	is  	 VBZ	O
to  	to  	 TO	O
improve  	improve  	 VB	O
the  	the  	 DT	O
drainage  	drainage  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinuses  	sinuses  	 NN	O
by  	by  	 IN	O
enlarging  	enlarging  	 VBG	O
the  	the  	 DT	O
ostia  	ostia  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
maxillary  	maxillary  	 NN	I-NP
and  	and  	 CC	O
frontal  	frontal  	 JJ	B-NP
sinuses 	sinuses 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
opening  	opening  	 VBG	O
the  	the  	 DT	O
ethmoid  	ethmoid  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
area  	area  	 NN	I-NP
by  	by  	 IN	O
removing  	removing  	 VBG	O
the  	the  	 DT	O
ethmoid  	ethmoid  	 JJ	B-NP
air  	air  	 NN	I-NP
cells  	cells  	 NNS	I-NP
under  	under  	 IN	O
direct  	direct  	 JJ	O
visualization 	visualization 	 NN	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
FESS  	FESS  	 NNP	B-NP
itself  	itself  	 PRP	O
creates  	creates  	 VBZ	O
inflammation 	inflammation 	 VBN	O
,  	,  	 ,	O
which  	which  	 WDT	O
can  	can  	 MD	O
lead  	lead  	 VB	O
to  	to  	 TO	O
post-operative  	post-operative  	 JJ	B-NP
fibrosis 	fibrosis 	 NN	I-NP
,  	,  	 ,	O
stenosis 	stenosis 	 NN	B-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
polyposis  	polyposis  	 NNS	B-NP
that  	that  	 WDT	O
frequently  	frequently  	 RB	O
obstructs  	obstructs  	 VB	O
the  	the  	 DT	O
newly  	newly  	 RB	O
opened  	opened  	 VBN	O
sinuses 	sinuses 	 NN	O
,  	,  	 ,	O
requiring  	requiring  	 VBG	O
the  	the  	 DT	O
surgeon  	surgeon  	 NN	O
to  	to  	 TO	O
reoperate  	reoperate  	 VB	O
to  	to  	 TO	O
revise  	revise  	 VB	O
the  	the  	 DT	O
ostia  	ostia  	 NN	B-NP
and  	and  	 CC	O
insert  	insert  	 JJ	O
stenting  	stenting  	 JJ	B-NP
devices  	devices  	 NNS	I-NP
to  	to  	 TO	O
keep  	keep  	 VB	O
sinus  	sinus  	 JJ	B-NP
ostia  	ostia  	 JJ	I-NP
patent 	patent 	 NN	O
.  	.  	 .	O
U.S.  	U.S.  	 NNP	O
Pat 	Pat 	 NNP	O
.  	.  	 .	O
No.  	No.  	 NNP	O
5,246,455  	5,246,455  	 NNP	O
( 	( 	 -LRB-	O
Shikani 	Shikani 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
U.S.  	U.S.  	 NNP	O
Pat 	Pat 	 NNP	O
.  	.  	 .	O
No.  	No.  	 NNP	O
5,693,065  	5,693,065  	 NNP	O
( 	( 	 -LRB-	O
Rains 	Rains 	 NNP	O
)  	)  	 -RRB-	O
describe  	describe  	 VBP	O
stents  	stents  	 VBN	O
for  	for  	 IN	O
insertion  	insertion  	 NN	O
into  	into  	 IN	O
sinus  	sinus  	 JJ	B-NP
ostia  	ostia  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
sinus  	sinus  	 JJ	B-NP
antrostomies  	antrostomies  	 NN	I-NP
or  	or  	 CC	O
fenestrations  	fenestrations  	 JJ	O
to  	to  	 TO	O
improve  	improve  	 VB	O
sinus  	sinus  	 JJ	B-NP
drainage 	drainage 	 NN	I-NP
,  	,  	 ,	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
degree  	degree  	 NN	O
of  	of  	 IN	O
adhesion  	adhesion  	 JJ	B-NP
formation 	formation 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
prevent  	prevent  	 VB	O
ostial  	ostial  	 JJ	B-NP
stenosis 	stenosis 	 NN	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
stents  	stents  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
Parrell  	Parrell  	 NNP	B-NP
Frontal  	Frontal  	 NNP	I-NP
Sinus  	Sinus  	 NNP	I-NP
T-Stent  	T-Stent  	 NNP	I-NP
( 	( 	 -LRB-	O
Medtronic  	Medtronic  	 NNP	B-NP
Xomed 	Xomed 	 NNP	I-NP
,  	,  	 ,	O
Inc. 	Inc. 	 NNP	O
,  	,  	 ,	O
Jacksonville 	Jacksonville 	 NNP	B-NP
,  	,  	 ,	O
Fla. 	Fla. 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
Jasin  	Jasin  	 NNP	O
Frontal  	Frontal  	 NNP	B-NP
Sinus  	Sinus  	 NNP	I-NP
Ostent 	Ostent 	 NNP	I-NP
& 	& 	 CC	O
# 	# 	 #	O
x2122 	x2122 	 CD	O
;  	;  	 :	O
Stent  	Stent  	 NNP	O
( 	( 	 -LRB-	O
Medtronic  	Medtronic  	 NNP	B-NP
Xomed 	Xomed 	 NNP	I-NP
,  	,  	 ,	O
Inc. 	Inc. 	 NNP	O
,  	,  	 ,	O
Jacksonville 	Jacksonville 	 NNP	B-NP
,  	,  	 ,	O
Fla. 	Fla. 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
Salman  	Salman  	 NNP	B-NP
FES  	FES  	 NNP	I-NP
Stent  	Stent  	 NNP	O
( 	( 	 -LRB-	O
Boston  	Boston  	 NNP	B-NP
Medical  	Medical  	 NNP	I-NP
Products 	Products 	 NNPS	I-NP
,  	,  	 ,	O
Westborough 	Westborough 	 NNP	B-NP
,  	,  	 ,	O
Mass. 	Mass. 	 NNP	O
)  	)  	 -RRB-	O
are  	are  	 VBP	O
currently  	currently  	 RB	O
used  	used  	 VBN	O
after  	after  	 IN	O
endoscopic  	endoscopic  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
surgery  	surgery  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
purpose 	purpose 	 NN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
these  	these  	 DT	O
stents  	stents  	 NNS	B-NP
are  	are  	 VBP	O
nonbiodegradable  	nonbiodegradable  	 VBN	O
and  	and  	 CC	O
thus  	thus  	 RB	O
require  	require  	 VB	O
a  	a  	 DT	O
follow-up  	follow-up  	 JJ	B-NP
procedure  	procedure  	 NN	I-NP
for  	for  	 IN	O
removal 	removal 	 NN	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
because  	because  	 IN	O
these  	these  	 DT	O
stents  	stents  	 NNS	B-NP
do  	do  	 VBP	O
not  	not  	 RB	O
deliver  	deliver  	 VB	O
a  	a  	 DT	O
therapeutically  	therapeutically  	 JJ	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
to  	to  	 TO	O
the  	the  	 DT	O
sinuses 	sinuses 	 NN	O
,  	,  	 ,	O
they  	they  	 PRP	O
often  	often  	 RB	O
only  	only  	 RB	O
delay  	delay  	 VB	O
stenosis  	stenosis  	 JJ	O
due  	due  	 JJ	O
to  	to  	 TO	O
postoperative  	postoperative  	 VB	O
inflammation  	inflammation  	 NNS	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
normal  	normal  	 JJ	B-NP
wound  	wound  	 NN	I-NP
healing  	healing  	 NN	I-NP
process 	process 	 NN	I-NP
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
they  	they  	 PRP	O
are  	are  	 VBP	O
typically  	typically  	 RB	O
used  	used  	 VBN	O
in  	in  	 IN	O
combination  	combination  	 NN	O
with  	with  	 IN	O
systemic  	systemic  	 JJ	B-NP
oral  	oral  	 JJ	I-NP
corticosteroids 	corticosteroids 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
may  	may  	 MD	O
result  	result  	 VB	O
in  	in  	 IN	O
undesirable  	undesirable  	 JJ	O
side-effects  	side-effects  	 JJ	B-NP
the  	the  	 DT	O
longer  	longer  	 RBR	O
they  	they  	 PRP	O
are  	are  	 VBP	O
administered 	administered 	 VBN	O
.  	.  	 .	O
Sinus  	Sinus  	 JJ	B-NP
stents  	stents  	 NN	I-NP
that  	that  	 IN	O
elute  	elute  	 JJ	B-NP
drug  	drug  	 NN	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
proposed  	proposed  	 VBN	O
by  	by  	 IN	O
others 	others 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
nonbiodegradable  	nonbiodegradable  	 NN	B-NP
or  	or  	 CC	O
biodegradable  	biodegradable  	 JJ	O
polymeric  	polymeric  	 NN	B-NP
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
spacer 	spacer 	 NNS	B-NP
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
device  	device  	 NN	O
for  	for  	 IN	O
placement  	placement  	 NN	O
into  	into  	 IN	O
surgically  	surgically  	 FW	O
created  	created  	 FW	O
frontal  	frontal  	 FW	B-NP
sinus  	sinus  	 FW	I-NP
fenestrations  	fenestrations  	 FW	I-NP
is  	is  	 VBZ	O
described  	described  	 VBN	O
in  	in  	 IN	O
U.S.  	U.S.  	 NNP	O
Published  	Published  	 NNP	B-NP
Application  	Application  	 NNP	I-NP
No 	No 	 NNP	O
.  	.  	 .	O
U.S.  	U.S.  	 NNP	O
2004 	2004 	 CD	O
/ 	/ 	 CD	O
0116958  	0116958  	 CD	O
to  	to  	 TO	O
Goferich  	Goferich  	 NNP	B-NP
et  	et  	 FW	O
al 	al 	 FW	O
.  	.  	 .	O
The  	The  	 DT	O
spacer  	spacer  	 NN	B-NP
is  	is  	 VBZ	O
tubular  	tubular  	 JJ	O
or  	or  	 CC	O
shaped  	shaped  	 VBN	O
like  	like  	 IN	O
an  	an  	 DT	O
hour-glass 	hour-glass 	 JJ	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
releasing  	releasing  	 VBG	O
medicinal  	medicinal  	 JJ	B-NP
substances  	substances  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
glucocorticosteroids 	glucocorticosteroids 	 NN	B-NP
,  	,  	 ,	O
tyrosine  	tyrosine  	 FW	B-NP
kinase  	kinase  	 FW	I-NP
inhibitors 	inhibitors 	 FW	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
mitosis  	mitosis  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
around  	around  	 IN	O
newly  	newly  	 RB	O
created  	created  	 VBN	B-NP
fenestrations 	fenestrations 	 NN	I-NP
.  	.  	 .	O
An  	An  	 DT	O
hour-glass  	hour-glass  	 JJ	B-NP
or  	or  	 CC	O
tubular  	tubular  	 JJ	B-NP
shape  	shape  	 NN	I-NP
is  	is  	 VBZ	O
described  	described  	 VBN	O
as  	as  	 RB	O
preferred  	preferred  	 VBN	O
because  	because  	 IN	O
it  	it  	 PRP	O
allows  	allows  	 VBZ	O
secretions  	secretions  	 VBN	O
to  	to  	 TO	O
drain  	drain  	 VB	O
from  	from  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
spacer  	spacer  	 NN	B-NP
is  	is  	 VBZ	O
placed  	placed  	 VBN	O
solely  	solely  	 RB	O
at  	at  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium  	ostium  	 NN	I-NP
and  	and  	 CC	O
does  	does  	 VBZ	O
not  	not  	 RB	O
undergo  	undergo  	 VB	O
a  	a  	 DT	O
structural  	structural  	 JJ	B-NP
change 	change 	 NN	I-NP
,  	,  	 ,	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
to  	to  	 TO	O
transition  	transition  	 NN	O
between  	between  	 IN	O
a  	a  	 DT	O
collapsed  	collapsed  	 JJ	O
and  	and  	 CC	O
expanded  	expanded  	 JJ	O
configuration 	configuration 	 NN	B-NP
,  	,  	 ,	O
upon  	upon  	 IN	O
delivery  	delivery  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
spacer  	spacer  	 NN	B-NP
primarily  	primarily  	 RB	O
lies  	lies  	 VBZ	O
within  	within  	 IN	O
the  	the  	 DT	O
natural  	natural  	 JJ	O
ostium  	ostium  	 NN	B-NP
or  	or  	 CC	O
surgically  	surgically  	 RB	O
created  	created  	 VBN	B-NP
fenestration 	fenestration 	 NN	I-NP
.  	.  	 .	O
It  	It  	 PRP	O
does  	does  	 VBZ	O
not  	not  	 RB	O
have  	have  	 VB	O
a  	a  	 DT	O
portion  	portion  	 NN	O
that  	that  	 WDT	O
extends  	extends  	 VBZ	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
to  	to  	 TO	O
contact  	contact  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall 	wall 	 NN	I-NP
.  	.  	 .	O
Another  	Another  	 DT	O
implantable  	implantable  	 JJ	B-NP
device  	device  	 NN	I-NP
for  	for  	 IN	I-NP
treating  	treating  	 VBG	I-NP
sinusitis  	sinusitis  	 NN	I-NP
is  	is  	 VBZ	O
described  	described  	 VBN	O
in  	in  	 IN	O
U.S.  	U.S.  	 NNP	O
Publication  	Publication  	 NNP	O
No.  	No.  	 NNP	O
2005 	2005 	 CD	O
/ 	/ 	 CD	O
0245906  	0245906  	 CD	O
to  	to  	 TO	O
Makower  	Makower  	 NNP	B-NP
et  	et  	 FW	O
al 	al 	 FW	O
.  	.  	 .	O
This  	This  	 DT	O
application  	application  	 NN	O
describes  	describes  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymeric  	polymeric  	 JJ	B-NP
device  	device  	 NN	I-NP
having  	having  	 VBG	O
a  	a  	 DT	O
spacer  	spacer  	 NN	B-NP
for  	for  	 IN	O
positioning  	positioning  	 NN	O
within  	within  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
body  	body  	 NN	O
comprised  	comprised  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
substance-eluting  	substance-eluting  	 JJ	B-NP
struts 	struts 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
struts  	struts  	 NNS	O
are  	are  	 VBP	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
lie  	lie  	 VB	O
substantially  	substantially  	 RB	O
parallel  	parallel  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
flow  	flow  	 NN	O
of  	of  	 IN	O
mucus  	mucus  	 NN	O
along  	along  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
walls  	walls  	 NNS	I-NP
without  	without  	 IN	O
substantially  	substantially  	 RB	O
touching  	touching  	 VBG	O
the  	the  	 DT	O
walls  	walls  	 NNS	O
so  	so  	 RB	O
that  	that  	 IN	O
mucociliary  	mucociliary  	 JJ	B-NP
transport  	transport  	 NN	I-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
interrupted 	interrupted 	 VBN	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
uncertain  	uncertain  	 JJ	O
how  	how  	 WRB	O
a  	a  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
design  	design  	 NN	O
would  	would  	 MD	O
be  	be  	 VB	O
constructed  	constructed  	 VBN	O
or  	or  	 CC	O
deployed 	deployed 	 VBN	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
given  	given  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
source  	source  	 NN	O
of  	of  	 IN	O
water  	water  	 NN	O
needed  	needed  	 VBN	O
for  	for  	 IN	O
device  	device  	 NN	B-NP
degradation  	degradation  	 NN	I-NP
and  	and  	 CC	O
drug  	drug  	 NN	B-NP
release 	release 	 NN	I-NP
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
questionable  	questionable  	 JJ	O
whether  	whether  	 IN	O
this  	this  	 DT	O
device  	device  	 NN	O
is  	is  	 VBZ	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
providing  	providing  	 VBG	O
a  	a  	 DT	O
dosing  	dosing  	 JJ	O
regimen  	regimen  	 JJ	O
effective  	effective  	 JJ	O
for  	for  	 IN	O
treating  	treating  	 VBG	B-NP
rhinosinusitis  	rhinosinusitis  	 NN	I-NP
because  	because  	 IN	O
it  	it  	 PRP	O
does  	does  	 VBZ	O
not  	not  	 RB	O
substantially  	substantially  	 RB	O
contact  	contact  	 VB	O
the  	the  	 DT	O
walls  	walls  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
Other  	Other  	 JJ	O
compositions  	compositions  	 NNS	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
rhinosinusitis 	rhinosinusitis 	 NN	B-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
aqueous  	aqueous  	 JJ	B-NP
solutions 	solutions 	 NNS	I-NP
,  	,  	 ,	O
creams 	creams 	 NNS	O
,  	,  	 ,	O
or  	or  	 CC	O
gels 	gels 	 NN	O
,  	,  	 ,	O
for  	for  	 IN	O
topical  	topical  	 JJ	B-NP
application  	application  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
nose  	nose  	 NN	O
have  	have  	 VBP	O
also  	also  	 RB	O
been  	been  	 VBN	O
formulated 	formulated 	 VBN	O
,  	,  	 ,	O
but  	but  	 CC	O
usually  	usually  	 RB	O
never  	never  	 RB	O
travel  	travel  	 VB	O
far  	far  	 RB	O
enough  	enough  	 RB	O
into  	into  	 IN	O
the  	the  	 DT	O
nose  	nose  	 NN	O
to  	to  	 TO	O
reach  	reach  	 VB	O
the  	the  	 DT	O
sinuses 	sinuses 	 NN	O
,  	,  	 ,	O
are  	are  	 VBP	O
blocked  	blocked  	 VBN	O
from  	from  	 IN	O
entering  	entering  	 VBG	O
the  	the  	 DT	O
sinuses  	sinuses  	 JJ	O
due  	due  	 JJ	O
to  	to  	 TO	O
obstructed  	obstructed  	 VB	B-NP
ostia 	ostia 	 NNS	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
have  	have  	 VBP	O
such  	such  	 JJ	O
short  	short  	 JJ	O
contact  	contact  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
that  	that  	 IN	O
absorption  	absorption  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
low 	low 	 JJ	O
.  	.  	 .	O
For  	For  	 IN	O
similar  	similar  	 JJ	O
reasons 	reasons 	 NNS	O
,  	,  	 ,	O
nasally  	nasally  	 FW	O
inhaled  	inhaled  	 FW	B-NP
steroid  	steroid  	 FW	I-NP
and  	and  	 CC	O
anti-infective  	anti-infective  	 JJ	B-NP
aerosols  	aerosols  	 NN	I-NP
that  	that  	 WDT	O
have  	have  	 VBP	O
been  	been  	 VBN	O
developed  	developed  	 VBN	O
to  	to  	 TO	O
treat  	treat  	 VB	O
sinusitis  	sinusitis  	 NNS	O
are  	are  	 VBP	O
equally  	equally  	 RB	O
ineffective 	ineffective 	 JJ	O
.  	.  	 .	O
Another  	Another  	 DT	O
method  	method  	 NN	O
that  	that  	 WDT	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
described  	described  	 VBN	O
for  	for  	 IN	O
locally  	locally  	 RB	O
treating  	treating  	 VBG	B-NP
sinusitis  	sinusitis  	 NN	I-NP
is  	is  	 VBZ	O
to  	to  	 TO	O
place  	place  	 VB	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
implant  	implant  	 NN	B-NP
into  	into  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
delivery  	delivery  	 NN	O
of  	of  	 IN	O
ampicillin  	ampicillin  	 NN	B-NP
from  	from  	 IN	O
a  	a  	 DT	O
rolled-up  	rolled-up  	 JJ	O
1.5  	1.5  	 CD	O
cm 	cm 	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
xd7 	xd7 	 CD	B-NP
; 	; 	 :	O
1.5  	1.5  	 CD	O
cm  	cm  	 CD	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactic-co-glycolic 	lactic-co-glycolic 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
acid  	acid  	 NN	I-NP
( 	( 	 -LRB-	O
PLGA 	PLGA 	 NNP	B-NP
)  	)  	 -RRB-	O
film  	film  	 NN	O
to  	to  	 TO	O
increase  	increase  	 VB	O
residence  	residence  	 NN	B-NP
time  	time  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
antibiotic  	antibiotic  	 NN	O
in  	in  	 IN	O
rabbit  	rabbit  	 JJ	O
sinuses  	sinuses  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
investigated  	investigated  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
sinusitis  	sinusitis  	 NNS	O
( 	( 	 -LRB-	O
Min  	Min  	 FW	O
et  	et  	 FW	O
al 	al 	 FW	O
.  	.  	 .	O
Mucociliary  	Mucociliary  	 JJ	B-NP
Activity  	Activity  	 NN	I-NP
and  	and  	 CC	O
Histopathology  	Histopathology  	 NNP	B-NP
of  	of  	 IN	I-NP
Sinus  	Sinus  	 NNP	I-NP
Mucosa  	Mucosa  	 NNP	I-NP
in  	in  	 IN	O
Experimental  	Experimental  	 NNP	B-NP
Maxillary  	Maxillary  	 NNP	I-NP
Sinusitis 	Sinusitis 	 NNP	I-NP
:  	:  	 :	O
A  	A  	 DT	O
Comparison  	Comparison  	 NNP	O
of  	of  	 IN	O
Systemic  	Systemic  	 NNP	B-NP
Administration  	Administration  	 NNP	I-NP
of  	of  	 IN	O
Antibiotic  	Antibiotic  	 NNP	O
and  	and  	 CC	O
Antibiotic  	Antibiotic  	 NNP	B-NP
Delivery  	Delivery  	 NN	I-NP
by  	by  	 IN	O
Polylactic  	Polylactic  	 NNP	B-NP
Acid  	Acid  	 NNP	I-NP
Polymer 	Polymer 	 NNP	I-NP
.  	.  	 .	O
Laryngoscope  	Laryngoscope  	 NNP	B-NP
105 	105 	 CD	O
: 	: 	 :	O
835-342  	835-342  	 CD	O
( 	( 	 -LRB-	O
1995 	1995 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
Min  	Min  	 NNP	O
et  	et  	 FW	O
al 	al 	 FW	O
.  	.  	 .	O
Application  	Application  	 NN	O
of  	of  	 IN	O
Polylactic  	Polylactic  	 NNP	B-NP
Acid  	Acid  	 NNP	I-NP
Polymer  	Polymer  	 NNP	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
Treatment  	Treatment  	 NNP	O
of  	of  	 IN	O
Acute  	Acute  	 NNP	B-NP
Maxillary  	Maxillary  	 NNP	I-NP
Sinusitis  	Sinusitis  	 NNP	I-NP
in  	in  	 IN	O
Rabbits 	Rabbits 	 NNP	O
.  	.  	 .	O
Acta  	Acta  	 NNP	B-NP
Otolaryngol  	Otolaryngol  	 NNP	I-NP
115 	115 	 CD	O
: 	: 	 :	O
548-552  	548-552  	 CD	O
( 	( 	 -LRB-	O
1995 	1995 	 CD	O
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Although  	Although  	 IN	O
clinical  	clinical  	 JJ	B-NP
signs  	signs  	 NNS	I-NP
of  	of  	 IN	O
sinusitis  	sinusitis  	 VBG	O
improved  	improved  	 VBN	O
over  	over  	 IN	O
28  	28  	 CD	O
days 	days 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
procedure  	procedure  	 NN	O
for  	for  	 IN	O
placing  	placing  	 VBG	O
the  	the  	 DT	O
film  	film  	 NN	O
was  	was  	 VBD	O
quite  	quite  	 RB	O
invasive 	invasive 	 JJ	O
,  	,  	 ,	O
requiring  	requiring  	 VBG	O
that  	that  	 IN	O
a  	a  	 DT	O
hole  	hole  	 NN	O
be  	be  	 VB	O
drilled  	drilled  	 VBN	O
through  	through  	 IN	O
the  	the  	 DT	O
anterior  	anterior  	 JJ	O
wall  	wall  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
maxillary  	maxillary  	 JJ	B-NP
sinus 	sinus 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
less  	less  	 RBR	O
invasive  	invasive  	 JJ	B-NP
method  	method  	 NN	I-NP
of  	of  	 IN	O
placing  	placing  	 VBG	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
implant  	implant  	 NN	B-NP
into  	into  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 NN	B-NP
for  	for  	 IN	O
the  	the  	 DT	O
local  	local  	 JJ	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
sinusitis  	sinusitis  	 NN	O
is  	is  	 VBZ	O
described  	described  	 VBN	O
in  	in  	 IN	O
commonly  	commonly  	 RB	O
owned  	owned  	 VBN	O
U.S.  	U.S.  	 NNP	O
Publication  	Publication  	 NNP	O
No.  	No.  	 NNP	O
2005 	2005 	 CD	O
/ 	/ 	 CD	O
0043706 	0043706 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
application 	application 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
implant  	implant  	 NN	B-NP
is  	is  	 VBZ	O
generally  	generally  	 RB	O
delivered  	delivered  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
through  	through  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
has  	has  	 VBZ	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
characteristic  	characteristic  	 NN	O
that  	that  	 WDT	O
substantially  	substantially  	 RB	O
prevents  	prevents  	 VBZ	O
its  	its  	 PRP$	O
clearance  	clearance  	 NN	O
by  	by  	 IN	O
the  	the  	 DT	O
mucociliary  	mucociliary  	 JJ	B-NP
transport  	transport  	 NN	I-NP
system 	system 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
implant  	implant  	 NN	B-NP
is  	is  	 VBZ	O
typically  	typically  	 RB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
possess  	possess  	 VB	O
a  	a  	 DT	O
mucoadhesiveness  	mucoadhesiveness  	 NN	B-NP
that  	that  	 WDT	O
substantially  	substantially  	 RB	O
prevents  	prevents  	 VBZ	O
implant  	implant  	 JJ	B-NP
clearance  	clearance  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
A  	A  	 DT	O
mucoadhesive  	mucoadhesive  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
is  	is  	 VBZ	O
incorporated  	incorporated  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
implant  	implant  	 NN	B-NP
to  	to  	 TO	O
make  	make  	 VB	O
it  	it  	 PRP	O
mucoadhesive 	mucoadhesive 	 VBD	O
.  	.  	 .	O
Mucoadhesive  	Mucoadhesive  	 JJ	B-NP
polymers  	polymers  	 NNS	I-NP
are  	are  	 VBP	O
usually  	usually  	 RB	O
hydrophilic 	hydrophilic 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
upon  	upon  	 IN	O
moistening 	moistening 	 NN	O
,  	,  	 ,	O
absorb  	absorb  	 JJ	O
water  	water  	 NN	O
to  	to  	 TO	O
swell  	swell  	 VB	O
and  	and  	 CC	O
become  	become  	 VB	O
adhesive 	adhesive 	 NN	B-NP
.  	.  	 .	O
This  	This  	 DT	O
implant  	implant  	 NN	B-NP
lacks  	lacks  	 VBZ	O
a  	a  	 DT	O
structural  	structural  	 JJ	B-NP
component  	component  	 NN	I-NP
that  	that  	 WDT	O
physically  	physically  	 RB	O
maintains  	maintains  	 VBZ	O
patency  	patency  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
Consequently 	Consequently 	 RB	O
,  	,  	 ,	O
new  	new  	 JJ	O
devices  	devices  	 NNS	O
for  	for  	 IN	O
locally  	locally  	 RB	O
administering  	administering  	 JJ	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinuses  	sinuses  	 NN	I-NP
for  	for  	 IN	O
treating  	treating  	 VBG	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
conditions 	conditions 	 NNS	I-NP
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
sinus  	sinus  	 FW	B-NP
inflammation  	inflammation  	 FW	I-NP
( 	( 	 -LRB-	O
including 	including 	 VBG	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
rhinosinusitis  	rhinosinusitis  	 NN	B-NP
and  	and  	 CC	O
sinus  	sinus  	 JJ	B-NP
procedures 	procedures 	 NNS	I-NP
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
FESS 	FESS 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
for  	for  	 IN	O
maintaining  	maintaining  	 VBG	B-NP
patency  	patency  	 NN	I-NP
of  	of  	 IN	I-NP
sinus  	sinus  	 JJ	I-NP
ostia 	ostia 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
methods  	methods  	 NNS	O
for  	for  	 IN	O
delivering  	delivering  	 VBG	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NNS	I-NP
are  	are  	 VBP	O
desirable 	desirable 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
devices 	devices 	 NNS	O
,  	,  	 ,	O
systems 	systems 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
methods  	methods  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
invention  	invention  	 NNS	O
are  	are  	 VBP	O
generally  	generally  	 RB	O
used  	used  	 VBN	O
to  	to  	 TO	O
treat  	treat  	 VB	O
patients  	patients  	 NNS	O
having  	having  	 VBG	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition 	condition 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
to  	to  	 TO	O
be  	be  	 VB	O
treated  	treated  	 VBN	O
is  	is  	 VBZ	O
typically  	typically  	 RB	O
postoperative  	postoperative  	 FW	B-NP
paranasal  	paranasal  	 FW	I-NP
sinus  	sinus  	 FW	I-NP
inflammation  	inflammation  	 FW	I-NP
due  	due  	 JJ	O
to  	to  	 TO	O
functional  	functional  	 VB	B-NP
endoscopic  	endoscopic  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
surgery  	surgery  	 NN	I-NP
( 	( 	 -LRB-	O
FESS 	FESS 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
sinusitis 	sinusitis 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
also  	also  	 RB	O
includes  	includes  	 VBZ	O
conditions  	conditions  	 NNS	O
such  	such  	 JJ	O
as 	as 	 RB	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
acute  	acute  	 JJ	B-NP
sinusitis 	sinusitis 	 NN	I-NP
,  	,  	 ,	O
chronic  	chronic  	 JJ	B-NP
sinusitis 	sinusitis 	 NN	I-NP
,  	,  	 ,	O
allergic  	allergic  	 JJ	B-NP
rhinitis 	rhinitis 	 NN	I-NP
,  	,  	 ,	O
rhinosinusitis 	rhinosinusitis 	 NN	B-NP
,  	,  	 ,	O
sinusitis  	sinusitis  	 VBG	O
that  	that  	 DT	O
recurs  	recurs  	 NN	O
after  	after  	 IN	O
FESS 	FESS 	 NNP	B-NP
,  	,  	 ,	O
upper  	upper  	 JJ	O
respiratory  	respiratory  	 JJ	B-NP
tract  	tract  	 NN	I-NP
infections 	infections 	 NNS	I-NP
,  	,  	 ,	O
otitis  	otitis  	 JJ	B-NP
media 	media 	 NNS	I-NP
,  	,  	 ,	O
bronchitis 	bronchitis 	 NN	O
,  	,  	 ,	O
bronchiolitis 	bronchiolitis 	 NN	B-NP
,  	,  	 ,	O
asthma 	asthma 	 NN	B-NP
,  	,  	 ,	O
tonsillitis  	tonsillitis  	 NN	O
and  	and  	 CC	O
other  	other  	 JJ	O
chronic  	chronic  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
tonsils  	tonsils  	 NN	O
and  	and  	 CC	O
adenoids 	adenoids 	 NN	B-NP
,  	,  	 ,	O
laryngitis 	laryngitis 	 NN	O
,  	,  	 ,	O
tracheitis 	tracheitis 	 NN	B-NP
,  	,  	 ,	O
nasal  	nasal  	 NN	B-NP
and  	and  	 CC	O
sinus  	sinus  	 JJ	B-NP
polyposis 	polyposis 	 NN	I-NP
,  	,  	 ,	O
neoplasms  	neoplasms  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
large  	large  	 JJ	O
and  	and  	 CC	O
small  	small  	 JJ	O
airways 	airways 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
nasal 	nasal 	 NN	B-NP
,  	,  	 ,	O
sinus 	sinus 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
nasopharynx  	nasopharynx  	 JJ	B-NP
tumors  	tumors  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
nasopharyngeal  	nasopharyngeal  	 JJ	B-NP
carcinoma 	carcinoma 	 NN	I-NP
,  	,  	 ,	O
plasmacytomas 	plasmacytomas 	 NN	B-NP
,  	,  	 ,	O
inverted  	inverted  	 JJ	O
papillomas 	papillomas 	 NN	B-NP
,  	,  	 ,	O
rhabdomyosarcomas 	rhabdomyosarcomas 	 NN	B-NP
,  	,  	 ,	O
squamous  	squamous  	 JJ	B-NP
cell  	cell  	 NN	I-NP
carcinomas 	carcinomas 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
lymphomas 	lymphomas 	 NN	B-NP
,  	,  	 ,	O
when  	when  	 WRB	O
they  	they  	 PRP	O
involve  	involve  	 VBP	O
the  	the  	 DT	O
sinuses  	sinuses  	 NN	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
passage 	passage 	 NN	I-NP
.  	.  	 .	O
As  	As  	 RB	O
used  	used  	 VBN	O
herein 	herein 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
terms  	terms  	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
paranasal  	paranasal  	 FW	B-NP
sinus  	sinus  	 FW	I-NP
inflammation 	inflammation 	 FW	I-NP
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
or  	or  	 CC	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
sinus  	sinus  	 JJ	B-NP
inflammation 	inflammation 	 NN	I-NP
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
refer  	refer  	 VBP	O
to  	to  	 TO	O
any  	any  	 DT	O
reaction  	reaction  	 NN	O
of  	of  	 IN	O
sinus  	sinus  	 JJ	B-NP
tissue 	tissue 	 NN	I-NP
,  	,  	 ,	O
sinus  	sinus  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
tissue 	tissue 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
tissue  	tissue  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
passage  	passage  	 NN	I-NP
proximate  	proximate  	 VBD	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostia  	ostia  	 NN	I-NP
that  	that  	 WDT	O
involves  	involves  	 VBZ	O
the  	the  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
response 	response 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
inflammation  	inflammation  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
processes  	processes  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
allergy  	allergy  	 NN	B-NP
( 	( 	 -LRB-	O
hypersensitivity 	hypersensitivity 	 LS	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
injury  	injury  	 NN	B-NP
to  	to  	 TO	O
sinus  	sinus  	 VB	O
mucosa  	mucosa  	 JJ	O
due  	due  	 JJ	O
to 	to 	 TO	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
trauma 	trauma 	 NN	O
;  	;  	 :	O
surgery 	surgery 	 NN	O
;  	;  	 :	O
infection  	infection  	 NN	B-NP
by  	by  	 IN	O
bacteria 	bacteria 	 NNS	O
,  	,  	 ,	O
viruses 	viruses 	 NN	O
,  	,  	 ,	O
fungi 	fungi 	 NNS	B-NP
,  	,  	 ,	O
chemicals 	chemicals 	 NNS	O
,  	,  	 ,	O
or  	or  	 CC	O
drugs 	drugs 	 NNS	O
;  	;  	 :	O
and  	and  	 CC	O
benign  	benign  	 JJ	O
or  	or  	 CC	O
malignant  	malignant  	 JJ	B-NP
tumors 	tumors 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
are  	are  	 VBP	O
formed  	formed  	 VBN	O
in  	in  	 IN	O
such  	such  	 PDT	O
a  	a  	 DT	O
way  	way  	 NN	O
to  	to  	 TO	O
locally  	locally  	 RB	O
deliver  	deliver  	 VB	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
,  	,  	 ,	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
passage  	passage  	 NN	I-NP
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
one  	one  	 CD	O
week  	week  	 NN	B-NP
to  	to  	 TO	O
treat  	treat  	 VB	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition 	condition 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
described  	described  	 JJ	O
devices  	devices  	 NNS	O
are  	are  	 VBP	O
useful  	useful  	 JJ	O
in  	in  	 IN	O
surgical 	surgical 	 JJ	O
,  	,  	 ,	O
non-surgical 	non-surgical 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
other  	other  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
interventions  	interventions  	 NNS	I-NP
related  	related  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinuses  	sinuses  	 NN	I-NP
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
passages  	passages  	 NNS	I-NP
to  	to  	 TO	O
restore  	restore  	 VB	O
anatomical  	anatomical  	 JJ	B-NP
function  	function  	 NN	I-NP
and  	and  	 CC	O
treat  	treat  	 VB	O
any  	any  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
aforementioned  	aforementioned  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
Accordingly 	Accordingly 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
support  	support  	 VB	O
sinus  	sinus  	 NNS	B-NP
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
surgery 	surgery 	 NN	I-NP
,  	,  	 ,	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
need  	need  	 NN	O
for  	for  	 IN	O
surgical  	surgical  	 JJ	B-NP
revision 	revision 	 NN	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
prevent 	prevent 	 VB	O
,  	,  	 ,	O
delay 	delay 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
reduce  	reduce  	 VB	O
recurrence  	recurrence  	 VBN	O
of  	of  	 IN	O
rhinosinusitis 	rhinosinusitis 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
conditions  	conditions  	 NNS	I-NP
may  	may  	 MD	O
include  	include  	 VB	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
that  	that  	 WDT	O
has  	has  	 VBZ	O
a  	a  	 DT	O
first  	first  	 JJ	O
collapsed  	collapsed  	 JJ	O
configuration  	configuration  	 NN	B-NP
that  	that  	 WDT	O
permits  	permits  	 VBZ	O
the  	the  	 DT	O
device  	device  	 NN	O
to  	to  	 TO	O
pass  	pass  	 VB	O
through  	through  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium  	ostium  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
second  	second  	 JJ	O
expanded  	expanded  	 JJ	O
configuration  	configuration  	 NN	B-NP
after  	after  	 IN	O
placement  	placement  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
As  	As  	 RB	O
used  	used  	 VBN	O
herein 	herein 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
terms  	terms  	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
expand 	expand 	 VB	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
; 	; 	 :	O
,  	,  	 ,	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
expansion 	expansion 	 NN	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
; 	; 	 :	O
,  	,  	 ,	O
or  	or  	 CC	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
expanding 	expanding 	 VBG	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
; 	; 	 :	O
,  	,  	 ,	O
refer  	refer  	 VBP	O
to  	to  	 TO	O
a  	a  	 DT	O
device  	device  	 NN	O
that  	that  	 IN	O
undergoes  	undergoes  	 JJ	B-NP
physical  	physical  	 JJ	I-NP
expansion 	expansion 	 NN	I-NP
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
from  	from  	 IN	O
a  	a  	 DT	O
compressed  	compressed  	 NN	O
to  	to  	 TO	O
an  	an  	 DT	O
expanded  	expanded  	 JJ	O
state 	state 	 NN	O
,  	,  	 ,	O
not  	not  	 RB	O
expansion  	expansion  	 JJ	O
due  	due  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
absorption  	absorption  	 NN	O
of  	of  	 IN	O
water 	water 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
their  	their  	 PRP$	O
expanded  	expanded  	 JJ	O
configuration 	configuration 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
in  	in  	 IN	O
some  	some  	 DT	O
variations  	variations  	 NNS	O
have  	have  	 VBP	O
a  	a  	 DT	O
surface  	surface  	 NN	O
area  	area  	 NN	O
to  	to  	 TO	O
volume  	volume  	 NN	B-NP
ratio  	ratio  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
substantially  	substantially  	 RB	O
unchanged  	unchanged  	 JJ	O
from  	from  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
in  	in  	 IN	O
their  	their  	 PRP$	O
collapsed  	collapsed  	 JJ	O
configuration 	configuration 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
upon  	upon  	 IN	O
expansion 	expansion 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
also  	also  	 RB	O
at  	at  	 IN	O
least  	least  	 JJS	O
partially  	partially  	 RB	O
conforms  	conforms  	 VBZ	O
to  	to  	 TO	O
the  	the  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
and  	and  	 CC	O
substantially  	substantially  	 RB	O
contacts  	contacts  	 VB	O
the  	the  	 DT	O
mucosa  	mucosa  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
sinus  	sinus  	 JJ	I-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
any  	any  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material 	material 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
they  	they  	 PRP	O
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
various  	various  	 JJ	O
metals  	metals  	 NNS	O
and  	and  	 CC	O
their  	their  	 PRP$	O
alloys 	alloys 	 NNS	O
,  	,  	 ,	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymers 	polymers 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
addition  	addition  	 NN	O
to  	to  	 TO	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
include  	include  	 VB	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
and  	and  	 CC	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
reside  	reside  	 VB	O
within  	within  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
attached  	attached  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
end  	end  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
ostial  	ostial  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
is  	is  	 VBZ	O
attached  	attached  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	B-NP
end  	end  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
lies  	lies  	 VBZ	O
within  	within  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
passage 	passage 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
incorporated  	incorporated  	 VBN	O
into  	into  	 IN	O
all  	all  	 DT	O
portions  	portions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
or  	or  	 CC	O
only  	only  	 RB	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
expandable  	expandable  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
aspect 	aspect 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
aspect 	aspect 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
yet  	yet  	 RB	O
a  	a  	 DT	O
further  	further  	 JJ	O
aspect 	aspect 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
may  	may  	 MD	O
contain  	contain  	 VB	O
and  	and  	 CC	O
deliver  	deliver  	 VB	O
the  	the  	 DT	O
same  	same  	 JJ	O
or  	or  	 CC	O
different  	different  	 JJ	O
active  	active  	 JJ	O
agents 	agents 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
may  	may  	 MD	O
deliver  	deliver  	 VB	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent 	agent 	 NN	B-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
over  	over  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
one  	one  	 CD	O
week 	week 	 NN	B-NP
,  	,  	 ,	O
over  	over  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
two  	two  	 CD	O
weeks 	weeks 	 NNS	O
,  	,  	 ,	O
over  	over  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
three  	three  	 CD	O
weeks 	weeks 	 NNS	O
,  	,  	 ,	O
over  	over  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
one  	one  	 CD	O
month 	month 	 NN	O
,  	,  	 ,	O
over  	over  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
two  	two  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
over  	over  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
three  	three  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
over  	over  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
four  	four  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
over  	over  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
five  	five  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
or  	or  	 CC	O
over  	over  	 RB	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
six  	six  	 CD	O
months  	months  	 NNS	O
or  	or  	 CC	O
more 	more 	 JJR	O
.  	.  	 .	O
Typically 	Typically 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
delivered  	delivered  	 VBN	O
over  	over  	 RP	O
about  	about  	 IN	O
four  	four  	 CD	O
weeks 	weeks 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
polymeric  	polymeric  	 JJ	B-NP
pliable  	pliable  	 JJ	I-NP
filaments 	filaments 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
that  	that  	 WDT	O
resemble  	resemble  	 VBP	O
a  	a  	 DT	O
fringed  	fringed  	 JJ	O
structure 	structure 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
flexible  	flexible  	 JJ	O
mesh 	mesh 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
whisk-like  	whisk-like  	 JJ	B-NP
structure 	structure 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like 	like 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
expandable 	expandable 	 NNS	B-NP
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
self-expand 	self-expand 	 JJ	O
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
expand  	expand  	 VBP	O
after  	after  	 IN	O
application  	application  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
expansive  	expansive  	 JJ	O
or  	or  	 CC	O
mechanical  	mechanical  	 JJ	B-NP
force 	force 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
expand  	expand  	 VB	O
after  	after  	 IN	O
balloon  	balloon  	 NN	B-NP
inflation 	inflation 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
instances 	instances 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
expand  	expand  	 VBP	O
to  	to  	 TO	O
substantially  	substantially  	 RB	O
contact  	contact  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
after  	after  	 IN	O
deployment  	deployment  	 NN	O
within  	within  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
Contact  	Contact  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
verified  	verified  	 VBN	O
by  	by  	 IN	O
incorporation  	incorporation  	 NN	B-NP
of  	of  	 IN	I-NP
radiopaque  	radiopaque  	 JJ	I-NP
markers  	markers  	 NN	I-NP
on  	on  	 IN	O
or  	or  	 CC	O
within  	within  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
members 	members 	 NNS	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
visualization  	visualization  	 VBP	B-NP
using  	using  	 VBG	O
endoscopy  	endoscopy  	 NNS	B-NP
or  	or  	 CC	O
other  	other  	 JJ	O
imaging  	imaging  	 NN	O
modalities 	modalities 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filament 	filament 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
may  	may  	 MD	O
contain  	contain  	 VB	O
a  	a  	 DT	O
plasticizer  	plasticizer  	 NN	B-NP
or  	or  	 CC	O
a  	a  	 DT	O
solvent  	solvent  	 NN	B-NP
which  	which  	 WDT	O
softens  	softens  	 VBZ	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
.  	.  	 .	O
Balloon  	Balloon  	 NN	B-NP
inflation  	inflation  	 NN	I-NP
or  	or  	 CC	O
other  	other  	 JJ	O
mechanical  	mechanical  	 JJ	B-NP
types  	types  	 NNS	I-NP
of  	of  	 IN	O
expansion  	expansion  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
expand  	expand  	 VB	O
variations  	variations  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
plasticized  	plasticized  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
member  	member  	 NN	I-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
not  	not  	 RB	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
self-expand 	self-expand 	 JJ	O
.  	.  	 .	O
Upon  	Upon  	 IN	O
contact  	contact  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
plasticized  	plasticized  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
member  	member  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
mucosal  	mucosal  	 JJ	B-NP
tissue 	tissue 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
plasticizer  	plasticizer  	 NN	B-NP
diffuses  	diffuses  	 VBD	O
out  	out  	 RP	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
plasticizer  	plasticizer  	 JJ	B-NP
diffusion  	diffusion  	 NNS	I-NP
hardens  	hardens  	 VBP	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
in  	in  	 IN	O
such  	such  	 PDT	O
a  	a  	 DT	O
way  	way  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
substantially  	substantially  	 RB	O
conforms  	conforms  	 VBZ	O
to  	to  	 TO	O
the  	the  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
As  	As  	 IN	O
an  	an  	 DT	O
example 	example 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
filament  	filament  	 NN	B-NP
made  	made  	 VBN	O
from  	from  	 IN	O
lactide 	lactide 	 FW	B-NP
/ 	/ 	 FW	I-NP
glycolide  	glycolide  	 FW	I-NP
polymer  	polymer  	 FW	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
plasticized  	plasticized  	 VBN	O
with  	with  	 IN	O
materials  	materials  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
triethyl  	triethyl  	 JJ	B-NP
citrate 	citrate 	 NN	I-NP
,  	,  	 ,	O
acetone  	acetone  	 NN	B-NP
and  	and  	 CC	O
other  	other  	 JJ	O
ketones 	ketones 	 NN	B-NP
,  	,  	 ,	O
ethanol  	ethanol  	 NN	B-NP
and  	and  	 CC	O
other  	other  	 JJ	O
alcohols 	alcohols 	 NN	O
,  	,  	 ,	O
N-methylpyrrolidone 	N-methylpyrrolidone 	 NNP	B-NP
,  	,  	 ,	O
ethyl  	ethyl  	 JJ	B-NP
acetate  	acetate  	 NN	I-NP
and  	and  	 CC	O
mixtures  	mixtures  	 JJ	O
thereof 	thereof 	 NN	O
.  	.  	 .	O
Upon  	Upon  	 IN	O
placement  	placement  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
filament  	filament  	 NN	B-NP
into  	into  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
plasticizer 	plasticizer 	 NN	B-NP
,  	,  	 ,	O
triethyl  	triethyl  	 JJ	B-NP
citrate 	citrate 	 NN	I-NP
,  	,  	 ,	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
diffuses  	diffuses  	 VBG	O
out  	out  	 RP	O
of  	of  	 IN	O
the  	the  	 DT	O
filament  	filament  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
to  	to  	 TO	O
result  	result  	 VB	O
in  	in  	 IN	O
a  	a  	 DT	O
hardened  	hardened  	 JJ	O
filament  	filament  	 NN	B-NP
that  	that  	 WDT	O
substantially  	substantially  	 RB	O
conforms  	conforms  	 VBZ	O
to  	to  	 TO	O
the  	the  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
described  	described  	 VBD	O
here  	here  	 RB	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
may  	may  	 MD	O
include  	include  	 VB	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
dispersed  	dispersed  	 NN	I-NP
within  	within  	 IN	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 JJ	B-NP
matrix 	matrix 	 NN	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
which  	which  	 WDT	O
the  	the  	 DT	O
device  	device  	 NN	O
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
optionally  	optionally  	 VBG	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
exhibits  	exhibits  	 VBZ	O
an  	an  	 DT	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
cumulative  	cumulative  	 JJ	I-NP
release  	release  	 NN	I-NP
profile  	profile  	 NN	I-NP
in  	in  	 IN	O
which  	which  	 WDT	O
a  	a  	 DT	O
therapeutically  	therapeutically  	 JJ	O
effective  	effective  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
said  	said  	 VBD	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
maintained  	maintained  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
4  	4  	 CD	O
days 	days 	 NNS	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
14  	14  	 CD	O
days 	days 	 NNS	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
25  	25  	 CD	O
days 	days 	 NNS	O
,  	,  	 ,	O
or  	or  	 CC	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
35  	35  	 CD	O
days  	days  	 NNS	O
after  	after  	 IN	O
implantation  	implantation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
delivered  	delivered  	 VBN	O
into  	into  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 NN	B-NP
using  	using  	 VBG	O
inserters  	inserters  	 NN	B-NP
of  	of  	 IN	O
various  	various  	 JJ	O
designs 	designs 	 NNS	O
.  	.  	 .	O
Typical  	Typical  	 JJ	B-NP
inserters  	inserters  	 NNS	I-NP
include  	include  	 VBP	O
a  	a  	 DT	O
conduit 	conduit 	 NN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
a  	a  	 DT	O
catheter 	catheter 	 NN	B-NP
,  	,  	 ,	O
needle 	needle 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
angiocatheter 	angiocatheter 	 NN	B-NP
,  	,  	 ,	O
having  	having  	 VBG	O
a  	a  	 DT	O
lumen 	lumen 	 NN	B-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
conduit  	conduit  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
such  	such  	 JJ	O
that  	that  	 IN	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
variable  	variable  	 JJ	O
stiffness  	stiffness  	 NN	O
along  	along  	 IN	O
its  	its  	 PRP$	O
length 	length 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
conduit  	conduit  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
pre-angulated  	pre-angulated  	 JJ	B-NP
to  	to  	 TO	O
facilitate  	facilitate  	 VB	O
access  	access  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
made  	made  	 VBD	O
such  	such  	 JJ	O
that  	that  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
is  	is  	 VBZ	O
malleable  	malleable  	 JJ	O
such  	such  	 JJ	O
that  	that  	 IN	O
the  	the  	 DT	O
physician  	physician  	 NN	O
may  	may  	 MD	O
angulate  	angulate  	 VB	O
the  	the  	 DT	O
conduit  	conduit  	 NN	O
prior  	prior  	 RB	O
to  	to  	 TO	O
accessing  	accessing  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
and  	and  	 CC	O
inserters  	inserters  	 NN	B-NP
for  	for  	 IN	O
their  	their  	 PRP$	O
deployment  	deployment  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
system  	system  	 NN	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition 	condition 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
general 	general 	 JJ	O
,  	,  	 ,	O
the  	the  	 DT	O
system  	system  	 NN	B-NP
works  	works  	 NNS	I-NP
by  	by  	 IN	O
first  	first  	 JJ	O
placing  	placing  	 VBG	O
the  	the  	 DT	O
inserter  	inserter  	 NN	B-NP
having  	having  	 VBG	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
devices  	devices  	 NNS	O
in  	in  	 IN	O
a  	a  	 DT	O
collapsed 	collapsed 	 JJ	O
,  	,  	 ,	O
folded 	folded 	 VBD	O
,  	,  	 ,	O
or  	or  	 CC	O
constrained  	constrained  	 JJ	O
configuration  	configuration  	 NN	B-NP
within  	within  	 IN	O
or  	or  	 CC	O
carried  	carried  	 VBN	O
on  	on  	 IN	O
its  	its  	 PRP$	O
distal  	distal  	 JJ	B-NP
end  	end  	 NN	I-NP
through  	through  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
Once  	Once  	 RB	O
within  	within  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
device  	device  	 NN	I-NP
transitions  	transitions  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
collapsed 	collapsed 	 NN	O
,  	,  	 ,	O
folded 	folded 	 VBD	O
,  	,  	 ,	O
or  	or  	 CC	O
constrained  	constrained  	 JJ	O
configuration  	configuration  	 NN	B-NP
to  	to  	 TO	O
a  	a  	 DT	O
second  	second  	 JJ	O
expanded  	expanded  	 JJ	O
configuration 	configuration 	 NN	B-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
sheath  	sheath  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
retracted  	retracted  	 VBN	O
to  	to  	 TO	O
slidably  	slidably  	 VB	O
deploy  	deploy  	 VBN	O
a  	a  	 DT	O
self-expanding  	self-expanding  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
that  	that  	 IN	O
contacts  	contacts  	 NNS	O
a  	a  	 DT	O
substantial  	substantial  	 JJ	O
portion  	portion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall 	wall 	 NN	I-NP
.  	.  	 .	O
Balloon  	Balloon  	 NN	B-NP
inflation  	inflation  	 NN	I-NP
or  	or  	 CC	O
other  	other  	 JJ	O
mechanical  	mechanical  	 JJ	B-NP
types  	types  	 NNS	I-NP
of  	of  	 IN	O
expansion  	expansion  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
expand  	expand  	 VB	O
variations  	variations  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
not  	not  	 RB	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
self-expand 	self-expand 	 JJ	O
.  	.  	 .	O
FIG.  	FIG.  	 CD	O
1  	1  	 CD	O
is  	is  	 VBZ	O
a  	a  	 DT	O
cross-sectional  	cross-sectional  	 JJ	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
maxillary  	maxillary  	 NN	I-NP
and  	and  	 CC	O
frontal  	frontal  	 JJ	B-NP
sinus 	sinus 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
2A-2M  	2A-2M  	 NNP	O
are  	are  	 VBP	O
transverse  	transverse  	 JJ	B-NP
cross-sectional  	cross-sectional  	 JJ	I-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	O
various  	various  	 JJ	O
pliable  	pliable  	 JJ	O
filaments 	filaments 	 NN	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
3A  	3A  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
cross-sectional  	cross-sectional  	 JJ	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
maxillary  	maxillary  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
having  	having  	 VBG	O
a  	a  	 DT	O
fringed  	fringed  	 JJ	O
structure  	structure  	 NN	O
according  	according  	 VBG	O
to  	to  	 TO	O
one  	one  	 CD	O
variation  	variation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
invention 	invention 	 NN	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
3B  	3B  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
cross-sectional  	cross-sectional  	 JJ	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
of  	of  	 IN	O
FIG.  	FIG.  	 CD	O
3A  	3A  	 CD	O
in  	in  	 IN	O
a  	a  	 DT	O
maxillary  	maxillary  	 JJ	B-NP
sinus 	sinus 	 NN	I-NP
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
4A  	4A  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
cross-sectional  	cross-sectional  	 JJ	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
frontal  	frontal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
having  	having  	 VBG	O
a  	a  	 DT	O
fringed  	fringed  	 JJ	O
structure  	structure  	 NN	O
according  	according  	 VBG	O
to  	to  	 TO	O
another  	another  	 DT	O
variation  	variation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
invention 	invention 	 NN	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
4B  	4B  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
cross-sectional  	cross-sectional  	 JJ	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
of  	of  	 IN	O
FIG.  	FIG.  	 CD	O
4A  	4A  	 CD	O
in  	in  	 IN	O
a  	a  	 DT	O
frontal  	frontal  	 JJ	B-NP
sinus 	sinus 	 NN	I-NP
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
5A  	5A  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
side  	side  	 NN	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
including  	including  	 VBG	O
an  	an  	 DT	O
expandable  	expandable  	 JJ	B-NP
mesh  	mesh  	 NN	I-NP
according  	according  	 VBG	O
to  	to  	 TO	O
another  	another  	 DT	O
variation  	variation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
invention 	invention 	 NN	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
5B  	5B  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
side  	side  	 NN	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
of  	of  	 IN	O
FIG.  	FIG.  	 CD	O
5A  	5A  	 CD	O
prior  	prior  	 JJ	O
to  	to  	 TO	O
expansion 	expansion 	 NN	O
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
6A-6F  	6A-6F  	 NNP	O
are  	are  	 VBP	O
side  	side  	 JJ	B-NP
cross-sectional  	cross-sectional  	 JJ	I-NP
view  	view  	 NN	I-NP
of  	of  	 IN	O
various  	various  	 JJ	O
filament  	filament  	 JJ	B-NP
anchoring  	anchoring  	 JJ	I-NP
mechanisms 	mechanisms 	 NNS	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
7A-7R  	7A-7R  	 NNP	O
are  	are  	 VBP	O
perspective  	perspective  	 JJ	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	O
various  	various  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
configurations 	configurations 	 NNS	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
8A-8C  	8A-8C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
coil-like  	coil-like  	 JJ	I-NP
ostial  	ostial  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
9A-9C  	9A-9C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
accordion-like  	accordion-like  	 JJ	I-NP
ostial  	ostial  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
10A-10C  	10A-10C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
mesh-like  	mesh-like  	 JJ	I-NP
ostial  	ostial  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
11A-11C  	11A-11C  	 NNP	O
depict  	depict  	 JJ	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
star-like  	star-like  	 JJ	I-NP
ostial  	ostial  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
12A-12C  	12A-12C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
hexagonal  	hexagonal  	 JJ	I-NP
shaped  	shaped  	 JJ	I-NP
ostial  	ostial  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
13A-13C  	13A-13C  	 NNP	O
depict  	depict  	 JJ	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	O
a  	a  	 DT	O
furled  	furled  	 JJ	O
sheet-like  	sheet-like  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
14A-14C  	14A-14C  	 NNP	O
depict  	depict  	 JJ	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
tubular  	tubular  	 JJ	I-NP
ostial  	ostial  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
15A-15C  	15A-15C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
pliable  	pliable  	 JJ	O
filaments 	filaments 	 NN	O
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
16A-16C  	16A-16C  	 NNP	O
depict  	depict  	 JJ	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
pliable  	pliable  	 JJ	O
ribbon-like  	ribbon-like  	 JJ	B-NP
or  	or  	 CC	O
strip-like  	strip-like  	 JJ	B-NP
filaments 	filaments 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
17A-17C  	17A-17C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
configured  	configured  	 NN	I-NP
as  	as  	 IN	O
an  	an  	 DT	O
expandable  	expandable  	 JJ	B-NP
pleated  	pleated  	 JJ	I-NP
tube 	tube 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
18A-18C  	18A-18C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
made  	made  	 VBN	O
from  	from  	 IN	O
gel  	gel  	 JJ	B-NP
foam 	foam 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
19A-19C  	19A-19C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
ostial 	ostial 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
cylindrical  	cylindrical  	 JJ	I-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
having  	having  	 VBG	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
lumens 	lumens 	 NN	B-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
20A-20F  	20A-20F  	 NNP	O
illustrate  	illustrate  	 VBP	O
various  	various  	 JJ	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
configurations 	configurations 	 NNS	I-NP
.  	.  	 .	O
FIG.  	FIG.  	 CD	O
21  	21  	 CD	O
depicts  	depicts  	 VBZ	O
a  	a  	 DT	O
perspective  	perspective  	 NN	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	O
an  	an  	 DT	O
exemplary  	exemplary  	 JJ	B-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device 	device 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
22A-22C  	22A-22C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
side  	side  	 NN	B-NP
cross-sectional 	cross-sectional 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
having  	having  	 VBG	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
formed  	formed  	 VBN	O
from  	from  	 IN	O
multiple  	multiple  	 JJ	O
loops  	loops  	 NNS	O
of  	of  	 IN	O
pliable  	pliable  	 JJ	O
filaments 	filaments 	 NN	O
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
23A-23C  	23A-23C  	 NNP	O
show  	show  	 NN	O
perspective 	perspective 	 NN	O
,  	,  	 ,	O
side  	side  	 NN	B-NP
cross-sectional 	cross-sectional 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
views  	views  	 NNS	I-NP
of  	of  	 IN	I-NP
a  	a  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
having  	having  	 VBG	O
a  	a  	 DT	O
looped  	looped  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
plate 	plate 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
24A-24F  	24A-24F  	 NNP	O
show  	show  	 VBP	O
exemplary  	exemplary  	 JJ	B-NP
drug  	drug  	 NN	I-NP
release  	release  	 NN	I-NP
curves  	curves  	 NN	I-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
devices 	devices 	 NNS	I-NP
.  	.  	 .	O
FIG.  	FIG.  	 CD	O
25  	25  	 CD	O
is  	is  	 VBZ	O
a  	a  	 DT	O
graph  	graph  	 NN	O
showing  	showing  	 VBG	O
cumulative  	cumulative  	 JJ	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
release  	release  	 NN	I-NP
of  	of  	 IN	I-NP
mometasone  	mometasone  	 JJ	I-NP
furoate  	furoate  	 NN	I-NP
from  	from  	 IN	O
various  	various  	 JJ	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
over  	over  	 IN	O
a  	a  	 DT	O
30-day  	30-day  	 JJ	O
time  	time  	 NN	B-NP
period 	period 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
invention  	invention  	 NN	O
may  	may  	 MD	O
take  	take  	 VB	O
various  	various  	 JJ	O
forms 	forms 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
some  	some  	 DT	O
are  	are  	 VBP	O
designed  	designed  	 VBN	O
to  	to  	 TO	O
include  	include  	 VB	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
deliver  	deliver  	 VB	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
conditions 	conditions 	 NNS	I-NP
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
sinus  	sinus  	 JJ	B-NP
inflammation 	inflammation 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
have  	have  	 VB	O
a  	a  	 DT	O
first  	first  	 JJ	O
collapsed  	collapsed  	 JJ	O
configuration  	configuration  	 NN	B-NP
that  	that  	 WDT	O
permits  	permits  	 VBZ	O
it  	it  	 PRP	O
to  	to  	 TO	O
be  	be  	 VB	O
inserted  	inserted  	 VBN	O
through  	through  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium  	ostium  	 NN	I-NP
or  	or  	 CC	O
surgically  	surgically  	 RB	O
created  	created  	 VBN	B-NP
fenestration 	fenestration 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
second  	second  	 JJ	O
expanded  	expanded  	 JJ	O
configuration  	configuration  	 NN	B-NP
upon  	upon  	 IN	O
placement  	placement  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
once  	once  	 RB	O
expanded 	expanded 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
structure  	structure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
generally  	generally  	 RB	O
has  	has  	 VBZ	O
a  	a  	 DT	O
surface  	surface  	 NN	O
area  	area  	 NN	O
to  	to  	 TO	O
volume  	volume  	 NN	B-NP
ratio  	ratio  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
not  	not  	 RB	O
substantially  	substantially  	 RB	O
different  	different  	 JJ	O
from  	from  	 IN	O
the  	the  	 DT	O
surface  	surface  	 NN	O
area  	area  	 NN	O
to  	to  	 TO	O
volume  	volume  	 NN	B-NP
ratio  	ratio  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
cavity  	cavity  	 JJ	I-NP
member  	member  	 NN	I-NP
in  	in  	 IN	O
its  	its  	 PRP$	O
collapsed  	collapsed  	 JJ	O
configuration 	configuration 	 NN	B-NP
.  	.  	 .	O
This  	This  	 DT	O
may  	may  	 MD	O
be  	be  	 VB	O
important  	important  	 JJ	O
because  	because  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
source  	source  	 NN	O
of  	of  	 IN	O
water  	water  	 NN	O
needed  	needed  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
from  	from  	 IN	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device 	device 	 NN	I-NP
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
if  	if  	 IN	O
the  	the  	 DT	O
surface  	surface  	 NN	O
area  	area  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
device  	device  	 NN	O
available  	available  	 JJ	O
for  	for  	 IN	O
contacting  	contacting  	 VBG	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
is  	is  	 VBZ	O
decreased 	decreased 	 VBN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
in  	in  	 IN	O
relation  	relation  	 NN	O
to  	to  	 TO	O
its  	its  	 PRP$	O
volume 	volume 	 NN	O
,  	,  	 ,	O
dissolution  	dissolution  	 NN	O
( 	( 	 -LRB-	O
and  	and  	 CC	O
subsequent  	subsequent  	 JJ	O
absorption 	absorption 	 NN	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
should  	should  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
decreased 	decreased 	 VBN	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
once  	once  	 RB	O
expanded 	expanded 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
substantially  	substantially  	 RB	O
contact  	contact  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall 	wall 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
generally  	generally  	 RB	O
functions  	functions  	 VBN	O
to  	to  	 TO	O
position  	position  	 NN	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
anchor  	anchor  	 VB	O
the  	the  	 DT	O
device  	device  	 NN	O
at  	at  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
,  	,  	 ,	O
preventing  	preventing  	 VBG	B-NP
lateralization  	lateralization  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
middle  	middle  	 JJ	I-NP
turbinate 	turbinate 	 NN	I-NP
,  	,  	 ,	O
occlusion  	occlusion  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
middle  	middle  	 JJ	B-NP
meatus 	meatus 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
formation  	formation  	 NN	O
of  	of  	 IN	O
tissue  	tissue  	 NN	O
adhesions 	adhesions 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
located  	located  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	B-NP
end  	end  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
cavity  	cavity  	 JJ	I-NP
member  	member  	 NN	I-NP
typically  	typically  	 RB	O
functions  	functions  	 VBN	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
patency  	patency  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
as  	as  	 RB	O
further  	further  	 RB	O
described  	described  	 VBN	O
below 	below 	 RB	O
,  	,  	 ,	O
each  	each  	 DT	O
component  	component  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
may  	may  	 MD	O
have  	have  	 VB	O
various  	various  	 JJ	O
functions 	functions 	 NNS	O
,  	,  	 ,	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
factors  	factors  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
particular  	particular  	 JJ	O
structure  	structure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
and  	and  	 CC	O
whether  	whether  	 IN	O
the  	the  	 DT	O
component  	component  	 NN	O
is  	is  	 VBZ	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
releasing  	releasing  	 VBG	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent 	agent 	 NN	B-NP
.  	.  	 .	O
As  	As  	 RB	O
used  	used  	 VBN	O
herein 	herein 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
terms  	terms  	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
paranasal  	paranasal  	 JJ	B-NP
sinus 	sinus 	 NN	I-NP
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
and  	and  	 CC	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
sinus 	sinus 	 NNS	B-NP
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
are  	are  	 VBP	O
used  	used  	 VBN	O
interchangeably 	interchangeably 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
refer  	refer  	 VBP	O
to  	to  	 TO	O
all  	all  	 DT	O
sinuses 	sinuses 	 NN	O
,  	,  	 ,	O
i.e. 	i.e. 	 FW	O
,  	,  	 ,	O
the  	the  	 DT	O
maxillary 	maxillary 	 NN	B-NP
,  	,  	 ,	O
frontal 	frontal 	 NN	O
,  	,  	 ,	O
ethmoid 	ethmoid 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
sphenoidal  	sphenoidal  	 JJ	B-NP
sinuses 	sinuses 	 NN	I-NP
.  	.  	 .	O
Each  	Each  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
opens  	opens  	 VBZ	O
into  	into  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
through  	through  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
As  	As  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
1 	1 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
maxillary  	maxillary  	 JJ	B-NP
sinus  	sinus  	 NN	I-NP
10  	10  	 CD	O
opens  	opens  	 NN	O
into  	into  	 IN	O
nasal  	nasal  	 CD	B-NP
cavity  	cavity  	 CD	I-NP
12  	12  	 CD	O
at  	at  	 IN	O
maxillary  	maxillary  	 CD	B-NP
sinus  	sinus  	 CD	I-NP
ostium  	ostium  	 CD	I-NP
14 	14 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
frontal  	frontal  	 JJ	B-NP
sinus  	sinus  	 NN	I-NP
16  	16  	 CD	O
opens  	opens  	 NN	O
into  	into  	 IN	O
nasal  	nasal  	 CD	B-NP
cavity  	cavity  	 CD	I-NP
12  	12  	 CD	O
at  	at  	 IN	O
frontal  	frontal  	 CD	B-NP
sinus  	sinus  	 CD	I-NP
ostium  	ostium  	 CD	I-NP
18 	18 	 CD	O
.  	.  	 .	O
As  	As  	 RB	O
used  	used  	 VBN	O
herein 	herein 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
terms  	terms  	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
treat 	treat 	 VB	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
; 	; 	 :	O
,  	,  	 ,	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
treating 	treating 	 VBG	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
; 	; 	 :	O
,  	,  	 ,	O
or  	or  	 CC	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
treatment 	treatment 	 NN	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
refer  	refer  	 VBP	O
to  	to  	 TO	O
the  	the  	 DT	O
resolution 	resolution 	 NN	O
,  	,  	 ,	O
reduction 	reduction 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
or  	or  	 CC	O
its  	its  	 PRP$	O
symptoms 	symptoms 	 NNS	B-NP
,  	,  	 ,	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
complications  	complications  	 JJ	B-NP
attributable  	attributable  	 JJ	O
to  	to  	 TO	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition 	condition 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
provision  	provision  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
beneficial  	beneficial  	 JJ	O
substance 	substance 	 NN	O
,  	,  	 ,	O
to  	to  	 TO	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus 	sinus 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
beneficial  	beneficial  	 JJ	O
substance  	substance  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
promote  	promote  	 VB	O
general  	general  	 JJ	O
health  	health  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
Once  	Once  	 RB	O
expanded 	expanded 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
conform  	conform  	 VB	O
at  	at  	 IN	O
least  	least  	 JJS	O
partly  	partly  	 RB	O
to  	to  	 TO	O
the  	the  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
and  	and  	 CC	O
substantially  	substantially  	 RB	O
contact  	contact  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall 	wall 	 NN	I-NP
.  	.  	 .	O
By  	By  	 IN	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
substantially  	substantially  	 RB	O
contact 	contact 	 VB	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
meant  	meant  	 VBN	O
the  	the  	 DT	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
surface  	surface  	 NN	O
area  	area  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
generally  	generally  	 RB	O
required  	required  	 VBN	O
to  	to  	 TO	O
contact  	contact  	 VB	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
( 	( 	 -LRB-	O
sinus  	sinus  	 FW	B-NP
mucosa 	mucosa 	 FW	I-NP
)  	)  	 -RRB-	O
that  	that  	 WDT	O
provides  	provides  	 VBZ	O
the  	the  	 DT	O
appropriate  	appropriate  	 JJ	O
release  	release  	 NN	B-NP
kinetics  	kinetics  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
throughout  	throughout  	 IN	O
a  	a  	 DT	O
treatment  	treatment  	 NN	B-NP
period 	period 	 NN	I-NP
,  	,  	 ,	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
week 	week 	 NN	B-NP
,  	,  	 ,	O
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
two  	two  	 CD	O
weeks 	weeks 	 NNS	O
,  	,  	 ,	O
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
three  	three  	 CD	O
weeks 	weeks 	 NNS	O
,  	,  	 ,	O
or  	or  	 CC	O
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
four  	four  	 CD	O
weeks  	weeks  	 NNS	O
or  	or  	 CC	O
more 	more 	 JJR	O
.  	.  	 .	O
Accordingly 	Accordingly 	 RB	O
,  	,  	 ,	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
surface  	surface  	 NN	O
area  	area  	 NN	O
needed  	needed  	 VBN	O
for  	for  	 IN	O
contact 	contact 	 NN	O
,  	,  	 ,	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
substantial  	substantial  	 JJ	O
contact 	contact 	 NN	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
may  	may  	 MD	O
refer  	refer  	 VB	O
to  	to  	 TO	O
contact  	contact  	 VB	O
of  	of  	 IN	O
about  	about  	 IN	O
10 	10 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
100 	100 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
about  	about  	 IN	O
20 	20 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
100 	100 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
about  	about  	 IN	O
30 	30 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
100 	100 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
about  	about  	 IN	O
40 	40 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
100 	100 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
about  	about  	 IN	O
50 	50 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
100 	100 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
about  	about  	 IN	O
60 	60 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
100 	100 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
about  	about  	 IN	O
70 	70 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
100 	100 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
about  	about  	 IN	O
80 	80 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
100 	100 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
about  	about  	 IN	O
90 	90 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
100 	100 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
surface  	surface  	 NN	O
area  	area  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall 	wall 	 NN	I-NP
.  	.  	 .	O
Importantly 	Importantly 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
pressure  	pressure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
is  	is  	 VBZ	O
sufficient  	sufficient  	 JJ	O
for  	for  	 IN	O
maintaining  	maintaining  	 VBG	B-NP
contact  	contact  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
cavity  	cavity  	 JJ	I-NP
member  	member  	 NN	I-NP
against  	against  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
but  	but  	 CC	O
does  	does  	 VBZ	O
not  	not  	 RB	O
cause  	cause  	 VB	O
significant  	significant  	 JJ	O
damage  	damage  	 NN	O
or  	or  	 CC	O
necrosis  	necrosis  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
mucosa 	mucosa 	 NN	B-NP
.  	.  	 .	O
As  	As  	 RB	O
used  	used  	 VBN	O
herein 	herein 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
terms  	terms  	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
active  	active  	 JJ	O
agent 	agent 	 NN	B-NP
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
; 	; 	 :	O
,  	,  	 ,	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
therapeutic  	therapeutic  	 JJ	B-NP
agent 	agent 	 NN	I-NP
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
; 	; 	 :	O
,  	,  	 ,	O
and  	and  	 CC	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
drug 	drug 	 NN	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
are  	are  	 VBP	O
used  	used  	 VBN	O
interchangeably  	interchangeably  	 NNS	O
and  	and  	 CC	O
refer  	refer  	 VBP	O
to  	to  	 TO	O
any  	any  	 DT	O
substance  	substance  	 NN	O
used  	used  	 VBN	O
to  	to  	 TO	O
treat  	treat  	 VB	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition 	condition 	 NN	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
as  	as  	 RB	O
used  	used  	 VBN	O
herein 	herein 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
term  	term  	 NN	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
therapeutic  	therapeutic  	 JJ	B-NP
amount 	amount 	 NN	I-NP
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
refers  	refers  	 VBZ	O
to  	to  	 TO	O
a  	a  	 DT	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
that  	that  	 WDT	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
locally  	locally  	 RB	O
delivered  	delivered  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
sinus  	sinus  	 NN	B-NP
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
passage  	passage  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
appropriate  	appropriate  	 JJ	O
to  	to  	 TO	O
safely  	safely  	 RB	O
treat  	treat  	 VB	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition 	condition 	 NN	I-NP
.  	.  	 .	O
General  	General  	 JJ	B-NP
elements 	elements 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
described  	described  	 VBD	O
here  	here  	 RB	O
may  	may  	 MD	O
be  	be  	 VB	O
configured  	configured  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
variety  	variety  	 NN	O
of  	of  	 IN	O
ways 	ways 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
they  	they  	 PRP	O
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
filaments 	filaments 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
include  	include  	 VBP	O
any  	any  	 DT	O
linear  	linear  	 JJ	B-NP
structure  	structure  	 NN	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
strands 	strands 	 NN	O
,  	,  	 ,	O
capillaries  	capillaries  	 NN	B-NP
and  	and  	 CC	O
tubular  	tubular  	 JJ	O
and  	and  	 CC	O
non-tubular  	non-tubular  	 JJ	B-NP
structures 	structures 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
film  	film  	 NN	O
or  	or  	 CC	O
sheet-like  	sheet-like  	 JJ	B-NP
starting  	starting  	 VBG	I-NP
material 	material 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
variable  	variable  	 JJ	O
stiffness  	stiffness  	 NN	O
and  	and  	 CC	O
take  	take  	 VB	O
a  	a  	 DT	O
variety  	variety  	 NN	O
of  	of  	 IN	O
suitable  	suitable  	 JJ	O
forms 	forms 	 NNS	O
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
threads 	threads 	 NNS	O
,  	,  	 ,	O
ribbons 	ribbons 	 NNS	O
,  	,  	 ,	O
strips 	strips 	 NNS	O
,  	,  	 ,	O
beaded  	beaded  	 JJ	B-NP
structures 	structures 	 NNS	I-NP
,  	,  	 ,	O
tubes 	tubes 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like 	like 	 JJ	O
,  	,  	 ,	O
so  	so  	 RB	O
long  	long  	 RB	O
as  	as  	 IN	O
they  	they  	 PRP	O
are  	are  	 VBP	O
flexible  	flexible  	 JJ	O
enough  	enough  	 JJ	O
to  	to  	 TO	O
substantially  	substantially  	 RB	O
contact  	contact  	 VB	O
a  	a  	 DT	O
portion  	portion  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
after  	after  	 IN	O
deployment 	deployment 	 NN	O
,  	,  	 ,	O
exhibit  	exhibit  	 VBG	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
release  	release  	 NN	B-NP
kinetics 	kinetics 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
deliver  	deliver  	 VB	O
an  	an  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
drug  	drug  	 NN	O
therapeutic  	therapeutic  	 NN	O
for  	for  	 IN	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition 	condition 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
different  	different  	 JJ	O
shapes  	shapes  	 NNS	O
generally 	generally 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
have  	have  	 VB	O
a  	a  	 DT	O
variety  	variety  	 NN	O
of  	of  	 IN	O
cross-sectional  	cross-sectional  	 JJ	B-NP
shapes 	shapes 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
desired  	desired  	 VBN	O
or  	or  	 CC	O
as  	as  	 IN	O
useful  	useful  	 JJ	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
mucosal  	mucosal  	 JJ	B-NP
contact  	contact  	 NN	I-NP
and  	and  	 CC	O
consistent  	consistent  	 JJ	O
deployment 	deployment 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 CD	O
2A-2M 	2A-2M 	 CD	O
,  	,  	 ,	O
they  	they  	 PRP	O
may  	may  	 MD	O
be  	be  	 VB	O
shaped  	shaped  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
circular  	circular  	 NNS	O
( 	( 	 -LRB-	O
2A 	2A 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
square  	square  	 JJ	O
( 	( 	 -LRB-	O
2B 	2B 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
elliptical  	elliptical  	 NNS	O
( 	( 	 -LRB-	O
2C 	2C 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
winged  	winged  	 NNS	O
( 	( 	 -LRB-	O
2D 	2D 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
diamond-like  	diamond-like  	 NNP	B-NP
( 	( 	 -LRB-	O
2E 	2E 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
rectangular  	rectangular  	 NNS	O
( 	( 	 -LRB-	O
2F 	2F 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
wedged  	wedged  	 NNS	O
( 	( 	 -LRB-	O
2G 	2G 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
ramped  	ramped  	 NNS	O
( 	( 	 -LRB-	O
2H 	2H 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
tubular  	tubular  	 JJ	O
( 	( 	 -LRB-	O
2I 	2I 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
parallelogram-like  	parallelogram-like  	 NNP	B-NP
( 	( 	 -LRB-	O
2J 	2J 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
arc-like  	arc-like  	 NNP	B-NP
( 	( 	 -LRB-	O
2K 	2K 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
dog  	dog  	 FW	B-NP
bone 	bone 	 FW	I-NP
/ 	/ 	 FW	I-NP
dumbbell  	dumbbell  	 FW	I-NP
shaped  	shaped  	 FW	O
( 	( 	 -LRB-	O
2L 	2L 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
slightly  	slightly  	 RB	O
concave  	concave  	 JJ	O
( 	( 	 -LRB-	O
2M 	2M 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like  	like  	 JJ	O
on  	on  	 IN	O
transverse  	transverse  	 JJ	B-NP
cross-section 	cross-section 	 NN	I-NP
.  	.  	 .	O
If  	If  	 IN	O
desired 	desired 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
combined  	combined  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
woven  	woven  	 JJ	O
structures  	structures  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
cords 	cords 	 NN	O
,  	,  	 ,	O
ropes 	ropes 	 NNS	O
,  	,  	 ,	O
braids 	braids 	 NNS	O
,  	,  	 ,	O
mesh 	mesh 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like 	like 	 JJ	O
.  	.  	 .	O
Tubular  	Tubular  	 JJ	B-NP
filaments  	filaments  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
combined  	combined  	 VBN	O
into  	into  	 IN	O
structures  	structures  	 NNS	O
with  	with  	 IN	O
multiple  	multiple  	 JJ	O
lumens 	lumens 	 NN	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
either  	either  	 DT	O
concentric  	concentric  	 NN	O
or  	or  	 CC	O
adjacent  	adjacent  	 JJ	B-NP
configurations 	configurations 	 NNS	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
directly  	directly  	 RB	O
formed  	formed  	 VBN	O
as  	as  	 IN	O
filaments  	filaments  	 NN	O
with  	with  	 IN	O
multiple  	multiple  	 JJ	O
lumens 	lumens 	 NN	B-NP
.  	.  	 .	O
Films  	Films  	 NNS	O
and  	and  	 CC	O
sheets  	sheets  	 NNS	O
may  	may  	 MD	O
also  	also  	 RB	O
include  	include  	 VB	O
non-woven  	non-woven  	 JJ	B-NP
meshes  	meshes  	 NN	I-NP
and  	and  	 CC	O
largely  	largely  	 RB	O
two  	two  	 CD	O
dimensional  	dimensional  	 CD	B-NP
materials 	materials 	 NNS	I-NP
,  	,  	 ,	O
where  	where  	 WRB	O
dimensional  	dimensional  	 JJ	B-NP
thickness  	thickness  	 NN	I-NP
is  	is  	 VBZ	O
much  	much  	 RB	O
less  	less  	 JJR	O
than  	than  	 IN	O
dimensional  	dimensional  	 JJ	B-NP
length  	length  	 NN	I-NP
or  	or  	 CC	O
width 	width 	 NN	B-NP
.  	.  	 .	O
Other  	Other  	 JJ	O
materials  	materials  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
gelfoam  	gelfoam  	 NNS	B-NP
may  	may  	 MD	O
form  	form  	 VB	O
such  	such  	 JJ	O
filaments  	filaments  	 NN	O
upon  	upon  	 IN	O
their  	their  	 PRP$	O
application 	application 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
variations  	variations  	 NNS	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
include  	include  	 VB	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
anchoring  	anchoring  	 JJ	O
elements  	elements  	 NNS	O
to  	to  	 TO	O
help  	help  	 VB	O
affix  	affix  	 VBN	O
the  	the  	 DT	O
filaments  	filaments  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
or  	or  	 CC	O
otherwise  	otherwise  	 RB	O
enhance  	enhance  	 VB	O
contact  	contact  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
filaments  	filaments  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa 	mucosa 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 CD	O
6A-6F 	6A-6F 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
anchoring  	anchoring  	 JJ	O
element  	element  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
hooks  	hooks  	 NNS	O
( 	( 	 -LRB-	O
6A 	6A 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
spikes  	spikes  	 NNS	O
( 	( 	 -LRB-	O
6B 	6B 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
opposed  	opposed  	 VBN	O
spikes  	spikes  	 NNS	O
( 	( 	 -LRB-	O
6C 	6C 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
arrows  	arrows  	 NNS	O
( 	( 	 -LRB-	O
6D 	6D 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
ridges  	ridges  	 NNS	O
( 	( 	 -LRB-	O
6E 	6E 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
barbs  	barbs  	 NNS	O
( 	( 	 -LRB-	O
6F 	6F 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like 	like 	 JJ	O
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
6E 	6E 	 CD	O
,  	,  	 ,	O
ridges  	ridges  	 NNS	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
triangular 	triangular 	 NNS	O
,  	,  	 ,	O
square 	square 	 JJ	O
,  	,  	 ,	O
round 	round 	 NN	O
,  	,  	 ,	O
semicircular 	semicircular 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like 	like 	 JJ	O
.  	.  	 .	O
Cavity  	Cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
are  	are  	 VBP	O
generally  	generally  	 RB	O
biodegradable 	biodegradable 	 JJ	O
,  	,  	 ,	O
but  	but  	 CC	O
they  	they  	 PRP	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
made  	made  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
nonbiodegradable 	nonbiodegradable 	 NNS	B-NP
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
whether  	whether  	 IN	O
formed  	formed  	 VBN	O
as  	as  	 IN	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable 	nonbiodegradable 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
attached  	attached  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
component 	component 	 NN	O
,  	,  	 ,	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
wire  	wire  	 NN	O
or  	or  	 CC	O
suture 	suture 	 NN	B-NP
,  	,  	 ,	O
that  	that  	 WDT	O
extends  	extends  	 VBZ	O
from  	from  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
out  	out  	 RB	O
through  	through  	 IN	O
the  	the  	 DT	O
ostium 	ostium 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
could  	could  	 MD	O
be  	be  	 VB	O
grasped  	grasped  	 VBN	O
by  	by  	 IN	O
an  	an  	 DT	O
instrument  	instrument  	 NN	O
to  	to  	 TO	O
remove  	remove  	 VB	O
it  	it  	 PRP	O
from  	from  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NNS	O
are  	are  	 VBP	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
a  	a  	 DT	O
fringed  	fringed  	 JJ	O
structure 	structure 	 NN	O
.  	.  	 .	O
As  	As  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
3A 	3A 	 CD	O
,  	,  	 ,	O
a  	a  	 DT	O
cross-section  	cross-section  	 JJ	O
of  	of  	 IN	O
fringed  	fringed  	 JJ	O
structure  	structure  	 NN	O
20  	20  	 CD	O
includes  	includes  	 VBZ	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
or  	or  	 CC	O
prongs  	prongs  	 CD	O
22  	22  	 CD	O
( 	( 	 -LRB-	O
expanded  	expanded  	 VBN	B-NP
configuration 	configuration 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Pliable  	Pliable  	 NNP	O
filaments  	filaments  	 VBD	O
22  	22  	 CD	O
are  	are  	 VBP	O
secured  	secured  	 VBN	O
at  	at  	 IN	O
their  	their  	 PRP$	O
proximal  	proximal  	 NN	B-NP
ends  	ends  	 VBZ	O
24  	24  	 CD	O
to  	to  	 TO	O
a  	a  	 DT	O
tubular  	tubular  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
26 	26 	 CD	O
.  	.  	 .	O
Once  	Once  	 RB	O
deployed  	deployed  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
maxillary  	maxillary  	 CD	B-NP
sinus  	sinus  	 CD	I-NP
21  	21  	 CD	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
3B 	3B 	 CD	O
,  	,  	 ,	O
pliable  	pliable  	 CD	O
filaments  	filaments  	 CD	O
22  	22  	 CD	O
radially  	radially  	 NNS	O
expand 	expand 	 VBP	O
,  	,  	 ,	O
unfurl 	unfurl 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
otherwise  	otherwise  	 RB	O
are  	are  	 VBP	O
adapted  	adapted  	 VBN	O
to  	to  	 TO	O
undergo  	undergo  	 VB	O
a  	a  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
configuration  	configuration  	 NN	B-NP
after  	after  	 IN	O
insertion  	insertion  	 NN	O
into  	into  	 IN	O
a  	a  	 DT	O
sinus 	sinus 	 NN	B-NP
,  	,  	 ,	O
to  	to  	 TO	O
substantially  	substantially  	 RB	O
contact  	contact  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
23  	23  	 CD	O
and  	and  	 CC	O
to  	to  	 TO	O
deliver  	deliver  	 VB	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	O
21 	21 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
length  	length  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
22  	22  	 CD	O
is  	is  	 VBZ	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
1  	1  	 CD	O
cm  	cm  	 NNS	O
and  	and  	 CC	O
about  	about  	 IN	O
6  	6  	 CD	O
cm 	cm 	 NN	O
,  	,  	 ,	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
2  	2  	 CD	O
cm  	cm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
6  	6  	 CD	O
cm 	cm 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
still  	still  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
3  	3  	 CD	O
cm  	cm  	 NNS	O
and  	and  	 CC	O
6  	6  	 CD	O
cm 	cm 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
26  	26  	 CD	O
is  	is  	 VBZ	O
placed  	placed  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium  	ostium  	 NN	I-NP
25  	25  	 CD	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
ostium  	ostium  	 JJ	B-NP
patency  	patency  	 NN	I-NP
so  	so  	 IN	O
that  	that  	 DT	O
drainage  	drainage  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	O
21  	21  	 CD	O
to  	to  	 TO	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
is  	is  	 VBZ	O
uninterrupted 	uninterrupted 	 VBN	O
.  	.  	 .	O
Nasal  	Nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
28  	28  	 CD	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
provided  	provided  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	B-NP
end  	end  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
Nasal  	Nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
28  	28  	 CD	O
extends  	extends  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
and  	and  	 CC	O
may  	may  	 MD	O
minimize  	minimize  	 VB	O
lateralization  	lateralization  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
middle  	middle  	 JJ	B-NP
turbinate  	turbinate  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
lateral  	lateral  	 JJ	B-NP
nasal  	nasal  	 JJ	I-NP
wall  	wall  	 NN	I-NP
and  	and  	 CC	O
ostia  	ostia  	 JJ	B-NP
opening 	opening 	 NN	I-NP
,  	,  	 ,	O
further  	further  	 RB	O
reducing  	reducing  	 VBG	O
the  	the  	 DT	O
possible  	possible  	 JJ	O
risk  	risk  	 NN	O
of  	of  	 IN	O
occlusion  	occlusion  	 NN	B-NP
and  	and  	 CC	O
adhesion  	adhesion  	 JJ	B-NP
formation  	formation  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
middle  	middle  	 JJ	B-NP
meatus 	meatus 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 NNP	O
4A  	4A  	 NNP	O
and  	and  	 CC	O
4B 	4B 	 NNP	O
,  	,  	 ,	O
pliable  	pliable  	 CD	O
filaments  	filaments  	 CD	O
32  	32  	 CD	O
are  	are  	 VBP	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
a  	a  	 DT	O
fringed  	fringed  	 JJ	O
structure  	structure  	 NN	O
30  	30  	 CD	O
in  	in  	 IN	O
a  	a  	 DT	O
frontal  	frontal  	 JJ	B-NP
sinus  	sinus  	 NN	I-NP
31 	31 	 CD	O
.  	.  	 .	O
Like  	Like  	 IN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 NNP	O
3A  	3A  	 NNP	O
and  	and  	 CC	O
3B 	3B 	 NNP	O
,  	,  	 ,	O
pliable  	pliable  	 CD	O
filaments  	filaments  	 CD	O
32  	32  	 CD	O
are  	are  	 VBP	O
secured  	secured  	 VBN	O
to  	to  	 TO	O
ostial  	ostial  	 VB	O
member  	member  	 NN	O
36  	36  	 CD	O
at  	at  	 IN	O
their  	their  	 PRP$	O
proximal  	proximal  	 NN	B-NP
ends  	ends  	 VBZ	O
34 	34 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
once  	once  	 RB	O
deployed 	deployed 	 VBN	O
,  	,  	 ,	O
substantially  	substantially  	 RB	O
contact  	contact  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
38  	38  	 CD	O
to  	to  	 TO	O
deliver  	deliver  	 VB	O
drug  	drug  	 NN	O
into  	into  	 IN	O
frontal  	frontal  	 CD	B-NP
sinus  	sinus  	 CD	I-NP
31 	31 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
length  	length  	 NN	O
of  	of  	 IN	O
pliable  	pliable  	 CD	O
filaments  	filaments  	 CD	O
32  	32  	 CD	O
are  	are  	 VBP	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
1  	1  	 CD	O
cm  	cm  	 NNS	O
and  	and  	 CC	O
about  	about  	 IN	O
5  	5  	 CD	O
cm 	cm 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
2  	2  	 CD	O
cm  	cm  	 NNS	O
and  	and  	 CC	O
about  	about  	 IN	O
5  	5  	 CD	O
cm 	cm 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
because  	because  	 IN	O
of  	of  	 IN	O
the  	the  	 DT	O
longer  	longer  	 JJR	O
passageway  	passageway  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
frontal  	frontal  	 JJ	B-NP
sinus  	sinus  	 NN	I-NP
ostium  	ostium  	 VBD	O
33  	33  	 CD	O
than  	than  	 IN	O
to  	to  	 TO	O
the  	the  	 DT	O
maxillary  	maxillary  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
because  	because  	 IN	O
the  	the  	 DT	O
frontal  	frontal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
30  	30  	 CD	O
is  	is  	 VBZ	O
subject  	subject  	 JJ	O
to  	to  	 TO	O
gravitational  	gravitational  	 VB	O
pull 	pull 	 VB	O
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
encompasses  	encompasses  	 VBG	O
a  	a  	 DT	O
longer  	longer  	 RB	O
narrower  	narrower  	 JJR	O
cavity  	cavity  	 JJ	B-NP
prone  	prone  	 JJ	I-NP
to  	to  	 TO	O
stenosis 	stenosis 	 VB	O
,  	,  	 ,	O
adhesions  	adhesions  	 NN	O
and  	and  	 CC	O
scarring 	scarring 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
tubular  	tubular  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
36  	36  	 CD	O
is  	is  	 VBZ	O
generally  	generally  	 RB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
longer  	longer  	 JJR	O
in  	in  	 IN	O
a  	a  	 DT	O
frontal  	frontal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device 	device 	 NN	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
length  	length  	 NN	O
of  	of  	 IN	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
36  	36  	 CD	O
may  	may  	 MD	O
be  	be  	 VB	O
shortened  	shortened  	 VBN	O
if  	if  	 IN	O
the  	the  	 DT	O
fringed  	fringed  	 JJ	O
structure  	structure  	 NN	O
30  	30  	 CD	O
( 	( 	 -LRB-	O
or  	or  	 CC	O
other  	other  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
anchor  	anchor  	 VB	O
the  	the  	 DT	O
device  	device  	 NN	O
within  	within  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
if  	if  	 IN	O
the  	the  	 DT	O
risk  	risk  	 NN	O
of  	of  	 IN	O
such  	such  	 JJ	O
aforementioned  	aforementioned  	 JJ	B-NP
complications  	complications  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
reduced  	reduced  	 VBN	O
through  	through  	 IN	O
varying  	varying  	 VBG	O
surgical  	surgical  	 JJ	B-NP
techniques  	techniques  	 NNS	I-NP
( 	( 	 -LRB-	O
more  	more  	 JJR	O
or  	or  	 CC	O
less  	less  	 RBR	O
extensive 	extensive 	 JJ	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
anatomical  	anatomical  	 JJ	B-NP
variations 	variations 	 NNS	I-NP
.  	.  	 .	O
Turning  	Turning  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
variation  	variation  	 NN	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 NNP	O
5A  	5A  	 NNP	O
and  	and  	 CC	O
5B 	5B 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NNS	O
are  	are  	 VBP	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
a  	a  	 DT	O
flexible  	flexible  	 JJ	O
mesh 	mesh 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 NNP	O
5B  	5B  	 NNP	O
( 	( 	 -LRB-	O
collapsed  	collapsed  	 JJ	O
configuration 	configuration 	 NN	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
flexible  	flexible  	 JJ	O
mesh  	mesh  	 NN	O
40  	40  	 CD	O
is  	is  	 VBZ	O
secured  	secured  	 VBN	O
to  	to  	 TO	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
42  	42  	 CD	O
( 	( 	 -LRB-	O
and  	and  	 CC	O
in  	in  	 IN	O
some  	some  	 DT	O
instances 	instances 	 NNS	O
,  	,  	 ,	O
also  	also  	 RB	O
to  	to  	 TO	O
nasal  	nasal  	 VB	O
portion  	portion  	 NN	O
46 	46 	 CD	O
)  	)  	 -RRB-	O
by  	by  	 IN	O
methods  	methods  	 NNS	O
well  	well  	 RB	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
by  	by  	 IN	O
welding 	welding 	 NN	O
,  	,  	 ,	O
annealing 	annealing 	 NN	O
,  	,  	 ,	O
heat  	heat  	 NN	B-NP
bonding 	bonding 	 NN	I-NP
,  	,  	 ,	O
attachment  	attachment  	 JJ	B-NP
bands  	bands  	 NNS	I-NP
or  	or  	 CC	O
adhesives  	adhesives  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
thermoplastic  	thermoplastic  	 JJ	B-NP
adhesives 	adhesives 	 NNS	I-NP
,  	,  	 ,	O
thermosetting  	thermosetting  	 JJ	O
adhesives 	adhesives 	 NNS	O
,  	,  	 ,	O
rubber-resin  	rubber-resin  	 JJ	B-NP
blend  	blend  	 JJ	I-NP
adhesives 	adhesives 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
other  	other  	 JJ	O
adhesives  	adhesives  	 NNS	O
well  	well  	 RB	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
.  	.  	 .	O
Upon  	Upon  	 IN	O
expansion 	expansion 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
5A 	5A 	 CD	O
,  	,  	 ,	O
flexible  	flexible  	 JJ	O
mesh  	mesh  	 NN	O
40  	40  	 CD	O
forms  	forms  	 NNS	O
a  	a  	 DT	O
spherical  	spherical  	 JJ	B-NP
structure  	structure  	 NN	I-NP
capable  	capable  	 NN	O
of  	of  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
partially  	partially  	 RB	O
conforming  	conforming  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
weave  	weave  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mesh  	mesh  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
adjusted  	adjusted  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
looser  	looser  	 JJR	O
or  	or  	 CC	O
tighter 	tighter 	 JJR	O
,  	,  	 ,	O
or  	or  	 CC	O
the  	the  	 DT	O
width  	width  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
adjusted  	adjusted  	 VBN	O
to  	to  	 TO	O
correspondingly  	correspondingly  	 VB	O
adjust  	adjust  	 VB	O
the  	the  	 DT	O
flexibility  	flexibility  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mesh 	mesh 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
flexible  	flexible  	 JJ	O
mesh  	mesh  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
expanded  	expanded  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
diameter  	diameter  	 NN	O
between  	between  	 IN	O
about  	about  	 IN	O
1  	1  	 CD	O
cm  	cm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
5  	5  	 CD	O
cm 	cm 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
2  	2  	 CD	O
cm  	cm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
5  	5  	 CD	O
cm 	cm 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
as  	as  	 RB	O
further  	further  	 RB	O
described  	described  	 VBN	O
below 	below 	 RB	O
,  	,  	 ,	O
may  	may  	 MD	O
form  	form  	 VB	O
a  	a  	 DT	O
self-expanding 	self-expanding 	 JJ	O
,  	,  	 ,	O
controllably  	controllably  	 JJ	B-NP
expandable 	expandable 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
balloon  	balloon  	 NN	O
expandable  	expandable  	 VBZ	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
various  	various  	 JJ	O
other  	other  	 JJ	O
designs 	designs 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
70  	70  	 CD	O
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
pliable  	pliable  	 NN	O
filament  	filament  	 VBD	O
72  	72  	 CD	O
( 	( 	 -LRB-	O
FIG.  	FIG.  	 NNP	O
7A 	7A 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Single  	Single  	 JJ	B-NP
pliable  	pliable  	 NN	I-NP
filament  	filament  	 VBD	O
72  	72  	 CD	O
may  	may  	 MD	O
curve  	curve  	 VB	O
in  	in  	 IN	O
such  	such  	 PDT	O
a  	a  	 DT	O
way  	way  	 NN	O
to  	to  	 TO	O
at  	at  	 IN	O
least  	least  	 JJS	O
partially  	partially  	 RB	O
conform  	conform  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
of  	of  	 IN	I-NP
implantation  	implantation  	 NN	I-NP
and  	and  	 CC	O
substantially  	substantially  	 RB	O
contact  	contact  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall 	wall 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
7B 	7B 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
74  	74  	 CD	O
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
single  	single  	 JJ	O
pliable  	pliable  	 JJ	O
filament  	filament  	 JJ	B-NP
configured  	configured  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
coil  	coil  	 JJ	O
76 	76 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
turns  	turns  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
coil  	coil  	 NN	O
will  	will  	 MD	O
vary  	vary  	 VB	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
such  	such  	 JJ	O
factors  	factors  	 NNS	O
as  	as  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
of  	of  	 IN	I-NP
implantation 	implantation 	 NN	I-NP
,  	,  	 ,	O
placement  	placement  	 NN	O
and  	and  	 CC	O
deployment  	deployment  	 JJ	B-NP
technique  	technique  	 NN	I-NP
used 	used 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
whether  	whether  	 IN	O
or  	or  	 CC	O
not  	not  	 RB	O
the  	the  	 DT	O
coil  	coil  	 NN	O
is  	is  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
used  	used  	 VBN	O
as  	as  	 IN	O
an  	an  	 DT	O
anchor  	anchor  	 NN	O
or  	or  	 CC	O
for  	for  	 IN	O
drug  	drug  	 NN	B-NP
delivery 	delivery 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
flexibility  	flexibility  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
filament 	filament 	 NN	B-NP
.  	.  	 .	O
Similarly 	Similarly 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
78  	78  	 CD	O
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
pliable  	pliable  	 JJ	O
filament  	filament  	 JJ	B-NP
configured  	configured  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
inserted  	inserted  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
random  	random  	 JJ	O
coil  	coil  	 NN	O
80  	80  	 CD	O
( 	( 	 -LRB-	O
FIG.  	FIG.  	 NNP	O
7C 	7C 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
arced  	arced  	 NNS	B-NP
or  	or  	 CC	O
looped  	looped  	 JJ	O
filaments 	filaments 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
7D 	7D 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
expanded  	expanded  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
82  	82  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
two  	two  	 CD	O
pliable  	pliable  	 CD	O
filaments  	filaments  	 CD	O
84 	84 	 CD	O
.  	.  	 .	O
Pliable  	Pliable  	 NNP	O
filaments  	filaments  	 VBD	O
84  	84  	 CD	O
are  	are  	 VBP	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
concentric  	concentric  	 JJ	B-NP
loops  	loops  	 NNS	I-NP
crossing  	crossing  	 VBG	O
each  	each  	 DT	O
other 	other 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
loops  	loops  	 NNS	O
are  	are  	 VBP	O
usually  	usually  	 RB	O
affixed  	affixed  	 VBN	O
to  	to  	 TO	O
each  	each  	 DT	O
other  	other  	 JJ	O
by  	by  	 IN	O
methods  	methods  	 NNS	O
described  	described  	 VBD	O
above  	above  	 RB	O
to  	to  	 TO	O
form  	form  	 VB	O
a  	a  	 DT	O
distal  	distal  	 JJ	B-NP
apex  	apex  	 NN	I-NP
86 	86 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
proximal  	proximal  	 NN	B-NP
ends  	ends  	 VBZ	O
88  	88  	 CD	O
of  	of  	 IN	O
pliable  	pliable  	 CD	O
filaments  	filaments  	 CD	O
84  	84  	 CD	O
may  	may  	 MD	O
be  	be  	 VB	O
joined  	joined  	 VBN	O
and  	and  	 CC	O
otherwise  	otherwise  	 RB	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
230  	230  	 CD	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
232 	232 	 CD	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
21 	21 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
expanded  	expanded  	 VBN	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
90  	90  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
pliable  	pliable  	 CD	O
filaments  	filaments  	 CD	O
92  	92  	 CD	O
configured  	configured  	 NN	O
to  	to  	 TO	O
form  	form  	 VB	O
multiple  	multiple  	 JJ	O
free  	free  	 JJ	O
loops  	loops  	 NNS	O
( 	( 	 -LRB-	O
FIG.  	FIG.  	 NNP	O
7E 	7E 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
proximal  	proximal  	 NN	B-NP
ends  	ends  	 VBZ	O
94  	94  	 CD	O
of  	of  	 IN	O
pliable  	pliable  	 CD	O
filaments  	filaments  	 CD	O
92  	92  	 CD	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
joined  	joined  	 VBN	O
or  	or  	 CC	O
otherwise  	otherwise  	 RB	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
yet  	yet  	 RB	O
a  	a  	 DT	O
further  	further  	 JJ	O
variation 	variation 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
7F 	7F 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
expanded  	expanded  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
pliable  	pliable  	 CD	O
filaments  	filaments  	 CD	O
98  	98  	 CD	O
configured  	configured  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
whisk-like  	whisk-like  	 JJ	B-NP
structure 	structure 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
spacing  	spacing  	 JJ	O
100  	100  	 CD	O
between  	between  	 IN	O
the  	the  	 DT	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
varied  	varied  	 VBN	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
particular  	particular  	 JJ	O
desired  	desired  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
configuration 	configuration 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
shaped  	shaped  	 VBN	O
by  	by  	 IN	O
adjusting  	adjusting  	 VBG	O
their  	their  	 PRP$	O
degree  	degree  	 NN	O
of  	of  	 IN	O
flexibility 	flexibility 	 NN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
by  	by  	 IN	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	I-NP
plasticizer 	plasticizer 	 NN	I-NP
,  	,  	 ,	O
use  	use  	 NN	O
of  	of  	 IN	O
various  	various  	 JJ	O
molding 	molding 	 NN	O
,  	,  	 ,	O
casting 	casting 	 VBG	O
,  	,  	 ,	O
bonding 	bonding 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
extrusion  	extrusion  	 JJ	B-NP
techniques 	techniques 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
by  	by  	 IN	O
other  	other  	 JJ	O
methods  	methods  	 NNS	O
well  	well  	 RB	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
angle  	angle  	 NN	O
between  	between  	 IN	O
each  	each  	 DT	O
looped  	looped  	 JJ	O
filament  	filament  	 NN	B-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
varied  	varied  	 VBN	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
particular  	particular  	 JJ	O
desired  	desired  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
configuration 	configuration 	 NN	I-NP
.  	.  	 .	O
Any  	Any  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
filaments  	filaments  	 NNS	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
employed  	employed  	 VBN	O
to  	to  	 TO	O
fabricate  	fabricate  	 VB	O
devices  	devices  	 NNS	O
with  	with  	 IN	O
any  	any  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
arced  	arced  	 NN	B-NP
or  	or  	 CC	O
looped  	looped  	 JJ	O
cavity  	cavity  	 JJ	B-NP
members 	members 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
yet  	yet  	 RB	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
ribbon  	ribbon  	 NN	O
or  	or  	 CC	O
strip-like  	strip-like  	 JJ	B-NP
filaments 	filaments 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
7G 	7G 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
100  	100  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
strip-like  	strip-like  	 JJ	B-NP
sub-filaments  	sub-filaments  	 JJ	I-NP
102  	102  	 CD	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
slitting  	slitting  	 VBG	O
a  	a  	 DT	O
single  	single  	 JJ	O
tubular  	tubular  	 JJ	B-NP
filament  	filament  	 JJ	I-NP
structure 	structure 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
7H 	7H 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
104  	104  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
strip-like  	strip-like  	 JJ	B-NP
filaments  	filaments  	 NN	I-NP
106  	106  	 CD	O
configured  	configured  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
pronged  	pronged  	 JJ	B-NP
structure 	structure 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
71 	71 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
108  	108  	 CD	O
is  	is  	 VBZ	O
made  	made  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
strip-like  	strip-like  	 JJ	B-NP
filaments  	filaments  	 NN	I-NP
110  	110  	 CD	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
slitting  	slitting  	 NN	O
and  	and  	 CC	O
deformation  	deformation  	 NN	B-NP
of  	of  	 IN	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
children 	children 	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
filaments  	filaments  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
parent 	parent 	 NN	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
tubular  	tubular  	 JJ	B-NP
filament  	filament  	 JJ	I-NP
structure 	structure 	 NN	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
7J-7O  	7J-7O  	 NNP	O
show  	show  	 VBP	O
yet  	yet  	 RB	O
further  	further  	 RBR	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
design  	design  	 NN	O
variations 	variations 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
7J 	7J 	 CD	O
,  	,  	 ,	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
112  	112  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
corrugated  	corrugated  	 JJ	O
ribbon-like  	ribbon-like  	 JJ	B-NP
filaments 	filaments 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
7K 	7K 	 CD	O
,  	,  	 ,	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
116  	116  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
filaments  	filaments  	 JJ	O
configured  	configured  	 NN	O
like  	like  	 IN	O
springs  	springs  	 CD	O
118 	118 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
filaments  	filaments  	 JJ	O
122  	122  	 CD	O
comprising  	comprising  	 CD	B-NP
gelfoam 	gelfoam 	 NNS	I-NP
.  	.  	 .	O
FIGS.  	FIGS.  	 NNP	O
7M-7O  	7M-7O  	 NNP	O
also  	also  	 RB	O
include  	include  	 VB	O
features  	features  	 NNS	O
allowing  	allowing  	 VBG	O
the  	the  	 DT	O
irreversible  	irreversible  	 JJ	O
deployment  	deployment  	 NN	O
of  	of  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
filaments  	filaments  	 NN	O
in  	in  	 IN	O
an  	an  	 DT	O
open  	open  	 JJ	O
or  	or  	 CC	O
tensed  	tensed  	 JJ	O
configuration  	configuration  	 NN	B-NP
using  	using  	 VBG	O
ridges  	ridges  	 NNS	O
( 	( 	 -LRB-	O
for  	for  	 IN	O
example  	example  	 NN	O
134 	134 	 CD	O
,  	,  	 ,	O
136 	136 	 CD	O
)  	)  	 -RRB-	O
on  	on  	 IN	O
the  	the  	 DT	O
filaments  	filaments  	 NN	O
and  	and  	 CC	O
opposing  	opposing  	 VBG	B-NP
ridges  	ridges  	 NNS	I-NP
upon  	upon  	 IN	O
the  	the  	 DT	O
adjacent  	adjacent  	 JJ	B-NP
lumens  	lumens  	 NN	I-NP
or  	or  	 CC	O
other  	other  	 JJ	O
structures  	structures  	 NNS	O
at  	at  	 IN	O
their  	their  	 PRP$	O
insertion  	insertion  	 JJ	B-NP
site 	site 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
7M 	7M 	 CD	O
,  	,  	 ,	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
124  	124  	 CD	O
consisting  	consisting  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
ridged  	ridged  	 JJ	O
loop  	loop  	 NN	O
is  	is  	 VBZ	O
inserted  	inserted  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
and  	and  	 CC	O
against  	against  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
wall  	wall  	 NN	I-NP
( 	( 	 -LRB-	O
arrows 	arrows 	 LS	O
)  	)  	 -RRB-	O
through  	through  	 IN	O
a  	a  	 DT	O
lumen  	lumen  	 NN	B-NP
with  	with  	 IN	O
an  	an  	 DT	O
opposing  	opposing  	 VBG	B-NP
ridge  	ridge  	 CD	I-NP
125  	125  	 CD	O
on  	on  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
126  	126  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
7N 	7N 	 CD	O
,  	,  	 ,	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
128  	128  	 CD	O
consisting  	consisting  	 NN	O
of  	of  	 IN	O
two  	two  	 CD	O
opposed  	opposed  	 VBD	O
loops  	loops  	 CD	O
129  	129  	 CD	O
is  	is  	 VBZ	O
similarly  	similarly  	 RB	O
inserted 	inserted 	 VBN	O
.  	.  	 .	O
These  	These  	 DT	O
ridges  	ridges  	 JJ	O
130  	130  	 CD	O
may  	may  	 MD	O
alternatively  	alternatively  	 RB	O
deform  	deform  	 VB	O
the  	the  	 DT	O
structure  	structure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
7O 	7O 	 CD	O
,  	,  	 ,	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
131  	131  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
type  	type  	 NN	O
described  	described  	 VBD	O
in  	in  	 IN	O
above  	above  	 JJ	O
in  	in  	 IN	O
FIG.  	FIG.  	 NNP	O
7I  	7I  	 NNP	O
is  	is  	 VBZ	O
modified  	modified  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	O
ridges  	ridges  	 CD	O
133  	133  	 CD	O
on  	on  	 IN	O
the  	the  	 DT	O
interior  	interior  	 NN	O
of  	of  	 IN	O
strip-like  	strip-like  	 JJ	B-NP
filaments  	filaments  	 NN	I-NP
135 	135 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
an  	an  	 DT	O
additional  	additional  	 JJ	O
interior  	interior  	 JJ	O
tubular  	tubular  	 JJ	B-NP
member  	member  	 NN	I-NP
with  	with  	 IN	O
opposing  	opposing  	 VBG	B-NP
ridges  	ridges  	 CD	I-NP
137  	137  	 CD	O
positioned  	positioned  	 JJ	O
concentrically  	concentrically  	 NN	O
within  	within  	 IN	O
the  	the  	 DT	O
parent  	parent  	 NN	O
slit  	slit  	 NN	O
tube 	tube 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
device 	device 	 NN	O
's  	's  	 POS	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
strip-like  	strip-like  	 JJ	I-NP
filaments  	filaments  	 NN	I-NP
135  	135  	 CD	O
are  	are  	 VBP	O
deployed  	deployed  	 VBN	O
through  	through  	 IN	O
their  	their  	 PRP$	O
deformation  	deformation  	 NN	B-NP
along  	along  	 IN	O
the  	the  	 DT	O
intersection  	intersection  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
strip  	strip  	 NN	O
ridges  	ridges  	 NNS	O
and  	and  	 CC	O
those  	those  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
opposing  	opposing  	 VBG	O
interior  	interior  	 JJ	O
ridges  	ridges  	 NNS	O
as  	as  	 IN	O
the  	the  	 DT	O
concentric  	concentric  	 JJ	B-NP
member  	member  	 NN	I-NP
137  	137  	 CD	O
is  	is  	 VBZ	O
independently  	independently  	 RB	O
pulled  	pulled  	 VBN	O
back  	back  	 RP	O
( 	( 	 -LRB-	O
towards  	towards  	 IN	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	B-NP
direction 	direction 	 NN	I-NP
)  	)  	 -RRB-	O
while  	while  	 IN	O
maintaining  	maintaining  	 VBG	O
constant  	constant  	 JJ	O
the  	the  	 DT	O
position  	position  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
external  	external  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
cavity  	cavity  	 JJ	I-NP
parent  	parent  	 NN	I-NP
slit  	slit  	 NN	I-NP
tube 	tube 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
result  	result  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
splayed  	splayed  	 NN	O
and  	and  	 CC	O
deformed  	deformed  	 JJ	O
open  	open  	 JJ	O
pattern  	pattern  	 NN	O
of  	of  	 IN	O
slit  	slit  	 NN	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
children 	children 	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
filaments  	filaments  	 NN	O
along  	along  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall 	wall 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
7R 	7R 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
132  	132  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
filaments  	filaments  	 CD	O
134  	134  	 CD	O
woven  	woven  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
mesh  	mesh  	 NN	O
and  	and  	 CC	O
configured  	configured  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
funnel-type  	funnel-type  	 JJ	B-NP
structure 	structure 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
film 	film 	 NN	O
,  	,  	 ,	O
non-woven 	non-woven 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
sheet-like  	sheet-like  	 JJ	B-NP
material 	material 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
film  	film  	 NN	O
or  	or  	 CC	O
sheet  	sheet  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
pleated 	pleated 	 NNS	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 NNP	O
7P  	7P  	 NNP	O
and  	and  	 CC	O
7Q 	7Q 	 NNP	O
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
7P  	7P  	 CD	O
the  	the  	 DT	O
sheet  	sheet  	 NN	O
140  	140  	 CD	O
has  	has  	 VBZ	O
pleats  	pleats  	 CD	O
138  	138  	 CD	O
that  	that  	 WDT	O
allow  	allow  	 VBP	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
136  	136  	 CD	O
to  	to  	 TO	O
be  	be  	 VB	O
configured  	configured  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
pleated  	pleated  	 JJ	O
cone 	cone 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
7Q 	7Q 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
sheet  	sheet  	 NN	O
142  	142  	 CD	O
has  	has  	 VBZ	O
pleats  	pleats  	 CD	O
144  	144  	 CD	O
that  	that  	 WDT	O
allow  	allow  	 VBP	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
146  	146  	 CD	O
to  	to  	 TO	O
be  	be  	 VB	O
configured  	configured  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
pleated  	pleated  	 JJ	O
fan 	fan 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
invention  	invention  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
adapted  	adapted  	 VBN	O
to  	to  	 TO	O
self-expand 	self-expand 	 JJ	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
if  	if  	 IN	O
they  	they  	 PRP	O
are  	are  	 VBP	O
made  	made  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
shape  	shape  	 NN	B-NP
memory  	memory  	 NN	I-NP
polymer  	polymer  	 NNS	I-NP
or  	or  	 CC	O
if  	if  	 IN	O
they  	they  	 PRP	O
are  	are  	 VBP	O
constrained  	constrained  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
sheath  	sheath  	 JJ	O
prior  	prior  	 JJ	O
to  	to  	 TO	O
sinus  	sinus  	 VB	O
insertion  	insertion  	 NNS	O
and  	and  	 CC	O
deployed  	deployed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
after  	after  	 IN	O
retraction  	retraction  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sheath 	sheath 	 NN	O
.  	.  	 .	O
They  	They  	 PRP	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
expanded  	expanded  	 VBN	O
via  	via  	 IN	O
methods  	methods  	 NNS	O
involving  	involving  	 VBG	O
mechanical  	mechanical  	 JJ	B-NP
expansion 	expansion 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
they  	they  	 PRP	O
may  	may  	 MD	O
be  	be  	 VB	O
expanded  	expanded  	 VBN	O
by  	by  	 IN	O
inflating  	inflating  	 VBG	O
a  	a  	 DT	O
balloon  	balloon  	 NN	O
or  	or  	 CC	O
pulling  	pulling  	 VBG	O
a  	a  	 DT	O
cord  	cord  	 NN	O
or  	or  	 CC	O
wire  	wire  	 NN	O
attached  	attached  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
end  	end  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
by  	by  	 IN	O
the  	the  	 DT	O
application  	application  	 NN	O
of  	of  	 IN	O
expansive  	expansive  	 JJ	B-NP
force  	force  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	B-NP
end  	end  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
by  	by  	 IN	O
deflecting  	deflecting  	 NN	O
or  	or  	 CC	O
deforming  	deforming  	 VBG	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
along  	along  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
walls 	walls 	 NNS	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
in  	in  	 IN	O
addition  	addition  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
methods  	methods  	 NNS	O
previously  	previously  	 RB	O
described 	described 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
invention  	invention  	 NN	O
also  	also  	 RB	O
contemplates  	contemplates  	 VBZ	O
mechanical  	mechanical  	 JJ	B-NP
expansion  	expansion  	 NN	I-NP
of  	of  	 IN	I-NP
cavity  	cavity  	 JJ	I-NP
members  	members  	 NNS	I-NP
made  	made  	 VBN	O
from  	from  	 IN	O
less  	less  	 RBR	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
that  	that  	 WDT	O
are  	are  	 VBP	O
equipped  	equipped  	 VBN	O
with  	with  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
joints  	joints  	 NNS	O
or  	or  	 CC	O
hinges  	hinges  	 NNS	O
and  	and  	 CC	O
which  	which  	 WDT	O
expand  	expand  	 VBP	O
by  	by  	 IN	O
movement  	movement  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
at  	at  	 IN	O
the  	the  	 DT	O
joints  	joints  	 NNS	O
or  	or  	 CC	O
hinges 	hinges 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
joint  	joint  	 JJ	O
or  	or  	 CC	O
hinge  	hinge  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
an  	an  	 DT	O
area  	area  	 NN	O
of  	of  	 IN	O
greater  	greater  	 JJR	O
flexibility  	flexibility  	 NN	O
along  	along  	 IN	O
the  	the  	 DT	O
filament  	filament  	 JJ	O
due  	due  	 JJ	O
to  	to  	 TO	O
use  	use  	 VB	O
of  	of  	 IN	O
a  	a  	 DT	O
polymer  	polymer  	 NN	B-NP
in  	in  	 IN	O
that  	that  	 DT	O
area  	area  	 NN	O
having  	having  	 VBG	O
a  	a  	 DT	O
lower  	lower  	 JJR	O
durometer 	durometer 	 NN	B-NP
,  	,  	 ,	O
decreasing  	decreasing  	 VBG	O
the  	the  	 DT	O
width  	width  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
filament 	filament 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
by  	by  	 IN	O
adjusting  	adjusting  	 VBG	O
other  	other  	 JJ	O
surface  	surface  	 NN	O
features  	features  	 NNS	O
or  	or  	 CC	O
mass  	mass  	 JJ	B-NP
density  	density  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
filament  	filament  	 NN	I-NP
in  	in  	 IN	O
that  	that  	 DT	O
area 	area 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
included  	included  	 VBN	O
in  	in  	 IN	O
any  	any  	 DT	O
portion  	portion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
When  	When  	 WRB	O
filaments  	filaments  	 NNS	O
are  	are  	 VBP	O
used 	used 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
incorporated  	incorporated  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
filaments  	filaments  	 NN	O
as  	as  	 IN	O
drug  	drug  	 NN	O
dispersed  	dispersed  	 NNS	O
or  	or  	 CC	O
dissolved  	dissolved  	 VBN	O
within  	within  	 IN	O
a  	a  	 DT	O
polymeric  	polymeric  	 JJ	B-NP
matrix 	matrix 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
coated  	coated  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments 	filaments 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
first  	first  	 JJ	O
encapsulated 	encapsulated 	 NN	O
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
microencapsulated 	microencapsulated 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
then  	then  	 RB	O
incorporated  	incorporated  	 VBN	O
within  	within  	 IN	O
or  	or  	 CC	O
coated  	coated  	 VBN	O
onto  	onto  	 IN	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments 	filaments 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
instances 	instances 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
constructed  	constructed  	 VBN	O
to  	to  	 TO	O
have  	have  	 VB	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
pouches  	pouches  	 NNS	O
or  	or  	 CC	O
pockets  	pockets  	 NNS	O
for  	for  	 IN	O
holding  	holding  	 VBG	B-NP
pellets  	pellets  	 NN	I-NP
of  	of  	 IN	O
drug 	drug 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
dosage  	dosage  	 NN	O
of  	of  	 IN	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
delivered  	delivered  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
adjusted  	adjusted  	 VBN	O
by 	by 	 IN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
increasing  	increasing  	 VBG	O
or  	or  	 CC	O
decreasing  	decreasing  	 VBG	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
drug-containing  	drug-containing  	 JJ	O
filaments  	filaments  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
increasing  	increasing  	 VBG	O
or  	or  	 CC	O
decreasing  	decreasing  	 VBG	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
drug  	drug  	 NN	O
contained  	contained  	 VBN	O
within  	within  	 IN	O
or  	or  	 CC	O
coated  	coated  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
filaments 	filaments 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
by  	by  	 IN	O
forming  	forming  	 VBG	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 JJ	O
such  	such  	 JJ	O
that  	that  	 IN	O
they  	they  	 PRP	O
can  	can  	 MD	O
be  	be  	 VB	O
broken  	broken  	 VBN	O
or  	or  	 CC	O
cut  	cut  	 NN	O
into  	into  	 IN	O
smaller  	smaller  	 JJR	O
filaments  	filaments  	 NNS	O
either  	either  	 CC	O
before  	before  	 RB	O
or  	or  	 CC	O
after  	after  	 IN	O
insertion  	insertion  	 NN	O
into  	into  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
include  	include  	 VB	O
predetermined  	predetermined  	 VBN	O
fracture  	fracture  	 JJ	B-NP
lines  	lines  	 NNS	I-NP
or  	or  	 CC	O
markings  	markings  	 NN	O
that  	that  	 IN	O
a  	a  	 DT	O
physician  	physician  	 NN	O
can  	can  	 MD	O
use  	use  	 VB	O
as  	as  	 IN	O
a  	a  	 DT	O
guide  	guide  	 NN	O
to  	to  	 TO	O
adjust  	adjust  	 VB	O
filament  	filament  	 JJ	B-NP
length  	length  	 NN	I-NP
prior  	prior  	 RB	I-NP
to  	to  	 TO	O
insertion 	insertion 	 VB	O
,  	,  	 ,	O
or  	or  	 CC	O
after  	after  	 IN	O
insertion  	insertion  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
adapted  	adapted  	 VBN	O
to  	to  	 TO	O
preferentially  	preferentially  	 VB	O
degrade  	degrade  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
fracture  	fracture  	 JJ	B-NP
lines  	lines  	 NNS	I-NP
into  	into  	 IN	O
smaller  	smaller  	 JJR	O
filaments 	filaments 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
instances 	instances 	 NNS	O
,  	,  	 ,	O
it  	it  	 PRP	O
may  	may  	 MD	O
be  	be  	 VB	O
desirable  	desirable  	 JJ	O
to  	to  	 TO	O
include  	include  	 VB	O
filaments  	filaments  	 VBN	O
having  	having  	 VBG	O
different  	different  	 JJ	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
Cavity  	Cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
pliable  	pliable  	 JJ	O
filament  	filament  	 JJ	B-NP
configurations  	configurations  	 NNS	I-NP
or  	or  	 CC	O
from  	from  	 IN	O
combinations  	combinations  	 NNS	B-NP
of  	of  	 IN	O
filaments  	filaments  	 NN	O
and  	and  	 CC	O
other  	other  	 JJ	O
described  	described  	 VBN	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
configurations 	configurations 	 NNS	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
structures  	structures  	 NNS	O
of  	of  	 IN	O
FIGS.  	FIGS.  	 NNP	O
3A-3B  	3A-3B  	 NNP	O
and  	and  	 CC	O
FIGS.  	FIGS.  	 NNP	O
4A-4B  	4A-4B  	 NNP	O
could  	could  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
support  	support  	 VB	O
the  	the  	 DT	O
flexible  	flexible  	 JJ	O
mesh  	mesh  	 NN	O
of  	of  	 IN	O
FIG.  	FIG.  	 CD	O
5A 	5A 	 CD	O
.  	.  	 .	O
If  	If  	 IN	O
desired 	desired 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
radiopaque  	radiopaque  	 JJ	B-NP
marker  	marker  	 NN	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
included  	included  	 VBN	O
on  	on  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
to  	to  	 TO	O
indicate  	indicate  	 VB	O
the  	the  	 DT	O
degree  	degree  	 NN	O
of  	of  	 IN	O
expansion  	expansion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
upon  	upon  	 IN	O
radiographic  	radiographic  	 JJ	B-NP
imaging 	imaging 	 NN	I-NP
.  	.  	 .	O
Usually 	Usually 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
marker  	marker  	 NN	O
will  	will  	 MD	O
be  	be  	 VB	O
detected  	detected  	 VBN	O
by  	by  	 IN	O
fluoroscopy 	fluoroscopy 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
if  	if  	 IN	O
nonbiodegradable 	nonbiodegradable 	 NN	B-NP
,  	,  	 ,	O
will  	will  	 MD	O
exit  	exit  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
normal  	normal  	 JJ	B-NP
mucus  	mucus  	 JJ	I-NP
flow  	flow  	 NN	I-NP
if  	if  	 IN	O
and  	and  	 CC	O
after  	after  	 IN	O
the  	the  	 DT	O
expandable  	expandable  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
member  	member  	 NN	I-NP
has  	has  	 VBZ	O
degraded 	degraded 	 VBN	O
.  	.  	 .	O
Biodegradable  	Biodegradable  	 JJ	B-NP
radiopacifiers  	radiopacifiers  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
particles  	particles  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
iodinated  	iodinated  	 JJ	B-NP
contrast  	contrast  	 NN	I-NP
agent  	agent  	 NN	I-NP
or  	or  	 CC	O
bismuth  	bismuth  	 JJ	O
salts  	salts  	 NN	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
used 	used 	 VBN	O
.  	.  	 .	O
Contact  	Contact  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
verified  	verified  	 VBN	O
by  	by  	 IN	O
incorporation  	incorporation  	 NN	B-NP
of  	of  	 IN	I-NP
radiopaque  	radiopaque  	 JJ	I-NP
markers  	markers  	 NN	I-NP
on  	on  	 IN	O
or  	or  	 CC	O
within  	within  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
members 	members 	 NNS	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
visualization  	visualization  	 VBP	B-NP
using  	using  	 VBG	O
endoscopy  	endoscopy  	 NNS	B-NP
or  	or  	 CC	O
other  	other  	 JJ	O
imaging  	imaging  	 NN	O
modalities 	modalities 	 NN	O
.  	.  	 .	O
Contact  	Contact  	 NN	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
anchoring  	anchoring  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
enhanced  	enhanced  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	I-NP
mucoadhesive  	mucoadhesive  	 JJ	I-NP
materials 	materials 	 NNS	I-NP
,  	,  	 ,	O
that  	that  	 WDT	O
may  	may  	 MD	O
or  	or  	 CC	O
may  	may  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
polymeric 	polymeric 	 NNS	B-NP
,  	,  	 ,	O
to  	to  	 TO	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments 	filaments 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
further  	further  	 RB	O
described  	described  	 VBN	O
below 	below 	 RB	O
,  	,  	 ,	O
by  	by  	 IN	O
adjusting  	adjusting  	 VBG	O
filament  	filament  	 JJ	B-NP
dimensions  	dimensions  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
decreasing  	decreasing  	 VBG	O
filament  	filament  	 JJ	B-NP
diameter  	diameter  	 NN	I-NP
or  	or  	 CC	O
otherwise  	otherwise  	 RB	O
decreasing  	decreasing  	 VBG	B-NP
aspect  	aspect  	 NN	I-NP
ratio 	ratio 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
by  	by  	 IN	O
forming  	forming  	 VBG	O
the  	the  	 DT	O
filaments 	filaments 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 CD	O
6A-6F 	6A-6F 	 CD	O
,  	,  	 ,	O
such  	such  	 JJ	O
that  	that  	 IN	O
they  	they  	 PRP	O
include  	include  	 VBP	O
hooked  	hooked  	 VBN	O
( 	( 	 -LRB-	O
7A 	7A 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
spiked  	spiked  	 JJ	O
( 	( 	 -LRB-	O
7B 	7B 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
double  	double  	 JJ	O
spiked  	spiked  	 NNS	O
( 	( 	 -LRB-	O
7C 	7C 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
arrow-like  	arrow-like  	 NNP	B-NP
( 	( 	 -LRB-	O
7D 	7D 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
ridged  	ridged  	 NNS	O
( 	( 	 -LRB-	O
7E 	7E 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
barb-like  	barb-like  	 JJ	B-NP
structures  	structures  	 NNS	I-NP
( 	( 	 -LRB-	O
7F 	7F 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
other  	other  	 JJ	O
anchoring  	anchoring  	 NN	O
or  	or  	 CC	O
texturizing  	texturizing  	 JJ	B-NP
elements  	elements  	 NNS	I-NP
for  	for  	 IN	O
grasping  	grasping  	 VBG	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa 	mucosa 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
configured  	configured  	 VBN	O
toward  	toward  	 IN	O
their  	their  	 PRP$	O
distal  	distal  	 JJ	B-NP
ends  	ends  	 NNS	I-NP
as  	as  	 IN	O
screws  	screws  	 NNS	O
or  	or  	 CC	O
springs  	springs  	 NNS	O
which  	which  	 WDT	O
are  	are  	 VBP	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
being  	being  	 VBG	O
fixed  	fixed  	 VBN	O
in  	in  	 IN	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
or  	or  	 CC	O
other  	other  	 JJ	O
sinus  	sinus  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
by  	by  	 IN	O
insertion  	insertion  	 NN	O
or  	or  	 CC	O
tension 	tension 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
yet  	yet  	 RB	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
fixed  	fixed  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
by  	by  	 IN	O
stapling  	stapling  	 NN	O
or  	or  	 CC	O
suturing 	suturing 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
anchored  	anchored  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
by  	by  	 IN	O
adjusting  	adjusting  	 VBG	O
its  	its  	 PRP$	O
size  	size  	 NN	O
such  	such  	 JJ	O
that  	that  	 IN	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
too  	too  	 RB	O
large  	large  	 JJ	O
to  	to  	 TO	O
move  	move  	 VB	O
out  	out  	 RP	O
of  	of  	 IN	O
the  	the  	 DT	O
ostium 	ostium 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
configuring  	configuring  	 VBG	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
such  	such  	 JJ	O
that  	that  	 IN	O
it  	it  	 PRP	O
expands  	expands  	 VBZ	O
to  	to  	 TO	O
fill  	fill  	 VB	O
the  	the  	 DT	O
entire  	entire  	 JJ	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
or  	or  	 CC	O
expands  	expands  	 VBZ	O
to  	to  	 TO	O
exert  	exert  	 VB	O
sufficient  	sufficient  	 JJ	O
pressure  	pressure  	 NN	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
it  	it  	 PRP	O
within  	within  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
may  	may  	 MD	O
have  	have  	 VB	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 JJ	O
configured  	configured  	 NN	O
to  	to  	 TO	O
have  	have  	 VB	O
flexibility  	flexibility  	 NN	O
such  	such  	 JJ	O
that  	that  	 IN	O
portions  	portions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
members  	members  	 NNS	I-NP
can  	can  	 MD	O
differentially  	differentially  	 VB	O
bow  	bow  	 VBN	O
to  	to  	 TO	O
conform  	conform  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
in  	in  	 IN	O
which  	which  	 WDT	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
deployed 	deployed 	 VBN	O
.  	.  	 .	O
Ostial  	Ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
keep  	keep  	 VB	O
the  	the  	 DT	O
ostia  	ostia  	 JJ	O
patent  	patent  	 NN	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
anchor  	anchor  	 VB	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
or  	or  	 CC	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
its  	its  	 PRP$	O
inclusion  	inclusion  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
to  	to  	 TO	O
simply  	simply  	 RB	O
connect  	connect  	 VB	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
to  	to  	 TO	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
or  	or  	 CC	O
other  	other  	 JJ	O
extra-sinus  	extra-sinus  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
mounted  	mounted  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	B-NP
end  	end  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
cavity  	cavity  	 JJ	I-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
is  	is  	 VBZ	O
positioned  	positioned  	 VBN	O
at  	at  	 IN	O
or  	or  	 CC	O
relatively  	relatively  	 RB	O
near  	near  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
Again 	Again 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
pressure  	pressure  	 NN	O
generated  	generated  	 VBD	O
by  	by  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
is  	is  	 VBZ	O
sufficient  	sufficient  	 JJ	O
to  	to  	 TO	O
keep  	keep  	 VB	O
the  	the  	 DT	O
ostium  	ostium  	 JJ	O
open 	open 	 JJ	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
so  	so  	 RB	O
great  	great  	 JJ	O
that  	that  	 IN	O
it  	it  	 PRP	O
compromises  	compromises  	 VBZ	O
blood  	blood  	 NN	O
flow  	flow  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa 	mucosa 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
various  	various  	 JJ	O
designs 	designs 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
formed  	formed  	 VBN	B-NP
form  	form  	 NN	I-NP
a  	a  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
pliable  	pliable  	 JJ	O
filaments 	filaments 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
8A 	8A 	 CD	O
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
148  	148  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
pliable  	pliable  	 NN	O
filament  	filament  	 VBD	O
150  	150  	 CD	O
configured  	configured  	 NN	O
as  	as  	 IN	O
an  	an  	 DT	O
expandable  	expandable  	 JJ	B-NP
coiled  	coiled  	 JJ	I-NP
filament  	filament  	 NN	I-NP
or  	or  	 CC	O
wire  	wire  	 NN	O
which  	which  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
varied  	varied  	 VBN	O
in  	in  	 IN	O
its  	its  	 PRP$	O
pitch 	pitch 	 NN	O
,  	,  	 ,	O
number  	number  	 NN	O
and  	and  	 CC	O
density  	density  	 NN	O
of  	of  	 IN	O
coils 	coils 	 NN	O
,  	,  	 ,	O
coil  	coil  	 JJ	B-NP
linear  	linear  	 NN	I-NP
and  	and  	 CC	O
non-linear  	non-linear  	 JJ	B-NP
or  	or  	 CC	O
patterned  	patterned  	 JJ	O
architecture  	architecture  	 NN	B-NP
and  	and  	 CC	O
other  	other  	 JJ	O
like  	like  	 IN	O
features 	features 	 NNS	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
8B  	8B  	 NNP	O
shows  	shows  	 VBZ	O
the  	the  	 DT	O
corkscrew  	corkscrew  	 JJ	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
148  	148  	 CD	O
positioned  	positioned  	 VBN	O
within  	within  	 IN	O
an  	an  	 DT	O
ostium 	ostium 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
FIG.  	FIG.  	 NNP	O
8C  	8C  	 NNP	O
shows  	shows  	 VBZ	O
an  	an  	 DT	O
end  	end  	 NN	B-NP
view  	view  	 NN	I-NP
ostial  	ostial  	 NN	I-NP
member  	member  	 NN	I-NP
148 	148 	 CD	O
.  	.  	 .	O
Lumen  	Lumen  	 NNP	B-NP
151  	151  	 CD	O
allows  	allows  	 JJ	O
flow  	flow  	 NN	O
of  	of  	 IN	O
mucus  	mucus  	 VBG	O
out  	out  	 RP	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
Ostial  	Ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
148  	148  	 CD	O
is  	is  	 VBZ	O
adapted  	adapted  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
laterally  	laterally  	 JJ	O
compressible  	compressible  	 NN	B-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
bendable  	bendable  	 VBP	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
arrows  	arrows  	 NN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
8B 	8B 	 CD	O
,  	,  	 ,	O
in  	in  	 IN	O
which  	which  	 WDT	O
case  	case  	 NN	O
the  	the  	 DT	O
coil  	coil  	 JJ	B-NP
diameter  	diameter  	 NN	I-NP
will  	will  	 MD	O
increase  	increase  	 VB	O
or  	or  	 CC	O
decrease 	decrease 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
15A 	15A 	 CD	O
,  	,  	 ,	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
filaments  	filaments  	 CD	O
154 	154 	 CD	O
,  	,  	 ,	O
which  	which  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
tubular  	tubular  	 JJ	B-NP
filaments  	filaments  	 NNS	I-NP
( 	( 	 -LRB-	O
having  	having  	 VBG	B-NP
lumens 	lumens 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
are  	are  	 VBP	O
attached  	attached  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
tubular  	tubular  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
152 	152 	 CD	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
15B  	15B  	 NNP	O
shows  	shows  	 VBZ	O
the  	the  	 DT	O
tubular  	tubular  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
152  	152  	 CD	O
within  	within  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium  	ostium  	 NN	I-NP
and  	and  	 CC	O
FIG.  	FIG.  	 NNP	O
15C  	15C  	 NNP	O
shows  	shows  	 VBZ	O
an  	an  	 DT	O
end  	end  	 NN	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
152 	152 	 CD	O
.  	.  	 .	O
Lumen  	Lumen  	 NNP	B-NP
156  	156  	 CD	O
allows  	allows  	 JJ	O
flow  	flow  	 NN	O
of  	of  	 IN	O
mucus  	mucus  	 VBG	O
out  	out  	 RP	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
would  	would  	 MD	O
the  	the  	 DT	O
lumens  	lumens  	 NN	B-NP
of  	of  	 IN	O
any  	any  	 DT	O
tubular  	tubular  	 JJ	B-NP
filament 	filament 	 NNS	I-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
if  	if  	 IN	O
used  	used  	 VBN	O
in  	in  	 IN	O
its  	its  	 PRP$	O
construction 	construction 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
158  	158  	 CD	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 NNP	O
16A-16C  	16A-16C  	 NNP	O
is  	is  	 VBZ	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
that  	that  	 DT	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 CD	O
15A-15C  	15A-15C  	 CD	O
except  	except  	 IN	O
that  	that  	 IN	O
the  	the  	 DT	O
filaments  	filaments  	 JJ	O
160  	160  	 CD	O
are  	are  	 VBP	O
formed  	formed  	 VBN	O
as  	as  	 IN	O
strips 	strips 	 NNS	O
.  	.  	 .	O
Ostial  	Ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
158  	158  	 CD	O
also  	also  	 RB	O
has  	has  	 VBZ	O
a  	a  	 DT	O
lumen  	lumen  	 JJ	O
162  	162  	 CD	O
that  	that  	 WDT	O
permits  	permits  	 VBZ	O
mucus  	mucus  	 VBN	O
to  	to  	 TO	O
flow  	flow  	 VB	O
from  	from  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
to  	to  	 TO	O
into  	into  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
passage 	passage 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
film  	film  	 NN	O
or  	or  	 CC	O
sheet-like  	sheet-like  	 JJ	B-NP
material 	material 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
9A 	9A 	 CD	O
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
164  	164  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
pleated  	pleated  	 JJ	O
sheet  	sheet  	 NN	O
( 	( 	 -LRB-	O
or  	or  	 CC	O
alternatively  	alternatively  	 RB	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
tubular  	tubular  	 JJ	B-NP
ring  	ring  	 NN	I-NP
structures  	structures  	 NNS	I-NP
linked  	linked  	 VBN	O
together 	together 	 RB	O
)  	)  	 -RRB-	O
166  	166  	 CD	O
configured  	configured  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
reversibly  	reversibly  	 JJ	B-NP
compressible  	compressible  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
bendable  	bendable  	 NNS	B-NP
( 	( 	 -LRB-	O
as  	as  	 RB	O
indicated  	indicated  	 VBN	O
by  	by  	 IN	O
arrows  	arrows  	 NNS	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
9B 	9B 	 CD	O
)  	)  	 -RRB-	O
accordion-like  	accordion-like  	 JJ	B-NP
tubular  	tubular  	 JJ	I-NP
structure 	structure 	 NN	I-NP
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
9B  	9B  	 NNP	O
depicts  	depicts  	 VBZ	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
164  	164  	 CD	O
within  	within  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
FIG.  	FIG.  	 NNP	O
9C  	9C  	 NNP	O
shows  	shows  	 VBZ	O
an  	an  	 DT	O
end  	end  	 NN	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
164 	164 	 CD	O
.  	.  	 .	O
Lumen  	Lumen  	 NNP	B-NP
168  	168  	 CD	O
allows  	allows  	 JJ	O
flow  	flow  	 NN	O
of  	of  	 IN	O
mucus  	mucus  	 VBG	O
out  	out  	 RP	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
.  	.  	 .	O
Referring  	Referring  	 VBG	O
now  	now  	 RB	O
to  	to  	 TO	O
FIG.  	FIG.  	 CD	O
10A 	10A 	 CD	O
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
170  	170  	 CD	O
includes  	includes  	 VBZ	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
shaped  	shaped  	 CD	O
apertures  	apertures  	 CD	O
172  	172  	 CD	O
cut  	cut  	 VBN	O
out  	out  	 RP	O
or  	or  	 CC	O
punched  	punched  	 VBD	O
out  	out  	 RP	O
from  	from  	 IN	O
film  	film  	 NN	O
or  	or  	 CC	O
sheet  	sheet  	 NN	O
material  	material  	 NN	O
174 	174 	 CD	O
,  	,  	 ,	O
creating  	creating  	 VBG	O
a  	a  	 DT	O
non-woven  	non-woven  	 JJ	B-NP
mesh  	mesh  	 NN	I-NP
Although  	Although  	 IN	O
the  	the  	 DT	O
apertures  	apertures  	 NNS	O
are  	are  	 VBP	O
shown  	shown  	 VBN	O
as  	as  	 IN	O
hexagonal  	hexagonal  	 NN	O
in  	in  	 IN	O
shape 	shape 	 NN	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
understood  	understood  	 VBN	O
that  	that  	 IN	O
various  	various  	 JJ	O
other  	other  	 JJ	O
aperture  	aperture  	 JJ	B-NP
shapes  	shapes  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
used 	used 	 VBN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
apertures  	apertures  	 JJ	O
172  	172  	 CD	O
may  	may  	 MD	O
be  	be  	 VB	O
triangles 	triangles 	 NNS	O
,  	,  	 ,	O
squares 	squares 	 NNS	O
,  	,  	 ,	O
octagons 	octagons 	 NN	O
,  	,  	 ,	O
diamonds 	diamonds 	 NNS	O
,  	,  	 ,	O
etc 	etc 	 FW	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
10B  	10B  	 NNP	O
shows  	shows  	 VBZ	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
170  	170  	 CD	O
within  	within  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
10C 	10C 	 CD	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
how  	how  	 WRB	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
design  	design  	 NN	O
allow  	allow  	 VBP	O
mucus  	mucus  	 VBN	O
to  	to  	 TO	O
flow  	flow  	 VB	O
out  	out  	 RP	O
through  	through  	 IN	O
lumen  	lumen  	 CD	B-NP
176  	176  	 CD	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 RB	O
through  	through  	 IN	O
apertures  	apertures  	 CD	O
172  	172  	 CD	O
( 	( 	 -LRB-	O
see  	see  	 VB	O
direction  	direction  	 NN	O
of  	of  	 IN	O
arrows 	arrows 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Ostial  	Ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
170  	170  	 CD	O
may  	may  	 MD	O
be  	be  	 VB	O
also  	also  	 RB	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
compressible 	compressible 	 NNS	B-NP
,  	,  	 ,	O
expandable 	expandable 	 NN	B-NP
,  	,  	 ,	O
bendable 	bendable 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like 	like 	 JJ	O
.  	.  	 .	O
Referring  	Referring  	 VBG	O
to  	to  	 TO	O
FIGS.  	FIGS.  	 CD	O
12A-12C 	12A-12C 	 CD	O
,  	,  	 ,	O
14A-14C 	14A-14C 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
13A-13C 	13A-13C 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
film  	film  	 NN	O
or  	or  	 CC	O
sheet-like  	sheet-like  	 JJ	B-NP
material  	material  	 NN	I-NP
176  	176  	 CD	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
a  	a  	 DT	O
simple  	simple  	 JJ	O
tube  	tube  	 NN	O
178 	178 	 CD	O
,  	,  	 ,	O
a  	a  	 DT	O
tubular  	tubular  	 JJ	B-NP
hexagon  	hexagon  	 NN	I-NP
180 	180 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
furled  	furled  	 JJ	O
tube  	tube  	 NN	O
182 	182 	 CD	O
.  	.  	 .	O
Lumens  	Lumens  	 NNP	B-NP
184 	184 	 CD	O
,  	,  	 ,	O
186 	186 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
188  	188  	 CD	O
allow  	allow  	 JJ	O
passage  	passage  	 NN	O
of  	of  	 IN	O
mucus  	mucus  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
passage 	passage 	 NN	I-NP
.  	.  	 .	O
Pressure  	Pressure  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
applied  	applied  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
direction  	direction  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
arrows  	arrows  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
furled  	furled  	 JJ	O
tube  	tube  	 NN	O
182  	182  	 CD	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
13C  	13C  	 CD	O
to  	to  	 TO	O
adjust  	adjust  	 VB	O
the  	the  	 DT	O
diameter  	diameter  	 NN	O
of  	of  	 IN	O
lumen  	lumen  	 CD	B-NP
188 	188 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
164  	164  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
sheets  	sheets  	 NNS	O
or  	or  	 CC	O
strip-like  	strip-like  	 JJ	B-NP
filaments  	filaments  	 NN	I-NP
166  	166  	 CD	O
configured  	configured  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
star  	star  	 NN	O
or  	or  	 CC	O
asterisk-like  	asterisk-like  	 JJ	B-NP
structure 	structure 	 NN	I-NP
.  	.  	 .	O
Spaces  	Spaces  	 NNP	O
168  	168  	 CD	O
between  	between  	 IN	O
each  	each  	 DT	O
strip  	strip  	 NN	O
allow  	allow  	 VBP	O
mucus  	mucus  	 VBN	O
to  	to  	 TO	O
flow  	flow  	 VB	O
past  	past  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
164  	164  	 CD	O
and  	and  	 CC	O
optionally  	optionally  	 NN	O
through  	through  	 IN	O
a  	a  	 DT	O
central  	central  	 JJ	O
lumen  	lumen  	 NN	B-NP
165 	165 	 CD	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
11B  	11B  	 NNP	O
shows  	shows  	 VBZ	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
164  	164  	 CD	O
within  	within  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
FIG.  	FIG.  	 NNP	O
11C  	11C  	 NNP	O
depicts  	depicts  	 VBZ	O
an  	an  	 DT	O
end  	end  	 NN	B-NP
view  	view  	 NN	I-NP
of  	of  	 IN	I-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
164 	164 	 CD	O
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
variations  	variations  	 NNS	I-NP
are  	are  	 VBP	O
illustrated  	illustrated  	 VBN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 CD	O
17-19 	17-19 	 CD	O
.  	.  	 .	O
Referring  	Referring  	 VBG	O
to  	to  	 TO	O
FIGS.  	FIGS.  	 CD	O
17A-17C 	17A-17C 	 CD	O
,  	,  	 ,	O
tubular  	tubular  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
190  	190  	 CD	O
( 	( 	 -LRB-	O
top 	top 	 JJ	O
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
corrugated  	corrugated  	 NN	O
or  	or  	 CC	O
pleated  	pleated  	 JJ	O
film  	film  	 NN	O
or  	or  	 CC	O
sheet  	sheet  	 NN	O
192 	192 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
190  	190  	 CD	O
may  	may  	 MD	O
be  	be  	 VB	O
expanded  	expanded  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
direction  	direction  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
arrows  	arrows  	 NNS	O
( 	( 	 -LRB-	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
17C 	17C 	 CD	O
)  	)  	 -RRB-	O
to  	to  	 TO	O
form  	form  	 VB	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
of  	of  	 IN	O
larger  	larger  	 JJR	O
diameter  	diameter  	 NN	O
194 	194 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
FIGS.  	FIGS.  	 CD	O
18A-18C 	18A-18C 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
tubular  	tubular  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
196  	196  	 CD	O
is  	is  	 VBZ	O
made  	made  	 VBN	O
from  	from  	 IN	O
gelfoam  	gelfoam  	 CD	B-NP
198 	198 	 CD	O
,  	,  	 ,	O
with  	with  	 IN	O
a  	a  	 DT	O
pierced  	pierced  	 JJ	O
lumen  	lumen  	 NN	B-NP
199 	199 	 CD	O
,  	,  	 ,	O
which  	which  	 WDT	O
may  	may  	 MD	O
or  	or  	 CC	O
not  	not  	 RB	O
be  	be  	 VB	O
supported  	supported  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	O
a  	a  	 DT	O
tube 	tube 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
200  	200  	 CD	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 NNP	O
19A-19C  	19A-19C  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
solid  	solid  	 JJ	O
but  	but  	 CC	O
porous  	porous  	 CD	B-NP
cylinder  	cylinder  	 CD	I-NP
204  	204  	 CD	O
having  	having  	 VBG	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
lumens  	lumens  	 CD	B-NP
202 	202 	 CD	O
.  	.  	 .	O
Lumens  	Lumens  	 NNP	B-NP
202  	202  	 CD	O
extend  	extend  	 NN	O
through  	through  	 IN	O
the  	the  	 DT	O
tubular  	tubular  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
200 	200 	 CD	O
,  	,  	 ,	O
either  	either  	 CC	O
directly  	directly  	 RB	O
( 	( 	 -LRB-	O
as  	as  	 RB	O
in  	in  	 IN	O
a  	a  	 DT	O
tube 	tube 	 NN	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
indirectly  	indirectly  	 RB	O
by  	by  	 IN	O
connection  	connection  	 NN	O
through  	through  	 IN	O
other  	other  	 JJ	O
internal  	internal  	 JJ	B-NP
cavities  	cavities  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
lumens  	lumens  	 NNS	B-NP
( 	( 	 -LRB-	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
)  	)  	 -RRB-	O
such  	such  	 JJ	O
that  	that  	 IN	O
mucus  	mucus  	 NNS	O
may  	may  	 MD	O
pass  	pass  	 VB	O
out  	out  	 RP	O
the  	the  	 DT	O
end  	end  	 NN	B-NP
walls  	walls  	 NNS	I-NP
206  	206  	 CD	O
and  	and  	 CC	O
outer  	outer  	 JJ	O
wall  	wall  	 NN	O
208  	208  	 CD	O
of  	of  	 IN	O
cylinder  	cylinder  	 CD	O
204 	204 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
rigid  	rigid  	 JJ	O
or  	or  	 CC	O
flexible 	flexible 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
coated  	coated  	 VBN	O
with  	with  	 IN	O
drug 	drug 	 NN	O
,  	,  	 ,	O
coated  	coated  	 VBN	O
with  	with  	 IN	O
microencapsulated  	microencapsulated  	 JJ	B-NP
drug 	drug 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
made  	made  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
polymer  	polymer  	 JJ	B-NP
matrix  	matrix  	 NN	I-NP
with  	with  	 IN	O
dispersed  	dispersed  	 NN	O
or  	or  	 CC	O
dissolved  	dissolved  	 JJ	O
drug 	drug 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
drug  	drug  	 NN	O
included  	included  	 VBD	O
with  	with  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
the  	the  	 DT	O
same  	same  	 JJ	O
or  	or  	 CC	O
different  	different  	 JJ	O
from  	from  	 IN	O
that  	that  	 DT	O
delivered  	delivered  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
expandable  	expandable  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
metal 	metal 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
dimensions  	dimensions  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
will  	will  	 MD	O
generally  	generally  	 RB	O
vary  	vary  	 VBP	O
with  	with  	 IN	O
the  	the  	 DT	O
intended  	intended  	 JJ	O
sinus  	sinus  	 NN	B-NP
of  	of  	 IN	O
deployment 	deployment 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
for  	for  	 IN	O
the  	the  	 DT	O
maxillary  	maxillary  	 JJ	B-NP
sinus 	sinus 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
length  	length  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
less  	less  	 JJR	O
than  	than  	 IN	O
2  	2  	 CD	O
mm 	mm 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
is  	is  	 VBZ	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
2  	2  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
6  	6  	 CD	O
mm 	mm 	 NN	O
,  	,  	 ,	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
2  	2  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
5  	5  	 CD	O
mm 	mm 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
still  	still  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
2  	2  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
4  	4  	 CD	O
mm 	mm 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
outer  	outer  	 JJ	O
diameter  	diameter  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
maxillary  	maxillary  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
5  	5  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
10  	10  	 CD	O
mm 	mm 	 NN	O
,  	,  	 ,	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
5  	5  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
9  	9  	 CD	O
mm 	mm 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
still  	still  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
8  	8  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
10  	10  	 CD	O
mm 	mm 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
internal  	internal  	 JJ	B-NP
diameter  	diameter  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
maxillary  	maxillary  	 JJ	I-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
3  	3  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
9  	9  	 CD	O
mm 	mm 	 NN	O
,  	,  	 ,	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
3  	3  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
8  	8  	 CD	O
mm 	mm 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
more  	more  	 RBR	O
usually  	usually  	 RB	O
still  	still  	 RB	O
between  	between  	 IN	O
about  	about  	 IN	O
3  	3  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
7  	7  	 CD	O
mm 	mm 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
the  	the  	 DT	O
frontal  	frontal  	 JJ	B-NP
sinus 	sinus 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
length  	length  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
between  	between  	 IN	O
about  	about  	 IN	O
0.5  	0.5  	 CD	O
mm  	mm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
5  	5  	 CD	O
cm 	cm 	 NN	O
,  	,  	 ,	O
between  	between  	 IN	O
about  	about  	 IN	O
0.5  	0.5  	 CD	O
cm  	cm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
4  	4  	 CD	O
cm 	cm 	 NN	O
,  	,  	 ,	O
between  	between  	 IN	O
about  	about  	 IN	O
0.5  	0.5  	 CD	O
cm  	cm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
3  	3  	 CD	O
cm 	cm 	 NN	O
,  	,  	 ,	O
between  	between  	 IN	O
about  	about  	 IN	O
0.5  	0.5  	 CD	O
cm  	cm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
2  	2  	 CD	O
cm 	cm 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
between  	between  	 IN	O
about  	about  	 IN	O
0.5  	0.5  	 CD	O
cm  	cm  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
1  	1  	 CD	O
cm 	cm 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
outer  	outer  	 JJ	O
diameter  	diameter  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
usually  	usually  	 RB	O
about  	about  	 IN	O
5  	5  	 CD	O
mm 	mm 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
internal  	internal  	 JJ	B-NP
diameter  	diameter  	 NN	I-NP
about  	about  	 IN	O
3  	3  	 CD	O
mm 	mm 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
inner  	inner  	 JJ	O
and  	and  	 CC	O
outer  	outer  	 JJ	O
diameters  	diameters  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
smaller 	smaller 	 JJR	O
,  	,  	 ,	O
especially  	especially  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
instance  	instance  	 NN	O
where  	where  	 WRB	O
anchoring  	anchoring  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
is  	is  	 VBZ	O
accomplished  	accomplished  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
Nasal  	Nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
invention  	invention  	 NN	O
may  	may  	 MD	O
include  	include  	 VB	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
plate  	plate  	 NN	I-NP
210  	210  	 CD	O
( 	( 	 -LRB-	O
FIG.  	FIG.  	 NNP	O
20D 	20D 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
to  	to  	 TO	O
aid  	aid  	 VB	O
in  	in  	 IN	O
maintaining  	maintaining  	 VBG	O
the  	the  	 DT	O
position  	position  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
as  	as  	 IN	O
an  	an  	 DT	O
aid  	aid  	 NN	O
in  	in  	 IN	O
reducing  	reducing  	 VBG	O
turbinate  	turbinate  	 JJ	B-NP
lateralization 	lateralization 	 NN	I-NP
,  	,  	 ,	O
possible  	possible  	 JJ	O
occlusion  	occlusion  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
middle  	middle  	 JJ	I-NP
meatus  	meatus  	 NN	I-NP
around  	around  	 IN	O
the  	the  	 DT	O
ostia 	ostia 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
tissue  	tissue  	 NN	O
adhesions 	adhesions 	 NN	O
.  	.  	 .	O
If  	If  	 IN	O
included 	included 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
element  	element  	 NN	O
46  	46  	 CD	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 NNP	O
5A-5B  	5A-5B  	 NNP	O
and  	and  	 CC	O
element  	element  	 NN	O
232  	232  	 CD	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
21 	21 	 CD	O
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
secured  	secured  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	B-NP
end  	end  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
to  	to  	 TO	O
extend  	extend  	 VB	O
into  	into  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
passage 	passage 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
may  	may  	 MD	O
lie  	lie  	 VB	O
against  	against  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
mucosa 	mucosa 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
have  	have  	 VB	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
opening  	opening  	 NN	O
through  	through  	 IN	O
which  	which  	 WDT	O
mucus  	mucus  	 VBP	O
flowing  	flowing  	 VBG	O
from  	from  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
can  	can  	 MD	O
drain  	drain  	 VB	O
into  	into  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
passage 	passage 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
opening  	opening  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
eccentrically  	eccentrically  	 VBN	O
located 	located 	 VBN	O
,  	,  	 ,	O
or  	or  	 CC	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
center  	center  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
20D 	20D 	 CD	O
,  	,  	 ,	O
opening  	opening  	 VBG	O
212  	212  	 CD	O
is  	is  	 VBZ	O
in  	in  	 IN	O
the  	the  	 DT	O
center  	center  	 NN	O
of  	of  	 IN	O
nasal  	nasal  	 JJ	B-NP
plate  	plate  	 NN	I-NP
210 	210 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
20E 	20E 	 CD	O
,  	,  	 ,	O
nasal  	nasal  	 JJ	B-NP
plate  	plate  	 NN	I-NP
214  	214  	 CD	O
has  	has  	 VBZ	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
openings  	openings  	 CD	O
216  	216  	 CD	O
that  	that  	 WDT	O
allow  	allow  	 VBP	O
drainage  	drainage  	 VBN	O
of  	of  	 IN	O
mucus  	mucus  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
into  	into  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
passage 	passage 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
from  	from  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
pliable  	pliable  	 JJ	O
filaments 	filaments 	 NN	O
.  	.  	 .	O
Referring  	Referring  	 VBG	O
to  	to  	 TO	O
FIG.  	FIG.  	 CD	O
20A 	20A 	 CD	O
,  	,  	 ,	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
218  	218  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
filaments  	filaments  	 CD	O
220  	220  	 CD	O
configured  	configured  	 NN	O
as  	as  	 IN	O
radially  	radially  	 NNS	O
extending  	extending  	 VBG	O
spokes 	spokes 	 NNS	O
,  	,  	 ,	O
which  	which  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
inserted  	inserted  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
more  	more  	 RBR	O
compact  	compact  	 JJ	O
bundle  	bundle  	 NN	O
of  	of  	 IN	O
aligned  	aligned  	 JJ	O
parallel  	parallel  	 JJ	B-NP
spokes 	spokes 	 NNS	I-NP
,  	,  	 ,	O
then  	then  	 RB	O
deployed  	deployed  	 VBN	O
or  	or  	 CC	O
unfurled  	unfurled  	 VBP	O
so  	so  	 RB	O
as  	as  	 RB	O
to  	to  	 TO	O
encircle  	encircle  	 VB	O
the  	the  	 DT	O
insertion  	insertion  	 JJ	B-NP
point  	point  	 NN	I-NP
( 	( 	 -LRB-	O
see  	see  	 VB	O
arrows  	arrows  	 NNS	O
and  	and  	 CC	O
insertion  	insertion  	 JJ	B-NP
view 	view 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Similarly 	Similarly 	 RB	O
,  	,  	 ,	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
20C 	20C 	 CD	O
,  	,  	 ,	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
226  	226  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
strip-like  	strip-like  	 JJ	B-NP
filaments  	filaments  	 NN	I-NP
228 	228 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
FIG.  	FIG.  	 CD	O
20B 	20B 	 CD	O
,  	,  	 ,	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
222  	222  	 CD	O
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
pliable  	pliable  	 NN	O
filament  	filament  	 VBD	O
224  	224  	 CD	O
configured  	configured  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
spiral 	spiral 	 NN	B-NP
/ 	/ 	 CD	I-NP
helical  	helical  	 JJ	I-NP
structure 	structure 	 NN	I-NP
.  	.  	 .	O
Another  	Another  	 DT	O
exemplary  	exemplary  	 JJ	B-NP
nasal  	nasal  	 JJ	I-NP
portion  	portion  	 NN	I-NP
is  	is  	 VBZ	O
depicted  	depicted  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
20F 	20F 	 CD	O
,  	,  	 ,	O
which  	which  	 WDT	O
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
compressible  	compressible  	 JJ	O
woven  	woven  	 NN	O
or  	or  	 CC	O
nonwoven  	nonwoven  	 JJ	O
fold  	fold  	 NN	O
of  	of  	 IN	O
sheeted  	sheeted  	 JJ	B-NP
material  	material  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
form  	form  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
wing-shaped  	wing-shaped  	 JJ	O
tube 	tube 	 NN	O
,  	,  	 ,	O
intended  	intended  	 VBN	O
to  	to  	 TO	O
adjustably  	adjustably  	 VB	O
conform  	conform  	 VBN	O
to  	to  	 TO	O
and  	and  	 CC	O
support  	support  	 VB	O
the  	the  	 DT	O
middle  	middle  	 JJ	O
meatus  	meatus  	 JJ	B-NP
space  	space  	 NN	I-NP
and  	and  	 CC	O
turbinate  	turbinate  	 JJ	B-NP
anatomy  	anatomy  	 NNS	I-NP
directly  	directly  	 RB	O
outside  	outside  	 JJ	O
of  	of  	 IN	O
an  	an  	 DT	O
ostium 	ostium 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
rigid 	rigid 	 JJ	O
,  	,  	 ,	O
flexible 	flexible 	 JJ	O
,  	,  	 ,	O
or  	or  	 CC	O
self-expanding 	self-expanding 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
coated  	coated  	 VBN	O
with  	with  	 IN	O
drug 	drug 	 NN	O
,  	,  	 ,	O
coated  	coated  	 VBN	O
with  	with  	 IN	O
microencapsulated  	microencapsulated  	 JJ	B-NP
drug 	drug 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
made  	made  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
polymer  	polymer  	 JJ	B-NP
matrix  	matrix  	 NN	I-NP
with  	with  	 IN	O
dispersed  	dispersed  	 NN	O
or  	or  	 CC	O
dissolved  	dissolved  	 JJ	O
drug  	drug  	 NN	O
within  	within  	 IN	O
the  	the  	 DT	O
polymer  	polymer  	 JJ	B-NP
matrix 	matrix 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
drug  	drug  	 NN	O
included  	included  	 VBD	O
with  	with  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
the  	the  	 DT	O
same  	same  	 JJ	O
or  	or  	 CC	O
different  	different  	 JJ	O
from  	from  	 IN	O
that  	that  	 DT	O
delivered  	delivered  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
metal 	metal 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
vary  	vary  	 VBP	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
such  	such  	 JJ	O
factors  	factors  	 NNS	O
as  	as  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
of  	of  	 IN	O
deployment  	deployment  	 NN	O
and  	and  	 CC	O
whether  	whether  	 IN	O
additional  	additional  	 JJ	O
sinuses 	sinuses 	 NN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
ethmoid  	ethmoid  	 JJ	B-NP
sinus 	sinus 	 NN	I-NP
,  	,  	 ,	O
are  	are  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
treated 	treated 	 VBN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
an  	an  	 DT	O
individual  	individual  	 JJ	B-NP
needing  	needing  	 JJ	I-NP
treatment  	treatment  	 NN	I-NP
for  	for  	 IN	O
both  	both  	 DT	O
maxillary  	maxillary  	 NN	B-NP
and  	and  	 CC	O
ethmoid  	ethmoid  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
inflammation 	inflammation 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
maxillary  	maxillary  	 JJ	B-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
having  	having  	 VBG	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
shaped  	shaped  	 VBN	O
to  	to  	 TO	O
contact  	contact  	 VB	O
a  	a  	 DT	O
portion  	portion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
ethmoid  	ethmoid  	 JJ	B-NP
air  	air  	 NN	I-NP
cells  	cells  	 NNS	I-NP
is  	is  	 VBZ	O
particularly  	particularly  	 RB	O
desirable 	desirable 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
may  	may  	 MD	O
include  	include  	 VB	O
any  	any  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
aforementioned  	aforementioned  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
members 	members 	 NNS	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
members 	members 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
portions 	portions 	 NNS	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
21 	21 	 CD	O
,  	,  	 ,	O
device  	device  	 NN	O
may  	may  	 MD	O
include  	include  	 VB	O
a  	a  	 DT	O
multiple  	multiple  	 JJ	O
looped  	looped  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
228  	228  	 CD	O
( 	( 	 -LRB-	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
for  	for  	 IN	O
FIG.  	FIG.  	 CD	O
7D 	7D 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
a  	a  	 DT	O
tubular  	tubular  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
( 	( 	 -LRB-	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
for  	for  	 IN	O
FIG.  	FIG.  	 CD	O
15A 	15A 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Nasal  	Nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
232  	232  	 CD	O
is  	is  	 VBZ	O
also  	also  	 RB	O
formed  	formed  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
filaments  	filaments  	 CD	O
234  	234  	 CD	O
configured  	configured  	 NN	O
as  	as  	 IN	O
splayed  	splayed  	 JJ	O
prongs 	prongs 	 NNS	O
.  	.  	 .	O
Each  	Each  	 DT	O
component  	component  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
,  	,  	 ,	O
i.e. 	i.e. 	 FW	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
contiguously  	contiguously  	 NNS	O
( 	( 	 -LRB-	O
each  	each  	 DT	O
filament 	filament 	 NN	B-NP
,  	,  	 ,	O
tube 	tube 	 NN	O
,  	,  	 ,	O
sheet 	sheet 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
film  	film  	 NN	O
forms  	forms  	 VBZ	O
all  	all  	 DT	O
components 	components 	 NNS	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
separately 	separately 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
then  	then  	 RB	O
attached  	attached  	 VBN	O
by  	by  	 IN	O
methods  	methods  	 NNS	O
previously  	previously  	 RB	O
described 	described 	 VBN	O
.  	.  	 .	O
Each  	Each  	 DT	O
component  	component  	 NN	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
perforated 	perforated 	 NNS	O
,  	,  	 ,	O
contain  	contain  	 VBP	O
pores 	pores 	 VBN	O
,  	,  	 ,	O
or  	or  	 CC	O
have  	have  	 VBP	O
other  	other  	 JJ	O
structural  	structural  	 JJ	O
or  	or  	 CC	O
surface  	surface  	 NN	O
features  	features  	 NNS	O
which  	which  	 WDT	O
enhance  	enhance  	 NNS	O
or  	or  	 CC	O
alternatively  	alternatively  	 RB	O
prevent  	prevent  	 VB	O
impedence  	impedence  	 VBN	O
of  	of  	 IN	O
mucociliary  	mucociliary  	 JJ	B-NP
clearance 	clearance 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
aid  	aid  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
placement  	placement  	 NN	O
and  	and  	 CC	O
deployment  	deployment  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
236  	236  	 CD	O
includes  	includes  	 VBZ	O
a  	a  	 DT	O
whisk-like  	whisk-like  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
member  	member  	 NN	I-NP
238  	238  	 CD	O
( 	( 	 -LRB-	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
for  	for  	 IN	O
FIG.  	FIG.  	 CD	O
7F 	7F 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
tubular  	tubular  	 JJ	B-NP
ostial  	ostial  	 JJ	I-NP
member  	member  	 NN	I-NP
240  	240  	 CD	O
( 	( 	 -LRB-	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
for  	for  	 IN	O
FIG.  	FIG.  	 CD	O
14A 	14A 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
another  	another  	 DT	O
whisk-like  	whisk-like  	 JJ	B-NP
component  	component  	 NN	I-NP
242  	242  	 CD	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
cavity  	cavity  	 VB	O
member  	member  	 NN	O
238  	238  	 CD	O
as  	as  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
242 	242 	 CD	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
22C  	22C  	 NNP	O
shows  	shows  	 VBZ	O
an  	an  	 DT	O
end  	end  	 NN	B-NP
view  	view  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
further  	further  	 JJ	O
variation 	variation 	 NN	O
,  	,  	 ,	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIGS.  	FIGS.  	 CD	O
23A-23C 	23A-23C 	 CD	O
,  	,  	 ,	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
244  	244  	 CD	O
includes  	includes  	 VBZ	O
a  	a  	 DT	O
multiple  	multiple  	 JJ	O
looped  	looped  	 JJ	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
246  	246  	 CD	O
( 	( 	 -LRB-	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
for  	for  	 IN	O
FIG.  	FIG.  	 CD	O
7D 	7D 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
plate  	plate  	 NN	I-NP
248  	248  	 CD	O
( 	( 	 -LRB-	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
for  	for  	 IN	O
FIG.  	FIG.  	 CD	O
20D 	20D 	 CD	O
.  	.  	 .	O
FIG.  	FIG.  	 NNP	O
23B  	23B  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
side  	side  	 NN	B-NP
cross-sectional  	cross-sectional  	 JJ	I-NP
view  	view  	 NN	I-NP
of  	of  	 IN	O
device  	device  	 NN	O
244  	244  	 CD	O
and  	and  	 CC	O
an  	an  	 DT	O
cross-section  	cross-section  	 JJ	B-NP
end  	end  	 NN	I-NP
view  	view  	 NN	I-NP
through  	through  	 IN	O
line  	line  	 NN	O
A-A  	A-A  	 NN	O
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
23C 	23C 	 CD	O
.  	.  	 .	O
Active  	Active  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
.  	.  	 .	O
Any  	Any  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
described  	described  	 VBD	O
herein  	herein  	 VBN	O
so  	so  	 RB	O
long  	long  	 RB	O
as  	as  	 IN	O
they  	they  	 PRP	O
are  	are  	 VBP	O
suitable  	suitable  	 JJ	O
to  	to  	 TO	O
treat  	treat  	 VB	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
and  	and  	 CC	O
are  	are  	 VBP	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
achieving  	achieving  	 VBG	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
release  	release  	 NN	B-NP
kinetics 	kinetics 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
to  	to  	 TO	O
treat  	treat  	 VB	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
anticholinergic  	anticholinergic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antihistamines 	antihistamines 	 NN	B-NP
,  	,  	 ,	O
anti-infective  	anti-infective  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antiscarring  	antiscarring  	 NN	B-NP
or  	or  	 CC	O
antiproliferative  	antiproliferative  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
chemotherapeutic 	chemotherapeutic 	 CD	B-NP
/ 	/ 	 CD	I-NP
antineoplastic  	antineoplastic  	 CD	I-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
cytokines  	cytokines  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
interfereon  	interfereon  	 NN	B-NP
and  	and  	 CC	O
interleukins 	interleukins 	 NN	B-NP
,  	,  	 ,	O
decongestants 	decongestants 	 NN	B-NP
,  	,  	 ,	O
healing  	healing  	 VBG	B-NP
promotion  	promotion  	 NN	I-NP
agents  	agents  	 NNS	I-NP
and  	and  	 CC	O
vitamins  	vitamins  	 NNS	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
retinoic  	retinoic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
,  	,  	 ,	O
vitamin  	vitamin  	 VBG	O
A 	A 	 DT	O
,  	,  	 ,	O
and  	and  	 CC	O
their  	their  	 PRP$	O
derivatives 	derivatives 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
hyperosmolar  	hyperosmolar  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
immunomodulator 	immunomodulator 	 CD	B-NP
/ 	/ 	 CD	I-NP
immunosuppressive  	immunosuppressive  	 CD	I-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
leukotriene  	leukotriene  	 JJ	B-NP
modifiers 	modifiers 	 NN	I-NP
,  	,  	 ,	O
mucolytics 	mucolytics 	 NN	B-NP
,  	,  	 ,	O
narcotic  	narcotic  	 JJ	B-NP
analgesics 	analgesics 	 NN	I-NP
,  	,  	 ,	O
small  	small  	 JJ	O
molecules 	molecules 	 NNS	O
,  	,  	 ,	O
tyrosine  	tyrosine  	 FW	B-NP
kinase  	kinase  	 FW	I-NP
inhibitors 	inhibitors 	 FW	I-NP
,  	,  	 ,	O
peptides 	peptides 	 NN	B-NP
,  	,  	 ,	O
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
nucleic  	nucleic  	 JJ	B-NP
acids 	acids 	 NNS	I-NP
,  	,  	 ,	O
vasoconstrictors 	vasoconstrictors 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
Anti-sense  	Anti-sense  	 JJ	B-NP
nucleic  	nucleic  	 JJ	I-NP
acid  	acid  	 NN	I-NP
oligomers  	oligomers  	 NNS	I-NP
or  	or  	 CC	O
other  	other  	 JJ	O
direct  	direct  	 JJ	O
transactivation  	transactivation  	 NN	B-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
transrepression  	transrepression  	 JJ	B-NP
modifiers  	modifiers  	 NN	I-NP
of  	of  	 IN	I-NP
mRNA  	mRNA  	 JJ	I-NP
expression 	expression 	 NN	I-NP
,  	,  	 ,	O
transcription 	transcription 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
protein  	protein  	 NN	B-NP
production  	production  	 NN	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
used 	used 	 VBN	O
.  	.  	 .	O
Anti-infective  	Anti-infective  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
generally  	generally  	 RB	O
include  	include  	 VB	O
antibacterial  	antibacterial  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antifungal  	antifungal  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antiparasitic  	antiparasitic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antiviral  	antiviral  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
antiseptics 	antiseptics 	 NN	O
.  	.  	 .	O
Anti-inflammatory  	Anti-inflammatory  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
generally  	generally  	 RB	O
include  	include  	 VB	O
steroidal  	steroidal  	 NNS	B-NP
and  	and  	 CC	O
nonsteroidal  	nonsteroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agents 	agents 	 NNS	I-NP
.  	.  	 .	O
Examples  	Examples  	 NNS	O
of  	of  	 IN	O
antibacterial  	antibacterial  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
suitable  	suitable  	 JJ	O
for  	for  	 IN	O
use  	use  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
described  	described  	 JJ	O
methods  	methods  	 NNS	O
and  	and  	 CC	O
devices  	devices  	 NNS	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
aminoglycosides 	aminoglycosides 	 NN	B-NP
,  	,  	 ,	O
amphenicols 	amphenicols 	 NN	B-NP
,  	,  	 ,	O
ansamycins 	ansamycins 	 NN	B-NP
,  	,  	 ,	O
& 	& 	 CC	O
# 	# 	 #	O
x3b2 	x3b2 	 CD	O
; 	; 	 :	O
-lactams 	-lactams 	 NNP	O
,  	,  	 ,	O
lincosamides 	lincosamides 	 NN	B-NP
,  	,  	 ,	O
macrolides 	macrolides 	 NN	B-NP
,  	,  	 ,	O
nitrofurans 	nitrofurans 	 NN	B-NP
,  	,  	 ,	O
quinolones 	quinolones 	 NN	B-NP
,  	,  	 ,	O
sulfonamides 	sulfonamides 	 NN	B-NP
,  	,  	 ,	O
sulfones 	sulfones 	 NN	B-NP
,  	,  	 ,	O
tetracyclines 	tetracyclines 	 NN	B-NP
,  	,  	 ,	O
vancomycin 	vancomycin 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
any  	any  	 DT	O
of  	of  	 IN	O
their  	their  	 PRP$	O
derivatives 	derivatives 	 NNS	O
,  	,  	 ,	O
or  	or  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
& 	& 	 CC	O
# 	# 	 #	O
x3b2 	x3b2 	 CD	O
; 	; 	 :	O
-lactams  	-lactams  	 NNS	O
are  	are  	 VBP	O
the  	the  	 DT	O
preferred  	preferred  	 JJ	O
antibacterial  	antibacterial  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
.  	.  	 .	O
& 	& 	 CC	O
# 	# 	 #	O
x3b2 	x3b2 	 CD	O
; 	; 	 :	O
-lactams  	-lactams  	 NN	O
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
suitable  	suitable  	 JJ	O
for  	for  	 IN	O
use  	use  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
described  	described  	 JJ	O
methods  	methods  	 NNS	O
and  	and  	 CC	O
devices  	devices  	 NNS	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
carbacephems 	carbacephems 	 NN	B-NP
,  	,  	 ,	O
carbapenems 	carbapenems 	 NN	B-NP
,  	,  	 ,	O
cephalosporins 	cephalosporins 	 NN	B-NP
,  	,  	 ,	O
cephamycins 	cephamycins 	 NN	B-NP
,  	,  	 ,	O
monobactams 	monobactams 	 NN	B-NP
,  	,  	 ,	O
oxacephems 	oxacephems 	 NN	B-NP
,  	,  	 ,	O
penicillins 	penicillins 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
any  	any  	 DT	O
of  	of  	 IN	O
their  	their  	 PRP$	O
derivatives 	derivatives 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
penicillins  	penicillins  	 NNS	O
( 	( 	 -LRB-	O
and  	and  	 CC	O
their  	their  	 PRP$	O
corresponding  	corresponding  	 JJ	O
salts 	salts 	 NN	O
)  	)  	 -RRB-	O
are  	are  	 VBP	O
the  	the  	 DT	O
preferred  	preferred  	 JJ	O
& 	& 	 CC	O
# 	# 	 #	O
x3b2 	x3b2 	 CD	O
; 	; 	 :	O
-lactams 	-lactams 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
penicillins  	penicillins  	 NN	O
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
suitable  	suitable  	 JJ	O
for  	for  	 IN	O
use  	use  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
described  	described  	 JJ	O
methods  	methods  	 NNS	O
and  	and  	 CC	O
devices  	devices  	 NNS	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
amdinocillin 	amdinocillin 	 NN	B-NP
,  	,  	 ,	O
amdinocillin  	amdinocillin  	 JJ	B-NP
pivoxil 	pivoxil 	 NN	I-NP
,  	,  	 ,	O
amoxicillin 	amoxicillin 	 NN	B-NP
,  	,  	 ,	O
ampicillin 	ampicillin 	 NN	B-NP
,  	,  	 ,	O
apalcillin 	apalcillin 	 NN	B-NP
,  	,  	 ,	O
aspoxicillin 	aspoxicillin 	 NN	B-NP
,  	,  	 ,	O
azidocillin 	azidocillin 	 NN	B-NP
,  	,  	 ,	O
azlocillin 	azlocillin 	 NN	B-NP
,  	,  	 ,	O
bacampicillin 	bacampicillin 	 NN	B-NP
,  	,  	 ,	O
benzylpenicillinic  	benzylpenicillinic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
,  	,  	 ,	O
benzylpenicillin  	benzylpenicillin  	 JJ	B-NP
sodium 	sodium 	 NN	I-NP
,  	,  	 ,	O
carbenicillin 	carbenicillin 	 NN	B-NP
,  	,  	 ,	O
carindacillin 	carindacillin 	 NN	B-NP
,  	,  	 ,	O
clometocillin 	clometocillin 	 NN	B-NP
,  	,  	 ,	O
cloxacillin 	cloxacillin 	 NN	B-NP
,  	,  	 ,	O
cyclacillin 	cyclacillin 	 NN	B-NP
,  	,  	 ,	O
dicloxacillin 	dicloxacillin 	 NN	B-NP
,  	,  	 ,	O
epicillin 	epicillin 	 NN	B-NP
,  	,  	 ,	O
fenbenicillin 	fenbenicillin 	 NN	B-NP
,  	,  	 ,	O
floxacillin 	floxacillin 	 NN	B-NP
,  	,  	 ,	O
hetacillin 	hetacillin 	 NN	B-NP
,  	,  	 ,	O
lenampicillin 	lenampicillin 	 NN	B-NP
,  	,  	 ,	O
metampicillin 	metampicillin 	 NN	B-NP
,  	,  	 ,	O
methicillin  	methicillin  	 JJ	B-NP
sodium 	sodium 	 NN	I-NP
,  	,  	 ,	O
mezlocillin 	mezlocillin 	 NN	B-NP
,  	,  	 ,	O
nafcillin  	nafcillin  	 JJ	B-NP
sodium 	sodium 	 NN	I-NP
,  	,  	 ,	O
oxacillin 	oxacillin 	 NN	B-NP
,  	,  	 ,	O
penamecillin 	penamecillin 	 NN	B-NP
,  	,  	 ,	O
penethamate  	penethamate  	 JJ	B-NP
hydriodide 	hydriodide 	 NN	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	B-NP
G  	G  	 NNP	I-NP
benethamine 	benethamine 	 NN	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	B-NP
G  	G  	 NNP	I-NP
benzathine 	benzathine 	 NN	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	B-NP
G  	G  	 NNP	I-NP
benzhydrylamine 	benzhydrylamine 	 NN	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	B-NP
G  	G  	 NNP	I-NP
calcium 	calcium 	 NN	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	B-NP
G  	G  	 NNP	I-NP
hydrabamine 	hydrabamine 	 NN	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	B-NP
G  	G  	 NNP	I-NP
potassium 	potassium 	 NN	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	B-NP
G  	G  	 NNP	I-NP
procaine 	procaine 	 NN	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	B-NP
N 	N 	 NNP	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	B-NP
O 	O 	 NNP	I-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	O
V 	V 	 NNP	O
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	O
V  	V  	 NNP	O
benzathine 	benzathine 	 NN	B-NP
,  	,  	 ,	O
penicillin  	penicillin  	 VBG	O
V  	V  	 NNP	O
hydrabamine 	hydrabamine 	 NN	B-NP
,  	,  	 ,	O
penimepicycline 	penimepicycline 	 NN	B-NP
,  	,  	 ,	O
phenethicillin  	phenethicillin  	 JJ	B-NP
potassium 	potassium 	 NN	I-NP
,  	,  	 ,	O
piperacillin 	piperacillin 	 NN	B-NP
,  	,  	 ,	O
pivampicillin 	pivampicillin 	 NN	B-NP
,  	,  	 ,	O
propicillin 	propicillin 	 NN	B-NP
,  	,  	 ,	O
quinacillin 	quinacillin 	 NN	B-NP
,  	,  	 ,	O
sulbenicillin 	sulbenicillin 	 NN	B-NP
,  	,  	 ,	O
sultamicillin 	sultamicillin 	 NN	B-NP
,  	,  	 ,	O
talampicillin 	talampicillin 	 NN	B-NP
,  	,  	 ,	O
temocillin 	temocillin 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
ticarcillin 	ticarcillin 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
amoxicillin  	amoxicillin  	 NNS	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device 	device 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
device  	device  	 NN	O
includes  	includes  	 VBZ	O
ampicillin 	ampicillin 	 VBN	O
.  	.  	 .	O
Penicillins  	Penicillins  	 RB	O
combined  	combined  	 VBN	O
with  	with  	 IN	O
clavulanic  	clavulanic  	 JJ	B-NP
acid  	acid  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
Augmentin 	Augmentin 	 NNP	B-NP
& 	& 	 CC	O
# 	# 	 #	O
xae 	xae 	 CD	B-NP
;  	;  	 :	O
( 	( 	 -LRB-	O
amoxicillin  	amoxicillin  	 NN	B-NP
and  	and  	 CC	O
clavulanic  	clavulanic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
)  	)  	 -RRB-	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
used 	used 	 VBN	O
.  	.  	 .	O
Examples  	Examples  	 NNS	O
of  	of  	 IN	O
antifungal  	antifungal  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
suitable  	suitable  	 JJ	O
for  	for  	 IN	O
use  	use  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
described  	described  	 JJ	O
methods  	methods  	 NNS	O
and  	and  	 CC	O
devices  	devices  	 NNS	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
allylamines 	allylamines 	 NN	B-NP
,  	,  	 ,	O
imidazoles 	imidazoles 	 NN	B-NP
,  	,  	 ,	O
polyenes 	polyenes 	 NN	B-NP
,  	,  	 ,	O
thiocarbamates 	thiocarbamates 	 NN	B-NP
,  	,  	 ,	O
triazoles 	triazoles 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
any  	any  	 DT	O
of  	of  	 IN	O
their  	their  	 PRP$	O
derivatives 	derivatives 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
imidazoles  	imidazoles  	 NNS	B-NP
are  	are  	 VBP	O
the  	the  	 DT	O
preferred  	preferred  	 JJ	O
antifungal  	antifungal  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
.  	.  	 .	O
Antiparasitic  	Antiparasitic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
employed  	employed  	 VBN	O
include  	include  	 VBP	O
such  	such  	 JJ	O
agents  	agents  	 NNS	O
as  	as  	 IN	O
atovaquone 	atovaquone 	 NN	B-NP
,  	,  	 ,	O
clindamycin 	clindamycin 	 NN	B-NP
,  	,  	 ,	O
dapsone 	dapsone 	 NN	B-NP
,  	,  	 ,	O
iodoquinol 	iodoquinol 	 NN	B-NP
,  	,  	 ,	O
metronidazole 	metronidazole 	 NN	B-NP
,  	,  	 ,	O
pentamidine 	pentamidine 	 NN	B-NP
,  	,  	 ,	O
primaquine 	primaquine 	 NN	B-NP
,  	,  	 ,	O
pyrimethamine 	pyrimethamine 	 NN	B-NP
,  	,  	 ,	O
sulfadiazine 	sulfadiazine 	 NN	B-NP
,  	,  	 ,	O
trimethoprim 	trimethoprim 	 FW	B-NP
/ 	/ 	 FW	I-NP
sulfamethoxazole 	sulfamethoxazole 	 FW	I-NP
,  	,  	 ,	O
trimetrexate 	trimetrexate 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
Examples  	Examples  	 NNS	O
of  	of  	 IN	O
antiviral  	antiviral  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
suitable  	suitable  	 JJ	O
for  	for  	 IN	O
use  	use  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
described  	described  	 JJ	O
methods  	methods  	 NNS	O
and  	and  	 CC	O
devices  	devices  	 NNS	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
acyclovir 	acyclovir 	 NN	B-NP
,  	,  	 ,	O
famciclovir 	famciclovir 	 NN	B-NP
,  	,  	 ,	O
valacyclovir 	valacyclovir 	 NN	B-NP
,  	,  	 ,	O
edoxudine 	edoxudine 	 NN	B-NP
,  	,  	 ,	O
ganciclovir 	ganciclovir 	 NN	B-NP
,  	,  	 ,	O
foscamet 	foscamet 	 NN	B-NP
,  	,  	 ,	O
cidovir  	cidovir  	 NNS	B-NP
( 	( 	 -LRB-	O
vistide 	vistide 	 LS	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
vitrasert 	vitrasert 	 NN	B-NP
,  	,  	 ,	O
formivirsen 	formivirsen 	 NN	B-NP
,  	,  	 ,	O
HPMPA  	HPMPA  	 NNP	B-NP
( 	( 	 -LRB-	I-NP
9- 	9- 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
3-hydroxy-2-phosphonomethoxypropyl 	3-hydroxy-2-phosphonomethoxypropyl 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
adenine 	adenine 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
PMEA  	PMEA  	 NNP	B-NP
( 	( 	 -LRB-	I-NP
9- 	9- 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
2-phosphonomethoxyethyl 	2-phosphonomethoxyethyl 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
adenine 	adenine 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
HPMPG  	HPMPG  	 NNP	B-NP
( 	( 	 -LRB-	I-NP
9- 	9- 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
3-Hydroxy-2- 	3-Hydroxy-2- 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
Phosphonomet-hoxy 	Phosphonomet-hoxy 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
propyl 	propyl 	 NN	I-NP
) 	) 	 -RRB-	I-NP
guanine 	guanine 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
PMEG  	PMEG  	 NNP	B-NP
( 	( 	 -LRB-	I-NP
9- 	9- 	 NNP	I-NP
[ 	[ 	 -LRB-	I-NP
2- 	2- 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
phosphonomethoxy 	phosphonomethoxy 	 LS	I-NP
) 	) 	 -RRB-	I-NP
ethyl 	ethyl 	 NN	I-NP
] 	] 	 -RRB-	O
guanine 	guanine 	 NN	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
HPMPC  	HPMPC  	 NNP	B-NP
( 	( 	 -LRB-	I-NP
1- 	1- 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
2-phosphonomethoxy-3-hydroxypropyl 	2-phosphonomethoxy-3-hydroxypropyl 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
-cytosine 	-cytosine 	 NNP	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
ribavirin 	ribavirin 	 NN	O
,  	,  	 ,	O
EICAR  	EICAR  	 NNP	B-NP
( 	( 	 -LRB-	O
5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamine 	5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamine 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
pyrazofurin  	pyrazofurin  	 NNS	B-NP
( 	( 	 -LRB-	I-NP
3- 	3- 	 NNP	I-NP
[ 	[ 	 -LRB-	I-NP
beta-D-ribofuranosyl 	beta-D-ribofuranosyl 	 NNP	I-NP
] 	] 	 -RRB-	I-NP
-4-hydroxypyrazole-5-carboxamine 	-4-hydroxypyrazole-5-carboxamine 	 CD	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
3-Deazaguanine 	3-Deazaguanine 	 NNP	O
,  	,  	 ,	O
GR-92938X  	GR-92938X  	 NNP	B-NP
( 	( 	 -LRB-	O
1-beta-D-ribofuranosylpyrazole-3,4-dicarboxami-de 	1-beta-D-ribofuranosylpyrazole-3,4-dicarboxami-de 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
LY253963  	LY253963  	 NNP	O
( 	( 	 -LRB-	O
1,3,4-thiadiazol-2-yl-cyanamide 	1,3,4-thiadiazol-2-yl-cyanamide 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
RD3-0028  	RD3-0028  	 NNP	B-NP
( 	( 	 -LRB-	O
1,4-dihydro-2,3-Benzodithiin 	1,4-dihydro-2,3-Benzodithiin 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
CL387626  	CL387626  	 NNP	O
( 	( 	 -LRB-	O
4,4 	4,4 	 NNP	O
& 	& 	 CC	O
# 	# 	 #	O
x2032 	x2032 	 CD	O
; 	; 	 :	O
-bis 	-bis 	 NNP	O
[ 	[ 	 -LRB-	O
4,6-d 	4,6-d 	 NNP	O
] 	] 	 -RRB-	O
& 	& 	 CC	O
# 	# 	 #	O
x3b2 	x3b2 	 CD	O
; 	; 	 :	O
-aminophenyl-N- 	-aminophenyl-N- 	 NNP	O
, 	, 	 ,	O
N-bis 	N-bis 	 NNP	O
( 	( 	 -LRB-	O
2-carbamoylethyl 	2-carbamoylethyl 	 NNP	O
) 	) 	 -RRB-	O
-sulfonilimino 	-sulfonilimino 	 NNP	O
] 	] 	 -RRB-	O
-1,3,5-triazin-2-ylamino-biphenyl-2- 	-1,3,5-triazin-2-ylamino-biphenyl-2- 	 NNP	O
, 	, 	 ,	O
2 	2 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2032 	x2032 	 CD	O
; 	; 	 :	O
-disulfonic  	-disulfonic  	 JJ	O
acid  	acid  	 NN	O
disodium  	disodium  	 NN	O
salt 	salt 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
BABIM  	BABIM  	 NNP	B-NP
( 	( 	 -LRB-	I-NP
Bis 	Bis 	 NNP	I-NP
[ 	[ 	 -LRB-	I-NP
5-Amidino-2-benzimidazoly-1 	5-Amidino-2-benzimidazoly-1 	 NNP	I-NP
] 	] 	 -RRB-	I-NP
-methane 	-methane 	 NNP	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
NIH351 	NIH351 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
Typically 	Typically 	 RB	O
,  	,  	 ,	O
if  	if  	 IN	O
inclusion  	inclusion  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
agent  	agent  	 NN	I-NP
is  	is  	 VBZ	O
desired 	desired 	 VBN	O
,  	,  	 ,	O
a  	a  	 DT	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent 	agent 	 NN	I-NP
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
a  	a  	 DT	O
corticosteroid 	corticosteroid 	 NN	B-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
employed 	employed 	 VBN	O
.  	.  	 .	O
Examples  	Examples  	 NNS	O
of  	of  	 IN	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agents  	agents  	 NNS	I-NP
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
include  	include  	 VBP	O
21-acetoxypregnenolone 	21-acetoxypregnenolone 	 RB	O
,  	,  	 ,	O
alclometasone 	alclometasone 	 NN	B-NP
,  	,  	 ,	O
algestone 	algestone 	 NN	B-NP
,  	,  	 ,	O
amcinonide 	amcinonide 	 NN	B-NP
,  	,  	 ,	O
beclomethasone 	beclomethasone 	 NN	B-NP
,  	,  	 ,	O
betamethasone 	betamethasone 	 NN	B-NP
,  	,  	 ,	O
budesonide 	budesonide 	 NN	B-NP
,  	,  	 ,	O
chloroprednisone 	chloroprednisone 	 NN	B-NP
,  	,  	 ,	O
clobetasol 	clobetasol 	 NN	B-NP
,  	,  	 ,	O
clobetasone 	clobetasone 	 NN	B-NP
,  	,  	 ,	O
clocortolone 	clocortolone 	 NN	B-NP
,  	,  	 ,	O
cloprednol 	cloprednol 	 NN	B-NP
,  	,  	 ,	O
corticosterone 	corticosterone 	 NN	B-NP
,  	,  	 ,	O
cortisone 	cortisone 	 NN	B-NP
,  	,  	 ,	O
cortivazol 	cortivazol 	 NN	B-NP
,  	,  	 ,	O
deflazacort 	deflazacort 	 NN	B-NP
,  	,  	 ,	O
desonide 	desonide 	 NN	B-NP
,  	,  	 ,	O
desoximetasone 	desoximetasone 	 NN	B-NP
,  	,  	 ,	O
dexamethasone 	dexamethasone 	 NN	B-NP
,  	,  	 ,	O
diflorasone 	diflorasone 	 NN	B-NP
,  	,  	 ,	O
diflucortolone 	diflucortolone 	 NN	B-NP
,  	,  	 ,	O
difluprednate 	difluprednate 	 NN	B-NP
,  	,  	 ,	O
enoxolone 	enoxolone 	 NN	B-NP
,  	,  	 ,	O
fluazacort 	fluazacort 	 NN	B-NP
,  	,  	 ,	O
flucloronide 	flucloronide 	 NN	B-NP
,  	,  	 ,	O
flumethasone 	flumethasone 	 NN	B-NP
,  	,  	 ,	O
flunisolide 	flunisolide 	 NN	B-NP
,  	,  	 ,	O
fluocinolone  	fluocinolone  	 JJ	B-NP
acetonide 	acetonide 	 NN	I-NP
,  	,  	 ,	O
fluocinonide 	fluocinonide 	 NN	B-NP
,  	,  	 ,	O
fluocortin  	fluocortin  	 JJ	B-NP
butyl 	butyl 	 NN	I-NP
,  	,  	 ,	O
fluocortolone 	fluocortolone 	 NN	B-NP
,  	,  	 ,	O
fluorometholone 	fluorometholone 	 NN	B-NP
,  	,  	 ,	O
fluperolone  	fluperolone  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
fluprednidene  	fluprednidene  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
fluprednisolone 	fluprednisolone 	 NN	B-NP
,  	,  	 ,	O
flurandrenolide 	flurandrenolide 	 NN	B-NP
,  	,  	 ,	O
fluticasone  	fluticasone  	 JJ	B-NP
propionate 	propionate 	 NN	I-NP
,  	,  	 ,	O
formocortal 	formocortal 	 NN	B-NP
,  	,  	 ,	O
halcinonide 	halcinonide 	 NN	B-NP
,  	,  	 ,	O
halobetasol  	halobetasol  	 JJ	B-NP
propionate 	propionate 	 NN	I-NP
,  	,  	 ,	O
halometasone 	halometasone 	 NN	B-NP
,  	,  	 ,	O
halopredone  	halopredone  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
hydrocortamate 	hydrocortamate 	 NN	B-NP
,  	,  	 ,	O
hydrocortisone 	hydrocortisone 	 NN	B-NP
,  	,  	 ,	O
loteprednol  	loteprednol  	 JJ	B-NP
etabonate 	etabonate 	 NN	I-NP
,  	,  	 ,	O
mazipredone 	mazipredone 	 NN	B-NP
,  	,  	 ,	O
medrysone 	medrysone 	 NN	B-NP
,  	,  	 ,	O
meprednisone 	meprednisone 	 NN	B-NP
,  	,  	 ,	O
methylprednisolone 	methylprednisolone 	 NN	B-NP
,  	,  	 ,	O
mometasone  	mometasone  	 JJ	B-NP
furoate 	furoate 	 NN	I-NP
,  	,  	 ,	O
paramethasone 	paramethasone 	 NN	B-NP
,  	,  	 ,	O
prednicarbate 	prednicarbate 	 NN	B-NP
,  	,  	 ,	O
prednisolone 	prednisolone 	 NN	B-NP
,  	,  	 ,	O
prednisolone  	prednisolone  	 CD	O
25-diethylamino-acetate 	25-diethylamino-acetate 	 CD	O
,  	,  	 ,	O
prednisolone  	prednisolone  	 FW	B-NP
sodium  	sodium  	 FW	I-NP
phosphate 	phosphate 	 FW	I-NP
,  	,  	 ,	O
prednisone 	prednisone 	 NN	B-NP
,  	,  	 ,	O
prednival 	prednival 	 NN	B-NP
,  	,  	 ,	O
prednylidene 	prednylidene 	 NN	B-NP
,  	,  	 ,	O
rimexolone 	rimexolone 	 NN	B-NP
,  	,  	 ,	O
tixocortol 	tixocortol 	 NN	B-NP
,  	,  	 ,	O
triamcinolone 	triamcinolone 	 NN	B-NP
,  	,  	 ,	O
triamcinolone  	triamcinolone  	 JJ	B-NP
acetonide 	acetonide 	 NN	I-NP
,  	,  	 ,	O
triamcinolone  	triamcinolone  	 JJ	B-NP
benetonide 	benetonide 	 NN	I-NP
,  	,  	 ,	O
triamcinolone  	triamcinolone  	 JJ	B-NP
hexacetonide 	hexacetonide 	 NN	I-NP
,  	,  	 ,	O
any  	any  	 DT	O
of  	of  	 IN	O
their  	their  	 PRP$	O
derivatives 	derivatives 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
budesonide  	budesonide  	 NN	B-NP
is  	is  	 VBZ	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
as  	as  	 IN	O
the  	the  	 DT	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent 	agent 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent  	agent  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
mometasone  	mometasone  	 JJ	B-NP
furoate 	furoate 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
yet  	yet  	 RB	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent  	agent  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
beclomethasone 	beclomethasone 	 NNS	B-NP
.  	.  	 .	O
In  	In  	 IN	O
yet  	yet  	 RB	O
a  	a  	 DT	O
further  	further  	 JJ	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent  	agent  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
fluticasone  	fluticasone  	 JJ	B-NP
propionate 	propionate 	 NN	I-NP
.  	.  	 .	O
If  	If  	 IN	O
a  	a  	 DT	O
nonsteroidal  	nonsteroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent  	agent  	 NN	I-NP
is  	is  	 VBZ	O
used 	used 	 VBN	O
,  	,  	 ,	O
suitable  	suitable  	 JJ	O
agents  	agents  	 NNS	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
COX  	COX  	 NNP	B-NP
inhibitors  	inhibitors  	 NNS	I-NP
( 	( 	 -LRB-	O
COX-1  	COX-1  	 NNP	B-NP
or  	or  	 CC	O
COX  	COX  	 NNP	B-NP
nonspecific  	nonspecific  	 FW	I-NP
inhibitors 	inhibitors 	 FW	I-NP
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
salicylic  	salicylic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
derivatives 	derivatives 	 NNS	I-NP
,  	,  	 ,	O
aspirin 	aspirin 	 NN	O
,  	,  	 ,	O
sodium  	sodium  	 JJ	B-NP
salicylate 	salicylate 	 NN	I-NP
,  	,  	 ,	O
choline  	choline  	 FW	B-NP
magnesium  	magnesium  	 FW	I-NP
trisalicylate 	trisalicylate 	 FW	I-NP
,  	,  	 ,	O
salsalate 	salsalate 	 NN	B-NP
,  	,  	 ,	O
diflunisal 	diflunisal 	 NN	B-NP
,  	,  	 ,	O
sulfasalazine  	sulfasalazine  	 NN	B-NP
and  	and  	 CC	O
olsalazine 	olsalazine 	 NNS	B-NP
;  	;  	 :	O
para-aminophenol  	para-aminophenol  	 JJ	B-NP
derivatives  	derivatives  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
acetaminophen 	acetaminophen 	 NNS	B-NP
;  	;  	 :	O
indole  	indole  	 NNS	B-NP
and  	and  	 CC	O
indene  	indene  	 JJ	B-NP
acetic  	acetic  	 NNS	I-NP
acids  	acids  	 VBP	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
indomethacin  	indomethacin  	 NN	B-NP
and  	and  	 CC	O
sulindac 	sulindac 	 NNS	B-NP
;  	;  	 :	O
heteroaryl  	heteroaryl  	 FW	B-NP
acetic  	acetic  	 FW	I-NP
acids  	acids  	 FW	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
tolmetin 	tolmetin 	 NN	B-NP
,  	,  	 ,	O
dicofenac  	dicofenac  	 NN	B-NP
and  	and  	 CC	O
ketorolac 	ketorolac 	 NNS	B-NP
;  	;  	 :	O
arylpropionic  	arylpropionic  	 JJ	B-NP
acids  	acids  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
ibuprofen 	ibuprofen 	 NN	O
,  	,  	 ,	O
naproxen 	naproxen 	 NN	B-NP
,  	,  	 ,	O
flurbiprofen 	flurbiprofen 	 NN	B-NP
,  	,  	 ,	O
ketoprofen 	ketoprofen 	 NN	B-NP
,  	,  	 ,	O
fenoprofen  	fenoprofen  	 NN	B-NP
and  	and  	 CC	O
oxaprozin 	oxaprozin 	 NNS	B-NP
;  	;  	 :	O
anthranilic  	anthranilic  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
( 	( 	 -LRB-	O
fenamates 	fenamates 	 LS	B-NP
)  	)  	 -RRB-	O
such  	such  	 JJ	O
as  	as  	 IN	O
mefenamic  	mefenamic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
and  	and  	 CC	O
meloxicam 	meloxicam 	 NNS	B-NP
;  	;  	 :	O
enolic  	enolic  	 JJ	B-NP
acids  	acids  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
oxicams  	oxicams  	 NN	B-NP
( 	( 	 -LRB-	O
piroxicam 	piroxicam 	 UH	B-NP
,  	,  	 ,	O
meloxicam 	meloxicam 	 CD	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
alkanones  	alkanones  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
nabumetone 	nabumetone 	 CD	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
selective  	selective  	 JJ	B-NP
COX-2  	COX-2  	 CD	I-NP
inhibitors  	inhibitors  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
diaryl-substituted  	diaryl-substituted  	 JJ	B-NP
furanones  	furanones  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
rofecoxib 	rofecoxib 	 NNS	B-NP
;  	;  	 :	O
diaryl-substituted  	diaryl-substituted  	 JJ	B-NP
pyrazoles  	pyrazoles  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
celecoxib 	celecoxib 	 NNS	B-NP
;  	;  	 :	O
indole  	indole  	 FW	B-NP
acetic  	acetic  	 FW	I-NP
acids  	acids  	 FW	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
etodolac  	etodolac  	 NN	B-NP
and  	and  	 CC	O
sulfonanilides  	sulfonanilides  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
nimesulide 	nimesulide 	 CD	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
chemotherapeutic 	chemotherapeutic 	 JJ	B-NP
/ 	/ 	 CD	I-NP
antineoplastic  	antineoplastic  	 CD	I-NP
agents  	agents  	 NNS	I-NP
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to  	to  	 TO	O
antitumor  	antitumor  	 VB	O
agents  	agents  	 NNS	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
cancer  	cancer  	 NN	B-NP
chemotherapeutic  	chemotherapeutic  	 NN	I-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
biological  	biological  	 JJ	B-NP
response  	response  	 NN	I-NP
modifiers 	modifiers 	 NN	I-NP
,  	,  	 ,	O
vascularization  	vascularization  	 JJ	B-NP
inhibitors 	inhibitors 	 NN	I-NP
,  	,  	 ,	O
hormone  	hormone  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
blockers 	blockers 	 NN	I-NP
,  	,  	 ,	O
cryotherapeutic  	cryotherapeutic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
or  	or  	 CC	O
other  	other  	 JJ	O
agents  	agents  	 NNS	O
that  	that  	 IN	O
destroy  	destroy  	 NN	O
or  	or  	 CC	O
inhibit  	inhibit  	 JJ	O
neoplasia  	neoplasia  	 NN	B-NP
or  	or  	 CC	O
tumorigenesis 	tumorigenesis 	 CD	B-NP
)  	)  	 -RRB-	O
such  	such  	 JJ	O
as  	as  	 IN	O
alkylating  	alkylating  	 JJ	O
agents  	agents  	 NNS	O
or  	or  	 CC	O
other  	other  	 JJ	O
agents  	agents  	 NNS	O
which  	which  	 WDT	O
directly  	directly  	 RB	O
kill  	kill  	 VB	O
cancer  	cancer  	 NN	B-NP
cells  	cells  	 NNS	I-NP
by  	by  	 IN	O
attacking  	attacking  	 VBG	O
their  	their  	 PRP$	O
DNA  	DNA  	 NN	B-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
cyclophosphamide 	cyclophosphamide 	 NN	B-NP
,  	,  	 ,	O
isophosphamide 	isophosphamide 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
nitrosoureas  	nitrosoureas  	 NN	B-NP
or  	or  	 CC	O
other  	other  	 JJ	O
agents  	agents  	 NNS	O
which  	which  	 WDT	O
kill  	kill  	 VBP	O
cancer  	cancer  	 NN	B-NP
cells  	cells  	 NNS	I-NP
by  	by  	 IN	O
inhibiting  	inhibiting  	 JJ	O
changes  	changes  	 NNS	O
necessary  	necessary  	 JJ	O
for  	for  	 IN	O
cellular  	cellular  	 JJ	B-NP
DNA  	DNA  	 NN	I-NP
repair  	repair  	 NN	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
carmustine  	carmustine  	 NNS	B-NP
( 	( 	 -LRB-	O
BCNU 	BCNU 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
lomustine  	lomustine  	 NNS	B-NP
( 	( 	 -LRB-	O
CCNU 	CCNU 	 NNP	B-NP
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
antimetabolites  	antimetabolites  	 NN	B-NP
and  	and  	 CC	O
other  	other  	 JJ	O
agents  	agents  	 NNS	O
that  	that  	 IN	O
block  	block  	 NN	B-NP
cancer  	cancer  	 NN	I-NP
cell  	cell  	 NN	I-NP
growth  	growth  	 NN	I-NP
by  	by  	 IN	O
interfering  	interfering  	 VBG	O
with  	with  	 IN	O
certain  	certain  	 JJ	O
cell  	cell  	 NN	O
functions 	functions 	 NNS	O
,  	,  	 ,	O
usually  	usually  	 RB	O
DNA  	DNA  	 NN	B-NP
synthesis  	synthesis  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
6  	6  	 CD	O
mercaptopurine  	mercaptopurine  	 NNS	B-NP
and  	and  	 CC	O
5-fluorouracil  	5-fluorouracil  	 NN	O
( 	( 	 -LRB-	O
5FU 	5FU 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
antitumor  	antitumor  	 JJ	B-NP
antibiotics  	antibiotics  	 NN	I-NP
and  	and  	 CC	O
other  	other  	 JJ	O
compounds  	compounds  	 NN	O
that  	that  	 IN	O
act  	act  	 NN	O
by  	by  	 IN	O
binding  	binding  	 JJ	O
or  	or  	 CC	O
intercalating  	intercalating  	 JJ	B-NP
DNA  	DNA  	 NN	I-NP
and  	and  	 CC	O
preventing  	preventing  	 VBG	B-NP
RNA  	RNA  	 NNP	I-NP
synthesis  	synthesis  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
doxorubicin 	doxorubicin 	 NN	B-NP
,  	,  	 ,	O
daunorubicin 	daunorubicin 	 NN	B-NP
,  	,  	 ,	O
epirubicin 	epirubicin 	 NN	B-NP
,  	,  	 ,	O
idarubicin 	idarubicin 	 NN	B-NP
,  	,  	 ,	O
mitomycin-C  	mitomycin-C  	 JJ	B-NP
and  	and  	 CC	O
bleomycin 	bleomycin 	 CD	B-NP
)  	)  	 -RRB-	O
plant  	plant  	 NN	O
( 	( 	 -LRB-	O
vinca 	vinca 	 LS	B-NP
)  	)  	 -RRB-	O
alkaloids  	alkaloids  	 NN	B-NP
and  	and  	 CC	O
other  	other  	 JJ	O
anti-tumor  	anti-tumor  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
derived  	derived  	 VBN	O
from  	from  	 IN	O
plants  	plants  	 NNS	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
vincristine  	vincristine  	 NN	B-NP
and  	and  	 CC	O
vinblastine 	vinblastine 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
steroid  	steroid  	 JJ	B-NP
hormones 	hormones 	 NNS	I-NP
,  	,  	 ,	O
hormone  	hormone  	 JJ	B-NP
inhibitors 	inhibitors 	 NN	I-NP
,  	,  	 ,	O
hormone  	hormone  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
antagonists  	antagonists  	 NNS	I-NP
and  	and  	 CC	O
other  	other  	 JJ	O
agents  	agents  	 NNS	O
which  	which  	 WDT	O
affect  	affect  	 VBP	O
the  	the  	 DT	O
growth  	growth  	 NN	B-NP
of  	of  	 IN	I-NP
hormone-responsive  	hormone-responsive  	 JJ	I-NP
cancers  	cancers  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
tamoxifen 	tamoxifen 	 NN	B-NP
,  	,  	 ,	O
herceptin 	herceptin 	 NN	B-NP
,  	,  	 ,	O
aromatase  	aromatase  	 JJ	B-NP
ingibitors  	ingibitors  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
aminoglutethamide  	aminoglutethamide  	 NN	B-NP
and  	and  	 CC	O
formestane 	formestane 	 NN	B-NP
,  	,  	 ,	O
trriazole  	trriazole  	 JJ	B-NP
inhibitors  	inhibitors  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
letrozole  	letrozole  	 NN	B-NP
and  	and  	 CC	O
anastrazole 	anastrazole 	 NN	B-NP
,  	,  	 ,	O
steroidal  	steroidal  	 JJ	B-NP
inhibitors  	inhibitors  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
exemestane 	exemestane 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
antiangiogenic  	antiangiogenic  	 JJ	B-NP
proteins 	proteins 	 NNS	I-NP
,  	,  	 ,	O
small  	small  	 JJ	O
molecules 	molecules 	 NNS	O
,  	,  	 ,	O
gene  	gene  	 NN	B-NP
therapies  	therapies  	 NNS	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
other  	other  	 JJ	O
agents  	agents  	 NNS	O
that  	that  	 WDT	O
inhibit  	inhibit  	 VBP	O
angiogenesis  	angiogenesis  	 VBN	O
or  	or  	 CC	O
vascularization  	vascularization  	 NN	B-NP
of  	of  	 IN	O
tumors  	tumors  	 NNS	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
meth-1 	meth-1 	 NNP	B-NP
,  	,  	 ,	O
meth-2 	meth-2 	 NNP	B-NP
,  	,  	 ,	O
thalidomide 	thalidomide 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
bevacizumab  	bevacizumab  	 NNS	B-NP
( 	( 	 -LRB-	O
Avastin 	Avastin 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
squalamine 	squalamine 	 NN	B-NP
,  	,  	 ,	O
endostatin 	endostatin 	 NN	B-NP
,  	,  	 ,	O
angiostatin 	angiostatin 	 NN	B-NP
,  	,  	 ,	O
Angiozyme 	Angiozyme 	 NNP	B-NP
,  	,  	 ,	O
AE-941  	AE-941  	 NNP	B-NP
( 	( 	 -LRB-	O
Neovastat 	Neovastat 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
CC-5013  	CC-5013  	 NNP	B-NP
( 	( 	 -LRB-	O
Revimid 	Revimid 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
medi-522  	medi-522  	 NNP	B-NP
( 	( 	 -LRB-	O
Vitaxin 	Vitaxin 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
2-methoxyestradiol  	2-methoxyestradiol  	 NNP	O
( 	( 	 -LRB-	O
2ME2 	2ME2 	 NNP	B-NP
,  	,  	 ,	O
Panzem 	Panzem 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
carboxyamidotriazole  	carboxyamidotriazole  	 NNS	B-NP
( 	( 	 -LRB-	O
CAI 	CAI 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
combretastatin  	combretastatin  	 FW	B-NP
A4  	A4  	 FW	I-NP
prodrug  	prodrug  	 FW	I-NP
( 	( 	 -LRB-	O
CA4P 	CA4P 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
SU6668 	SU6668 	 NNP	O
,  	,  	 ,	O
SU11248 	SU11248 	 NNP	O
,  	,  	 ,	O
BMS-275291 	BMS-275291 	 NNP	B-NP
,  	,  	 ,	O
COL-3 	COL-3 	 NNP	B-NP
,  	,  	 ,	O
EMD  	EMD  	 NNP	B-NP
121974 	121974 	 CD	O
,  	,  	 ,	O
IMC-1C11 	IMC-1C11 	 NNP	B-NP
,  	,  	 ,	O
IM862 	IM862 	 NNP	B-NP
,  	,  	 ,	O
TNP-470 	TNP-470 	 NNP	B-NP
,  	,  	 ,	O
celecoxib  	celecoxib  	 NNS	B-NP
( 	( 	 -LRB-	O
Celebrex 	Celebrex 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
rofecoxib  	rofecoxib  	 NNS	B-NP
( 	( 	 -LRB-	O
Vioxx 	Vioxx 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
interferon  	interferon  	 JJ	O
alpha 	alpha 	 NN	O
,  	,  	 ,	O
interleukin-12  	interleukin-12  	 NNP	B-NP
( 	( 	 -LRB-	O
IL-12 	IL-12 	 NNP	B-NP
)  	)  	 -RRB-	O
or  	or  	 CC	O
any  	any  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
compounds  	compounds  	 NN	O
identified  	identified  	 VBN	O
in  	in  	 IN	O
Science  	Science  	 NNP	B-NP
Vol.  	Vol.  	 CD	I-NP
289 	289 	 CD	O
,  	,  	 ,	O
Pages  	Pages  	 NNP	O
1197-1201  	1197-1201  	 NNP	O
( 	( 	 -LRB-	O
Aug.  	Aug.  	 NNP	O
17 	17 	 CD	O
,  	,  	 ,	O
2000 	2000 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
expressly  	expressly  	 RB	O
incorporated  	incorporated  	 VBN	O
herein  	herein  	 VBN	O
by  	by  	 IN	O
reference 	reference 	 NN	O
,  	,  	 ,	O
biological  	biological  	 JJ	B-NP
response  	response  	 NN	I-NP
modifiers  	modifiers  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
interferon 	interferon 	 NN	O
,  	,  	 ,	O
bacillus  	bacillus  	 JJ	B-NP
calmette-guerin  	calmette-guerin  	 NN	I-NP
( 	( 	 -LRB-	O
BCG 	BCG 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
monoclonal  	monoclonal  	 JJ	B-NP
antibodies 	antibodies 	 NNS	I-NP
,  	,  	 ,	O
interluken  	interluken  	 CD	B-NP
2 	2 	 CD	O
,  	,  	 ,	O
granulocyte  	granulocyte  	 JJ	B-NP
colony  	colony  	 NN	I-NP
stimulating  	stimulating  	 VBG	I-NP
factor  	factor  	 NN	I-NP
( 	( 	 -LRB-	O
GCSF 	GCSF 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
etc. 	etc. 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
PGDF  	PGDF  	 NNP	B-NP
receptor  	receptor  	 NN	I-NP
antagonists 	antagonists 	 NNS	I-NP
,  	,  	 ,	O
herceptin 	herceptin 	 NN	B-NP
,  	,  	 ,	O
asparaginase 	asparaginase 	 NN	B-NP
,  	,  	 ,	O
busulphan 	busulphan 	 NN	B-NP
,  	,  	 ,	O
carboplatin 	carboplatin 	 NN	B-NP
,  	,  	 ,	O
cisplatin 	cisplatin 	 NN	B-NP
,  	,  	 ,	O
carmustine 	carmustine 	 NN	B-NP
,  	,  	 ,	O
cchlorambucil 	cchlorambucil 	 NN	B-NP
,  	,  	 ,	O
cytarabine 	cytarabine 	 NN	B-NP
,  	,  	 ,	O
dacarbazine 	dacarbazine 	 NN	B-NP
,  	,  	 ,	O
etoposide 	etoposide 	 NN	B-NP
,  	,  	 ,	O
flucarbazine 	flucarbazine 	 NN	B-NP
,  	,  	 ,	O
flurouracil 	flurouracil 	 NN	B-NP
,  	,  	 ,	O
gemcitabine 	gemcitabine 	 NN	B-NP
,  	,  	 ,	O
hydroxyurea 	hydroxyurea 	 NN	B-NP
,  	,  	 ,	O
ifosphamide 	ifosphamide 	 NN	B-NP
,  	,  	 ,	O
irinotecan 	irinotecan 	 NN	B-NP
,  	,  	 ,	O
lomustine 	lomustine 	 NN	B-NP
,  	,  	 ,	O
melphalan 	melphalan 	 NN	B-NP
,  	,  	 ,	O
mercaptopurine 	mercaptopurine 	 NN	B-NP
,  	,  	 ,	O
methotrexate 	methotrexate 	 NN	B-NP
,  	,  	 ,	O
thioguanine 	thioguanine 	 NN	B-NP
,  	,  	 ,	O
thiotepa 	thiotepa 	 NN	B-NP
,  	,  	 ,	O
tomudex 	tomudex 	 NN	B-NP
,  	,  	 ,	O
topotecan 	topotecan 	 NN	B-NP
,  	,  	 ,	O
treosulfan 	treosulfan 	 NN	B-NP
,  	,  	 ,	O
vinblastine 	vinblastine 	 NN	B-NP
,  	,  	 ,	O
vincristine 	vincristine 	 NN	B-NP
,  	,  	 ,	O
mitoazitrone 	mitoazitrone 	 NN	B-NP
,  	,  	 ,	O
oxaliplatin 	oxaliplatin 	 NN	B-NP
,  	,  	 ,	O
procarbazine 	procarbazine 	 NN	B-NP
,  	,  	 ,	O
streptocin 	streptocin 	 NN	B-NP
,  	,  	 ,	O
taxol  	taxol  	 NN	B-NP
or  	or  	 CC	O
paclitaxel 	paclitaxel 	 NN	B-NP
,  	,  	 ,	O
taxotere 	taxotere 	 NN	B-NP
,  	,  	 ,	O
analogs 	analogs 	 FW	B-NP
/ 	/ 	 FW	I-NP
congeners 	congeners 	 FW	I-NP
,  	,  	 ,	O
derivatives  	derivatives  	 NNS	O
of  	of  	 IN	O
such  	such  	 JJ	O
compounds 	compounds 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
Exemplary  	Exemplary  	 JJ	B-NP
decongestants  	decongestants  	 NN	I-NP
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
incorporated  	incorporated  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices 	devices 	 NNS	I-NP
,  	,  	 ,	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
epinephrine 	epinephrine 	 NN	B-NP
,  	,  	 ,	O
pseudoephedrine 	pseudoephedrine 	 NN	B-NP
,  	,  	 ,	O
oxymetazoline 	oxymetazoline 	 NN	B-NP
,  	,  	 ,	O
phenylephrine 	phenylephrine 	 NN	B-NP
,  	,  	 ,	O
tetrahydrozolidine 	tetrahydrozolidine 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
xylometazoline 	xylometazoline 	 NN	B-NP
.  	.  	 .	O
Mucolytics  	Mucolytics  	 NNS	B-NP
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limted  	limted  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
acetylcysteine 	acetylcysteine 	 NN	B-NP
,  	,  	 ,	O
domase  	domase  	 JJ	B-NP
alpha 	alpha 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
guaifenesin 	guaifenesin 	 NN	B-NP
.  	.  	 .	O
Anti-histamines  	Anti-histamines  	 JJ	B-NP
such  	such  	 JJ	O
as  	as  	 IN	O
azelastine 	azelastine 	 NN	B-NP
,  	,  	 ,	O
diphenhydramine 	diphenhydramine 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
loratidine  	loratidine  	 NNS	B-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
used 	used 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
those  	those  	 DT	O
instances  	instances  	 NNS	O
where  	where  	 WRB	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
desirable  	desirable  	 JJ	O
to  	to  	 TO	O
remove  	remove  	 VB	O
water  	water  	 NN	O
from  	from  	 IN	O
tissue 	tissue 	 NN	O
,  	,  	 ,	O
e.g 	e.g 	 NNP	O
,  	,  	 ,	O
to  	to  	 TO	O
remove  	remove  	 VB	O
fluid  	fluid  	 VBN	O
from  	from  	 IN	O
polyps  	polyps  	 NNS	O
or  	or  	 CC	O
edematous  	edematous  	 JJ	B-NP
tissue 	tissue 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
hyperosmolar  	hyperosmolar  	 JJ	B-NP
agent  	agent  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
employed 	employed 	 VBN	O
.  	.  	 .	O
Suitable  	Suitable  	 JJ	B-NP
hyperosmolar  	hyperosmolar  	 JJ	I-NP
agents  	agents  	 NNS	I-NP
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
furosemide 	furosemide 	 NN	B-NP
,  	,  	 ,	O
sodium  	sodium  	 JJ	B-NP
chloride  	chloride  	 NN	I-NP
gel 	gel 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
other  	other  	 JJ	O
salt  	salt  	 NN	B-NP
preparations  	preparations  	 NNS	I-NP
that  	that  	 IN	O
draw  	draw  	 JJ	O
water  	water  	 NN	O
from  	from  	 IN	O
tissue  	tissue  	 NN	O
or  	or  	 CC	O
substances  	substances  	 NNS	O
that  	that  	 WDT	O
directly  	directly  	 RB	O
or  	or  	 CC	O
indirectly  	indirectly  	 RB	O
change  	change  	 VB	O
the  	the  	 DT	O
osmolar  	osmolar  	 JJ	B-NP
content  	content  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
mucous  	mucous  	 JJ	I-NP
layer 	layer 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
constitute  	constitute  	 VB	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
95 	95 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
95 	95 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
90 	90 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
80 	80 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
70 	70 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
60 	60 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
50 	50 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
40 	40 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
30 	30 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
20 	20 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
10 	10 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
5 	5 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
1 	1 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
from  	from  	 IN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
0.25 	0.25 	 CD	O
%  	%  	 NN	O
by  	by  	 IN	O
weight  	weight  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
releasing  	releasing  	 JJ	O
portion  	portion  	 NN	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
)  	)  	 -RRB-	O
or  	or  	 CC	O
releasing  	releasing  	 JJ	O
material  	material  	 NN	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
layer  	layer  	 NN	O
or  	or  	 CC	O
layers  	layers  	 NNS	O
having  	having  	 VBG	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent 	agent 	 NN	B-NP
)  	)  	 -RRB-	O
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
used  	used  	 VBN	O
will  	will  	 MD	O
usually  	usually  	 RB	O
depend  	depend  	 VB	O
on  	on  	 IN	O
factors  	factors  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
particular  	particular  	 JJ	O
agent  	agent  	 NN	B-NP
incorporated 	incorporated 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
being  	being  	 VBG	O
treated 	treated 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
severity  	severity  	 NN	O
of  	of  	 IN	O
clinical  	clinical  	 JJ	B-NP
symptoms 	symptoms 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
in  	in  	 IN	O
all  	all  	 DT	O
instances  	instances  	 NNS	O
will  	will  	 MD	O
usually  	usually  	 RB	O
be  	be  	 VB	O
an  	an  	 DT	O
amount  	amount  	 NN	O
that  	that  	 WDT	O
is  	is  	 VBZ	O
effective  	effective  	 JJ	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
upon  	upon  	 IN	O
delivery  	delivery  	 NN	O
into  	into  	 IN	O
a  	a  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
when  	when  	 WRB	O
treating  	treating  	 VBG	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
inflammation 	inflammation 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
device  	device  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
deliver  	deliver  	 VB	O
per  	per  	 IN	O
day 	day 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
1  	1  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
100  	100  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g 	g 	 CD	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
10  	10  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
50  	50  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g 	g 	 CD	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
10  	10  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
40  	40  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g 	g 	 CD	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
10  	10  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
30  	30  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g 	g 	 CD	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
10  	10  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
25  	25  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g 	g 	 CD	O
,  	,  	 ,	O
or  	or  	 CC	O
from  	from  	 IN	O
about  	about  	 IN	O
10  	10  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
20  	20  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 NN	O
of  	of  	 IN	O
mometasone  	mometasone  	 JJ	B-NP
furoate  	furoate  	 NN	I-NP
into  	into  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
device  	device  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
deliver  	deliver  	 VB	O
per  	per  	 IN	O
day 	day 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
10  	10  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
700  	700  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g 	g 	 CD	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
25  	25  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
400  	400  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g 	g 	 CD	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
75  	75  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
300  	300  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g 	g 	 CD	O
,  	,  	 ,	O
or  	or  	 CC	O
about  	about  	 IN	O
100  	100  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
200  	200  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x3bc 	x3bc 	 CD	O
; 	; 	 :	O
g  	g  	 NN	O
of  	of  	 IN	O
fluticasone  	fluticasone  	 JJ	B-NP
propionate  	propionate  	 NN	I-NP
into  	into  	 IN	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
instances 	instances 	 NNS	O
,  	,  	 ,	O
crystal  	crystal  	 NN	O
forms 	forms 	 NNS	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
hydrous  	hydrous  	 NN	B-NP
and  	and  	 CC	O
anhydrous  	anhydrous  	 JJ	B-NP
crystal  	crystal  	 NN	I-NP
forms 	forms 	 NNS	I-NP
,  	,  	 ,	O
of  	of  	 IN	O
drugs  	drugs  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
methods  	methods  	 NNS	O
and  	and  	 CC	O
devices  	devices  	 NNS	O
described  	described  	 VBD	O
here 	here 	 RB	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
mometasone  	mometasone  	 FW	B-NP
furoate  	furoate  	 FW	I-NP
monohydrate  	monohydrate  	 FW	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
used 	used 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
incorporated  	incorporated  	 VBN	O
and  	and  	 CC	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
coated  	coated  	 VBN	O
onto  	onto  	 IN	O
the  	the  	 DT	O
surface  	surface  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
An  	An  	 DT	O
exemplary  	exemplary  	 JJ	B-NP
way  	way  	 NN	I-NP
the  	the  	 DT	O
coating  	coating  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
achieved  	achieved  	 VBN	O
is  	is  	 VBZ	O
by  	by  	 IN	O
dissolving  	dissolving  	 NN	O
or  	or  	 CC	O
suspending  	suspending  	 VBG	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
solution  	solution  	 NN	B-NP
or  	or  	 CC	O
melt  	melt  	 VB	O
of  	of  	 IN	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
exemplary  	exemplary  	 JJ	B-NP
way 	way 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
powder  	powder  	 VBN	O
coated  	coated  	 VBN	O
onto  	onto  	 IN	O
the  	the  	 DT	O
surface  	surface  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
filament  	filament  	 NN	B-NP
that  	that  	 WDT	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
made  	made  	 VBN	O
adhesive  	adhesive  	 NN	B-NP
by 	by 	 IN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
heating  	heating  	 VBG	O
or  	or  	 CC	O
softening  	softening  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
solvent  	solvent  	 JJ	O
or  	or  	 CC	O
plasticizer 	plasticizer 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
yet  	yet  	 RB	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
microencapsulated  	microencapsulated  	 JJ	B-NP
drug  	drug  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
attached  	attached  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
surface  	surface  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
As  	As  	 RB	O
previously  	previously  	 RB	O
mentioned 	mentioned 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
incorporated  	incorporated  	 VBN	O
throughout  	throughout  	 IN	O
all  	all  	 DT	O
portions  	portions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
or  	or  	 CC	O
in  	in  	 IN	O
particular  	particular  	 JJ	O
portions  	portions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
and  	and  	 CC	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
etc. 	etc. 	 FW	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
such  	such  	 JJ	O
that  	that  	 IN	O
differential  	differential  	 JJ	B-NP
release  	release  	 NN	I-NP
results 	results 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
differential  	differential  	 JJ	B-NP
release  	release  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
or  	or  	 CC	O
for  	for  	 IN	O
different  	different  	 JJ	O
active  	active  	 JJ	O
agents 	agents 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
variable  	variable  	 JJ	O
release  	release  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
achieved  	achieved  	 VBN	O
using  	using  	 VBG	O
methods  	methods  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
bulk  	bulk  	 JJ	B-NP
loading 	loading 	 NN	I-NP
,  	,  	 ,	O
surface  	surface  	 NN	O
coating  	coating  	 NN	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
by  	by  	 IN	O
having  	having  	 VBG	O
a  	a  	 DT	O
higher  	higher  	 JJR	O
load  	load  	 NN	O
layer 	layer 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
surface  	surface  	 NN	O
loading  	loading  	 NN	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
by  	by  	 IN	O
embedding 	embedding 	 NN	O
,  	,  	 ,	O
spraying 	spraying 	 VBG	O
,  	,  	 ,	O
or  	or  	 CC	O
absorbing  	absorbing  	 JJ	O
drug  	drug  	 NN	O
onto  	onto  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	B-NP
surface 	surface 	 NN	I-NP
,  	,  	 ,	O
etc. 	etc. 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
other  	other  	 JJ	O
techniques  	techniques  	 NNS	O
well  	well  	 RB	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
.  	.  	 .	O
Variable  	Variable  	 JJ	B-NP
release  	release  	 NN	I-NP
of  	of  	 IN	O
different  	different  	 JJ	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
achieved 	achieved 	 VBN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
by  	by  	 IN	O
segmenting  	segmenting  	 VBG	O
the  	the  	 DT	O
drugs  	drugs  	 NNS	O
into  	into  	 IN	O
different  	different  	 JJ	O
layers 	layers 	 NNS	O
,  	,  	 ,	O
reservoirs  	reservoirs  	 NNS	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
microspheres 	microspheres 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
themselves  	themselves  	 PRP	O
may  	may  	 MD	O
have  	have  	 VB	O
differing  	differing  	 VBG	B-NP
permeability  	permeability  	 NNS	I-NP
or  	or  	 CC	O
biodegradation  	biodegradation  	 JJ	B-NP
profiles 	profiles 	 NNS	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 RB	O
by  	by  	 IN	O
other  	other  	 JJ	O
techniques  	techniques  	 NNS	O
well  	well  	 RB	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
.  	.  	 .	O
Polymers 	Polymers 	 NNS	O
.  	.  	 .	O
When  	When  	 WRB	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
are  	are  	 VBP	O
made  	made  	 VBN	O
with  	with  	 IN	O
polymers 	polymers 	 NNS	O
,  	,  	 ,	O
selection  	selection  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
to  	to  	 TO	O
be  	be  	 VB	O
employed  	employed  	 VBN	O
will  	will  	 MD	O
vary  	vary  	 VB	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
residence  	residence  	 NN	B-NP
time  	time  	 NN	I-NP
and  	and  	 CC	O
release  	release  	 NN	B-NP
kinetics  	kinetics  	 VBZ	I-NP
desired 	desired 	 VBN	O
,  	,  	 ,	O
method  	method  	 NN	O
of  	of  	 IN	O
device  	device  	 NN	B-NP
delivery 	delivery 	 NN	I-NP
,  	,  	 ,	O
particular  	particular  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
agent  	agent  	 NN	I-NP
used 	used 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like 	like 	 JJ	O
.  	.  	 .	O
In  	In  	 IN	O
all  	all  	 DT	O
instances 	instances 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
when  	when  	 WRB	O
degraded  	degraded  	 JJ	O
results  	results  	 NNS	O
in  	in  	 IN	O
physiologically  	physiologically  	 JJ	B-NP
acceptable  	acceptable  	 JJ	I-NP
degradation  	degradation  	 NN	I-NP
products 	products 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
may  	may  	 MD	O
constitute  	constitute  	 VB	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
5 	5 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
10 	10 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
20 	20 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
30 	30 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
40 	40 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
50 	50 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
60 	60 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
70 	70 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
80 	80 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
90 	90 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
95 	95 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
100 	100 	 CD	O
%  	%  	 NN	O
by  	by  	 IN	O
weight  	weight  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
or  	or  	 CC	O
component  	component  	 NN	O
that  	that  	 IN	O
it  	it  	 PRP	O
makes  	makes  	 VBZ	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Suitable  	Suitable  	 JJ	O
biodegradable  	biodegradable  	 NN	O
and  	and  	 CC	O
biocompatible  	biocompatible  	 JJ	B-NP
polymers  	polymers  	 NNS	I-NP
for  	for  	 IN	O
use  	use  	 NN	O
in  	in  	 IN	O
making  	making  	 VBG	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
polymers  	polymers  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolide 	glycolide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolic  	glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid-co-glycolic  	acid-co-glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolide 	glycolide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolic  	glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid-co-glycolic  	acid-co-glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
caprolactone 	caprolactone 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
caprolactone 	caprolactone 	 LS	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers  	copolymers  	 FW	I-NP
a  	a  	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
orthoester 	orthoester 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
phosphazene 	phosphazene 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
hydroxybutyrate 	hydroxybutyrate 	 LS	I-NP
)  	)  	 -RRB-	I-NP
or  	or  	 CC	O
a  	a  	 DT	O
copolymer  	copolymer  	 NN	B-NP
including  	including  	 VBG	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
hydroxybutyrate 	hydroxybutyrate 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-caprolactone 	lactide-co-caprolactone 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
polycarbonate 	polycarbonate 	 NN	O
;  	;  	 :	O
a  	a  	 DT	O
polyesteramide 	polyesteramide 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
polyanhidride 	polyanhidride 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
dioxanone 	dioxanone 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
alkylene  	alkylene  	 FW	I-NP
alkylate 	alkylate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
copolymer  	copolymer  	 NN	B-NP
of  	of  	 IN	I-NP
polyethylene  	polyethylene  	 NN	I-NP
glycol  	glycol  	 NNS	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
polyorthoester 	polyorthoester 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polyurethane 	polyurethane 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
amino  	amino  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
polyetherester 	polyetherester 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
polyacetal 	polyacetal 	 NN	O
;  	;  	 :	O
a  	a  	 DT	O
polycyanoacrylate 	polycyanoacrylate 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
oxyethylene 	oxyethylene 	 LS	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
oxypropylene 	oxypropylene 	 LS	I-NP
)  	)  	 -RRB-	I-NP
copolymer 	copolymer 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
a  	a  	 DT	O
blend  	blend  	 NN	O
or  	or  	 CC	O
copolymer  	copolymer  	 JJ	O
thereof 	thereof 	 NN	O
.  	.  	 .	O
Biodegradable  	Biodegradable  	 JJ	B-NP
shape  	shape  	 NN	I-NP
memory  	memory  	 NN	I-NP
polymers 	polymers 	 NNS	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
those  	those  	 DT	O
commercialized  	commercialized  	 NN	O
by  	by  	 IN	O
nmemoScience  	nmemoScience  	 JJ	O
in  	in  	 IN	O
Aachen 	Aachen 	 NNP	B-NP
,  	,  	 ,	O
Germany 	Germany 	 NNP	O
,  	,  	 ,	O
or  	or  	 CC	O
those  	those  	 DT	O
described  	described  	 VBN	O
in  	in  	 IN	O
U.S.  	U.S.  	 NNP	O
Pat 	Pat 	 NNP	O
.  	.  	 .	O
No.  	No.  	 NNP	O
5,189,110  	5,189,110  	 NNP	O
or  	or  	 CC	O
U.S.  	U.S.  	 NNP	O
Pat 	Pat 	 NNP	O
.  	.  	 .	O
No.  	No.  	 NNP	O
5,139,832 	5,139,832 	 NNP	O
,  	,  	 ,	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
employed 	employed 	 VBN	O
.  	.  	 .	O
As  	As  	 RB	O
used  	used  	 VBN	O
herein 	herein 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolide 	glycolide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolic  	glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid-co-glycolic  	acid-co-glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
)  	)  	 -RRB-	I-NP
will  	will  	 MD	O
all  	all  	 RB	O
be  	be  	 VB	O
referred  	referred  	 VBN	O
to  	to  	 TO	O
as  	as  	 IN	O
PLG 	PLG 	 NNP	B-NP
,  	,  	 ,	O
PLG  	PLG  	 NNP	B-NP
polymers 	polymers 	 NNS	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
lactide 	lactide 	 FW	B-NP
/ 	/ 	 FW	I-NP
glycolide  	glycolide  	 FW	I-NP
polymers 	polymers 	 FW	I-NP
.  	.  	 .	O
Lactide 	Lactide 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
glycolide  	glycolide  	 NN	I-NP
polymers  	polymers  	 NNS	I-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
drug  	drug  	 NN	I-NP
delivery  	delivery  	 NN	I-NP
devices  	devices  	 NNS	I-NP
and  	and  	 CC	O
compositions  	compositions  	 NNS	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
invention  	invention  	 NNS	O
are  	are  	 VBP	O
typically  	typically  	 RB	O
made  	made  	 VBN	O
by  	by  	 IN	O
melt  	melt  	 JJ	O
polymerization  	polymerization  	 NN	B-NP
through  	through  	 IN	O
the  	the  	 DT	O
ring  	ring  	 NN	B-NP
opening  	opening  	 NN	I-NP
of  	of  	 IN	I-NP
lactide  	lactide  	 NN	I-NP
and  	and  	 CC	O
glycolide  	glycolide  	 JJ	B-NP
monomers 	monomers 	 NN	I-NP
.  	.  	 .	O
Some  	Some  	 DT	O
polymers  	polymers  	 NNS	O
are  	are  	 VBP	O
available  	available  	 JJ	O
with  	with  	 IN	O
or  	or  	 CC	O
without  	without  	 IN	O
carboxylic  	carboxylic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
end  	end  	 NN	I-NP
groups 	groups 	 NNS	I-NP
.  	.  	 .	O
When  	When  	 WRB	O
the  	the  	 DT	O
end  	end  	 NN	B-NP
group  	group  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
poly 	poly 	 NN	I-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
glycolide 	glycolide 	 LS	I-NP
)  	)  	 -RRB-	I-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
a  	a  	 DT	O
carboxylic  	carboxylic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
,  	,  	 ,	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
an  	an  	 DT	O
ester 	ester 	 NN	B-NP
,  	,  	 ,	O
then  	then  	 RB	O
the  	the  	 DT	O
resultant  	resultant  	 JJ	O
polymer  	polymer  	 NN	B-NP
is  	is  	 VBZ	O
referred  	referred  	 VBN	O
to  	to  	 TO	O
herein  	herein  	 VB	O
as  	as  	 RB	O
blocked  	blocked  	 VBN	O
or  	or  	 CC	O
capped 	capped 	 VBD	O
.  	.  	 .	O
The  	The  	 DT	O
unblocked  	unblocked  	 JJ	O
polymer 	polymer 	 NN	B-NP
,  	,  	 ,	O
conversely 	conversely 	 NN	O
,  	,  	 ,	O
has  	has  	 VBZ	O
a  	a  	 DT	O
terminal  	terminal  	 NN	B-NP
carboxylic  	carboxylic  	 NN	I-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
linear  	linear  	 FW	B-NP
lactide 	lactide 	 FW	I-NP
/ 	/ 	 FW	I-NP
glycolide  	glycolide  	 FW	I-NP
polymers  	polymers  	 NNS	I-NP
are  	are  	 VBP	O
used 	used 	 VBN	O
;  	;  	 :	O
however 	however 	 RB	O
,  	,  	 ,	O
star  	star  	 NN	B-NP
polymers  	polymers  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
as  	as  	 IN	O
well 	well 	 RB	O
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
high  	high  	 JJ	O
molecular  	molecular  	 JJ	B-NP
weight  	weight  	 NN	I-NP
polymers  	polymers  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
invention 	invention 	 NN	O
,  	,  	 ,	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
to  	to  	 TO	O
meet  	meet  	 VB	O
strength  	strength  	 NN	B-NP
requirements  	requirements  	 NNS	I-NP
and  	and  	 CC	O
extend  	extend  	 VB	O
bioabsorption  	bioabsorption  	 JJ	B-NP
time 	time 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
instances 	instances 	 NNS	O
,  	,  	 ,	O
low  	low  	 JJ	O
molecular  	molecular  	 JJ	B-NP
weight  	weight  	 NN	I-NP
polymers  	polymers  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
when  	when  	 WRB	O
resorption  	resorption  	 JJ	B-NP
time  	time  	 NN	I-NP
and  	and  	 CC	O
not  	not  	 RB	O
material  	material  	 JJ	B-NP
strength  	strength  	 NN	I-NP
is  	is  	 VBZ	O
important 	important 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
lactide  	lactide  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
polymer  	polymer  	 NN	I-NP
has  	has  	 VBZ	O
an  	an  	 DT	O
asymmetric  	asymmetric  	 JJ	B-NP
carbon 	carbon 	 NN	I-NP
.  	.  	 .	O
Racemic  	Racemic  	 NNP	B-NP
DL- 	DL- 	 NNP	I-NP
,  	,  	 ,	O
L- 	L- 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
D-polymers  	D-polymers  	 NNS	B-NP
are  	are  	 VBP	O
commercially  	commercially  	 RB	O
available  	available  	 JJ	O
to  	to  	 TO	O
include  	include  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
invention 	invention 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
L-polymers  	L-polymers  	 NNS	B-NP
are  	are  	 VBP	O
more  	more  	 RBR	O
crystalline  	crystalline  	 JJ	O
and  	and  	 CC	O
resorb  	resorb  	 VBG	O
slower  	slower  	 JJR	O
than  	than  	 IN	O
DL-polymers 	DL-polymers 	 JJ	B-NP
.  	.  	 .	O
In  	In  	 IN	O
addition  	addition  	 NN	O
to  	to  	 TO	O
copolymers  	copolymers  	 VB	O
comprising  	comprising  	 VBG	B-NP
glycolide  	glycolide  	 NNS	I-NP
and  	and  	 CC	O
DL-lactide  	DL-lactide  	 JJ	B-NP
or  	or  	 CC	O
L-lactide 	L-lactide 	 JJ	B-NP
,  	,  	 ,	O
copolymers  	copolymers  	 VBG	O
of  	of  	 IN	O
L-lactide  	L-lactide  	 JJ	B-NP
and  	and  	 CC	O
DL-lactide  	DL-lactide  	 NNS	B-NP
are  	are  	 VBP	O
also  	also  	 RB	O
commercially  	commercially  	 RB	O
available 	available 	 JJ	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
homopolymers  	homopolymers  	 VBG	O
of  	of  	 IN	O
lactide  	lactide  	 NN	B-NP
or  	or  	 CC	O
glycolide  	glycolide  	 NNS	B-NP
are  	are  	 VBP	O
commercially  	commercially  	 RB	O
available 	available 	 JJ	O
.  	.  	 .	O
Star  	Star  	 NNP	B-NP
polymers  	polymers  	 NNS	I-NP
of  	of  	 IN	I-NP
lactide  	lactide  	 NN	I-NP
or  	or  	 CC	O
glycolide  	glycolide  	 NNS	B-NP
or  	or  	 CC	O
lactide 	lactide 	 CD	B-NP
/ 	/ 	 CD	I-NP
glycolide  	glycolide  	 CD	I-NP
copolymers  	copolymers  	 NNS	I-NP
are  	are  	 VBP	O
also  	also  	 RB	O
commercially  	commercially  	 RB	O
available 	available 	 JJ	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
case  	case  	 NN	O
when  	when  	 WRB	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
is  	is  	 VBZ	O
poly 	poly 	 JJ	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
glycolide 	glycolide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
lactide  	lactide  	 NN	B-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
glycolide  	glycolide  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
polymer  	polymer  	 NN	B-NP
may  	may  	 MD	O
vary 	vary 	 VB	O
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
contains  	contains  	 VBZ	O
from  	from  	 IN	O
about  	about  	 IN	O
0  	0  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
100  	100  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
40  	40  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
100  	100  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
50  	50  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
100  	100  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
60  	60  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
100  	100  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
70  	70  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
100  	100  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
from  	from  	 IN	O
about  	about  	 IN	O
80  	80  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
100  	100  	 CD	O
mole  	mole  	 JJ	B-NP
%  	%  	 NN	O
lactide 	lactide 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
from  	from  	 IN	O
about  	about  	 IN	O
0  	0  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
100  	100  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0  	0  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
60  	60  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
10  	10  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
40  	40  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
20  	20  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
40  	40  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
from  	from  	 IN	O
about  	about  	 IN	O
30  	30  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
40  	40  	 CD	O
mole  	mole  	 JJ	B-NP
%  	%  	 NN	O
glycolide 	glycolide 	 NN	B-NP
,  	,  	 ,	O
wherein  	wherein  	 VBG	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
lactide  	lactide  	 NN	B-NP
and  	and  	 CC	O
glycolide  	glycolide  	 NN	B-NP
is  	is  	 VBZ	O
100  	100  	 CD	O
mole  	mole  	 JJ	B-NP
% 	% 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
about  	about  	 IN	O
85 	85 	 CD	O
: 	: 	 :	O
15  	15  	 CD	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
about  	about  	 IN	O
75 	75 	 CD	O
: 	: 	 :	O
25  	25  	 CD	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
about  	about  	 IN	O
65 	65 	 CD	O
: 	: 	 :	O
35  	35  	 CD	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
about  	about  	 IN	O
50 	50 	 CD	O
: 	: 	 :	O
50  	50  	 CD	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
where  	where  	 WRB	O
the  	the  	 DT	O
ratios  	ratios  	 NNS	O
are  	are  	 VBP	O
mole  	mole  	 JJ	B-NP
ratios 	ratios 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
when  	when  	 WRB	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
is  	is  	 VBZ	O
poly 	poly 	 JJ	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
glycolide 	glycolide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
polymer  	polymer  	 NN	B-NP
has  	has  	 VBZ	O
an  	an  	 DT	O
intrinsic  	intrinsic  	 JJ	B-NP
viscosity  	viscosity  	 NN	I-NP
of  	of  	 IN	O
from  	from  	 IN	O
about  	about  	 IN	O
0.15  	0.15  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
1.5  	1.5  	 CD	O
dL 	dL 	 JJ	O
/ 	/ 	 CD	O
g 	g 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.25  	0.25  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
1.5  	1.5  	 CD	O
dL 	dL 	 JJ	O
/ 	/ 	 CD	O
g 	g 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.25  	0.25  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
1.0  	1.0  	 CD	O
dL 	dL 	 JJ	O
/ 	/ 	 CD	O
g 	g 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.25  	0.25  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
0.8  	0.8  	 CD	O
dL 	dL 	 JJ	O
/ 	/ 	 CD	O
g 	g 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0.25  	0.25  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
0.6  	0.6  	 CD	O
dL 	dL 	 JJ	O
/ 	/ 	 CD	O
g 	g 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
from  	from  	 IN	O
about  	about  	 IN	O
0.25  	0.25  	 CD	O
to  	to  	 TO	O
about  	about  	 RB	O
0.4  	0.4  	 CD	O
dL 	dL 	 JJ	O
/ 	/ 	 NN	O
g  	g  	 VBZ	O
as  	as  	 RB	O
measured  	measured  	 VBN	O
in  	in  	 IN	O
chloroform  	chloroform  	 NN	B-NP
at  	at  	 IN	O
a  	a  	 DT	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	O
0.5  	0.5  	 CD	O
g 	g 	 CD	B-NP
/ 	/ 	 CD	I-NP
dL  	dL  	 NN	I-NP
at  	at  	 IN	O
30 	30 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
C 	C 	 NNP	O
.  	.  	 .	O
If  	If  	 IN	O
a  	a  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
is  	is  	 VBZ	O
used  	used  	 VBN	O
to  	to  	 TO	O
make  	make  	 VB	O
or  	or  	 CC	O
incorporate  	incorporate  	 VB	O
into  	into  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
or  	or  	 CC	O
composition 	composition 	 NN	O
,  	,  	 ,	O
suitable  	suitable  	 JJ	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymers  	polymers  	 NNS	I-NP
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
vinyl  	vinyl  	 FW	I-NP
acetate 	acetate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
vinyl  	vinyl  	 FW	I-NP
acetate 	acetate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
silicone  	silicone  	 JJ	B-NP
polymers 	polymers 	 NNS	I-NP
,  	,  	 ,	O
polyurethanes 	polyurethanes 	 NN	O
,  	,  	 ,	O
polysaccharides  	polysaccharides  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
a  	a  	 DT	O
cellulosic  	cellulosic  	 JJ	B-NP
polymers  	polymers  	 NNS	I-NP
and  	and  	 CC	O
cellulose  	cellulose  	 JJ	B-NP
derivatives 	derivatives 	 NNS	I-NP
,  	,  	 ,	O
acyl  	acyl  	 FW	B-NP
substituted  	substituted  	 FW	I-NP
cellulose  	cellulose  	 FW	I-NP
acetates  	acetates  	 FW	I-NP
and  	and  	 CC	O
derivatives  	derivatives  	 NNS	O
thereof 	thereof 	 RB	O
,  	,  	 ,	O
copolymers  	copolymers  	 VBG	O
of  	of  	 IN	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
and  	and  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
butylene  	butylene  	 FW	I-NP
terephthalate 	terephthalate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
polystyrenes 	polystyrenes 	 NN	O
,  	,  	 ,	O
polyvinyl  	polyvinyl  	 JJ	B-NP
chloride 	chloride 	 NN	I-NP
,  	,  	 ,	O
polyvinyl  	polyvinyl  	 JJ	B-NP
fluoride 	fluoride 	 NN	I-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
vinyl  	vinyl  	 FW	I-NP
imidazole 	imidazole 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
chorosulphonated  	chorosulphonated  	 JJ	B-NP
polyolefins 	polyolefins 	 NN	I-NP
,  	,  	 ,	O
polyethylene  	polyethylene  	 NN	B-NP
oxide 	oxide 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
copolymers  	copolymers  	 NNS	O
and  	and  	 CC	O
blends  	blends  	 JJ	O
thereof 	thereof 	 NN	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
any  	any  	 DT	O
biocompatible 	biocompatible 	 NN	B-NP
,  	,  	 ,	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
mucoadhesive 	mucoadhesive 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
instances 	instances 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
plate  	plate  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
coated  	coated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
mucoadhesive 	mucoadhesive 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
may  	may  	 MD	O
or  	or  	 CC	O
may  	may  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
a  	a  	 DT	O
polymer 	polymer 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
polymer  	polymer  	 NN	B-NP
that  	that  	 WDT	O
carries  	carries  	 VBZ	O
a  	a  	 DT	O
charge 	charge 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
natural  	natural  	 JJ	O
polymers  	polymers  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
used 	used 	 VBN	O
.  	.  	 .	O
Representative  	Representative  	 JJ	B-NP
natural  	natural  	 JJ	O
polymers  	polymers  	 NNS	O
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
zein 	zein 	 NN	B-NP
,  	,  	 ,	O
modified  	modified  	 VBN	B-NP
zein 	zein 	 NN	I-NP
,  	,  	 ,	O
casein 	casein 	 NN	B-NP
,  	,  	 ,	O
chitin 	chitin 	 NN	B-NP
,  	,  	 ,	O
gelatin 	gelatin 	 NN	B-NP
,  	,  	 ,	O
gluten 	gluten 	 NN	B-NP
,  	,  	 ,	O
serum  	serum  	 JJ	B-NP
albumin 	albumin 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
collagen 	collagen 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
polysaccharides 	polysaccharides 	 NN	B-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
cellulose 	cellulose 	 NN	B-NP
,  	,  	 ,	O
dextrans 	dextrans 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
polyhyaluronic  	polyhyaluronic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
.  	.  	 .	O
Hydrogel  	Hydrogel  	 NNP	B-NP
or  	or  	 CC	O
sol-gel  	sol-gel  	 JJ	B-NP
mixtures  	mixtures  	 NNS	I-NP
of  	of  	 IN	I-NP
polysaccharides  	polysaccharides  	 NNS	I-NP
are  	are  	 VBP	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
employed 	employed 	 VBN	O
.  	.  	 .	O
Other  	Other  	 JJ	O
materials 	materials 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
metal 	metal 	 NN	O
.  	.  	 .	O
Examples  	Examples  	 NNS	O
of  	of  	 IN	O
suitable  	suitable  	 JJ	O
metals  	metals  	 NNS	O
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
cobalt 	cobalt 	 NN	O
,  	,  	 ,	O
chromium 	chromium 	 NN	O
,  	,  	 ,	O
nickel 	nickel 	 NN	O
,  	,  	 ,	O
platinum 	platinum 	 NN	O
,  	,  	 ,	O
stainless  	stainless  	 JJ	O
steel 	steel 	 NN	O
,  	,  	 ,	O
titanium 	titanium 	 NN	B-NP
,  	,  	 ,	O
tantalum 	tantalum 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
any  	any  	 DT	O
of  	of  	 IN	O
their  	their  	 PRP$	O
alloys 	alloys 	 NNS	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
nickel-titanium  	nickel-titanium  	 JJ	B-NP
alloys 	alloys 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
.  	.  	 .	O
Additional  	Additional  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
and  	and  	 CC	O
compositions  	compositions  	 NNS	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
invention  	invention  	 NN	O
may  	may  	 MD	O
further  	further  	 RB	O
include  	include  	 VB	O
components  	components  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
preservatives 	preservatives 	 NN	O
,  	,  	 ,	O
buffers 	buffers 	 NN	O
,  	,  	 ,	O
binders 	binders 	 NNS	O
,  	,  	 ,	O
disintegrants 	disintegrants 	 NN	B-NP
,  	,  	 ,	O
lubricants 	lubricants 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
any  	any  	 DT	O
other  	other  	 JJ	O
excipients  	excipients  	 JJ	O
necessary  	necessary  	 JJ	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
the  	the  	 DT	O
structure  	structure  	 NN	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
function  	function  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
devices 	devices 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
contain  	contain  	 VB	O
a  	a  	 DT	O
plasticizer  	plasticizer  	 NN	B-NP
or  	or  	 CC	O
solvent  	solvent  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
acetone 	acetone 	 NN	B-NP
,  	,  	 ,	O
methyl  	methyl  	 FW	B-NP
ethyl  	ethyl  	 FW	I-NP
ketone 	ketone 	 FW	I-NP
,  	,  	 ,	O
ethyl  	ethyl  	 JJ	B-NP
lactate 	lactate 	 NN	I-NP
,  	,  	 ,	O
ethyl  	ethyl  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
dichloromethane 	dichloromethane 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
ethyl  	ethyl  	 CD	B-NP
acetate 	acetate 	 CD	I-NP
/ 	/ 	 CD	I-NP
alcohol  	alcohol  	 NN	I-NP
blends  	blends  	 NNS	I-NP
that  	that  	 WDT	O
would  	would  	 MD	O
soften  	soften  	 VB	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
or  	or  	 CC	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
plasticizer  	plasticizer  	 NN	B-NP
or  	or  	 CC	O
solvent  	solvent  	 NNS	B-NP
would  	would  	 MD	O
diffuse  	diffuse  	 VB	O
or  	or  	 CC	O
otherwise  	otherwise  	 RB	O
be  	be  	 VB	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa  	mucosa  	 NN	I-NP
after  	after  	 IN	O
deployment  	deployment  	 NN	O
and  	and  	 CC	O
expansion  	expansion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
to  	to  	 TO	O
harden  	harden  	 VB	O
the  	the  	 DT	O
polymeric  	polymeric  	 JJ	B-NP
filaments  	filaments  	 NNS	I-NP
( 	( 	 -LRB-	O
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
)  	)  	 -RRB-	O
such  	such  	 JJ	O
that  	that  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
substantially  	substantially  	 RB	O
conforms  	conforms  	 VBZ	O
to  	to  	 TO	O
the  	the  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity 	cavity 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
to  	to  	 TO	O
the  	the  	 DT	O
extent  	extent  	 NN	O
that  	that  	 IN	O
a  	a  	 DT	O
better  	better  	 JJR	O
friction  	friction  	 NN	B-NP
fit  	fit  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
cavity  	cavity  	 JJ	I-NP
member  	member  	 NN	I-NP
against  	against  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall  	wall  	 NN	I-NP
is  	is  	 VBZ	O
provided 	provided 	 VBN	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
as  	as  	 RB	O
previously  	previously  	 RB	O
described 	described 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
also  	also  	 RB	O
include  	include  	 VB	O
a  	a  	 DT	O
mucoadhesive  	mucoadhesive  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
to  	to  	 TO	O
enhance  	enhance  	 VB	O
contact  	contact  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
mucosa 	mucosa 	 NN	I-NP
.  	.  	 .	O
Examples  	Examples  	 NNS	O
of  	of  	 IN	O
mucoadhesive  	mucoadhesive  	 JJ	B-NP
polymers  	polymers  	 NNS	I-NP
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
employed  	employed  	 VBN	O
include  	include  	 VBP	O
homopolymers  	homopolymers  	 VBN	O
of  	of  	 IN	O
acrylic  	acrylic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
monomers  	monomers  	 VBZ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
polyacrylic  	polyacrylic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
and  	and  	 CC	O
any  	any  	 DT	O
of  	of  	 IN	O
its  	its  	 PRP$	O
pharmaceutically  	pharmaceutically  	 JJ	B-NP
acceptable  	acceptable  	 JJ	I-NP
salts 	salts 	 NN	I-NP
;  	;  	 :	O
copolymers  	copolymers  	 NN	O
of  	of  	 IN	O
acrylic  	acrylic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
and  	and  	 CC	O
methacrylic  	methacrylic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
,  	,  	 ,	O
styrene 	styrene 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
vinyl  	vinyl  	 JJ	B-NP
ethers 	ethers 	 NN	I-NP
;  	;  	 :	O
vinyl  	vinyl  	 JJ	B-NP
polymers  	polymers  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
polyhydroxyethyl  	polyhydroxyethyl  	 JJ	B-NP
acrylate 	acrylate 	 NN	I-NP
,  	,  	 ,	O
polyhydroxyethyl  	polyhydroxyethyl  	 JJ	B-NP
methacrylate 	methacrylate 	 NN	I-NP
,  	,  	 ,	O
polyvinyl  	polyvinyl  	 JJ	B-NP
alcohol 	alcohol 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
polyvinyl  	polyvinyl  	 JJ	B-NP
pyrrolidone 	pyrrolidone 	 NN	I-NP
;  	;  	 :	O
cellulosic  	cellulosic  	 JJ	B-NP
derivatives  	derivatives  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
methyl  	methyl  	 JJ	B-NP
cellulose 	cellulose 	 NN	I-NP
,  	,  	 ,	O
ethyl  	ethyl  	 JJ	B-NP
cellulose 	cellulose 	 NN	I-NP
,  	,  	 ,	O
hydroxyethyl  	hydroxyethyl  	 JJ	B-NP
cellulose 	cellulose 	 NN	I-NP
,  	,  	 ,	O
hydroxypropyl  	hydroxypropyl  	 JJ	B-NP
cellulose 	cellulose 	 NN	I-NP
,  	,  	 ,	O
hydroxypropylmethyl  	hydroxypropylmethyl  	 JJ	B-NP
cellulose 	cellulose 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
carboxymethyl  	carboxymethyl  	 JJ	B-NP
cellulose 	cellulose 	 NN	I-NP
;  	;  	 :	O
polysaccharides  	polysaccharides  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
alginic  	alginic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
,  	,  	 ,	O
sodium  	sodium  	 JJ	B-NP
alginate 	alginate 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
tragacanth  	tragacanth  	 JJ	B-NP
gum 	gum 	 NN	I-NP
;  	;  	 :	O
collagen 	collagen 	 NN	B-NP
;  	;  	 :	O
gelatin 	gelatin 	 CD	B-NP
;  	;  	 :	O
and  	and  	 CC	O
any  	any  	 DT	O
combination  	combination  	 NN	O
thereof 	thereof 	 NN	O
.  	.  	 .	O
Release  	Release  	 NN	B-NP
kinetics 	kinetics 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
described  	described  	 VBD	O
here  	here  	 RB	O
may  	may  	 MD	O
be  	be  	 VB	O
formulated  	formulated  	 VBN	O
with  	with  	 IN	O
particles  	particles  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
dispersed  	dispersed  	 NNS	O
or  	or  	 CC	O
dissolved  	dissolved  	 VBN	O
within  	within  	 IN	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 JJ	B-NP
matrix 	matrix 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
formulated  	formulated  	 VBN	O
to  	to  	 TO	O
provide  	provide  	 VB	O
sustained  	sustained  	 VBN	B-NP
release  	release  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent 	agent 	 NN	B-NP
.  	.  	 .	O
If  	If  	 IN	O
made  	made  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
non-swellable  	non-swellable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
lactide 	lactide 	 FW	B-NP
/ 	/ 	 FW	I-NP
glycolide  	glycolide  	 FW	I-NP
polymers 	polymers 	 FW	I-NP
,  	,  	 ,	O
release  	release  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
from  	from  	 IN	O
the  	the  	 DT	O
matrix  	matrix  	 NN	B-NP
is  	is  	 VBZ	O
most  	most  	 RBS	O
likely  	likely  	 RB	O
achieved  	achieved  	 VBN	O
by  	by  	 IN	O
erosion  	erosion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 JJ	B-NP
matrix  	matrix  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
by  	by  	 IN	O
diffusion  	diffusion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
into  	into  	 IN	O
the  	the  	 DT	O
mucous  	mucous  	 JJ	B-NP
layer  	layer  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
sinus 	sinus 	 NN	I-NP
.  	.  	 .	O
Factors  	Factors  	 NNS	O
that  	that  	 WDT	O
may  	may  	 MD	O
influence  	influence  	 VB	O
the  	the  	 DT	O
release  	release  	 NN	B-NP
kinetics  	kinetics  	 NNS	I-NP
include  	include  	 VBP	O
such  	such  	 JJ	O
characteristics  	characteristics  	 NNS	O
as  	as  	 IN	O
the  	the  	 DT	O
size  	size  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
particles 	particles 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
solubility  	solubility  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent 	agent 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
ratio  	ratio  	 NN	O
of  	of  	 IN	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
to  	to  	 TO	O
polymer 	polymer 	 VB	O
( 	( 	 -LRB-	O
s 	s 	 LS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
porosity  	porosity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
polymer 	polymer 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
method  	method  	 NN	O
of  	of  	 IN	O
device  	device  	 NN	B-NP
manufacture 	manufacture 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
exposed  	exposed  	 JJ	O
surface  	surface  	 NN	O
area  	area  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
surface  	surface  	 NN	O
area  	area  	 NN	O
to  	to  	 TO	O
volume  	volume  	 NN	B-NP
ratio  	ratio  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
erosion  	erosion  	 NN	B-NP
rate  	rate  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
matrix  	matrix  	 JJ	I-NP
polymer 	polymer 	 NNS	I-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
) 	) 	 -RRB-	I-NP
.  	.  	 .	O
The  	The  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
over  	over  	 IN	O
a  	a  	 DT	O
prolonged  	prolonged  	 JJ	O
time  	time  	 NN	B-NP
period  	period  	 NN	I-NP
including 	including 	 VBG	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
one  	one  	 CD	O
week 	week 	 NN	B-NP
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
two  	two  	 CD	O
weeks 	weeks 	 NNS	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
three  	three  	 CD	O
weeks 	weeks 	 NNS	O
,  	,  	 ,	O
or  	or  	 CC	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
four  	four  	 CD	O
weeks 	weeks 	 NNS	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
two  	two  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
three  	three  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
four  	four  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
five  	five  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
or  	or  	 CC	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
six  	six  	 CD	O
months  	months  	 NNS	O
or  	or  	 CC	O
more 	more 	 JJR	O
.  	.  	 .	O
In  	In  	 IN	O
one  	one  	 CD	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
therapeutic  	therapeutic  	 JJ	B-NP
agent  	agent  	 NN	I-NP
is  	is  	 VBZ	O
released  	released  	 VBN	O
over  	over  	 RP	O
about  	about  	 IN	O
two  	two  	 CD	O
weeks  	weeks  	 NNS	O
to  	to  	 TO	O
about  	about  	 RB	O
four  	four  	 CD	O
weeks 	weeks 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
drug  	drug  	 NN	B-NP
release  	release  	 NN	I-NP
profile  	profile  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
adjusted  	adjusted  	 VBN	O
by  	by  	 IN	O
various  	various  	 JJ	O
techniques 	techniques 	 NNS	O
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
through  	through  	 IN	O
use  	use  	 NN	O
of  	of  	 IN	O
different  	different  	 JJ	O
drug 	drug 	 NN	O
,  	,  	 ,	O
polymer 	polymer 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
excipient  	excipient  	 JJ	B-NP
formulations  	formulations  	 NNS	I-NP
or  	or  	 CC	O
adjustment  	adjustment  	 NN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
amounts  	amounts  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
formulations 	formulations 	 NN	B-NP
,  	,  	 ,	O
use  	use  	 NN	O
of  	of  	 IN	O
release  	release  	 NN	O
and  	and  	 CC	O
drug  	drug  	 NN	B-NP
barrier  	barrier  	 NN	I-NP
layers 	layers 	 NNS	I-NP
,  	,  	 ,	O
differential  	differential  	 JJ	B-NP
bead 	bead 	 NN	I-NP
,  	,  	 ,	O
microsphere 	microsphere 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
microcapsule  	microcapsule  	 JJ	B-NP
constructions  	constructions  	 NNS	I-NP
( 	( 	 -LRB-	O
with  	with  	 IN	O
shells  	shells  	 NNS	O
of  	of  	 IN	O
varying  	varying  	 VBG	O
molecular  	molecular  	 JJ	B-NP
weights  	weights  	 NNS	I-NP
or  	or  	 CC	O
thicknesses 	thicknesses 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like 	like 	 JJ	O
,  	,  	 ,	O
as  	as  	 RB	O
is  	is  	 VBZ	O
well  	well  	 RB	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
duration  	duration  	 NN	O
of  	of  	 IN	O
release  	release  	 NN	O
can  	can  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
adjusted  	adjusted  	 VBN	O
through  	through  	 IN	O
polymer  	polymer  	 JJ	B-NP
blending  	blending  	 NN	I-NP
ratios 	ratios 	 NNS	I-NP
,  	,  	 ,	O
monomer  	monomer  	 JJ	B-NP
average  	average  	 JJ	I-NP
molecular  	molecular  	 JJ	I-NP
weights 	weights 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
coatings 	coatings 	 NNS	O
.  	.  	 .	O
As  	As  	 RB	O
previously  	previously  	 RB	O
mentioned 	mentioned 	 VBN	O
,  	,  	 ,	O
differential  	differential  	 JJ	B-NP
release  	release  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
drug 	drug 	 NN	I-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
effected 	effected 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
differential  	differential  	 JJ	B-NP
release  	release  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
or  	or  	 CC	O
for  	for  	 IN	O
different  	different  	 JJ	O
active  	active  	 JJ	O
agents 	agents 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
variable  	variable  	 JJ	O
release  	release  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
achieved  	achieved  	 VBN	O
using  	using  	 VBG	O
methods  	methods  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
bulk  	bulk  	 JJ	B-NP
loading 	loading 	 NN	I-NP
,  	,  	 ,	O
surface  	surface  	 NN	O
coating  	coating  	 NN	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
by  	by  	 IN	O
having  	having  	 VBG	O
a  	a  	 DT	O
higher  	higher  	 JJR	O
load  	load  	 NN	O
layer 	layer 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
surface  	surface  	 NN	O
loading  	loading  	 NN	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
by  	by  	 IN	O
embedding 	embedding 	 NN	O
,  	,  	 ,	O
spraying 	spraying 	 VBG	O
,  	,  	 ,	O
or  	or  	 CC	O
absorbing  	absorbing  	 JJ	O
drug  	drug  	 NN	O
onto  	onto  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	B-NP
surface 	surface 	 NN	I-NP
,  	,  	 ,	O
etc. 	etc. 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
other  	other  	 JJ	O
techniques  	techniques  	 NNS	O
well  	well  	 RB	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
.  	.  	 .	O
Variable  	Variable  	 JJ	B-NP
release  	release  	 NN	I-NP
of  	of  	 IN	O
different  	different  	 JJ	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
achieved 	achieved 	 VBN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
by  	by  	 IN	O
segmenting  	segmenting  	 VBG	O
the  	the  	 DT	O
drugs  	drugs  	 NNS	O
into  	into  	 IN	O
different  	different  	 JJ	O
layers 	layers 	 NNS	O
,  	,  	 ,	O
reservoirs  	reservoirs  	 NNS	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
microspheres 	microspheres 	 NN	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 RB	O
by  	by  	 IN	O
other  	other  	 JJ	O
techniques  	techniques  	 NNS	O
well  	well  	 RB	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
.  	.  	 .	O
Delayed  	Delayed  	 JJ	B-NP
drug  	drug  	 NN	I-NP
release 	release 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 NNP	O
24A  	24A  	 NNP	O
is  	is  	 VBZ	O
useful  	useful  	 JJ	O
for  	for  	 IN	O
adjunctive  	adjunctive  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 IN	O
when  	when  	 WRB	O
tapering  	tapering  	 VBG	O
off  	off  	 RP	O
of  	of  	 IN	O
intravenous  	intravenous  	 NN	O
or  	or  	 CC	O
oral  	oral  	 JJ	B-NP
steroids  	steroids  	 NNS	I-NP
previously  	previously  	 RB	O
given  	given  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
patient 	patient 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
when  	when  	 WRB	O
releasing  	releasing  	 VBG	B-NP
anti-scarring  	anti-scarring  	 JJ	I-NP
and  	and  	 CC	O
anti-restenosis  	anti-restenosis  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
later  	later  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
healing  	healing  	 NN	B-NP
process 	process 	 NN	I-NP
.  	.  	 .	O
Substantially  	Substantially  	 RB	O
zero  	zero  	 CD	O
order  	order  	 NN	B-NP
drug  	drug  	 NN	I-NP
release 	release 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 NNP	O
24B  	24B  	 NNP	O
is  	is  	 VBZ	O
useful  	useful  	 JJ	O
for  	for  	 IN	O
chronic  	chronic  	 JJ	B-NP
disease  	disease  	 NN	I-NP
maintenance  	maintenance  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
without  	without  	 IN	O
trauma  	trauma  	 NN	O
or  	or  	 CC	O
scarring 	scarring 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
for  	for  	 IN	O
anti-infective  	anti-infective  	 JJ	B-NP
agent  	agent  	 NN	I-NP
courses  	courses  	 NNS	I-NP
of  	of  	 IN	O
therapy 	therapy 	 NN	O
,  	,  	 ,	O
providing  	providing  	 VBG	O
a  	a  	 DT	O
constant  	constant  	 JJ	O
equilibrium  	equilibrium  	 NN	B-NP
concentration  	concentration  	 NN	I-NP
of  	of  	 IN	O
drug  	drug  	 NN	O
and  	and  	 CC	O
maximizing  	maximizing  	 JJ	O
receptor  	receptor  	 NN	B-NP
target  	target  	 NN	I-NP
occupation  	occupation  	 NN	I-NP
levels 	levels 	 NNS	I-NP
.  	.  	 .	O
Upfront  	Upfront  	 JJ	B-NP
bolus  	bolus  	 JJ	I-NP
drug  	drug  	 NN	I-NP
release 	release 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
24C  	24C  	 CD	O
during  	during  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
five  	five  	 CD	O
to  	to  	 TO	O
ten  	ten  	 VB	O
days  	days  	 NNS	O
is  	is  	 VBZ	O
useful  	useful  	 JJ	O
for  	for  	 IN	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
post-surgical  	post-surgical  	 JJ	O
or  	or  	 CC	O
implant  	implant  	 JJ	B-NP
insertion  	insertion  	 JJ	I-NP
trauma  	trauma  	 NN	I-NP
and  	and  	 CC	O
for  	for  	 IN	O
creating  	creating  	 VBG	O
maximum  	maximum  	 JJ	B-NP
diffusion  	diffusion  	 NN	I-NP
into  	into  	 IN	O
the  	the  	 DT	O
adjacent  	adjacent  	 JJ	B-NP
surgical  	surgical  	 JJ	I-NP
anatomy 	anatomy 	 NN	I-NP
.  	.  	 .	O
Delayed  	Delayed  	 VBN	B-NP
bolus  	bolus  	 JJ	I-NP
drug  	drug  	 NN	I-NP
release 	release 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 NNP	O
24D  	24D  	 NNP	O
is  	is  	 VBZ	O
useful  	useful  	 JJ	O
in  	in  	 IN	O
post-operative  	post-operative  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
,  	,  	 ,	O
particularly  	particularly  	 RB	O
amelioration  	amelioration  	 VBN	O
of  	of  	 IN	O
trauma  	trauma  	 NN	O
in  	in  	 IN	O
post-operative  	post-operative  	 JJ	B-NP
debridement  	debridement  	 JJ	I-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
Degradation  	Degradation  	 JJ	O
dependent  	dependent  	 JJ	O
release 	release 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
24E 	24E 	 CD	O
,  	,  	 ,	O
increasing  	increasing  	 VBG	O
as  	as  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
is  	is  	 VBZ	O
fully  	fully  	 RB	O
bioabsorbed 	bioabsorbed 	 JJ	O
,  	,  	 ,	O
is  	is  	 VBZ	O
useful  	useful  	 JJ	O
for  	for  	 IN	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
any  	any  	 DT	O
implant 	implant 	 JJ	B-NP
/ 	/ 	 CD	I-NP
device  	device  	 NN	I-NP
elimination  	elimination  	 NN	I-NP
trauma  	trauma  	 NN	I-NP
or  	or  	 CC	O
complications  	complications  	 JJ	B-NP
due  	due  	 JJ	O
to  	to  	 TO	O
bioabsorption 	bioabsorption 	 VB	O
.  	.  	 .	O
Combinations  	Combinations  	 NNS	B-NP
are  	are  	 VBP	O
possible  	possible  	 JJ	O
of  	of  	 IN	O
any  	any  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
above  	above  	 JJ	O
drug  	drug  	 NN	B-NP
release  	release  	 NN	I-NP
curves  	curves  	 NN	I-NP
by  	by  	 IN	O
integrating  	integrating  	 VBG	O
various  	various  	 JJ	O
drug  	drug  	 NN	B-NP
release  	release  	 NN	I-NP
methods  	methods  	 NNS	I-NP
( 	( 	 -LRB-	O
for  	for  	 IN	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
drugs 	drugs 	 NNS	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
device 	device 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
illustrated  	illustrated  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
24F 	24F 	 CD	O
,  	,  	 ,	O
a  	a  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
initial  	initial  	 JJ	O
bolus 	bolus 	 NN	B-NP
,  	,  	 ,	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
substantially  	substantially  	 RB	O
zero  	zero  	 CD	O
order  	order  	 NN	B-NP
release 	release 	 NN	I-NP
,  	,  	 ,	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
final  	final  	 JJ	B-NP
release  	release  	 NN	I-NP
burst  	burst  	 NN	I-NP
is  	is  	 VBZ	O
particularly  	particularly  	 RB	O
useful  	useful  	 JJ	O
in  	in  	 IN	O
post-surgical  	post-surgical  	 JJ	B-NP
application  	application  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
,  	,  	 ,	O
treating  	treating  	 VBG	O
surgical  	surgical  	 JJ	O
and  	and  	 CC	O
implantation  	implantation  	 JJ	B-NP
trauma  	trauma  	 NNS	I-NP
( 	( 	 -LRB-	O
initial  	initial  	 JJ	O
bolus 	bolus 	 NN	B-NP
)  	)  	 -RRB-	O
then  	then  	 RB	O
surgical  	surgical  	 JJ	B-NP
healing  	healing  	 NN	I-NP
and  	and  	 CC	O
disease  	disease  	 NN	B-NP
recurrence  	recurrence  	 NN	I-NP
( 	( 	 -LRB-	O
substantially  	substantially  	 RB	O
zero  	zero  	 CD	O
order 	order 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
ultimately  	ultimately  	 RB	O
any  	any  	 DT	O
implant  	implant  	 JJ	B-NP
elimination  	elimination  	 NN	I-NP
trauma  	trauma  	 NNS	I-NP
( 	( 	 -LRB-	O
final  	final  	 JJ	B-NP
release  	release  	 NN	I-NP
burst 	burst 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Applications 	Applications 	 NNS	B-NP
.  	.  	 .	O
Therapeutic  	Therapeutic  	 JJ	B-NP
action  	action  	 NN	I-NP
of  	of  	 IN	O
device 	device 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
structure  	structure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
itself  	itself  	 PRP	O
may  	may  	 MD	O
also  	also  	 RB	O
have  	have  	 VB	O
a  	a  	 DT	O
therapeutic  	therapeutic  	 JJ	B-NP
function 	function 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
device  	device  	 NN	O
may  	may  	 MD	O
provide  	provide  	 VB	O
such  	such  	 JJ	O
functions  	functions  	 NNS	O
as  	as  	 IN	O
fixation  	fixation  	 NN	O
or  	or  	 CC	O
splinting  	splinting  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
via  	via  	 IN	O
space  	space  	 NN	B-NP
filling 	filling 	 NN	I-NP
,  	,  	 ,	O
fastening 	fastening 	 NN	O
,  	,  	 ,	O
deflection 	deflection 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
provide  	provide  	 VB	O
support  	support  	 NN	O
and  	and  	 CC	O
to  	to  	 TO	O
keep  	keep  	 VB	O
a  	a  	 DT	O
body  	body  	 NN	O
structure  	structure  	 NN	O
open 	open 	 JJ	O
,  	,  	 ,	O
as  	as  	 RB	O
in  	in  	 IN	O
stenting  	stenting  	 NN	B-NP
or  	or  	 CC	O
packing  	packing  	 VBG	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
the  	the  	 DT	O
lateralization  	lateralization  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
middle  	middle  	 JJ	I-NP
turbinate  	turbinate  	 NN	I-NP
and  	and  	 CC	O
occlusion  	occlusion  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
middle  	middle  	 JJ	I-NP
meatus 	meatus 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
by  	by  	 IN	O
providing  	providing  	 VBG	O
a  	a  	 DT	O
physical  	physical  	 JJ	B-NP
barrier  	barrier  	 NN	I-NP
to  	to  	 TO	O
adhesions  	adhesions  	 VB	O
which  	which  	 WDT	O
may  	may  	 MD	O
form  	form  	 VB	O
between  	between  	 IN	O
various  	various  	 JJ	O
post-surgical  	post-surgical  	 JJ	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
inflamed  	inflamed  	 JJ	O
tissue  	tissue  	 NN	O
surfaces 	surfaces 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
any  	any  	 DT	O
device  	device  	 NN	O
incorporating  	incorporating  	 VBG	O
a  	a  	 DT	O
solid 	solid 	 JJ	O
,  	,  	 ,	O
semi-solid  	semi-solid  	 NNP	B-NP
( 	( 	 -LRB-	O
gel 	gel 	 LS	B-NP
)  	)  	 -RRB-	O
or  	or  	 CC	O
woven  	woven  	 NNS	O
or  	or  	 CC	O
nonwoven  	nonwoven  	 JJ	O
mesh  	mesh  	 JJ	O
structure  	structure  	 NN	O
could  	could  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
practice  	practice  	 VB	O
this  	this  	 DT	O
method 	method 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
device  	device  	 NN	O
may  	may  	 MD	O
non-occlusively  	non-occlusively  	 RB	B-NP
maintain  	maintain  	 VB	O
patency  	patency  	 VBN	O
through  	through  	 IN	O
the  	the  	 DT	O
implant  	implant  	 JJ	B-NP
feature  	feature  	 NN	I-NP
area  	area  	 NN	I-NP
providing  	providing  	 VBG	O
the  	the  	 DT	O
device  	device  	 NN	B-NP
action  	action  	 NN	I-NP
by  	by  	 IN	O
direct  	direct  	 JJ	O
provision  	provision  	 NN	O
and  	and  	 CC	O
maintenance  	maintenance  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
channel 	channel 	 NN	O
,  	,  	 ,	O
fenestration  	fenestration  	 NN	B-NP
or  	or  	 CC	O
port  	port  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
sinuses  	sinuses  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
infundibulum 	infundibulum 	 NN	B-NP
,  	,  	 ,	O
osteomeatal  	osteomeatal  	 JJ	B-NP
complex 	complex 	 NN	I-NP
,  	,  	 ,	O
meatus  	meatus  	 NN	B-NP
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
passage  	passage  	 NN	I-NP
by  	by  	 IN	O
which  	which  	 WDT	O
mucociliary  	mucociliary  	 JJ	B-NP
flow  	flow  	 NN	I-NP
may  	may  	 MD	O
travel 	travel 	 VB	O
.  	.  	 .	O
Such  	Such  	 PDT	O
a  	a  	 DT	O
channel  	channel  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
within  	within  	 IN	O
and  	and  	 CC	O
support  	support  	 VB	O
the  	the  	 DT	O
structure  	structure  	 NN	O
of  	of  	 IN	O
natural  	natural  	 JJ	O
ostia  	ostia  	 NN	B-NP
or  	or  	 CC	O
within  	within  	 IN	O
and  	and  	 CC	O
support  	support  	 VB	O
a  	a  	 DT	O
surgically  	surgically  	 NN	O
created  	created  	 VBN	O
or  	or  	 CC	O
modified  	modified  	 JJ	O
antrostomy  	antrostomy  	 NN	B-NP
to  	to  	 TO	O
the  	the  	 DT	O
sinus 	sinus 	 NN	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
may  	may  	 MD	O
not  	not  	 RB	O
totally  	totally  	 RB	O
occlude  	occlude  	 JJ	O
such  	such  	 JJ	O
openings 	openings 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
any  	any  	 DT	O
device  	device  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
lumen  	lumen  	 NN	B-NP
or  	or  	 CC	O
pore  	pore  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
a  	a  	 DT	O
tube  	tube  	 NN	O
or  	or  	 CC	O
cannula 	cannula 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
stent  	stent  	 NN	B-NP
with  	with  	 IN	O
a  	a  	 DT	O
lumen 	lumen 	 NN	B-NP
,  	,  	 ,	O
could  	could  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
practice  	practice  	 VB	O
this  	this  	 DT	O
method 	method 	 NN	O
,  	,  	 ,	O
as  	as  	 RB	O
could  	could  	 MD	O
a  	a  	 DT	O
highly  	highly  	 RB	O
porous  	porous  	 JJ	B-NP
packing  	packing  	 JJ	I-NP
material 	material 	 NN	I-NP
,  	,  	 ,	O
three  	three  	 CD	O
dimensional  	dimensional  	 JJ	B-NP
mesh 	mesh 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
surface  	surface  	 NN	O
or  	or  	 CC	O
interior  	interior  	 JJ	O
structured  	structured  	 JJ	O
device  	device  	 NN	O
through  	through  	 IN	O
which  	which  	 WDT	O
mucus  	mucus  	 NNS	O
can  	can  	 MD	O
flow  	flow  	 VB	O
and  	and  	 CC	O
which  	which  	 WDT	O
does  	does  	 VBZ	O
not  	not  	 RB	O
become  	become  	 VB	O
occlusive  	occlusive  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
provided  	provided  	 VBN	O
channel  	channel  	 NN	O
through  	through  	 IN	O
absorbancy 	absorbancy 	 NN	B-NP
,  	,  	 ,	O
expansion 	expansion 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
degradation 	degradation 	 NN	O
.  	.  	 .	O
Reduction  	Reduction  	 NN	O
of  	of  	 IN	O
complications  	complications  	 NNS	B-NP
upon  	upon  	 IN	O
implantation 	implantation 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
yet  	yet  	 RB	O
another  	another  	 DT	O
variation 	variation 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
device  	device  	 NN	O
may  	may  	 MD	O
possess  	possess  	 VB	O
a  	a  	 DT	O
structural  	structural  	 JJ	B-NP
feature  	feature  	 NN	I-NP
or  	or  	 CC	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
that  	that  	 WDT	O
helps  	helps  	 VBZ	O
to  	to  	 TO	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
complications  	complications  	 NNS	B-NP
of  	of  	 IN	I-NP
device  	device  	 NN	I-NP
implantation 	implantation 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
device  	device  	 NN	O
may 	may 	 MD	O
:  	:  	 :	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
prevent  	prevent  	 VB	O
trauma  	trauma  	 JJ	O
due  	due  	 JJ	O
to  	to  	 TO	O
device  	device  	 NN	B-NP
removal  	removal  	 NN	I-NP
by  	by  	 IN	O
use  	use  	 NN	O
of  	of  	 IN	O
bioabsorbable  	bioabsorbable  	 JJ	B-NP
materials 	materials 	 NNS	I-NP
;  	;  	 :	O
2 	2 	 LS	O
)  	)  	 -RRB-	O
prevent  	prevent  	 VB	O
biofilm  	biofilm  	 JJ	B-NP
formation  	formation  	 NN	I-NP
by  	by  	 IN	O
use  	use  	 NN	O
of  	of  	 IN	O
coatings 	coatings 	 NNS	O
,  	,  	 ,	O
physical  	physical  	 JJ	B-NP
surface  	surface  	 NN	I-NP
treatments 	treatments 	 NNS	I-NP
,  	,  	 ,	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
incorporation  	incorporation  	 NNS	B-NP
or  	or  	 CC	O
elution  	elution  	 NN	B-NP
of  	of  	 IN	O
an  	an  	 DT	O
anti-infective  	anti-infective  	 JJ	B-NP
or  	or  	 CC	O
antiseptic  	antiseptic  	 JJ	B-NP
substance 	substance 	 NN	I-NP
;  	;  	 :	O
3 	3 	 LS	O
)  	)  	 -RRB-	O
prevent  	prevent  	 VB	O
foreign  	foreign  	 JJ	O
body  	body  	 NN	O
reactions  	reactions  	 NNS	O
by  	by  	 IN	O
incorporating  	incorporating  	 VBG	B-NP
low-dose  	low-dose  	 JJ	I-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
substances  	substances  	 NNS	I-NP
including  	including  	 VBG	I-NP
steroidal  	steroidal  	 NNS	I-NP
and  	and  	 CC	O
non-steroidal  	non-steroidal  	 JJ	B-NP
anti-inflammatories  	anti-inflammatories  	 NN	I-NP
( 	( 	 -LRB-	O
for  	for  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
including  	including  	 VBG	O
the  	the  	 DT	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	O
low  	low  	 JJ	O
dose  	dose  	 NN	B-NP
macrolide  	macrolide  	 NN	I-NP
antibiotics 	antibiotics 	 NN	I-NP
) 	) 	 -RRB-	O
;  	;  	 :	O
and  	and  	 CC	O
4 	4 	 LS	O
)  	)  	 -RRB-	O
prevent  	prevent  	 VB	O
device  	device  	 NN	B-NP
migration  	migration  	 NN	I-NP
by  	by  	 IN	O
specific  	specific  	 JJ	O
active  	active  	 JJ	O
or  	or  	 CC	O
passive  	passive  	 JJ	B-NP
fixation  	fixation  	 NN	I-NP
and  	and  	 CC	O
anchoring  	anchoring  	 JJ	O
features  	features  	 NNS	O
incorporated  	incorporated  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
Substances  	Substances  	 NNS	O
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
biofilm  	biofilm  	 JJ	B-NP
formation  	formation  	 NN	I-NP
include 	include 	 VBP	O
,  	,  	 ,	O
but  	but  	 CC	O
are  	are  	 VBP	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
alcohol 	alcohol 	 NN	B-NP
,  	,  	 ,	O
chlorhexidine 	chlorhexidine 	 NN	B-NP
,  	,  	 ,	O
iodine 	iodine 	 NN	O
,  	,  	 ,	O
triclosan 	triclosan 	 NN	B-NP
,  	,  	 ,	O
hexachlorophene 	hexachlorophene 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
silver-based  	silver-based  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
silver  	silver  	 JJ	B-NP
chloride 	chloride 	 NN	I-NP
,  	,  	 ,	O
silver  	silver  	 JJ	B-NP
oxide 	oxide 	 NN	I-NP
,  	,  	 ,	O
silver  	silver  	 JJ	B-NP
nanoparticles 	nanoparticles 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
variations 	variations 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
surface  	surface  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
may  	may  	 MD	O
treated  	treated  	 VB	O
by  	by  	 IN	O
a  	a  	 DT	O
process  	process  	 NN	O
( 	( 	 -LRB-	O
e.g.  	e.g.  	 FW	O
ion  	ion  	 FW	B-NP
embedding 	embedding 	 FW	O
,  	,  	 ,	O
plasma  	plasma  	 JJ	B-NP
etching 	etching 	 NN	I-NP
,  	,  	 ,	O
etc. 	etc. 	 FW	O
)  	)  	 -RRB-	O
altering  	altering  	 VBG	O
the  	the  	 DT	O
physical  	physical  	 JJ	B-NP
properties  	properties  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
surface  	surface  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
biofilm  	biofilm  	 JJ	B-NP
formation 	formation 	 NN	I-NP
.  	.  	 .	O
Exploitation  	Exploitation  	 NNP	B-NP
of  	of  	 IN	I-NP
mucociliary  	mucociliary  	 JJ	I-NP
clearance 	clearance 	 NN	I-NP
.  	.  	 .	O
Normal  	Normal  	 JJ	B-NP
mucociliary  	mucociliary  	 JJ	I-NP
clearance  	clearance  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
extend  	extend  	 VB	O
drug  	drug  	 NN	B-NP
diffusion  	diffusion  	 NNS	I-NP
and  	and  	 CC	O
effect  	effect  	 NN	O
beyond  	beyond  	 IN	O
the  	the  	 DT	O
physical  	physical  	 JJ	B-NP
location  	location  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
useful  	useful  	 JJ	O
in  	in  	 IN	O
both  	both  	 DT	O
normal  	normal  	 JJ	O
and  	and  	 CC	O
particularly  	particularly  	 RB	O
diseased  	diseased  	 JJ	O
mucociliary  	mucociliary  	 JJ	B-NP
flow  	flow  	 NN	I-NP
patterns 	patterns 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
later  	later  	 JJ	O
case 	case 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
device  	device  	 NN	O
is  	is  	 VBZ	O
useful  	useful  	 JJ	O
in  	in  	 IN	O
effecting  	effecting  	 VBG	O
the  	the  	 DT	O
build  	build  	 VB	O
up  	up  	 RP	O
of  	of  	 IN	O
therapeutically  	therapeutically  	 JJ	B-NP
desirable  	desirable  	 JJ	I-NP
concentrations  	concentrations  	 NNS	I-NP
of  	of  	 IN	I-NP
released  	released  	 VBN	I-NP
drug  	drug  	 NN	I-NP
at  	at  	 IN	O
blockages  	blockages  	 NN	O
when  	when  	 WRB	O
the  	the  	 DT	O
normal  	normal  	 JJ	B-NP
mucociliary  	mucociliary  	 JJ	I-NP
flow  	flow  	 NN	I-NP
is  	is  	 VBZ	O
interrupted  	interrupted  	 VBN	O
or  	or  	 CC	O
impeded  	impeded  	 VBN	O
by  	by  	 IN	O
disease 	disease 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
increasing  	increasing  	 VBG	B-NP
drug  	drug  	 NN	I-NP
concentration  	concentration  	 NN	I-NP
gradients  	gradients  	 NN	I-NP
where  	where  	 WRB	O
mucociliary  	mucociliary  	 JJ	B-NP
function  	function  	 NN	I-NP
is  	is  	 VBZ	O
most  	most  	 RBS	O
impacted  	impacted  	 JJ	O
by  	by  	 IN	O
disease 	disease 	 NN	O
.  	.  	 .	O
Anatomical  	Anatomical  	 JJ	B-NP
blockages  	blockages  	 NN	I-NP
and  	and  	 CC	O
areas  	areas  	 NNS	O
of  	of  	 IN	O
mucociliary  	mucociliary  	 JJ	B-NP
dysfunction  	dysfunction  	 NN	I-NP
or  	or  	 CC	O
ciliary  	ciliary  	 JJ	B-NP
dysmotility  	dysmotility  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
particularly  	particularly  	 RB	O
desirable  	desirable  	 JJ	O
areas  	areas  	 NNS	O
of  	of  	 IN	O
such  	such  	 JJ	O
drug  	drug  	 NN	B-NP
treatments  	treatments  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
anti-inflammatories  	anti-inflammatories  	 JJ	B-NP
and  	and  	 CC	O
anti-infectives 	anti-infectives 	 NNS	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
also  	also  	 RB	O
including  	including  	 VBG	O
chemotherapeutic  	chemotherapeutic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
so  	so  	 RB	O
as  	as  	 RB	O
to  	to  	 TO	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
chemically  	chemically  	 RB	O
open 	open 	 JJ	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
the  	the  	 DT	O
blockage  	blockage  	 NN	O
and  	and  	 CC	O
to  	to  	 TO	O
increase  	increase  	 VB	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
damaged  	damaged  	 JJ	O
mucosa 	mucosa 	 NN	B-NP
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
natural  	natural  	 JJ	O
sinus  	sinus  	 NN	B-NP
and  	and  	 CC	O
upstream  	upstream  	 JJ	O
locations  	locations  	 NNS	O
along  	along  	 IN	O
the  	the  	 DT	O
mucociliary  	mucociliary  	 JJ	B-NP
clearance  	clearance  	 NN	I-NP
pathway  	pathway  	 NNS	I-NP
may  	may  	 MD	O
serve  	serve  	 VB	O
as  	as  	 IN	O
drug  	drug  	 NN	B-NP
depots 	depots 	 NNS	I-NP
,  	,  	 ,	O
with  	with  	 IN	O
drug  	drug  	 NN	O
traveling  	traveling  	 VBG	O
to  	to  	 TO	O
desired  	desired  	 VB	O
sites  	sites  	 NNS	O
downstream  	downstream  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
pathway 	pathway 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
contrasts  	contrasts  	 NN	O
with  	with  	 IN	O
previous  	previous  	 JJ	O
and  	and  	 CC	O
current  	current  	 JJ	O
teachings  	teachings  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
field  	field  	 NN	O
which  	which  	 WDT	O
seek  	seek  	 VBP	O
to  	to  	 TO	O
impede  	impede  	 VB	O
or  	or  	 CC	O
reduce  	reduce  	 VB	O
mucociliary  	mucociliary  	 JJ	B-NP
clearance  	clearance  	 NN	I-NP
of  	of  	 IN	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
maximize  	maximize  	 VB	O
dose  	dose  	 JJ	O
duration 	duration 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
addition  	addition  	 NN	O
to  	to  	 TO	O
treating  	treating  	 VBG	O
any  	any  	 DT	O
one  	one  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
aforementioned  	aforementioned  	 JJ	B-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
conditions 	conditions 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
described  	described  	 VBD	O
herein  	herein  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
placed  	placed  	 VBN	O
during 	during 	 IN	O
,  	,  	 ,	O
or  	or  	 CC	O
as  	as  	 IN	O
an  	an  	 DT	O
adjunct  	adjunct  	 NN	B-NP
to 	to 	 TO	O
,  	,  	 ,	O
a  	a  	 DT	O
surgical 	surgical 	 JJ	O
,  	,  	 ,	O
non-surgical 	non-surgical 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
other  	other  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
intervention  	intervention  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
sinuses  	sinuses  	 NN	O
or  	or  	 CC	O
nasal  	nasal  	 JJ	B-NP
passages 	passages 	 NNS	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
device  	device  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
during  	during  	 IN	O
or  	or  	 CC	O
as  	as  	 IN	O
an  	an  	 DT	O
adjunt  	adjunt  	 NN	B-NP
to  	to  	 TO	O
such  	such  	 JJ	O
procedures  	procedures  	 NNS	O
including 	including 	 VBG	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
septoplasty  	septoplasty  	 NNS	B-NP
( 	( 	 -LRB-	O
surgical  	surgical  	 JJ	B-NP
removal  	removal  	 NN	I-NP
or  	or  	 CC	O
adjustment  	adjustment  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
septum 	septum 	 NN	I-NP
) 	) 	 -RRB-	O
;  	;  	 :	O
turbinoplasty  	turbinoplasty  	 CD	B-NP
( 	( 	 -LRB-	O
surgical  	surgical  	 JJ	B-NP
removal  	removal  	 NN	I-NP
or  	or  	 CC	O
adjustment  	adjustment  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
turbinate  	turbinate  	 JJ	B-NP
bones 	bones 	 NNS	I-NP
) 	) 	 -RRB-	O
;  	;  	 :	O
rhinoplasty  	rhinoplasty  	 VBP	O
generally 	generally 	 RB	O
;  	;  	 :	O
sinus  	sinus  	 JJ	B-NP
surgery  	surgery  	 NN	I-NP
( 	( 	 -LRB-	O
including  	including  	 VBG	O
the  	the  	 DT	O
exploration 	exploration 	 NN	O
,  	,  	 ,	O
revision 	revision 	 NN	O
,  	,  	 ,	O
repair 	repair 	 NN	O
,  	,  	 ,	O
tissue  	tissue  	 NN	O
dissection  	dissection  	 NN	O
or  	or  	 CC	O
removal  	removal  	 NN	O
of  	of  	 IN	O
some  	some  	 DT	O
or  	or  	 CC	O
part  	part  	 NN	O
of  	of  	 IN	O
any  	any  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
sinuses 	sinuses 	 NN	O
,  	,  	 ,	O
including  	including  	 VBG	O
the  	the  	 DT	O
ethmoid  	ethmoid  	 JJ	B-NP
sinuses  	sinuses  	 NNS	I-NP
( 	( 	 -LRB-	O
as  	as  	 RB	O
in  	in  	 IN	O
ethmoidectomy 	ethmoidectomy 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
maxillary  	maxillary  	 JJ	B-NP
sinuses 	sinuses 	 NN	I-NP
,  	,  	 ,	O
frontal  	frontal  	 JJ	B-NP
sinuses 	sinuses 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
sphenoid  	sphenoid  	 JJ	B-NP
sinuses 	sinuses 	 NN	I-NP
) 	) 	 -RRB-	O
;  	;  	 :	O
polyp  	polyp  	 JJ	B-NP
removal  	removal  	 NN	I-NP
in  	in  	 IN	O
any  	any  	 DT	O
part  	part  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinuses  	sinuses  	 NN	I-NP
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
passages 	passages 	 NNS	I-NP
;  	;  	 :	O
cannulation 	cannulation 	 CD	B-NP
,  	,  	 ,	O
irrigation 	irrigation 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
therapy  	therapy  	 NN	B-NP
instillation  	instillation  	 NNS	I-NP
or  	or  	 CC	O
injection  	injection  	 NN	B-NP
of  	of  	 IN	O
any  	any  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
above  	above  	 JJ	O
sinuses  	sinuses  	 NN	O
or  	or  	 CC	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
passages 	passages 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
through  	through  	 IN	O
nasal 	nasal 	 NN	B-NP
,  	,  	 ,	O
trans-ostial 	trans-ostial 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
external  	external  	 JJ	B-NP
puncture  	puncture  	 JJ	I-NP
approaches  	approaches  	 NNS	I-NP
( 	( 	 -LRB-	O
such  	such  	 JJ	O
as  	as  	 IN	O
through  	through  	 IN	O
antral  	antral  	 JJ	B-NP
puncture 	puncture 	 NN	I-NP
,  	,  	 ,	O
trephination  	trephination  	 NN	B-NP
or  	or  	 CC	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
Caldwell-Luc 	Caldwell-Luc 	 JJ	B-NP
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
procedures 	procedures 	 NNS	O
) 	) 	 -RRB-	O
;  	;  	 :	O
surgical  	surgical  	 JJ	B-NP
revision 	revision 	 NN	I-NP
,  	,  	 ,	O
dissection 	dissection 	 NN	O
,  	,  	 ,	O
reconstruction  	reconstruction  	 NN	B-NP
or  	or  	 CC	O
repair  	repair  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
anatomy  	anatomy  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinuses  	sinuses  	 NN	I-NP
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
passages 	passages 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
any  	any  	 DT	O
removal  	removal  	 NN	O
or  	or  	 CC	O
adjustment  	adjustment  	 NN	O
of  	of  	 IN	O
neoplasms 	neoplasms 	 NN	O
,  	,  	 ,	O
foreign  	foreign  	 JJ	O
bodies 	bodies 	 NNS	O
,  	,  	 ,	O
lesions 	lesions 	 NNS	O
,  	,  	 ,	O
adhesions 	adhesions 	 NN	O
,  	,  	 ,	O
defects 	defects 	 NNS	O
,  	,  	 ,	O
stenosis 	stenosis 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
fistula  	fistula  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
natural  	natural  	 JJ	O
or  	or  	 CC	O
post-surgical  	post-surgical  	 JJ	B-NP
anatomy 	anatomy 	 NN	I-NP
;  	;  	 :	O
ligation 	ligation 	 CD	B-NP
,  	,  	 ,	O
cauterization 	cauterization 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
ablation  	ablation  	 JJ	B-NP
procedures  	procedures  	 NNS	I-NP
to  	to  	 TO	O
control  	control  	 VB	O
nasal  	nasal  	 JJ	B-NP
bleeding  	bleeding  	 NN	I-NP
and  	and  	 CC	O
repair  	repair  	 VB	O
vasculature  	vasculature  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
anatomy  	anatomy  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinuses  	sinuses  	 NN	I-NP
and  	and  	 CC	O
nasal  	nasal  	 JJ	B-NP
passages 	passages 	 NNS	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
as  	as  	 IN	O
an  	an  	 DT	O
adjunct  	adjunct  	 NN	B-NP
or  	or  	 CC	O
technique  	technique  	 NN	O
to  	to  	 TO	O
perform  	perform  	 VB	O
any  	any  	 DT	O
such  	such  	 JJ	O
surgical  	surgical  	 JJ	O
or  	or  	 CC	O
non-surgical  	non-surgical  	 JJ	B-NP
procedure 	procedure 	 NN	I-NP
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
described  	described  	 VBD	O
here  	here  	 RB	O
may  	may  	 MD	O
have  	have  	 VB	O
a  	a  	 DT	O
variety  	variety  	 NN	O
of  	of  	 IN	O
functions 	functions 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
they  	they  	 PRP	O
may  	may  	 MD	O
deliver  	deliver  	 VB	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
to  	to  	 TO	O
treat  	treat  	 VB	O
rhinosinusitis 	rhinosinusitis 	 NNS	B-NP
,  	,  	 ,	O
have  	have  	 VBP	O
a  	a  	 DT	O
structure  	structure  	 NN	O
that  	that  	 WDT	O
prevents  	prevents  	 VBZ	O
lateralization  	lateralization  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
middle  	middle  	 JJ	B-NP
turbinate  	turbinate  	 NN	I-NP
and  	and  	 CC	O
formation  	formation  	 NN	O
of  	of  	 IN	O
adhesions 	adhesions 	 NN	O
,  	,  	 ,	O
have  	have  	 VBP	O
a  	a  	 DT	O
structure  	structure  	 NN	O
which  	which  	 WDT	O
directly  	directly  	 RB	O
or  	or  	 CC	O
indirectly  	indirectly  	 RB	O
preserves  	preserves  	 VBZ	O
ostial  	ostial  	 JJ	B-NP
patency 	patency 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 RB	O
have  	have  	 VB	O
a  	a  	 DT	O
coating  	coating  	 NN	O
that  	that  	 WDT	O
prevents  	prevents  	 VBZ	O
biofilm  	biofilm  	 JJ	B-NP
formation 	formation 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
include  	include  	 VB	O
any  	any  	 DT	O
number  	number  	 NN	O
and  	and  	 CC	O
combination  	combination  	 NN	O
of  	of  	 IN	O
functions  	functions  	 NNS	O
listed  	listed  	 VBN	O
above 	above 	 IN	O
.  	.  	 .	O
Delivery  	Delivery  	 NN	B-NP
devices  	devices  	 NNS	I-NP
and  	and  	 CC	O
methods  	methods  	 NNS	O
of  	of  	 IN	O
use 	use 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
placed  	placed  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 NN	B-NP
using  	using  	 VBG	O
various  	various  	 JJ	O
types  	types  	 NNS	O
of  	of  	 IN	O
sinus  	sinus  	 JJ	B-NP
inserters 	inserters 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
inserter  	inserter  	 NN	B-NP
may  	may  	 MD	O
include  	include  	 VB	O
a  	a  	 DT	O
conduit 	conduit 	 NN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
a  	a  	 DT	O
catheter  	catheter  	 NN	B-NP
with  	with  	 IN	O
a  	a  	 DT	O
lumen 	lumen 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
conduit  	conduit  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
flexible  	flexible  	 JJ	O
or  	or  	 CC	O
rigid 	rigid 	 JJ	O
,  	,  	 ,	O
or  	or  	 CC	O
may  	may  	 MD	O
be  	be  	 VB	O
designed  	designed  	 VBN	O
to  	to  	 TO	O
have  	have  	 VB	O
varying  	varying  	 VBG	B-NP
degrees  	degrees  	 NNS	I-NP
of  	of  	 IN	O
stiffness  	stiffness  	 NN	O
along  	along  	 IN	O
its  	its  	 PRP$	O
length 	length 	 NN	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
conduit  	conduit  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
stiffer  	stiffer  	 JJR	O
than  	than  	 IN	O
the  	the  	 DT	O
proximal  	proximal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
conduit  	conduit  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
variously  	variously  	 JJ	O
angulated  	angulated  	 NN	O
to  	to  	 TO	O
facilitate  	facilitate  	 VB	O
positioning  	positioning  	 NN	O
and  	and  	 CC	O
advancement  	advancement  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
conduit  	conduit  	 NN	O
through  	through  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
angulated  	angulated  	 VBN	O
from  	from  	 IN	O
about  	about  	 IN	O
0 	0 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
to  	to  	 TO	O
about  	about  	 RB	O
175 	175 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
; 	; 	 :	O
,  	,  	 ,	O
from  	from  	 IN	O
about  	about  	 IN	O
0 	0 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
to  	to  	 TO	O
about  	about  	 RB	O
135 	135 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
; 	; 	 :	O
,  	,  	 ,	O
or  	or  	 CC	O
from  	from  	 IN	O
about  	about  	 IN	O
0 	0 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
to  	to  	 TO	O
about  	about  	 RB	O
90 	90 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
; 	; 	 :	O
.  	.  	 .	O
If  	If  	 IN	O
desired 	desired 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
conduit  	conduit  	 NN	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
malleable 	malleable 	 NNS	B-NP
.  	.  	 .	O
The  	The  	 DT	O
conduit  	conduit  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
from  	from  	 IN	O
any  	any  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
including 	including 	 VBG	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
limited  	limited  	 VBN	O
to 	to 	 TO	O
,  	,  	 ,	O
stainless  	stainless  	 JJ	O
steel  	steel  	 NN	O
and  	and  	 CC	O
any  	any  	 DT	O
of  	of  	 IN	O
its  	its  	 PRP$	O
alloys 	alloys 	 NNS	O
;  	;  	 :	O
titanium  	titanium  	 JJ	B-NP
alloys 	alloys 	 NNS	I-NP
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
nickel-titanium  	nickel-titanium  	 JJ	B-NP
alloys 	alloys 	 NNS	I-NP
;  	;  	 :	O
polymers 	polymers 	 NNS	O
,  	,  	 ,	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
polyethylene  	polyethylene  	 NN	B-NP
and  	and  	 CC	O
copolymers  	copolymers  	 JJ	O
thereof 	thereof 	 NN	O
,  	,  	 ,	O
polyethylene  	polyethylene  	 NN	B-NP
terephthalate  	terephthalate  	 NNS	I-NP
or  	or  	 CC	O
copolymers  	copolymers  	 JJ	O
thereof 	thereof 	 NN	O
,  	,  	 ,	O
nylon 	nylon 	 NN	B-NP
,  	,  	 ,	O
silicone 	silicone 	 NN	B-NP
,  	,  	 ,	O
polyurethanes 	polyurethanes 	 NN	O
,  	,  	 ,	O
fluoropolymers 	fluoropolymers 	 NN	B-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
vinylchloride 	vinylchloride 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 JJ	B-NP
thereof 	thereof 	 NN	O
,  	,  	 ,	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
flexibility  	flexibility  	 NN	O
or  	or  	 CC	O
stiffness  	stiffness  	 JJ	O
desired 	desired 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
inserter  	inserter  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
preloaded  	preloaded  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
on  	on  	 IN	O
or  	or  	 CC	O
within  	within  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
end  	end  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
conduit 	conduit 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
more  	more  	 JJR	O
than  	than  	 IN	O
one  	one  	 CD	O
device  	device  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
preloaded  	preloaded  	 VBN	O
if  	if  	 IN	O
desired 	desired 	 NN	O
.  	.  	 .	O
It  	It  	 PRP	O
may  	may  	 MD	O
be  	be  	 VB	O
preloaded  	preloaded  	 VBN	O
on  	on  	 IN	O
or  	or  	 CC	O
within  	within  	 IN	O
the  	the  	 DT	O
inserter  	inserter  	 NN	B-NP
by  	by  	 IN	O
the  	the  	 DT	O
physician  	physician  	 NN	O
prior  	prior  	 RB	O
to  	to  	 TO	O
insertion  	insertion  	 VB	O
or  	or  	 CC	O
preloaded  	preloaded  	 NN	O
on  	on  	 IN	O
or  	or  	 CC	O
within  	within  	 IN	O
the  	the  	 DT	O
inserter  	inserter  	 NN	B-NP
during  	during  	 IN	O
the  	the  	 DT	O
manufacturing  	manufacturing  	 NN	B-NP
process 	process 	 NN	I-NP
.  	.  	 .	O
Once  	Once  	 IN	O
access  	access  	 NN	O
through  	through  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium  	ostium  	 NN	I-NP
or  	or  	 CC	O
surgically  	surgically  	 RB	O
created  	created  	 VBN	B-NP
fenestration  	fenestration  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
obtained  	obtained  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
conduit 	conduit 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
sheath  	sheath  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
retracted  	retracted  	 VBN	O
to  	to  	 TO	O
slidably  	slidably  	 VB	O
deploy  	deploy  	 VBN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
If  	If  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
self-expanding 	self-expanding 	 JJ	O
,  	,  	 ,	O
then  	then  	 RB	O
retraction  	retraction  	 VBN	O
of  	of  	 IN	O
a  	a  	 DT	O
sheath  	sheath  	 NN	O
also  	also  	 RB	O
causes  	causes  	 VBZ	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
to  	to  	 TO	O
be  	be  	 VB	O
deployed 	deployed 	 VBN	O
.  	.  	 .	O
If  	If  	 IN	O
expansion  	expansion  	 NN	O
using  	using  	 VBG	O
a  	a  	 DT	O
balloon  	balloon  	 NN	O
is  	is  	 VBZ	O
required 	required 	 VBN	O
,  	,  	 ,	O
any  	any  	 DT	O
balloon  	balloon  	 NN	B-NP
catheter  	catheter  	 NN	I-NP
( 	( 	 -LRB-	O
including  	including  	 VBG	O
double  	double  	 JJ	O
balloon  	balloon  	 NN	B-NP
catheters 	catheters 	 NNS	I-NP
)  	)  	 -RRB-	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art  	art  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
advanced  	advanced  	 VBN	O
through  	through  	 IN	O
the  	the  	 DT	O
lumen  	lumen  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
conduit  	conduit  	 NN	O
until  	until  	 IN	O
the  	the  	 DT	O
balloon  	balloon  	 NN	O
lies  	lies  	 VBZ	O
within  	within  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
.  	.  	 .	O
Inflation  	Inflation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
balloon  	balloon  	 NN	O
thereby  	thereby  	 RB	O
causes  	causes  	 VBZ	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
to  	to  	 TO	O
change  	change  	 VB	O
from  	from  	 IN	O
a  	a  	 DT	O
first  	first  	 JJ	O
collapsed  	collapsed  	 JJ	O
configuration  	configuration  	 NN	B-NP
to  	to  	 TO	O
a  	a  	 DT	O
second  	second  	 JJ	O
expanded  	expanded  	 JJ	O
configuration  	configuration  	 NN	B-NP
and  	and  	 CC	O
contact  	contact  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 JJ	I-NP
wall 	wall 	 NN	I-NP
.  	.  	 .	O
An  	An  	 DT	O
endoscope  	endoscope  	 NN	B-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
used  	used  	 VBN	O
while  	while  	 IN	O
positioning  	positioning  	 VBG	O
the  	the  	 DT	O
inserter  	inserter  	 NN	B-NP
to  	to  	 TO	O
aid  	aid  	 VB	O
with  	with  	 IN	O
visualization  	visualization  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
ostium 	ostium 	 NN	I-NP
.  	.  	 .	O
Irrigation  	Irrigation  	 JJ	B-NP
tools  	tools  	 NNS	I-NP
and  	and  	 CC	O
electrocautery  	electrocautery  	 NNS	B-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
employed  	employed  	 VBN	O
if  	if  	 IN	O
needed 	needed 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
following  	following  	 JJ	O
description  	description  	 NN	O
provides  	provides  	 VBZ	O
an  	an  	 DT	O
exemplary  	exemplary  	 JJ	B-NP
way  	way  	 NN	I-NP
of  	of  	 IN	O
a  	a  	 DT	O
how  	how  	 WRB	O
a  	a  	 DT	O
single  	single  	 JJ	O
device  	device  	 NN	O
might  	might  	 MD	O
be  	be  	 VB	O
deployed  	deployed  	 VBN	O
into  	into  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 NN	B-NP
using  	using  	 VBG	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
inserter 	inserter 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
sinus  	sinus  	 JJ	B-NP
inserter  	inserter  	 NNS	I-NP
typically  	typically  	 RB	O
includes  	includes  	 VBZ	O
a  	a  	 DT	O
distal  	distal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
device  	device  	 NN	I-NP
in  	in  	 IN	O
its  	its  	 PRP$	O
collapsed  	collapsed  	 JJ	O
configuration  	configuration  	 NN	B-NP
on  	on  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
handle 	handle 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
conduit  	conduit  	 NN	O
having  	having  	 VBG	O
a  	a  	 DT	O
lumen 	lumen 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
sheath  	sheath  	 NN	O
connected  	connected  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
retractable  	retractable  	 JJ	O
knob 	knob 	 NN	B-NP
.  	.  	 .	O
Upon  	Upon  	 IN	O
pulling  	pulling  	 VBG	O
the  	the  	 DT	O
retractable  	retractable  	 JJ	O
knob 	knob 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
knob  	knob  	 JJ	B-NP
moves  	moves  	 NNS	I-NP
proximally  	proximally  	 VBP	O
to  	to  	 TO	O
abut  	abut  	 VB	O
the  	the  	 DT	O
handle  	handle  	 NN	O
and  	and  	 CC	O
slidably  	slidably  	 NNS	O
deploy  	deploy  	 VBP	O
the  	the  	 DT	O
self-expanding  	self-expanding  	 JJ	O
nasal  	nasal  	 JJ	B-NP
plate  	plate  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device 	device 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
balloon  	balloon  	 NN	B-NP
catheter  	catheter  	 NN	I-NP
may  	may  	 MD	O
then  	then  	 RB	O
be  	be  	 VB	O
advanced  	advanced  	 VBN	O
through  	through  	 IN	O
the  	the  	 DT	O
lumen  	lumen  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
conduit  	conduit  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
inserter  	inserter  	 NN	I-NP
and  	and  	 CC	O
inflated  	inflated  	 VBN	O
to  	to  	 TO	O
expand  	expand  	 VB	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
device 	device 	 NN	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
flexible  	flexible  	 JJ	O
mesh  	mesh  	 NN	O
40  	40  	 CD	O
of  	of  	 IN	O
FIGS.  	FIGS.  	 CD	O
4A-4B 	4A-4B 	 CD	O
.  	.  	 .	O
Method  	Method  	 NN	O
of  	of  	 IN	O
manufacture 	manufacture 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
method  	method  	 NN	O
of  	of  	 IN	O
preparing  	preparing  	 VBG	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
invention  	invention  	 NN	O
will  	will  	 MD	O
generally  	generally  	 RB	O
depend  	depend  	 VB	O
on  	on  	 IN	O
the  	the  	 DT	O
particular  	particular  	 JJ	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
or  	or  	 CC	O
polymer  	polymer  	 VB	O
used 	used 	 VBN	O
,  	,  	 ,	O
form  	form  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
release  	release  	 NN	B-NP
kinetics  	kinetics  	 VBZ	I-NP
desired 	desired 	 VBN	O
,  	,  	 ,	O
but  	but  	 CC	O
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
by  	by  	 IN	O
any  	any  	 DT	O
one  	one  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
numerous  	numerous  	 JJ	B-NP
methods  	methods  	 NNS	I-NP
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
devices  	devices  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
by  	by  	 IN	O
such  	such  	 JJ	O
processes  	processes  	 NNS	O
as  	as  	 IN	O
extrusion 	extrusion 	 NN	O
;  	;  	 :	O
injection  	injection  	 NN	B-NP
or  	or  	 CC	O
form  	form  	 NN	B-NP
molding 	molding 	 NNS	I-NP
;  	;  	 :	O
blow 	blow 	 NN	O
,  	,  	 ,	O
film 	film 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
melt  	melt  	 JJ	O
casting 	casting 	 NN	O
;  	;  	 :	O
welding 	welding 	 CD	O
;  	;  	 :	O
and  	and  	 CC	O
other  	other  	 JJ	O
manufacturing  	manufacturing  	 NN	B-NP
techniques  	techniques  	 NNS	I-NP
well  	well  	 RB	O
known  	known  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
art  	art  	 NN	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
cutting  	cutting  	 VBG	O
and  	and  	 CC	O
annealing 	annealing 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
filaments  	filaments  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
wet  	wet  	 JJ	O
or  	or  	 CC	O
melt  	melt  	 VB	O
spun 	spun 	 VBN	O
,  	,  	 ,	O
formed  	formed  	 VBN	O
by  	by  	 IN	O
laser  	laser  	 NN	O
or  	or  	 CC	O
other  	other  	 JJ	O
cutting 	cutting 	 NN	O
,  	,  	 ,	O
formed  	formed  	 VBN	O
by  	by  	 IN	O
slitting 	slitting 	 NN	O
,  	,  	 ,	O
formed  	formed  	 VBN	O
by  	by  	 IN	O
extrusion 	extrusion 	 NN	O
,  	,  	 ,	O
injection  	injection  	 NN	B-NP
or  	or  	 CC	O
other  	other  	 JJ	O
molding 	molding 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
casting 	casting 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
following  	following  	 JJ	O
examples  	examples  	 NNS	O
serve  	serve  	 VBP	O
to  	to  	 TO	O
more  	more  	 RBR	O
fully  	fully  	 RB	O
describe  	describe  	 VB	O
the  	the  	 DT	O
manner  	manner  	 NN	O
of  	of  	 IN	O
making  	making  	 VBG	O
and  	and  	 CC	O
using  	using  	 VBG	O
the  	the  	 DT	O
above-described  	above-described  	 JJ	O
devices 	devices 	 NNS	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
understood  	understood  	 VBN	O
that  	that  	 IN	O
these  	these  	 DT	O
examples  	examples  	 NNS	O
in  	in  	 IN	O
no  	no  	 DT	O
way  	way  	 NN	O
serve  	serve  	 VBP	O
to  	to  	 TO	O
limit  	limit  	 VB	O
the  	the  	 DT	O
scope  	scope  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
invention 	invention 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
rather  	rather  	 RB	O
are  	are  	 VBP	O
presented  	presented  	 VBN	O
for  	for  	 IN	O
illustrative  	illustrative  	 JJ	B-NP
purposes 	purposes 	 NNS	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
following  	following  	 JJ	O
examples  	examples  	 NNS	O
will  	will  	 MD	O
employ 	employ 	 VB	O
,  	,  	 ,	O
unless  	unless  	 IN	O
otherwise  	otherwise  	 RB	O
indicated 	indicated 	 VBN	O
,  	,  	 ,	O
conventional  	conventional  	 JJ	B-NP
techniques  	techniques  	 NNS	I-NP
of  	of  	 IN	I-NP
pharmaceutical  	pharmaceutical  	 JJ	I-NP
formulation 	formulation 	 NN	I-NP
,  	,  	 ,	O
medicinal  	medicinal  	 JJ	B-NP
chemistry 	chemistry 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
like 	like 	 JJ	O
,  	,  	 ,	O
which  	which  	 WDT	O
are  	are  	 VBP	O
within  	within  	 IN	O
the  	the  	 DT	O
skill  	skill  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
art 	art 	 NN	O
.  	.  	 .	O
Such  	Such  	 JJ	O
techniques  	techniques  	 NNS	O
are  	are  	 VBP	O
explained  	explained  	 VBN	O
fully  	fully  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
literature 	literature 	 NN	O
.  	.  	 .	O
Efforts  	Efforts  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
made  	made  	 VBN	O
to  	to  	 TO	O
ensure  	ensure  	 VB	O
accuracy  	accuracy  	 NN	B-NP
with  	with  	 IN	O
respect  	respect  	 NN	O
to  	to  	 TO	O
numbers  	numbers  	 NNS	O
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
amounts 	amounts 	 NNS	O
,  	,  	 ,	O
temperature 	temperature 	 NN	O
,  	,  	 ,	O
etc. 	etc. 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
some  	some  	 DT	O
experimental  	experimental  	 JJ	B-NP
error  	error  	 NN	I-NP
and  	and  	 CC	O
deviation  	deviation  	 NN	O
should  	should  	 MD	O
be  	be  	 VB	O
accounted  	accounted  	 VBN	O
for 	for 	 IN	O
.  	.  	 .	O
Unless  	Unless  	 IN	O
indicated  	indicated  	 VBN	O
otherwise 	otherwise 	 RB	O
,  	,  	 ,	O
parts  	parts  	 NNS	O
are  	are  	 VBP	O
parts  	parts  	 NNS	O
by  	by  	 IN	O
weight 	weight 	 NN	O
,  	,  	 ,	O
temperature  	temperature  	 NN	O
is  	is  	 VBZ	O
in  	in  	 IN	O
degrees  	degrees  	 JJ	O
Celsius  	Celsius  	 NNP	B-NP
( 	( 	 -LRB-	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
C. 	C. 	 LS	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
pressure  	pressure  	 NN	O
is  	is  	 VBZ	O
at  	at  	 IN	O
or  	or  	 CC	O
near  	near  	 IN	O
atmospheric  	atmospheric  	 JJ	B-NP
pressure  	pressure  	 NN	I-NP
at  	at  	 IN	O
sea  	sea  	 NN	B-NP
level 	level 	 NN	I-NP
.  	.  	 .	O
All  	All  	 DT	O
components  	components  	 NNS	O
are  	are  	 VBP	O
obtainable  	obtainable  	 JJ	O
commercially  	commercially  	 NN	O
unless  	unless  	 IN	O
otherwise  	otherwise  	 RB	O
indicated 	indicated 	 VBN	O
.  	.  	 .	O
Extruded  	Extruded  	 JJ	B-NP
ribbon  	ribbon  	 JJ	I-NP
fiber  	fiber  	 NN	I-NP
was  	was  	 VBD	O
made  	made  	 VBN	O
with  	with  	 IN	O
mometasone  	mometasone  	 JJ	B-NP
furoate  	furoate  	 NN	I-NP
and  	and  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
DL-lactide-co-glycolide 	DL-lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
.  	.  	 .	O
The  	The  	 DT	O
desired  	desired  	 JJ	O
mometasone  	mometasone  	 JJ	B-NP
furoate  	furoate  	 JJ	I-NP
content  	content  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
was  	was  	 VBD	O
5  	5  	 CD	O
wt  	wt  	 JJ	O
%  	%  	 NN	O
mometasone  	mometasone  	 NN	B-NP
furoate 	furoate 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
DL-lactide-co-glycolide 	DL-lactide-co-glycolide 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
was  	was  	 VBD	O
ester  	ester  	 VBN	B-NP
capped  	capped  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
molar  	molar  	 JJ	B-NP
ratio  	ratio  	 NN	I-NP
of  	of  	 IN	O
70 	70 	 CD	O
/ 	/ 	 CD	O
30  	30  	 CD	O
DL-lactide 	DL-lactide 	 JJ	B-NP
/ 	/ 	 CD	I-NP
glycolide  	glycolide  	 NNS	I-NP
and  	and  	 CC	O
had  	had  	 VBD	O
an  	an  	 DT	O
inherent  	inherent  	 JJ	O
viscosity  	viscosity  	 NN	O
of  	of  	 IN	O
0.81  	0.81  	 NNP	O
dL 	dL 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
g 	g 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
inherent  	inherent  	 JJ	O
viscosity  	viscosity  	 NN	O
was  	was  	 VBD	O
measured  	measured  	 VBN	O
at  	at  	 IN	O
30 	30 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
C.  	C.  	 NNP	O
with  	with  	 IN	O
0.5  	0.5  	 CD	O
gm 	gm 	 CD	B-NP
/ 	/ 	 CD	I-NP
dL  	dL  	 JJ	I-NP
polymer  	polymer  	 JJ	I-NP
concentration  	concentration  	 NN	I-NP
in  	in  	 IN	O
chloroform 	chloroform 	 NN	B-NP
.  	.  	 .	O
First  	First  	 JJ	B-NP
mometasone  	mometasone  	 JJ	I-NP
furoate  	furoate  	 NNS	I-NP
( 	( 	 -LRB-	O
0.5  	0.5  	 CD	O
gm 	gm 	 CD	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
DL-lactide-co-glycolide 	DL-lactide-co-glycolide 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
( 	( 	 -LRB-	O
9.5  	9.5  	 CD	O
gm 	gm 	 CD	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
dissolved  	dissolved  	 VBN	O
in  	in  	 IN	O
methylene  	methylene  	 JJ	B-NP
chloride  	chloride  	 NN	I-NP
( 	( 	 -LRB-	O
40  	40  	 CD	O
gm 	gm 	 CD	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
thin  	thin  	 JJ	O
film  	film  	 NN	O
was  	was  	 VBD	O
cast  	cast  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
resulting  	resulting  	 JJ	O
solution 	solution 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
cast  	cast  	 NN	B-NP
film  	film  	 NN	I-NP
was  	was  	 VBD	O
dried  	dried  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
vacuum  	vacuum  	 NN	B-NP
oven  	oven  	 NN	I-NP
for  	for  	 IN	O
48-96  	48-96  	 CD	O
hours  	hours  	 NNS	O
to  	to  	 TO	O
remove  	remove  	 VB	O
residual  	residual  	 JJ	B-NP
methylene  	methylene  	 JJ	I-NP
chloride 	chloride 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cast  	cast  	 NN	B-NP
film  	film  	 NN	I-NP
was  	was  	 VBD	O
cut  	cut  	 VBN	O
into  	into  	 IN	O
thin  	thin  	 JJ	O
strips  	strips  	 NNS	O
approximately  	approximately  	 RB	O
10-20  	10-20  	 CD	O
mm  	mm  	 CD	O
wide  	wide  	 JJ	O
and  	and  	 CC	O
100-150  	100-150  	 NNP	O
mm  	mm  	 VBD	O
long 	long 	 RB	O
.  	.  	 .	O
Next  	Next  	 IN	B-NP
a  	a  	 DT	O
Tinius  	Tinius  	 NNP	B-NP
Olsen  	Olsen  	 NNP	I-NP
Model  	Model  	 NNP	I-NP
UE-4-78  	UE-4-78  	 NNP	I-NP
melt  	melt  	 NN	O
plastometer  	plastometer  	 NNS	B-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
extrude  	extrude  	 VB	O
the  	the  	 DT	O
cast  	cast  	 NN	B-NP
film  	film  	 NN	I-NP
strips 	strips 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
solid  	solid  	 JJ	O
block  	block  	 NN	O
of  	of  	 IN	O
steel  	steel  	 NN	O
about  	about  	 IN	O
80  	80  	 CD	O
mm  	mm  	 NN	O
in  	in  	 IN	O
diameter  	diameter  	 NN	O
and  	and  	 CC	O
about  	about  	 IN	O
160  	160  	 CD	O
mm  	mm  	 CD	O
high 	high 	 JJ	O
/ 	/ 	 NN	O
long  	long  	 RB	O
with  	with  	 IN	O
a  	a  	 DT	O
hollow  	hollow  	 JJ	O
core  	core  	 NN	O
about  	about  	 IN	O
13  	13  	 CD	O
mm  	mm  	 NN	O
in  	in  	 IN	O
diameter 	diameter 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
discharge  	discharge  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
core  	core  	 NN	O
has  	has  	 VBZ	O
a  	a  	 DT	O
shoulder  	shoulder  	 NN	O
that  	that  	 WDT	O
allows  	allows  	 VBZ	O
different  	different  	 JJ	O
size  	size  	 NN	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
dies 	dies 	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
to  	to  	 TO	O
be  	be  	 VB	O
used  	used  	 VBN	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
diameter  	diameter  	 NN	O
of  	of  	 IN	O
extruded  	extruded  	 JJ	O
rod 	rod 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
this  	this  	 DT	O
run 	run 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
custom  	custom  	 NN	O
machined  	machined  	 NNS	O
die  	die  	 VBP	O
was  	was  	 VBD	O
used  	used  	 VBN	O
with  	with  	 IN	O
internal  	internal  	 JJ	B-NP
core  	core  	 NN	I-NP
dimensions  	dimensions  	 NNS	I-NP
of  	of  	 IN	O
0.3556  	0.3556  	 CD	O
mm 	mm 	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
xd7 	xd7 	 CD	B-NP
; 	; 	 :	O
2.0015  	2.0015  	 CD	O
mm 	mm 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
main  	main  	 JJ	O
block  	block  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
has  	has  	 VBZ	O
heater  	heater  	 JJ	B-NP
bands  	bands  	 JJ	I-NP
encased  	encased  	 NN	O
by  	by  	 IN	O
insulation  	insulation  	 NN	B-NP
and  	and  	 CC	O
a  	a  	 DT	O
shroud  	shroud  	 NN	O
that  	that  	 WDT	O
allow  	allow  	 VBP	O
the  	the  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
to  	to  	 TO	O
be  	be  	 VB	O
heated  	heated  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
desired  	desired  	 JJ	O
temperature 	temperature 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
thermocouple  	thermocouple  	 NN	B-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
measure  	measure  	 VB	O
the  	the  	 DT	O
temperature  	temperature  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
block 	block 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
control  	control  	 NN	B-NP
system  	system  	 NN	I-NP
then  	then  	 RB	O
uses  	uses  	 VBZ	O
the  	the  	 DT	O
thermocouple  	thermocouple  	 JJ	B-NP
values  	values  	 NNS	I-NP
to  	to  	 TO	O
either  	either  	 RB	O
turn  	turn  	 VB	O
the  	the  	 DT	O
heater  	heater  	 JJ	B-NP
bands  	bands  	 NNS	I-NP
on  	on  	 IN	O
or  	or  	 CC	O
off 	off 	 RB	O
.  	.  	 .	O
Throughout  	Throughout  	 IN	O
the  	the  	 DT	O
extrusion  	extrusion  	 NN	B-NP
process 	process 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
heater  	heater  	 JJ	B-NP
bands  	bands  	 NNS	I-NP
will  	will  	 MD	O
switch  	switch  	 VB	O
off  	off  	 RP	O
and  	and  	 CC	O
on  	on  	 IN	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
temperature 	temperature 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
cast  	cast  	 NN	B-NP
film  	film  	 NN	I-NP
strips 	strips 	 NNS	I-NP
,  	,  	 ,	O
approximately  	approximately  	 RB	O
4  	4  	 CD	O
gm 	gm 	 NN	B-NP
,  	,  	 ,	O
were  	were  	 VBD	O
loaded  	loaded  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
which  	which  	 WDT	O
had  	had  	 VBD	O
been  	been  	 VBN	O
equilibrated  	equilibrated  	 VBN	O
to  	to  	 TO	O
120 	120 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
C.  	C.  	 NNP	O
A  	A  	 NNP	O
charging  	charging  	 VBG	O
rod  	rod  	 NN	O
was  	was  	 VBD	O
placed  	placed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
core  	core  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
to  	to  	 TO	O
compress  	compress  	 VB	O
the  	the  	 DT	O
blend  	blend  	 NN	O
and  	and  	 CC	O
a  	a  	 DT	O
weight  	weight  	 NN	O
of  	of  	 IN	O
10  	10  	 CD	O
kg  	kg  	 NNS	B-NP
was  	was  	 VBD	O
placed  	placed  	 VBN	B-NP
oh  	oh  	 VBG	I-NP
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
charging  	charging  	 VBG	O
rod  	rod  	 NN	O
to  	to  	 TO	O
aid  	aid  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
compaction  	compaction  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
blend 	blend 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
equilibration  	equilibration  	 JJ	B-NP
time  	time  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
blend  	blend  	 NN	O
to  	to  	 TO	O
melt  	melt  	 VB	O
lasted  	lasted  	 VBN	O
for  	for  	 IN	O
about  	about  	 IN	O
20  	20  	 CD	O
minutes 	minutes 	 NNS	O
.  	.  	 .	O
After  	After  	 IN	O
an  	an  	 DT	O
extrusion  	extrusion  	 NN	B-NP
load  	load  	 NN	I-NP
of  	of  	 IN	O
10,000  	10,000  	 CD	O
gm  	gm  	 NNS	B-NP
was  	was  	 VBD	O
placed  	placed  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
charging  	charging  	 VBG	O
rod 	rod 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
plug  	plug  	 NN	O
was  	was  	 VBD	O
removed  	removed  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
discharge  	discharge  	 NN	B-NP
area  	area  	 NN	I-NP
to  	to  	 TO	O
begin  	begin  	 VB	O
the  	the  	 DT	O
extrusion  	extrusion  	 NN	B-NP
run 	run 	 NN	I-NP
.  	.  	 .	O
As  	As  	 IN	O
the  	the  	 DT	O
ribbon  	ribbon  	 JJ	B-NP
fiber  	fiber  	 NN	I-NP
was  	was  	 VBD	O
extruded  	extruded  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
discharge 	discharge 	 NN	O
,  	,  	 ,	O
it  	it  	 PRP	O
was  	was  	 VBD	O
pulled  	pulled  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
conveyor  	conveyor  	 JJ	B-NP
belt  	belt  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
dimensions  	dimensions  	 NNS	O
( 	( 	 -LRB-	O
0.3-0.4  	0.3-0.4  	 CD	O
mm 	mm 	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
xd7 	xd7 	 CD	B-NP
; 	; 	 :	O
1.0-1.2  	1.0-1.2  	 CD	O
mm 	mm 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
4-gm  	4-gm  	 JJ	O
charge  	charge  	 NN	O
afforded  	afforded  	 VBN	O
7-10  	7-10  	 CD	O
segments  	segments  	 NNS	O
of  	of  	 IN	O
extruded  	extruded  	 JJ	O
fiber  	fiber  	 NN	B-NP
each  	each  	 DT	O
having  	having  	 VBG	O
a  	a  	 DT	O
length  	length  	 NN	O
of  	of  	 IN	O
about  	about  	 IN	O
100  	100  	 CD	O
cm 	cm 	 NNS	O
.  	.  	 .	O
Extruded  	Extruded  	 JJ	B-NP
ribbon  	ribbon  	 JJ	I-NP
fiber  	fiber  	 NN	I-NP
was  	was  	 VBD	O
made  	made  	 VBN	O
with  	with  	 IN	O
mometasone  	mometasone  	 JJ	B-NP
furoate 	furoate 	 NN	I-NP
,  	,  	 ,	O
triethyl  	triethyl  	 FW	B-NP
citrate  	citrate  	 FW	I-NP
( 	( 	 -LRB-	O
plasticizer 	plasticizer 	 LS	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
DL-lactide-co-glycolide 	DL-lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
.  	.  	 .	O
The  	The  	 DT	O
desired  	desired  	 JJ	O
mometasone  	mometasone  	 JJ	B-NP
furoate  	furoate  	 JJ	I-NP
content  	content  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
was  	was  	 VBD	O
5  	5  	 CD	O
wt  	wt  	 JJ	O
%  	%  	 NN	O
mometasone  	mometasone  	 NN	B-NP
furoate 	furoate 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
DL-lactide-co-glycolide 	DL-lactide-co-glycolide 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
was  	was  	 VBD	O
ester  	ester  	 VBN	B-NP
capped  	capped  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
molar  	molar  	 JJ	B-NP
ratio  	ratio  	 NN	I-NP
of  	of  	 IN	O
70 	70 	 CD	O
/ 	/ 	 CD	O
30  	30  	 CD	O
DL-lactide 	DL-lactide 	 JJ	B-NP
/ 	/ 	 CD	I-NP
glycolide  	glycolide  	 NNS	I-NP
and  	and  	 CC	O
had  	had  	 VBD	O
an  	an  	 DT	O
inherent  	inherent  	 JJ	O
viscosity  	viscosity  	 NN	O
of  	of  	 IN	O
0.81  	0.81  	 NNP	O
dL 	dL 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
g 	g 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
inherent  	inherent  	 JJ	O
viscosity  	viscosity  	 NN	O
was  	was  	 VBD	O
measured  	measured  	 VBN	O
at  	at  	 IN	O
30 	30 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
C.  	C.  	 NNP	O
with  	with  	 IN	O
0.5  	0.5  	 CD	O
gm 	gm 	 CD	B-NP
/ 	/ 	 CD	I-NP
dL  	dL  	 JJ	I-NP
polymer  	polymer  	 JJ	I-NP
concentration  	concentration  	 NN	I-NP
in  	in  	 IN	O
chloroform 	chloroform 	 NN	B-NP
.  	.  	 .	O
First  	First  	 JJ	B-NP
mometasone  	mometasone  	 JJ	I-NP
furoate  	furoate  	 NNS	I-NP
( 	( 	 -LRB-	O
0.5  	0.5  	 CD	O
gm 	gm 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
triethyl  	triethyl  	 FW	B-NP
citrate  	citrate  	 FW	I-NP
( 	( 	 -LRB-	O
0.2  	0.2  	 CD	O
gm 	gm 	 CD	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
DL-lactide-co-glycolide 	DL-lactide-co-glycolide 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
( 	( 	 -LRB-	O
9.3  	9.3  	 CD	O
gm 	gm 	 CD	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
dissolved  	dissolved  	 VBN	O
in  	in  	 IN	O
ethyl  	ethyl  	 JJ	B-NP
acetate  	acetate  	 NNS	I-NP
( 	( 	 -LRB-	O
40  	40  	 CD	O
gm 	gm 	 CD	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
thin  	thin  	 JJ	O
film  	film  	 NN	O
was  	was  	 VBD	O
cast  	cast  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
resulting  	resulting  	 JJ	O
solution 	solution 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
cast  	cast  	 NN	B-NP
film  	film  	 NN	I-NP
was  	was  	 VBD	O
dried  	dried  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
vacuum  	vacuum  	 NN	B-NP
oven  	oven  	 NN	I-NP
for  	for  	 IN	O
48-96  	48-96  	 CD	O
hours  	hours  	 NNS	O
to  	to  	 TO	O
remove  	remove  	 VB	O
residual  	residual  	 JJ	B-NP
methylene  	methylene  	 JJ	I-NP
chloride 	chloride 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cast  	cast  	 NN	B-NP
film  	film  	 NN	I-NP
was  	was  	 VBD	O
cut  	cut  	 VBN	O
into  	into  	 IN	O
thin  	thin  	 JJ	O
strips  	strips  	 NNS	O
approximately  	approximately  	 RB	O
10-20  	10-20  	 CD	O
mm  	mm  	 CD	O
wide  	wide  	 JJ	O
and  	and  	 CC	O
100-150  	100-150  	 NNP	O
mm  	mm  	 VBD	O
long 	long 	 RB	O
.  	.  	 .	O
Next  	Next  	 IN	B-NP
a  	a  	 DT	O
Tinius  	Tinius  	 NNP	B-NP
Olsen  	Olsen  	 NNP	I-NP
Model  	Model  	 NNP	I-NP
UE-4-78  	UE-4-78  	 NNP	I-NP
melt  	melt  	 NN	O
plastometer  	plastometer  	 NNS	B-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
extrude  	extrude  	 VB	O
the  	the  	 DT	O
cast  	cast  	 NN	B-NP
film  	film  	 NN	I-NP
strips 	strips 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
solid  	solid  	 JJ	O
block  	block  	 NN	O
of  	of  	 IN	O
steel  	steel  	 NN	O
about  	about  	 IN	O
80  	80  	 CD	O
mm  	mm  	 NN	O
in  	in  	 IN	O
diameter  	diameter  	 NN	O
and  	and  	 CC	O
about  	about  	 IN	O
160  	160  	 CD	O
mm  	mm  	 CD	O
high 	high 	 JJ	O
/ 	/ 	 NN	O
long  	long  	 RB	O
with  	with  	 IN	O
a  	a  	 DT	O
hollow  	hollow  	 JJ	O
core  	core  	 NN	O
about  	about  	 IN	O
13  	13  	 CD	O
mm  	mm  	 NN	O
in  	in  	 IN	O
diameter 	diameter 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
discharge  	discharge  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
core  	core  	 NN	O
has  	has  	 VBZ	O
a  	a  	 DT	O
shoulder  	shoulder  	 NN	O
that  	that  	 WDT	O
allows  	allows  	 VBZ	O
different  	different  	 JJ	O
size  	size  	 NN	O
& 	& 	 CC	O
# 	# 	 #	O
x201c 	x201c 	 CD	O
; 	; 	 :	O
dies 	dies 	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
x201d 	x201d 	 CD	O
;  	;  	 :	O
to  	to  	 TO	O
be  	be  	 VB	O
used  	used  	 VBN	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
diameter  	diameter  	 NN	O
of  	of  	 IN	O
extruded  	extruded  	 JJ	O
rod 	rod 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
this  	this  	 DT	O
run 	run 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
custom  	custom  	 NN	O
machined  	machined  	 NNS	O
die  	die  	 VBP	O
was  	was  	 VBD	O
used  	used  	 VBN	O
with  	with  	 IN	O
internal  	internal  	 JJ	B-NP
core  	core  	 NN	I-NP
dimensions  	dimensions  	 NNS	I-NP
of  	of  	 IN	O
0.3556  	0.3556  	 CD	O
mm 	mm 	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
xd7 	xd7 	 CD	B-NP
; 	; 	 :	O
2.0015  	2.0015  	 CD	O
mm 	mm 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
main  	main  	 JJ	O
block  	block  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
has  	has  	 VBZ	O
heater  	heater  	 JJ	B-NP
bands  	bands  	 JJ	I-NP
encased  	encased  	 NN	O
by  	by  	 IN	O
insulation  	insulation  	 NN	B-NP
and  	and  	 CC	O
a  	a  	 DT	O
shroud  	shroud  	 NN	O
that  	that  	 WDT	O
allow  	allow  	 VBP	O
the  	the  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
to  	to  	 TO	O
be  	be  	 VB	O
heated  	heated  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
desired  	desired  	 JJ	O
temperature 	temperature 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
thermocouple  	thermocouple  	 NN	B-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
measure  	measure  	 VB	O
the  	the  	 DT	O
temperature  	temperature  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
block 	block 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
control  	control  	 NN	B-NP
system  	system  	 NN	I-NP
then  	then  	 RB	O
used  	used  	 VBN	O
the  	the  	 DT	O
thermocouple  	thermocouple  	 JJ	B-NP
values  	values  	 NNS	I-NP
to  	to  	 TO	O
either  	either  	 RB	O
turn  	turn  	 VB	O
the  	the  	 DT	O
heater  	heater  	 JJ	B-NP
bands  	bands  	 NNS	I-NP
on  	on  	 IN	O
or  	or  	 CC	O
off 	off 	 RB	O
.  	.  	 .	O
Throughout  	Throughout  	 IN	O
the  	the  	 DT	O
extrusion  	extrusion  	 NN	B-NP
process 	process 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
heater  	heater  	 JJ	B-NP
bands  	bands  	 NNS	I-NP
switched  	switched  	 VBD	O
off  	off  	 RP	O
and  	and  	 CC	O
on  	on  	 IN	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
temperature 	temperature 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
cast  	cast  	 NN	B-NP
film  	film  	 NN	I-NP
strips 	strips 	 NNS	I-NP
,  	,  	 ,	O
approximately  	approximately  	 RB	O
4  	4  	 CD	O
gm 	gm 	 NN	B-NP
,  	,  	 ,	O
were  	were  	 VBD	O
loaded  	loaded  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
which  	which  	 WDT	O
had  	had  	 VBD	O
been  	been  	 VBN	O
equilibrated  	equilibrated  	 VBN	O
to  	to  	 TO	O
120 	120 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
C.  	C.  	 NNP	O
A  	A  	 NNP	O
charging  	charging  	 VBG	O
rod  	rod  	 NN	O
was  	was  	 VBD	O
placed  	placed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
core  	core  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Tinius  	Tinius  	 NNP	O
Olsen  	Olsen  	 NNP	O
to  	to  	 TO	O
compress  	compress  	 VB	O
the  	the  	 DT	O
blend  	blend  	 NN	O
and  	and  	 CC	O
a  	a  	 DT	O
weight  	weight  	 NN	O
of  	of  	 IN	O
10  	10  	 CD	O
kg  	kg  	 NNS	B-NP
was  	was  	 VBD	O
placed  	placed  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
charging  	charging  	 VBG	O
rod  	rod  	 NN	O
to  	to  	 TO	O
aid  	aid  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
compaction  	compaction  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
blend 	blend 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
equilibration  	equilibration  	 JJ	B-NP
time  	time  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
blend  	blend  	 NN	O
to  	to  	 TO	O
melt  	melt  	 VB	O
lasted  	lasted  	 VBN	O
for  	for  	 IN	O
about  	about  	 IN	O
20  	20  	 CD	O
minutes 	minutes 	 NNS	O
.  	.  	 .	O
After  	After  	 IN	O
an  	an  	 DT	O
extrusion  	extrusion  	 NN	B-NP
load  	load  	 NN	I-NP
of  	of  	 IN	O
10,000  	10,000  	 CD	O
gm  	gm  	 NNS	B-NP
was  	was  	 VBD	O
placed  	placed  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
charging  	charging  	 VBG	O
rod 	rod 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
plug  	plug  	 NN	O
was  	was  	 VBD	O
removed  	removed  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
discharge  	discharge  	 NN	B-NP
area  	area  	 NN	I-NP
to  	to  	 TO	O
begin  	begin  	 VB	O
the  	the  	 DT	O
extrusion  	extrusion  	 NN	B-NP
run 	run 	 NN	I-NP
.  	.  	 .	O
As  	As  	 IN	O
the  	the  	 DT	O
ribbon  	ribbon  	 JJ	B-NP
fiber  	fiber  	 NN	I-NP
was  	was  	 VBD	O
extruded  	extruded  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
discharge 	discharge 	 NN	O
,  	,  	 ,	O
it  	it  	 PRP	O
was  	was  	 VBD	O
pulled  	pulled  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
conveyor  	conveyor  	 JJ	B-NP
belt  	belt  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
dimensions  	dimensions  	 NNS	O
( 	( 	 -LRB-	O
0.3-0.4  	0.3-0.4  	 CD	O
mm 	mm 	 NNS	O
& 	& 	 CC	O
# 	# 	 #	O
xd7 	xd7 	 CD	B-NP
; 	; 	 :	O
1.0-1.2  	1.0-1.2  	 CD	O
mm 	mm 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
4-gm  	4-gm  	 JJ	O
charge  	charge  	 NN	O
afforded  	afforded  	 VBN	O
7-10  	7-10  	 CD	O
segments  	segments  	 NNS	O
of  	of  	 IN	O
extruded  	extruded  	 JJ	O
fiber  	fiber  	 NN	B-NP
each  	each  	 DT	O
having  	having  	 VBG	O
a  	a  	 DT	O
length  	length  	 NN	O
of  	of  	 IN	O
about  	about  	 IN	O
100  	100  	 CD	O
cm 	cm 	 NNS	O
.  	.  	 .	O
Various  	Various  	 JJ	B-NP
compositions  	compositions  	 NNS	I-NP
of  	of  	 IN	I-NP
ribbon  	ribbon  	 JJ	I-NP
fiber  	fiber  	 NN	I-NP
were  	were  	 VBD	O
made  	made  	 VBN	O
following  	following  	 VBG	O
fabrication  	fabrication  	 NN	B-NP
techniques  	techniques  	 NNS	I-NP
similar  	similar  	 JJ	O
to  	to  	 TO	O
those  	those  	 DT	O
described  	described  	 VBN	O
in  	in  	 IN	O
Examples  	Examples  	 NNP	O
1  	1  	 CD	O
and  	and  	 CC	O
2 	2 	 CD	O
.  	.  	 .	O
Table  	Table  	 NN	O
1  	1  	 CD	O
below  	below  	 IN	O
lists  	lists  	 NNS	O
these  	these  	 DT	O
formulation  	formulation  	 JJ	B-NP
compositions  	compositions  	 NNS	I-NP
having  	having  	 VBG	O
varying  	varying  	 JJ	O
amounts  	amounts  	 NNS	O
of  	of  	 IN	O
mometasone  	mometasone  	 JJ	B-NP
furoate 	furoate 	 NN	I-NP
,  	,  	 ,	O
plasticizers 	plasticizers 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
porosigens  	porosigens  	 NNS	B-NP
and  	and  	 CC	O
showing  	showing  	 VBG	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
different  	different  	 JJ	O
processing  	processing  	 NN	B-NP
solvents  	solvents  	 NNS	I-NP
( 	( 	 -LRB-	O
ethyl  	ethyl  	 JJ	B-NP
acetate  	acetate  	 NN	I-NP
and  	and  	 CC	O
methylene  	methylene  	 JJ	B-NP
chloride 	chloride 	 NN	I-NP
)  	)  	 -RRB-	O
to  	to  	 TO	O
prepare  	prepare  	 VB	O
material  	material  	 NN	O
to  	to  	 TO	O
place  	place  	 VB	O
into  	into  	 IN	O
an  	an  	 DT	O
extruder 	extruder 	 NN	B-NP
.  	.  	 .	O
TABLE  	TABLE  	 NN	O
1  	1  	 CD	O
Compositions  	Compositions  	 NNS	B-NP
of  	of  	 IN	O
ribbon  	ribbon  	 JJ	O
fibers  	fibers  	 NNS	O
prepared  	prepared  	 VBN	O
by  	by  	 IN	O
melt  	melt  	 JJ	O
extrusion  	extrusion  	 NN	B-NP
Batch  	Batch  	 NNP	I-NP
Plasticizer  	Plasticizer  	 NNP	I-NP
Porosigen  	Porosigen  	 NNP	I-NP
Fiber  	Fiber  	 NNP	I-NP
Dimensions  	Dimensions  	 NNP	I-NP
Batch  	Batch  	 NNP	I-NP
Size  	Size  	 NNP	I-NP
Polymer  	Polymer  	 NNP	I-NP
Mometasone  	Mometasone  	 NNP	I-NP
Content  	Content  	 NNP	I-NP
Content  	Content  	 NNP	I-NP
Thickness  	Thickness  	 NNP	I-NP
Width  	Width  	 NNP	I-NP
Number  	Number  	 NNP	O
( 	( 	 -LRB-	O
g 	g 	 LS	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
DL-PLG 	DL-PLG 	 NNP	B-NP
)  	)  	 -RRB-	O
Load  	Load  	 NNP	O
( 	( 	 -LRB-	O
wt  	wt  	 JJ	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
Processing  	Processing  	 NNP	B-NP
Solvent  	Solvent  	 NNP	I-NP
Plasticizer  	Plasticizer  	 NNP	I-NP
( 	( 	 -LRB-	O
wt  	wt  	 JJ	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
Porosigen  	Porosigen  	 NNP	B-NP
( 	( 	 -LRB-	O
wt  	wt  	 JJ	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
mm 	mm 	 LS	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
mm 	mm 	 LS	O
)  	)  	 -RRB-	O
0015-50  	0015-50  	 CD	O
5  	5  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
2  	2  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
2  	2  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.4  	0.4  	 CD	O
1.50  	1.50  	 CD	O
0015-51  	0015-51  	 CD	O
5  	5  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
2  	2  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
4  	4  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.50  	0.50  	 CD	O
1.45  	1.45  	 CD	O
0015-52  	0015-52  	 CD	O
5  	5  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
5  	5  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
0  	0  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.36  	0.36  	 CD	O
1.00  	1.00  	 CD	O
0015-53  	0015-53  	 CD	O
5  	5  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
5  	5  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
2  	2  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.52  	0.52  	 CD	O
1.45  	1.45  	 CD	O
0015-54  	0015-54  	 CD	O
5  	5  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
5  	5  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
4  	4  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.56  	0.56  	 CD	O
1.50  	1.50  	 CD	O
0015-55  	0015-55  	 CD	O
5  	5  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
10  	10  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
4  	4  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.50  	0.50  	 CD	O
1.30  	1.30  	 CD	O
0015-56  	0015-56  	 CD	O
5  	5  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
10  	10  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
2  	2  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.50  	0.50  	 CD	O
1.38  	1.38  	 CD	O
0065-01  	0065-01  	 CD	O
3.9  	3.9  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
2  	2  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
2  	2  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.53  	0.53  	 CD	O
1.33  	1.33  	 CD	O
0065-02  	0065-02  	 CD	O
3.8  	3.8  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
5  	5  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
0  	0  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.38  	0.38  	 CD	O
1.28  	1.28  	 CD	O
0065-03  	0065-03  	 CD	O
3.9  	3.9  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
5  	5  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
TEC  	TEC  	 NNP	I-NP
2  	2  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.42  	0.42  	 CD	O
1.46  	1.46  	 CD	O
0065-09  	0065-09  	 CD	O
3.9  	3.9  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
2  	2  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.39  	0.39  	 CD	O
1.25  	1.25  	 CD	O
0065-10  	0065-10  	 CD	O
1.9  	1.9  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
2  	2  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.35  	0.35  	 CD	O
1.18  	1.18  	 CD	O
0065-15  	0065-15  	 CD	O
4.2  	4.2  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
0.5  	0.5  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.43  	0.43  	 CD	O
1.37  	1.37  	 CD	O
0065-16  	0065-16  	 CD	O
4.1  	4.1  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
0.5  	0.5  	 CD	O
Methylene  	Methylene  	 NNP	B-NP
Chloride  	Chloride  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.35  	0.35  	 CD	O
1.20  	1.20  	 CD	O
0065-17  	0065-17  	 CD	O
4.1  	4.1  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
0.5  	0.5  	 CD	O
Ethyl  	Ethyl  	 NNP	B-NP
Acetate  	Acetate  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
PEG  	PEG  	 CD	O
1500  	1500  	 CD	O
2  	2  	 CD	O
0.42  	0.42  	 CD	O
1.38  	1.38  	 CD	O
0065-18  	0065-18  	 CD	O
4.2  	4.2  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
0.5  	0.5  	 CD	O
Methylene  	Methylene  	 NNP	B-NP
Chloride  	Chloride  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
PEG  	PEG  	 CD	O
1500  	1500  	 CD	O
2  	2  	 CD	O
0.38  	0.38  	 CD	O
1.23  	1.23  	 CD	O
0065-37  	0065-37  	 CD	O
4  	4  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
5.0  	5.0  	 CD	O
Methylene  	Methylene  	 NNP	B-NP
Chloride  	Chloride  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.34  	0.34  	 CD	O
1.19  	1.19  	 CD	O
0065-38  	0065-38  	 CD	O
3.9  	3.9  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
2.0  	2.0  	 CD	O
Methylene  	Methylene  	 NNP	B-NP
Chloride  	Chloride  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.30  	0.30  	 CD	O
1.02  	1.02  	 CD	O
0065-39  	0065-39  	 CD	O
4.1  	4.1  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
0.5  	0.5  	 CD	O
Methylene  	Methylene  	 NNP	B-NP
Chloride  	Chloride  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
NA  	NA  	 CD	B-NP
0  	0  	 CD	O
0.32  	0.32  	 CD	O
1.09  	1.09  	 CD	O
0065-40  	0065-40  	 CD	O
4  	4  	 CD	O
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
0.25  	0.25  	 CD	O
Methylene  	Methylene  	 NNP	B-NP
Chloride  	Chloride  	 NNP	I-NP
NA  	NA  	 NNP	I-NP
0  	0  	 CD	O
PEG  	PEG  	 CD	O
1500  	1500  	 CD	O
2  	2  	 CD	O
0.39  	0.39  	 CD	O
1.22  	1.22  	 CD	O
A  	A  	 DT	O
fiber  	fiber  	 NN	B-NP
formulation  	formulation  	 NN	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
with  	with  	 IN	O
fluticasone  	fluticasone  	 JJ	B-NP
proprionate  	proprionate  	 NN	I-NP
with  	with  	 IN	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
DL-lactide 	DL-lactide 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
or  	or  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
.  	.  	 .	O
The  	The  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
)  	)  	 -RRB-	I-NP
or  	or  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
capped  	capped  	 VBN	O
or  	or  	 CC	O
have  	have  	 VBP	O
acid  	acid  	 JJ	B-NP
end  	end  	 NN	I-NP
groups 	groups 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
desired  	desired  	 JJ	O
fluticasone  	fluticasone  	 JJ	B-NP
proprionate  	proprionate  	 JJ	I-NP
content  	content  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
fiber  	fiber  	 NN	B-NP
can  	can  	 MD	O
range  	range  	 VB	O
from  	from  	 IN	O
0.1  	0.1  	 CD	O
wt  	wt  	 JJ	O
%  	%  	 NN	O
to  	to  	 TO	O
20  	20  	 CD	O
wt  	wt  	 JJ	O
% 	% 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
prepare  	prepare  	 VB	O
a  	a  	 DT	O
long-acting  	long-acting  	 JJ	B-NP
formulation  	formulation  	 NN	I-NP
of  	of  	 IN	I-NP
fluticasone  	fluticasone  	 JJ	I-NP
proprionate 	proprionate 	 NN	I-NP
,  	,  	 ,	O
particles  	particles  	 VBG	O
of  	of  	 IN	O
fluticasone  	fluticasone  	 JJ	B-NP
proprionate  	proprionate  	 NN	I-NP
and  	and  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
DL-lactide-co-glycolide 	DL-lactide-co-glycolide 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
or  	or  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
dry  	dry  	 JJ	O
blended  	blended  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
variety  	variety  	 NN	O
of  	of  	 IN	O
ways  	ways  	 NNS	O
including  	including  	 VBG	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
mortar 	mortar 	 JJ	O
/ 	/ 	 CD	O
pestle  	pestle  	 NNS	O
or  	or  	 CC	O
by  	by  	 IN	O
mixing  	mixing  	 VBG	O
preformed  	preformed  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
and  	and  	 CC	O
peptide  	peptide  	 JJ	B-NP
particles  	particles  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
V-blender  	V-blender  	 JJ	B-NP
to  	to  	 TO	O
form  	form  	 VB	O
a  	a  	 DT	O
blended  	blended  	 JJ	O
powder 	powder 	 NN	O
.  	.  	 .	O
Next  	Next  	 IN	B-NP
this  	this  	 DT	O
blend  	blend  	 NN	O
or  	or  	 CC	O
admixture  	admixture  	 NNS	B-NP
can  	can  	 MD	O
be  	be  	 VB	O
added  	added  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
twin-screw  	twin-screw  	 JJ	B-NP
extruder  	extruder  	 NNS	I-NP
having  	having  	 VBG	O
a  	a  	 DT	O
machined  	machined  	 JJ	O
die  	die  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
2-mm  	2-mm  	 JJ	O
diameter 	diameter 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
temperature  	temperature  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
extruder  	extruder  	 NN	B-NP
should  	should  	 MD	O
be  	be  	 VB	O
about  	about  	 IN	O
120 	120 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
C.  	C.  	 NNP	O
As  	As  	 IN	O
the  	the  	 DT	O
fiber  	fiber  	 NN	B-NP
is  	is  	 VBZ	O
extruded  	extruded  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
extruder 	extruder 	 NN	B-NP
,  	,  	 ,	O
it  	it  	 PRP	O
will  	will  	 MD	O
be  	be  	 VB	O
collected  	collected  	 VBN	O
on  	on  	 IN	O
a  	a  	 DT	O
conveyor  	conveyor  	 JJ	B-NP
belt 	belt 	 NN	I-NP
.  	.  	 .	O
Ribbon  	Ribbon  	 JJ	B-NP
fiber  	fiber  	 NN	I-NP
as  	as  	 IN	O
prepared  	prepared  	 VBN	O
by  	by  	 IN	O
Example  	Example  	 NNP	O
1 	1 	 CD	O
,  	,  	 ,	O
was  	was  	 VBD	O
fabricated  	fabricated  	 VBN	O
into  	into  	 IN	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
following  	following  	 JJ	O
manner 	manner 	 NN	O
.  	.  	 .	O
Four  	Four  	 CD	O
strands  	strands  	 NN	O
of  	of  	 IN	O
ribbon  	ribbon  	 JJ	B-NP
fiber  	fiber  	 NN	I-NP
were  	were  	 VBD	O
cut  	cut  	 VBN	O
to  	to  	 TO	O
approximately  	approximately  	 RB	O
35  	35  	 CD	O
mm  	mm  	 NNS	O
and  	and  	 CC	O
then  	then  	 RB	O
looped  	looped  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
whisk-like  	whisk-like  	 JJ	B-NP
structures  	structures  	 NNS	I-NP
as  	as  	 IN	O
previously  	previously  	 RB	O
described 	described 	 VBN	O
.  	.  	 .	O
Paranasal  	Paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
devices  	devices  	 NNS	I-NP
prepared  	prepared  	 VBN	O
as  	as  	 RB	O
described  	described  	 VBN	O
in  	in  	 IN	O
Example  	Example  	 NNP	O
4  	4  	 CD	O
were  	were  	 VBD	O
sterilized  	sterilized  	 VBN	O
with  	with  	 IN	O
2.5  	2.5  	 CD	O
Mrad  	Mrad  	 NNS	B-NP
of  	of  	 IN	I-NP
gamma  	gamma  	 JJ	I-NP
radiation  	radiation  	 NN	I-NP
and  	and  	 CC	O
placed  	placed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
maxillary  	maxillary  	 JJ	B-NP
sinuses  	sinuses  	 NNS	I-NP
( 	( 	 -LRB-	O
right  	right  	 NN	O
and  	and  	 CC	O
left  	left  	 JJ	O
sides 	sides 	 NNS	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
5-kg  	5-kg  	 CD	O
rabbits  	rabbits  	 NN	O
through  	through  	 IN	O
dorsal  	dorsal  	 FW	B-NP
nasal  	nasal  	 FW	I-NP
maxillary  	maxillary  	 FW	I-NP
sinusotomies 	sinusotomies 	 FW	I-NP
.  	.  	 .	O
Three  	Three  	 CD	O
formulations  	formulations  	 NNS	B-NP
were  	were  	 VBD	O
tested 	tested 	 VBN	O
.  	.  	 .	O
These  	These  	 DT	O
were  	were  	 VBD	O
as  	as  	 RB	O
follows 	follows 	 VBZ	O
:  	:  	 :	O
PLG  	PLG  	 NNP	B-NP
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
with  	with  	 IN	O
5 	5 	 CD	O
%  	%  	 NN	O
mometasone  	mometasone  	 NNS	B-NP
and  	and  	 CC	O
0 	0 	 CD	O
%  	%  	 NN	O
triethylcitrate  	triethylcitrate  	 NNS	B-NP
( 	( 	 -LRB-	O
TEC 	TEC 	 NNP	O
)  	)  	 -RRB-	O
PLG  	PLG  	 NNP	B-NP
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
with  	with  	 IN	O
5 	5 	 CD	O
%  	%  	 NN	O
mometasone  	mometasone  	 NNS	B-NP
and  	and  	 CC	O
2 	2 	 CD	O
%  	%  	 NN	O
TEC  	TEC  	 FW	O
PLG  	PLG  	 NNP	B-NP
69 	69 	 CD	O
: 	: 	 :	O
31  	31  	 CD	O
with  	with  	 IN	O
10 	10 	 CD	O
%  	%  	 NN	O
mometasone  	mometasone  	 NNS	B-NP
and  	and  	 CC	O
2 	2 	 CD	O
%  	%  	 NN	O
TEC  	TEC  	 FW	O
The  	The  	 DT	O
same  	same  	 JJ	O
formulation  	formulation  	 NN	B-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
for  	for  	 IN	O
both  	both  	 DT	O
right  	right  	 NN	O
and  	and  	 CC	O
left  	left  	 VBD	O
sinuses  	sinuses  	 VBN	O
of  	of  	 IN	O
a  	a  	 DT	O
given  	given  	 VBN	O
rabbit 	rabbit 	 NN	O
.  	.  	 .	O
Fifteen  	Fifteen  	 JJ	O
rabbits  	rabbits  	 NN	O
were  	were  	 VBD	O
implanted 	implanted 	 VBN	O
.  	.  	 .	O
Five  	Five  	 CD	O
rabbits  	rabbits  	 NNS	O
were  	were  	 VBD	O
implanted  	implanted  	 VBN	O
with  	with  	 IN	O
each  	each  	 DT	O
device  	device  	 NN	B-NP
formulation 	formulation 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
devices  	devices  	 NNS	O
were  	were  	 VBD	O
explanted  	explanted  	 VBN	O
at  	at  	 IN	O
approximately  	approximately  	 RB	O
weekly  	weekly  	 JJ	O
intervals  	intervals  	 JJ	O
post  	post  	 NN	B-NP
implantation  	implantation  	 NN	I-NP
over  	over  	 IN	O
a  	a  	 DT	O
5-week  	5-week  	 JJ	O
period 	period 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
mucosa  	mucosa  	 NN	B-NP
of  	of  	 IN	O
both  	both  	 DT	O
right  	right  	 NN	O
and  	and  	 CC	O
left  	left  	 VBD	O
maxillary  	maxillary  	 JJ	B-NP
sinuses  	sinuses  	 NN	I-NP
was  	was  	 VBD	O
removed  	removed  	 VBN	O
completely  	completely  	 RB	O
at  	at  	 IN	O
the  	the  	 DT	O
time  	time  	 NN	O
of  	of  	 IN	O
explanation 	explanation 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
tissue  	tissue  	 NN	O
was  	was  	 VBD	O
rapidly  	rapidly  	 RB	O
frozen  	frozen  	 VBN	O
and  	and  	 CC	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
mometasone  	mometasone  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
tissue  	tissue  	 NN	O
was  	was  	 VBD	O
quantitated  	quantitated  	 VBN	O
by  	by  	 IN	O
liquid  	liquid  	 JJ	B-NP
chromatography 	chromatography 	 FW	I-NP
/ 	/ 	 FW	I-NP
mass  	mass  	 FW	I-NP
spectroscopy  	spectroscopy  	 FW	I-NP
( 	( 	 -LRB-	O
LC 	LC 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
MS 	MS 	 NNP	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
mometasone  	mometasone  	 VBG	O
maintained  	maintained  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
tissue  	tissue  	 NN	O
over  	over  	 IN	O
a  	a  	 DT	O
35-day  	35-day  	 JJ	O
period  	period  	 NN	O
is  	is  	 VBZ	O
reported  	reported  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
table  	table  	 NN	O
below 	below 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
is  	is  	 VBZ	O
equivalent  	equivalent  	 JJ	O
to  	to  	 TO	O
10 	10 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2212 	x2212 	 CD	O
; 	; 	 :	O
5  	5  	 CD	O
M  	M  	 NNP	O
to  	to  	 TO	O
10 	10 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2212 	x2212 	 CD	O
; 	; 	 :	O
7  	7  	 CD	O
M  	M  	 NNP	O
concentration  	concentration  	 NN	B-NP
at  	at  	 IN	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
site  	site  	 NN	O
of  	of  	 IN	O
action 	action 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
all  	all  	 DT	O
time  	time  	 NN	B-NP
points  	points  	 NNS	I-NP
demonstrating  	demonstrating  	 VBG	O
a  	a  	 DT	O
sustained  	sustained  	 JJ	O
release  	release  	 NN	O
and  	and  	 CC	O
bioavailability  	bioavailability  	 NN	B-NP
of  	of  	 IN	O
drug  	drug  	 NN	O
at  	at  	 IN	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
tissue  	tissue  	 NN	O
concentration  	concentration  	 NN	O
which  	which  	 WDT	O
are  	are  	 VBP	O
known  	known  	 VBN	O
to  	to  	 TO	O
have  	have  	 VB	O
therapeutic  	therapeutic  	 JJ	B-NP
efficacy  	efficacy  	 NNS	I-NP
( 	( 	 -LRB-	O
see  	see  	 VB	O
below 	below 	 IN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Mometasone  	Mometasone  	 NNP	B-NP
Levels  	Levels  	 NNP	I-NP
Measured  	Measured  	 NNP	O
in  	in  	 IN	O
Excised  	Excised  	 NNP	B-NP
Sinus  	Sinus  	 NNP	I-NP
Mucosa  	Mucosa  	 NNP	I-NP
( 	( 	 -LRB-	O
micrograms  	micrograms  	 FW	B-NP
Mometasone  	Mometasone  	 FW	I-NP
per  	per  	 FW	O
gram  	gram  	 FW	O
tissue 	tissue 	 FW	O
)  	)  	 -RRB-	O
4  	4  	 CD	O
day  	day  	 NN	O
14  	14  	 CD	O
25  	25  	 CD	O
30  	30  	 CD	O
35  	35  	 CD	O
pooled  	pooled  	 JJ	O
day  	day  	 NN	O
day  	day  	 NN	O
day  	day  	 NN	O
day  	day  	 NN	O
10 	10 	 CD	O
%  	%  	 NN	O
Mometasone  	Mometasone  	 NNP	B-NP
R  	R  	 NNP	I-NP
0.915  	0.915  	 CD	O
1.41  	1.41  	 CD	O
183  	183  	 CD	O
139  	139  	 CD	O
97.6  	97.6  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2002 	x2002 	 CD	O
; 	; 	 :	O
2 	2 	 CD	O
%  	%  	 NN	O
TEC  	TEC  	 NNP	O
L  	L  	 NNP	O
0.823  	0.823  	 CD	O
5.95  	5.95  	 CD	O
7.57  	7.57  	 CD	O
152  	152  	 CD	O
335  	335  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2002 	x2002 	 CD	O
; 	; 	 :	O
5 	5 	 CD	O
%  	%  	 NN	O
Mometasone  	Mometasone  	 NNP	B-NP
R  	R  	 NNP	I-NP
1.17  	1.17  	 CD	O
1.01  	1.01  	 CD	O
1.44  	1.44  	 CD	O
0.76  	0.76  	 CD	O
81.7  	81.7  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2002 	x2002 	 CD	O
; 	; 	 :	O
2 	2 	 CD	O
%  	%  	 NN	O
TEC  	TEC  	 NNP	O
L  	L  	 NNP	O
( 	( 	 -LRB-	O
st  	st  	 FW	B-NP
dev  	dev  	 FW	I-NP
=  	=  	 FW	O
No  	No  	 DT	O
peak  	peak  	 NN	O
44.3  	44.3  	 CD	O
86.4  	86.4  	 CD	O
153  	153  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2002 	x2002 	 CD	O
; 	; 	 :	O
5 	5 	 CD	O
%  	%  	 NN	O
Mometasone  	Mometasone  	 NNP	B-NP
R  	R  	 NNP	I-NP
0.18 	0.18 	 CD	O
)  	)  	 -RRB-	O
246  	246  	 CD	O
1.28  	1.28  	 CD	O
2.11  	2.11  	 CD	O
178  	178  	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2002 	x2002 	 CD	O
; 	; 	 :	O
0 	0 	 CD	O
%  	%  	 NN	O
TEC  	TEC  	 NNP	O
L  	L  	 NNP	O
2.57  	2.57  	 CD	O
0.54  	0.54  	 CD	O
158  	158  	 CD	O
The  	The  	 DT	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
release  	release  	 NN	I-NP
of  	of  	 IN	I-NP
mometasone  	mometasone  	 JJ	I-NP
furoate  	furoate  	 NN	I-NP
from  	from  	 IN	O
candidate  	candidate  	 NN	B-NP
formulations  	formulations  	 NNS	I-NP
was  	was  	 VBD	O
determined 	determined 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
25 	25 	 CD	O
.  	.  	 .	O
To  	To  	 TO	O
carry  	carry  	 VB	O
out  	out  	 RP	O
this  	this  	 DT	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
release  	release  	 NN	I-NP
study 	study 	 NN	I-NP
,  	,  	 ,	O
each  	each  	 DT	O
device  	device  	 NN	O
was  	was  	 VBD	O
placed  	placed  	 VBN	O
at  	at  	 IN	O
37 	37 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
xb0 	xb0 	 CD	B-NP
;  	;  	 :	O
C.  	C.  	 NNP	O
in  	in  	 IN	O
1.0  	1.0  	 CD	O
wt  	wt  	 JJ	O
%  	%  	 NN	O
sodium  	sodium  	 FW	B-NP
dodectyl  	dodectyl  	 FW	I-NP
sulfate  	sulfate  	 FW	I-NP
( 	( 	 -LRB-	O
SDS 	SDS 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
nanopure  	nanopure  	 JJ	B-NP
water 	water 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
receiving  	receiving  	 VBG	B-NP
fluid 	fluid 	 NN	I-NP
.  	.  	 .	O
At  	At  	 IN	O
each  	each  	 DT	O
time  	time  	 NN	B-NP
point 	point 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
receiving  	receiving  	 VBG	B-NP
fluid  	fluid  	 NN	I-NP
was  	was  	 VBD	O
removed  	removed  	 VBN	O
completely  	completely  	 RB	O
and  	and  	 CC	O
fresh  	fresh  	 JJ	O
receiving  	receiving  	 VBG	B-NP
fluid  	fluid  	 NN	I-NP
was  	was  	 VBD	O
added 	added 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
mometasone  	mometasone  	 VBG	O
released  	released  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
receiving  	receiving  	 VBG	O
at  	at  	 IN	O
each  	each  	 DT	O
time  	time  	 NN	B-NP
point  	point  	 NN	I-NP
was  	was  	 VBD	O
quantified  	quantified  	 VBN	O
by  	by  	 IN	O
HPLC 	HPLC 	 NNP	B-NP
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
first  	first  	 JJ	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
cumulative  	cumulative  	 JJ	I-NP
release  	release  	 NN	I-NP
study 	study 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
FIG.  	FIG.  	 CD	O
25 	25 	 CD	O
,  	,  	 ,	O
cumulative  	cumulative  	 JJ	B-NP
release  	release  	 NN	I-NP
of  	of  	 IN	I-NP
mometasone  	mometasone  	 JJ	I-NP
furoate  	furoate  	 NN	I-NP
from  	from  	 IN	O
a  	a  	 DT	O
2 	2 	 CD	O
%  	%  	 NN	O
mometasone 	mometasone 	 VBD	O
/ 	/ 	 CD	O
4 	4 	 CD	O
%  	%  	 NN	O
TEC  	TEC  	 NNP	B-NP
fiber  	fiber  	 NN	I-NP
was  	was  	 VBD	O
about  	about  	 IN	O
6 	6 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
7 	7 	 CD	O
,  	,  	 ,	O
about  	about  	 IN	O
11 	11 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
14 	14 	 CD	O
,  	,  	 ,	O
about  	about  	 IN	O
14 	14 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
21 	21 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
about  	about  	 IN	O
15 	15 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
28 	28 	 CD	O
.  	.  	 .	O
For  	For  	 IN	O
the  	the  	 DT	O
5 	5 	 CD	O
%  	%  	 NN	O
mometasone 	mometasone 	 VBD	O
/ 	/ 	 CD	O
0 	0 	 CD	O
%  	%  	 NN	O
TEC  	TEC  	 NNP	B-NP
fiber 	fiber 	 NN	I-NP
,  	,  	 ,	O
cumulative  	cumulative  	 JJ	B-NP
mometasone  	mometasone  	 JJ	I-NP
release  	release  	 NN	I-NP
was  	was  	 VBD	O
about  	about  	 IN	O
4 	4 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
7 	7 	 CD	O
,  	,  	 ,	O
about  	about  	 IN	O
10 	10 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
14 	14 	 CD	O
,  	,  	 ,	O
about  	about  	 IN	O
12 	12 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
21 	21 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
about  	about  	 IN	O
12  	12  	 CD	O
at  	at  	 IN	O
day  	day  	 NN	O
28 	28 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
5 	5 	 CD	O
%  	%  	 NN	O
mometasone 	mometasone 	 VBD	O
/ 	/ 	 CD	O
2 	2 	 CD	O
%  	%  	 NN	O
TEC  	TEC  	 NNP	B-NP
fiber  	fiber  	 NN	I-NP
cumulative  	cumulative  	 JJ	I-NP
mometasone  	mometasone  	 JJ	I-NP
release  	release  	 NN	I-NP
was  	was  	 VBD	O
about  	about  	 IN	O
3 	3 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
7 	7 	 CD	O
,  	,  	 ,	O
about  	about  	 IN	O
7 	7 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
14 	14 	 CD	O
,  	,  	 ,	O
about  	about  	 IN	O
9 	9 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
21 	21 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
about  	about  	 IN	O
9 	9 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
28 	28 	 CD	O
.  	.  	 .	O
For  	For  	 IN	O
the  	the  	 DT	O
10 	10 	 CD	O
%  	%  	 NN	O
mometasone 	mometasone 	 VBD	O
/ 	/ 	 CD	O
2 	2 	 CD	O
%  	%  	 NN	O
TEC  	TEC  	 NNP	B-NP
fiber 	fiber 	 NN	I-NP
,  	,  	 ,	O
cumulative  	cumulative  	 JJ	B-NP
mometasone  	mometasone  	 NNS	I-NP
release  	release  	 VBP	O
measured  	measured  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
about  	about  	 IN	O
4 	4 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
7 	7 	 CD	O
,  	,  	 ,	O
9 	9 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
14 	14 	 CD	O
,  	,  	 ,	O
12 	12 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
21 	21 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
12 	12 	 CD	O
%  	%  	 NN	O
at  	at  	 IN	O
day  	day  	 NN	O
28 	28 	 CD	O
.  	.  	 .	O
Additional  	Additional  	 JJ	B-NP
drug  	drug  	 NN	I-NP
release  	release  	 NN	I-NP
due  	due  	 JJ	O
to  	to  	 TO	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
polymer  	polymer  	 JJ	I-NP
biodegradation  	biodegradation  	 NN	I-NP
and  	and  	 CC	O
clearance  	clearance  	 NN	O
was  	was  	 VBD	O
demonstrated  	demonstrated  	 VBN	O
and  	and  	 CC	O
directly  	directly  	 RB	O
observed  	observed  	 VBD	O
as  	as  	 RB	O
described  	described  	 VBN	O
above  	above  	 IN	O
in  	in  	 IN	O
the  	the  	 DT	O
tissue  	tissue  	 NN	O
concentration  	concentration  	 NN	O
data 	data 	 NNS	O
.  	.  	 .	O
Published  	Published  	 VBN	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
cellular  	cellular  	 JJ	I-NP
models  	models  	 NNS	I-NP
using  	using  	 VBG	O
cultured  	cultured  	 JJ	O
human  	human  	 JJ	O
airway  	airway  	 JJ	B-NP
epithelial  	epithelial  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
indicate  	indicate  	 VBP	O
drug  	drug  	 NN	B-NP
concentration  	concentration  	 NN	I-NP
dose  	dose  	 NN	I-NP
response  	response  	 NN	I-NP
curves  	curves  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
potent  	potent  	 JJ	O
glucocorticoids 	glucocorticoids 	 NN	B-NP
,  	,  	 ,	O
mometasone  	mometasone  	 JJ	B-NP
furoate  	furoate  	 NN	I-NP
and  	and  	 CC	O
fluticasone  	fluticasone  	 JJ	B-NP
propionate 	propionate 	 NN	I-NP
,  	,  	 ,	O
beginning  	beginning  	 VBG	O
as  	as  	 IN	O
low  	low  	 JJ	O
as  	as  	 IN	O
10 	10 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2212 	x2212 	 CD	O
; 	; 	 :	O
12  	12  	 CD	O
M  	M  	 NNP	O
( 	( 	 -LRB-	O
picomolar 	picomolar 	 LS	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
EC50  	EC50  	 CD	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
transcriptional  	transcriptional  	 JJ	I-NP
response  	response  	 NN	I-NP
at  	at  	 IN	O
10 	10 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2212 	x2212 	 CD	O
; 	; 	 :	O
10  	10  	 CD	O
M  	M  	 NNP	O
( 	( 	 -LRB-	O
100  	100  	 CD	O
picomolar 	picomolar 	 NNS	B-NP
;  	;  	 :	O
maximal  	maximal  	 JJ	B-NP
transcriptional  	transcriptional  	 JJ	I-NP
response  	response  	 NN	I-NP
was  	was  	 VBD	O
seen  	seen  	 VBN	O
in  	in  	 IN	O
most  	most  	 JJS	O
cases  	cases  	 NNS	O
by  	by  	 IN	O
10 	10 	 CD	O
& 	& 	 CC	O
# 	# 	 #	O
x2212 	x2212 	 CD	O
; 	; 	 :	O
9  	9  	 CD	O
M  	M  	 NNP	O
( 	( 	 -LRB-	O
nanomolar 	nanomolar 	 LS	B-NP
)  	)  	 -RRB-	O
drug  	drug  	 NN	B-NP
concentrations 	concentrations 	 NNS	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
models  	models  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
accepted  	accepted  	 VBN	O
as  	as  	 IN	O
equivalent  	equivalent  	 JJ	O
to  	to  	 TO	O
and  	and  	 CC	O
highly  	highly  	 RB	O
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
models  	models  	 NNS	I-NP
of  	of  	 IN	O
efficacy  	efficacy  	 NNS	O
( 	( 	 -LRB-	O
Romestan  	Romestan  	 NNP	B-NP
C.  	C.  	 NNP	I-NP
et  	et  	 FW	O
al  	al  	 FW	O
Fluticasone  	Fluticasone  	 NNP	B-NP
Propionate  	Propionate  	 NNP	I-NP
and  	and  	 CC	O
Mometasone  	Mometasone  	 NNP	B-NP
Furoate  	Furoate  	 NNP	I-NP
Have  	Have  	 NNP	O
Equivalent  	Equivalent  	 NNP	B-NP
Transcriptional  	Transcriptional  	 NNP	I-NP
Potencies 	Potencies 	 NNP	I-NP
,  	,  	 ,	O
Clin  	Clin  	 NNP	B-NP
Exp  	Exp  	 NNP	I-NP
Allergy  	Allergy  	 NNP	I-NP
2003 	2003 	 CD	O
;  	;  	 :	O
33 	33 	 CD	O
:  	:  	 :	O
895-901 	895-901 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
All  	All  	 DT	O
publications 	publications 	 NNS	B-NP
,  	,  	 ,	O
patents 	patents 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
patent  	patent  	 NN	O
applications  	applications  	 NNS	B-NP
cited  	cited  	 VBD	O
herein  	herein  	 NNS	O
are  	are  	 VBP	O
hereby  	hereby  	 VBN	O
incorporated  	incorporated  	 VBN	O
by  	by  	 IN	O
reference  	reference  	 NN	O
in  	in  	 IN	O
their  	their  	 PRP$	O
entirety  	entirety  	 NN	O
for  	for  	 IN	O
all  	all  	 DT	O
purposes  	purposes  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
same  	same  	 JJ	O
extent  	extent  	 NN	O
as  	as  	 IN	O
if  	if  	 IN	O
each  	each  	 DT	O
individual  	individual  	 JJ	O
publication 	publication 	 NN	O
,  	,  	 ,	O
patent 	patent 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
patent  	patent  	 NN	O
application  	application  	 NN	O
were  	were  	 VBD	O
specifically  	specifically  	 RB	O
and  	and  	 CC	O
individually  	individually  	 RB	O
indicated  	indicated  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
so  	so  	 RB	O
incorporated  	incorporated  	 VBN	O
by  	by  	 IN	O
reference 	reference 	 NN	O
.  	.  	 .	O
Although  	Although  	 IN	O
the  	the  	 DT	O
foregoing  	foregoing  	 JJ	O
invention  	invention  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
described  	described  	 VBN	O
in  	in  	 IN	O
some  	some  	 DT	O
detail  	detail  	 NN	O
by  	by  	 IN	O
way  	way  	 NN	O
of  	of  	 IN	O
illustration  	illustration  	 NN	B-NP
and  	and  	 CC	O
example  	example  	 NN	O
for  	for  	 IN	O
purposes  	purposes  	 NNS	O
of  	of  	 IN	O
clarity  	clarity  	 NN	O
of  	of  	 IN	O
understanding 	understanding 	 NN	O
,  	,  	 ,	O
it  	it  	 PRP	O
will  	will  	 MD	O
be  	be  	 VB	O
readily  	readily  	 RB	O
apparent  	apparent  	 JJ	O
to  	to  	 TO	O
those  	those  	 DT	O
of  	of  	 IN	O
ordinary  	ordinary  	 JJ	B-NP
skill  	skill  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
art  	art  	 NN	O
in  	in  	 IN	O
light  	light  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
teachings  	teachings  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
invention  	invention  	 NN	O
that  	that  	 IN	O
certain  	certain  	 JJ	O
changes  	changes  	 NNS	O
and  	and  	 CC	O
modifications  	modifications  	 NNS	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
made  	made  	 VBN	O
thereto  	thereto  	 VBN	O
without  	without  	 IN	O
departing  	departing  	 VBG	O
from  	from  	 IN	O
the  	the  	 DT	O
spirit  	spirit  	 NN	O
and  	and  	 CC	O
scope  	scope  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
appended  	appended  	 JJ	O
claims 	claims 	 NNS	O
.  	.  	 .	O
What  	What  	 WP	O
is  	is  	 VBZ	O
claimed  	claimed  	 VBN	O
as  	as  	 IN	O
new  	new  	 JJ	O
and  	and  	 CC	O
desired  	desired  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
protected  	protected  	 VBN	O
by  	by  	 IN	O
Letters  	Letters  	 NNP	O
Patent  	Patent  	 NNP	O
of  	of  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States  	States  	 NNPS	I-NP
is 	is 	 VBZ	O
:  	:  	 :	O
1 	1 	 LS	O
.  	.  	 .	O
A  	A  	 DT	O
device  	device  	 NN	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
comprising  	comprising  	 VBG	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
for  	for  	 IN	O
sustained  	sustained  	 JJ	O
release.  	release.  	 CD	O
2 	2 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
has  	has  	 VBZ	O
a  	a  	 DT	O
first  	first  	 JJ	O
collapsed  	collapsed  	 JJ	O
configuration  	configuration  	 NN	B-NP
that  	that  	 WDT	O
permits  	permits  	 VBZ	O
the  	the  	 DT	O
device  	device  	 NN	O
to  	to  	 TO	O
pass  	pass  	 VB	O
through  	through  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium  	ostium  	 NN	I-NP
or  	or  	 CC	O
surgically  	surgically  	 RB	O
created  	created  	 VBN	B-NP
fenestration  	fenestration  	 NNS	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
second  	second  	 JJ	O
expanded  	expanded  	 JJ	O
configuration  	configuration  	 NN	B-NP
after  	after  	 IN	O
placement  	placement  	 NN	O
into  	into  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity.  	cavity.  	 CD	I-NP
3 	3 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
2  	2  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
expanded  	expanded  	 JJ	O
configuration  	configuration  	 NN	B-NP
has  	has  	 VBZ	O
a  	a  	 DT	O
surface  	surface  	 NN	O
area  	area  	 NN	O
to  	to  	 TO	O
volume  	volume  	 NN	B-NP
ratio  	ratio  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
substantially  	substantially  	 RB	O
unchanged  	unchanged  	 JJ	O
from  	from  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
collapsed  	collapsed  	 JJ	O
configuration.  	configuration.  	 CD	B-NP
4 	4 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
2  	2  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
expanded  	expanded  	 JJ	O
configuration  	configuration  	 NN	B-NP
substantially  	substantially  	 RB	O
contacts  	contacts  	 VB	O
the  	the  	 DT	O
mucosal  	mucosal  	 JJ	B-NP
surface  	surface  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
sinus  	sinus  	 JJ	I-NP
cavity.  	cavity.  	 CD	I-NP
5 	5 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
are  	are  	 VBP	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member.  	member.  	 CD	I-NP
6 	6 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
are  	are  	 VBP	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion.  	portion.  	 CD	I-NP
7 	7 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
are  	are  	 VBP	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion.  	portion.  	 CD	I-NP
8 	8 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
further  	further  	 JJ	O
comprising  	comprising  	 VBG	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member.  	member.  	 CD	I-NP
9 	9 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
8  	8  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
patency  	patency  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium.  	ostium.  	 CD	I-NP
10 	10 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
8  	8  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
comprises  	comprises  	 VBZ	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 JJ	O
configured  	configured  	 NN	O
to  	to  	 TO	O
anchor  	anchor  	 VB	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity.  	cavity.  	 CD	I-NP
11 	11 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
8  	8  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
sheet-like  	sheet-like  	 JJ	B-NP
material  	material  	 NN	I-NP
configured  	configured  	 NN	I-NP
to  	to  	 TO	O
anchor  	anchor  	 VB	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity.  	cavity.  	 CD	I-NP
12 	12 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
8  	8  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
are  	are  	 VBP	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member.  	member.  	 CD	I-NP
13 	13 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
8  	8  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
are  	are  	 VBP	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member.  	member.  	 CD	I-NP
14 	14 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
8  	8  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
are  	are  	 VBP	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion.  	portion.  	 CD	I-NP
15 	15 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
comprises  	comprises  	 VBZ	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 JJ	O
configured  	configured  	 NN	O
to  	to  	 TO	O
anchor  	anchor  	 VB	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity.  	cavity.  	 CD	I-NP
16 	16 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
comprises  	comprises  	 VBZ	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 JJ	O
configured  	configured  	 NN	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
displacement  	displacement  	 VBN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
cavity  	cavity  	 JJ	I-NP
member  	member  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity.  	cavity.  	 CD	I-NP
17 	17 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
comprises  	comprises  	 VBZ	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 JJ	O
configured  	configured  	 NN	O
to  	to  	 TO	O
anchor  	anchor  	 VB	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
portion.  	portion.  	 CD	I-NP
18 	18 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
8  	8  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
comprise  	comprise  	 VBP	O
a  	a  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material.  	material.  	 CD	I-NP
19 	19 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
18  	18  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
comprise  	comprise  	 VBP	O
the  	the  	 DT	O
same  	same  	 JJ	O
biocompatible  	biocompatible  	 NN	B-NP
material.  	material.  	 CD	I-NP
20 	20 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
18  	18  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
comprise  	comprise  	 VBP	O
different  	different  	 JJ	O
biocompatible  	biocompatible  	 NN	B-NP
materials.  	materials.  	 CD	I-NP
21 	21 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
18  	18  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer 	polymer 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
metal 	metal 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
a  	a  	 DT	O
combination  	combination  	 NN	O
thereof.  	thereof.  	 CD	O
22 	22 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
21  	21  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer.  	polymer.  	 CD	B-NP
23 	23 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
22  	22  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolide 	glycolide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolic  	glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid-co-glycolic  	acid-co-glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolide 	glycolide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
glycolic  	glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid-co-glycolic  	acid-co-glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
caprolactone 	caprolactone 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
caprolactone 	caprolactone 	 LS	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
orthoester 	orthoester 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
phosphazene 	phosphazene 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
hydroxybutyrate 	hydroxybutyrate 	 LS	I-NP
)  	)  	 -RRB-	I-NP
or  	or  	 CC	O
a  	a  	 DT	O
copolymer  	copolymer  	 NN	B-NP
including  	including  	 VBG	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
hydroxybutyrate 	hydroxybutyrate 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-caprolactone 	lactide-co-caprolactone 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
polycarbonate 	polycarbonate 	 NN	O
;  	;  	 :	O
a  	a  	 DT	O
polyesteramide 	polyesteramide 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
polyanhidride 	polyanhidride 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
dioxanone 	dioxanone 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
alkylene  	alkylene  	 FW	I-NP
alkylate 	alkylate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
copolymer  	copolymer  	 NN	B-NP
of  	of  	 IN	I-NP
polyethylene  	polyethylene  	 NN	I-NP
glycol  	glycol  	 NNS	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
polyorthoester 	polyorthoester 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polyurethane 	polyurethane 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
amino  	amino  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
a  	a  	 DT	O
polyetherester 	polyetherester 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
polyacetal 	polyacetal 	 NN	O
;  	;  	 :	O
a  	a  	 DT	O
polycyanoacrylate 	polycyanoacrylate 	 NN	B-NP
;  	;  	 :	O
a  	a  	 DT	O
poly 	poly 	 NN	B-NP
( 	( 	 -LRB-	I-NP
oxyethylene 	oxyethylene 	 LS	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
oxypropylene 	oxypropylene 	 LS	I-NP
)  	)  	 -RRB-	I-NP
copolymer 	copolymer 	 NN	I-NP
;  	;  	 :	O
and  	and  	 CC	O
blends  	blends  	 NNS	O
or  	or  	 CC	O
copolymers  	copolymers  	 CD	O
thereof.  	thereof.  	 CD	O
24 	24 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
23  	23  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
lactide 	lactide 	 JJ	B-NP
/ 	/ 	 CD	I-NP
glycolide  	glycolide  	 CD	I-NP
polymer.  	polymer.  	 CD	I-NP
25 	25 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
18  	18  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer.  	polymer.  	 CD	I-NP
26 	26 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
25  	25  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
vinyl  	vinyl  	 FW	I-NP
acetate 	acetate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
vinyl  	vinyl  	 FW	I-NP
acetate 	acetate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
silicone  	silicone  	 JJ	B-NP
polymers 	polymers 	 NNS	I-NP
,  	,  	 ,	O
polyurethanes 	polyurethanes 	 NN	O
,  	,  	 ,	O
polysaccharides  	polysaccharides  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
a  	a  	 DT	O
cellulosic  	cellulosic  	 JJ	B-NP
polymers  	polymers  	 NNS	I-NP
and  	and  	 CC	O
cellulose  	cellulose  	 JJ	B-NP
derivatives 	derivatives 	 NNS	I-NP
,  	,  	 ,	O
acyl  	acyl  	 FW	B-NP
substituted  	substituted  	 FW	I-NP
cellulose  	cellulose  	 FW	I-NP
acetates  	acetates  	 FW	I-NP
and  	and  	 CC	O
derivatives  	derivatives  	 NNS	O
thereof 	thereof 	 RB	O
,  	,  	 ,	O
copolymers  	copolymers  	 VBG	O
of  	of  	 IN	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
and  	and  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
butylene  	butylene  	 FW	I-NP
terephthalate 	terephthalate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
polystyrenes 	polystyrenes 	 NN	O
,  	,  	 ,	O
polyvinyl  	polyvinyl  	 JJ	B-NP
chloride 	chloride 	 NN	I-NP
,  	,  	 ,	O
polyvinyl  	polyvinyl  	 JJ	B-NP
fluoride 	fluoride 	 NN	I-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
vinyl  	vinyl  	 FW	I-NP
imidazole 	imidazole 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
chorosulphonated  	chorosulphonated  	 JJ	B-NP
polyolefins 	polyolefins 	 NN	I-NP
,  	,  	 ,	O
polyethylene  	polyethylene  	 NN	B-NP
oxide 	oxide 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
copolymers  	copolymers  	 NNS	O
and  	and  	 CC	O
blends  	blends  	 CD	O
thereof.  	thereof.  	 CD	O
27 	27 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
18  	18  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
metal.  	metal.  	 CD	O
28 	28 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
27  	27  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
metal  	metal  	 NN	O
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
cobalt 	cobalt 	 NN	O
,  	,  	 ,	O
chromium 	chromium 	 NN	O
,  	,  	 ,	O
nickel 	nickel 	 NN	O
,  	,  	 ,	O
platinum 	platinum 	 NN	O
,  	,  	 ,	O
stainless  	stainless  	 JJ	O
steel 	steel 	 NN	O
,  	,  	 ,	O
titanium 	titanium 	 NN	B-NP
,  	,  	 ,	O
tantalum 	tantalum 	 NN	O
,  	,  	 ,	O
nickel-titanium 	nickel-titanium 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
alloys  	alloys  	 NNS	O
and  	and  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
29 	29 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
or  	or  	 CC	O
8  	8  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
are  	are  	 VBP	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
anticholinergic  	anticholinergic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antihistamines 	antihistamines 	 NN	B-NP
,  	,  	 ,	O
anti-infective  	anti-infective  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antiscarring  	antiscarring  	 NN	B-NP
or  	or  	 CC	O
antiproliferative  	antiproliferative  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
chemotherapeutic  	chemotherapeutic  	 NN	B-NP
or  	or  	 CC	O
antineoplastic  	antineoplastic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
cytokines 	cytokines 	 NN	B-NP
,  	,  	 ,	O
decongestants 	decongestants 	 NN	B-NP
,  	,  	 ,	O
healing  	healing  	 VBG	B-NP
promotion  	promotion  	 NN	I-NP
agents  	agents  	 NNS	I-NP
and  	and  	 CC	O
vitamins 	vitamins 	 NN	O
,  	,  	 ,	O
hyperosmolar  	hyperosmolar  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
immunomodulator  	immunomodulator  	 NN	B-NP
or  	or  	 CC	O
immunosuppressive  	immunosuppressive  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
leukotriene  	leukotriene  	 JJ	B-NP
modifiers 	modifiers 	 NN	I-NP
,  	,  	 ,	O
mucolytics 	mucolytics 	 NN	B-NP
,  	,  	 ,	O
narcotic  	narcotic  	 JJ	B-NP
analgesics 	analgesics 	 NN	I-NP
,  	,  	 ,	O
small  	small  	 JJ	O
molecules 	molecules 	 NNS	O
,  	,  	 ,	O
tyrosine  	tyrosine  	 FW	B-NP
kinase  	kinase  	 FW	I-NP
inhibitors 	inhibitors 	 FW	I-NP
,  	,  	 ,	O
peptides 	peptides 	 NN	B-NP
,  	,  	 ,	O
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
nucleic  	nucleic  	 JJ	B-NP
acids 	acids 	 NNS	I-NP
,  	,  	 ,	O
vasoconstrictors 	vasoconstrictors 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
30 	30 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
29  	29  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
comprises  	comprises  	 VBZ	O
an  	an  	 DT	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
agent.  	agent.  	 CD	I-NP
31 	31 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
30  	30  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
agent  	agent  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent.  	agent.  	 CD	I-NP
32 	32 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
31  	31  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent  	agent  	 NN	I-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
21-acetoxypregnenolone 	21-acetoxypregnenolone 	 NNP	O
,  	,  	 ,	O
alclometasone 	alclometasone 	 NN	B-NP
,  	,  	 ,	O
algestone 	algestone 	 NN	B-NP
,  	,  	 ,	O
amcinonide 	amcinonide 	 NN	B-NP
,  	,  	 ,	O
beclomethasone 	beclomethasone 	 NN	B-NP
,  	,  	 ,	O
betamethasone 	betamethasone 	 NN	B-NP
,  	,  	 ,	O
budesonide 	budesonide 	 NN	B-NP
,  	,  	 ,	O
chloroprednisone 	chloroprednisone 	 NN	B-NP
,  	,  	 ,	O
clobetasol 	clobetasol 	 NN	B-NP
,  	,  	 ,	O
clobetasone 	clobetasone 	 NN	B-NP
,  	,  	 ,	O
clocortolone 	clocortolone 	 NN	B-NP
,  	,  	 ,	O
cloprednol 	cloprednol 	 NN	B-NP
,  	,  	 ,	O
corticosterone 	corticosterone 	 NN	B-NP
,  	,  	 ,	O
cortisone 	cortisone 	 NN	B-NP
,  	,  	 ,	O
cortivazol 	cortivazol 	 NN	B-NP
,  	,  	 ,	O
deflazacort 	deflazacort 	 NN	B-NP
,  	,  	 ,	O
desonide 	desonide 	 NN	B-NP
,  	,  	 ,	O
desoximetasone 	desoximetasone 	 NN	B-NP
,  	,  	 ,	O
dexamethasone 	dexamethasone 	 NN	B-NP
,  	,  	 ,	O
diflorasone 	diflorasone 	 NN	B-NP
,  	,  	 ,	O
diflucortolone 	diflucortolone 	 NN	B-NP
,  	,  	 ,	O
difluprednate 	difluprednate 	 NN	B-NP
,  	,  	 ,	O
enoxolone 	enoxolone 	 NN	B-NP
,  	,  	 ,	O
fluazacort 	fluazacort 	 NN	B-NP
,  	,  	 ,	O
flucloronide 	flucloronide 	 NN	B-NP
,  	,  	 ,	O
flumethasone 	flumethasone 	 NN	B-NP
,  	,  	 ,	O
flunisolide 	flunisolide 	 NN	B-NP
,  	,  	 ,	O
fluocinolone  	fluocinolone  	 JJ	B-NP
acetonide 	acetonide 	 NN	I-NP
,  	,  	 ,	O
fluocinonide 	fluocinonide 	 NN	B-NP
,  	,  	 ,	O
fluocortin  	fluocortin  	 JJ	B-NP
butyl 	butyl 	 NN	I-NP
,  	,  	 ,	O
fluocortolone 	fluocortolone 	 NN	B-NP
,  	,  	 ,	O
fluorometholone 	fluorometholone 	 NN	B-NP
,  	,  	 ,	O
fluperolone  	fluperolone  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
fluprednidene  	fluprednidene  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
fluprednisolone 	fluprednisolone 	 NN	B-NP
,  	,  	 ,	O
flurandrenolide 	flurandrenolide 	 NN	B-NP
,  	,  	 ,	O
fluticasone  	fluticasone  	 JJ	B-NP
propionate 	propionate 	 NN	I-NP
,  	,  	 ,	O
formocortal 	formocortal 	 NN	B-NP
,  	,  	 ,	O
halcinonide 	halcinonide 	 NN	B-NP
,  	,  	 ,	O
halobetasol  	halobetasol  	 JJ	B-NP
propionate 	propionate 	 NN	I-NP
,  	,  	 ,	O
halometasone 	halometasone 	 NN	B-NP
,  	,  	 ,	O
halopredone  	halopredone  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
hydrocortamate 	hydrocortamate 	 NN	B-NP
,  	,  	 ,	O
hydrocortisone 	hydrocortisone 	 NN	B-NP
,  	,  	 ,	O
loteprednol  	loteprednol  	 JJ	B-NP
etabonate 	etabonate 	 NN	I-NP
,  	,  	 ,	O
mazipredone 	mazipredone 	 NN	B-NP
,  	,  	 ,	O
medrysone 	medrysone 	 NN	B-NP
,  	,  	 ,	O
meprednisone 	meprednisone 	 NN	B-NP
,  	,  	 ,	O
methylprednisolone 	methylprednisolone 	 NN	B-NP
,  	,  	 ,	O
mometasone  	mometasone  	 JJ	B-NP
furoate 	furoate 	 NN	I-NP
,  	,  	 ,	O
paramethasone 	paramethasone 	 NN	B-NP
,  	,  	 ,	O
prednicarbate 	prednicarbate 	 NN	B-NP
,  	,  	 ,	O
prednisolone 	prednisolone 	 NN	B-NP
,  	,  	 ,	O
prednisolone  	prednisolone  	 CD	O
25-diethylamino-acetate 	25-diethylamino-acetate 	 CD	O
,  	,  	 ,	O
prednisolone  	prednisolone  	 FW	B-NP
sodium  	sodium  	 FW	I-NP
phosphate 	phosphate 	 FW	I-NP
,  	,  	 ,	O
prednisone 	prednisone 	 NN	B-NP
,  	,  	 ,	O
prednival 	prednival 	 NN	B-NP
,  	,  	 ,	O
prednylidene 	prednylidene 	 NN	B-NP
,  	,  	 ,	O
rimexolone 	rimexolone 	 NN	B-NP
,  	,  	 ,	O
tixocortol 	tixocortol 	 NN	B-NP
,  	,  	 ,	O
triamcinolone 	triamcinolone 	 NN	B-NP
,  	,  	 ,	O
triamcinolone  	triamcinolone  	 JJ	B-NP
acetonide 	acetonide 	 NN	I-NP
,  	,  	 ,	O
triamcinolone  	triamcinolone  	 JJ	B-NP
benetonide 	benetonide 	 NN	I-NP
,  	,  	 ,	O
triamcinolone  	triamcinolone  	 JJ	B-NP
hexacetonide 	hexacetonide 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
derivatives  	derivatives  	 NNS	O
and  	and  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
33 	33 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
32  	32  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
agent  	agent  	 NN	I-NP
comprises  	comprises  	 VBZ	O
mometasone  	mometasone  	 CD	B-NP
furoate.  	furoate.  	 CD	I-NP
34 	34 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
29  	29  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
comprises  	comprises  	 VBZ	O
an  	an  	 DT	O
anti-infective  	anti-infective  	 JJ	B-NP
agent.  	agent.  	 CD	I-NP
35 	35 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
34  	34  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
anti-infective  	anti-infective  	 JJ	B-NP
agent  	agent  	 NN	I-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
antibacterial  	antibacterial  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antifungal  	antifungal  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antiparasitic  	antiparasitic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antiviral  	antiviral  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antiseptics 	antiseptics 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
36 	36 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
35  	35  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
anti-infective  	anti-infective  	 JJ	B-NP
agent  	agent  	 NN	I-NP
comprises  	comprises  	 VBZ	O
an  	an  	 DT	O
antibacterial  	antibacterial  	 JJ	B-NP
agent.  	agent.  	 CD	I-NP
37 	37 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
36  	36  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
antibacterial  	antibacterial  	 JJ	B-NP
agent  	agent  	 NN	I-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
aminoglycosides 	aminoglycosides 	 NN	B-NP
,  	,  	 ,	O
amphenicols 	amphenicols 	 NN	B-NP
,  	,  	 ,	O
ansamycins 	ansamycins 	 NN	B-NP
,  	,  	 ,	O
& 	& 	 CC	O
# 	# 	 #	O
x3b2 	x3b2 	 CD	O
; 	; 	 :	O
-lactams 	-lactams 	 NNP	O
,  	,  	 ,	O
lincosamides 	lincosamides 	 NN	B-NP
,  	,  	 ,	O
macrolides 	macrolides 	 NN	B-NP
,  	,  	 ,	O
nitrofurans 	nitrofurans 	 NN	B-NP
,  	,  	 ,	O
quinolones 	quinolones 	 NN	B-NP
,  	,  	 ,	O
sulfonamides 	sulfonamides 	 NN	B-NP
,  	,  	 ,	O
sulfones 	sulfones 	 NN	B-NP
,  	,  	 ,	O
tetracyclines 	tetracyclines 	 NN	B-NP
,  	,  	 ,	O
vancomycin 	vancomycin 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
any  	any  	 DT	O
derivatives  	derivatives  	 NNS	O
and  	and  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
38 	38 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
device  	device  	 NN	O
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
differentially  	differentially  	 VB	O
release  	release  	 VB	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents.  	agents.  	 CD	O
39 	39 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
included  	included  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
coating  	coating  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
device.  	device.  	 CD	O
40 	40 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
39  	39  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
coating  	coating  	 NN	O
further  	further  	 RB	O
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
polymer.  	polymer.  	 CD	B-NP
41 	41 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
40  	40  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
polymer  	polymer  	 NN	B-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer.  	polymer.  	 CD	B-NP
42 	42 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
or  	or  	 CC	O
8  	8  	 CD	O
comprising  	comprising  	 NN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
40 	40 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
by  	by  	 IN	O
weight.  	weight.  	 CD	O
43 	43 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
or  	or  	 CC	O
8  	8  	 CD	O
comprising  	comprising  	 NN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
30 	30 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
by  	by  	 IN	O
weight.  	weight.  	 CD	O
44 	44 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
or  	or  	 CC	O
8  	8  	 CD	O
comprising  	comprising  	 NN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
20 	20 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
by  	by  	 IN	O
weight.  	weight.  	 CD	O
45 	45 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
or  	or  	 CC	O
8  	8  	 CD	O
comprising  	comprising  	 NN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
10 	10 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
by  	by  	 IN	O
weight.  	weight.  	 CD	O
46 	46 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
or  	or  	 CC	O
8  	8  	 CD	O
comprising  	comprising  	 NN	O
about  	about  	 IN	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
about  	about  	 RB	O
1 	1 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
active  	active  	 JJ	O
agents  	agents  	 NNS	O
by  	by  	 IN	O
weight.  	weight.  	 CD	O
47 	47 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
sinus  	sinus  	 JJ	B-NP
inflammation  	inflammation  	 JJ	I-NP
due  	due  	 JJ	O
to  	to  	 TO	O
functional  	functional  	 VB	B-NP
endoscopic  	endoscopic  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
surgery  	surgery  	 NN	I-NP
( 	( 	 -LRB-	O
FESS 	FESS 	 NNP	B-NP
) 	) 	 -RRB-	O
;  	;  	 :	O
acute  	acute  	 JJ	B-NP
sinusitis 	sinusitis 	 NN	I-NP
;  	;  	 :	O
chronic  	chronic  	 JJ	B-NP
sinusitis 	sinusitis 	 NN	I-NP
;  	;  	 :	O
allergic  	allergic  	 JJ	B-NP
rhinitis 	rhinitis 	 NN	I-NP
;  	;  	 :	O
rhinosinusitis 	rhinosinusitis 	 CD	B-NP
;  	;  	 :	O
sinusitis  	sinusitis  	 NN	O
that  	that  	 IN	O
recurs  	recurs  	 NN	O
after  	after  	 IN	O
FESS 	FESS 	 NNP	B-NP
;  	;  	 :	O
upper  	upper  	 JJ	O
respiratory  	respiratory  	 JJ	B-NP
tract  	tract  	 NN	I-NP
infections 	infections 	 NNS	I-NP
;  	;  	 :	O
otitis  	otitis  	 JJ	B-NP
media 	media 	 NNS	I-NP
;  	;  	 :	O
bronchitis 	bronchitis 	 CD	O
;  	;  	 :	O
bronchiolitis 	bronchiolitis 	 CD	B-NP
;  	;  	 :	O
asthma 	asthma 	 NN	B-NP
;  	;  	 :	O
tonsillitis  	tonsillitis  	 NNS	O
and  	and  	 CC	O
other  	other  	 JJ	O
chronic  	chronic  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
tonsils  	tonsils  	 NN	O
and  	and  	 CC	O
adenoids 	adenoids 	 NNS	B-NP
;  	;  	 :	O
laryngitis 	laryngitis 	 CD	O
;  	;  	 :	O
tracheitis 	tracheitis 	 CD	B-NP
;  	;  	 :	O
nasal  	nasal  	 NNS	B-NP
and  	and  	 CC	O
sinus  	sinus  	 JJ	B-NP
polyposis 	polyposis 	 NN	I-NP
;  	;  	 :	O
neoplasms  	neoplasms  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
large  	large  	 JJ	O
and  	and  	 CC	O
small  	small  	 JJ	O
airways 	airways 	 NN	B-NP
;  	;  	 :	O
and  	and  	 CC	O
nasal 	nasal 	 NN	B-NP
,  	,  	 ,	O
sinus 	sinus 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
nasopharynx  	nasopharynx  	 CD	B-NP
tumors.  	tumors.  	 CD	I-NP
48 	48 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
47  	47  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
is  	is  	 VBZ	O
sinus  	sinus  	 JJ	B-NP
inflammation  	inflammation  	 JJ	I-NP
due  	due  	 JJ	O
to  	to  	 TO	O
functional  	functional  	 VB	B-NP
endoscopic  	endoscopic  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
surgery  	surgery  	 NN	I-NP
( 	( 	 -LRB-	O
FESS 	FESS 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
49 	49 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
47  	47  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
is  	is  	 VBZ	O
rhinosinusitis.  	rhinosinusitis.  	 CD	B-NP
50 	50 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
further  	further  	 JJ	O
comprising  	comprising  	 VBG	O
a  	a  	 DT	O
substance  	substance  	 NN	O
that  	that  	 WDT	O
prevents  	prevents  	 VBZ	O
biofilm  	biofilm  	 CD	B-NP
formation.  	formation.  	 CD	I-NP
51 	51 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
50  	50  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
substance  	substance  	 NN	O
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
alcohol 	alcohol 	 NN	B-NP
,  	,  	 ,	O
chlorhexidine 	chlorhexidine 	 NN	B-NP
,  	,  	 ,	O
iodine 	iodine 	 NN	O
,  	,  	 ,	O
triclosan 	triclosan 	 NN	B-NP
,  	,  	 ,	O
hexachlorophene 	hexachlorophene 	 NN	B-NP
,  	,  	 ,	O
silver-based  	silver-based  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
52 	52 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
1  	1  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
surface  	surface  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
treated  	treated  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
process  	process  	 NN	O
altering  	altering  	 VBG	O
the  	the  	 DT	O
physical  	physical  	 JJ	B-NP
properties  	properties  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
surface  	surface  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
biofilm  	biofilm  	 CD	B-NP
formation.  	formation.  	 CD	I-NP
53 	53 	 CD	O
.  	.  	 .	O
A  	A  	 DT	O
device  	device  	 NN	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
comprising 	comprising 	 NNS	O
:  	:  	 :	O
a 	a 	 LS	O
)  	)  	 -RRB-	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
having  	having  	 VBG	O
a  	a  	 DT	O
proximal  	proximal  	 JJ	B-NP
end  	end  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
distal  	distal  	 JJ	B-NP
end 	end 	 NN	I-NP
;  	;  	 :	O
b 	b 	 LS	O
)  	)  	 -RRB-	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
attached  	attached  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
distal  	distal  	 NN	I-NP
end 	end 	 NN	I-NP
;  	;  	 :	O
c 	c 	 LS	O
)  	)  	 -RRB-	O
optionally 	optionally 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
attached  	attached  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
proximal  	proximal  	 NN	I-NP
end 	end 	 NN	I-NP
;  	;  	 :	O
and  	and  	 CC	O
d 	d 	 LS	O
)  	)  	 -RRB-	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
for  	for  	 IN	O
sustained  	sustained  	 JJ	O
release 	release 	 NN	O
,  	,  	 ,	O
wherein  	wherein  	 VBG	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
optional  	optional  	 JJ	B-NP
nasal  	nasal  	 JJ	I-NP
portion  	portion  	 NN	I-NP
comprise  	comprise  	 VBP	O
a  	a  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
any  	any  	 DT	O
combination  	combination  	 NN	O
thereof 	thereof 	 RB	O
,  	,  	 ,	O
to  	to  	 TO	O
treat  	treat  	 VB	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 NN	I-NP
condition.  	condition.  	 CD	I-NP
54 	54 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer 	polymer 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
metal 	metal 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
a  	a  	 DT	O
combination  	combination  	 NN	O
thereof.  	thereof.  	 CD	O
55 	55 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
54  	54  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer.  	polymer.  	 CD	B-NP
56 	56 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
55  	55  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
lactide 	lactide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
glycolide 	glycolide 	 LS	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-glycolide 	lactide-co-glycolide 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
glycolic  	glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
lactic  	lactic  	 JJ	I-NP
acid-co-glycolic  	acid-co-glycolic  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
caprolactone 	caprolactone 	 LS	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
orthoester 	orthoester 	 LS	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
phosphazene 	phosphazene 	 LS	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
hydroxybutyrate 	hydroxybutyrate 	 LS	I-NP
) 	) 	 -RRB-	I-NP
s  	s  	 VBZ	O
or  	or  	 CC	O
copolymers  	copolymers  	 VBP	O
including  	including  	 VBG	B-NP
poly 	poly 	 NNS	I-NP
( 	( 	 -LRB-	I-NP
hydroxybutyrate 	hydroxybutyrate 	 LS	I-NP
) 	) 	 -RRB-	I-NP
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
lactide-co-caprolactone 	lactide-co-caprolactone 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
polycarbonates 	polycarbonates 	 CD	O
;  	;  	 :	O
polyesteramides 	polyesteramides 	 CD	B-NP
;  	;  	 :	O
polyanhidrides 	polyanhidrides 	 CD	B-NP
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
dioxanone 	dioxanone 	 LS	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
alkylene  	alkylene  	 FW	I-NP
alkylate 	alkylate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
copolymers  	copolymers  	 NN	O
of  	of  	 IN	O
polyethylene  	polyethylene  	 NN	B-NP
glycol  	glycol  	 NNS	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
polyorthoester 	polyorthoester 	 NN	B-NP
;  	;  	 :	O
biodegradable  	biodegradable  	 JJ	O
polyurethanes 	polyurethanes 	 NN	O
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
amino  	amino  	 JJ	I-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	I-NP
s 	s 	 VBZ	O
;  	;  	 :	O
polyetheresters 	polyetheresters 	 CD	B-NP
;  	;  	 :	O
polyacetals 	polyacetals 	 CD	O
;  	;  	 :	O
polycyanoacrylates 	polycyanoacrylates 	 CD	B-NP
;  	;  	 :	O
poly 	poly 	 CD	B-NP
( 	( 	 -LRB-	I-NP
oxyethylene 	oxyethylene 	 LS	I-NP
) 	) 	 -RRB-	I-NP
/ 	/ 	 FW	O
poly 	poly 	 FW	B-NP
( 	( 	 -LRB-	I-NP
oxypropylene 	oxypropylene 	 LS	I-NP
)  	)  	 -RRB-	I-NP
copolymers 	copolymers 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
blends  	blends  	 NNS	O
and  	and  	 CC	O
copolymers  	copolymers  	 CD	O
thereof.  	thereof.  	 CD	O
57 	57 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
56  	56  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
lactide 	lactide 	 JJ	B-NP
/ 	/ 	 CD	I-NP
glycolide  	glycolide  	 CD	I-NP
polymer.  	polymer.  	 CD	I-NP
58 	58 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
54  	54  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer.  	polymer.  	 CD	I-NP
59 	59 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
58  	58  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer  	polymer  	 NN	I-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
vinyl  	vinyl  	 FW	I-NP
acetate 	acetate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
vinyl  	vinyl  	 FW	I-NP
acetate 	acetate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
silicone  	silicone  	 JJ	B-NP
polymers 	polymers 	 NNS	I-NP
,  	,  	 ,	O
polyurethanes 	polyurethanes 	 NN	O
,  	,  	 ,	O
polysaccharides  	polysaccharides  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
a  	a  	 DT	O
cellulosic  	cellulosic  	 JJ	B-NP
polymers  	polymers  	 NNS	I-NP
and  	and  	 CC	O
cellulose  	cellulose  	 JJ	B-NP
derivatives 	derivatives 	 NNS	I-NP
,  	,  	 ,	O
acyl  	acyl  	 FW	B-NP
substituted  	substituted  	 FW	I-NP
cellulose  	cellulose  	 FW	I-NP
acetates  	acetates  	 FW	I-NP
and  	and  	 CC	O
derivatives  	derivatives  	 NNS	O
thereof 	thereof 	 RB	O
,  	,  	 ,	O
copolymers  	copolymers  	 VBG	O
of  	of  	 IN	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
ethylene  	ethylene  	 FW	I-NP
glycol 	glycol 	 FW	I-NP
)  	)  	 -RRB-	I-NP
and  	and  	 CC	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
butylene  	butylene  	 FW	I-NP
terephthalate 	terephthalate 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
polystyrenes 	polystyrenes 	 NN	O
,  	,  	 ,	O
polyvinyl  	polyvinyl  	 JJ	B-NP
chloride 	chloride 	 NN	I-NP
,  	,  	 ,	O
polyvinyl  	polyvinyl  	 JJ	B-NP
fluoride 	fluoride 	 NN	I-NP
,  	,  	 ,	O
poly 	poly 	 NNS	B-NP
( 	( 	 -LRB-	I-NP
vinyl  	vinyl  	 FW	I-NP
imidazole 	imidazole 	 FW	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
chorosulphonated  	chorosulphonated  	 JJ	B-NP
polyolefins 	polyolefins 	 NN	I-NP
,  	,  	 ,	O
polyethylene  	polyethylene  	 NN	B-NP
oxide 	oxide 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
copolymers  	copolymers  	 NNS	O
and  	and  	 CC	O
blends  	blends  	 CD	O
thereof.  	thereof.  	 CD	O
60 	60 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
54  	54  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biocompatible  	biocompatible  	 JJ	B-NP
material  	material  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
metal.  	metal.  	 CD	O
61 	61 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
60  	60  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
metal  	metal  	 NN	O
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
cobalt 	cobalt 	 NN	O
,  	,  	 ,	O
chromium 	chromium 	 NN	O
,  	,  	 ,	O
nickel 	nickel 	 NN	O
,  	,  	 ,	O
platinum 	platinum 	 NN	O
,  	,  	 ,	O
stainless  	stainless  	 JJ	O
steel 	steel 	 NN	O
,  	,  	 ,	O
titanium 	titanium 	 NN	B-NP
,  	,  	 ,	O
tantalum 	tantalum 	 NN	O
,  	,  	 ,	O
nickel-titanium 	nickel-titanium 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
any  	any  	 DT	O
alloy  	alloy  	 NN	O
or  	or  	 CC	O
combination  	combination  	 NN	O
thereof.  	thereof.  	 CD	O
62 	62 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
anticholinergic  	anticholinergic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antihistamines 	antihistamines 	 NN	B-NP
,  	,  	 ,	O
anti-infective  	anti-infective  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
antiscarring  	antiscarring  	 NN	B-NP
or  	or  	 CC	O
antiproliferative  	antiproliferative  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
chemotherapeutic  	chemotherapeutic  	 NN	B-NP
or  	or  	 CC	O
antineoplastic  	antineoplastic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
cytokines 	cytokines 	 NN	B-NP
,  	,  	 ,	O
decongestants 	decongestants 	 NN	B-NP
,  	,  	 ,	O
healing  	healing  	 VBG	B-NP
promotion  	promotion  	 NN	I-NP
agents  	agents  	 NNS	I-NP
and  	and  	 CC	O
vitamins 	vitamins 	 NN	O
,  	,  	 ,	O
hyperosmolar  	hyperosmolar  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
immunomodulator  	immunomodulator  	 NN	B-NP
or  	or  	 CC	O
immunosuppressive  	immunosuppressive  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
leukotriene  	leukotriene  	 JJ	B-NP
modifiers 	modifiers 	 NN	I-NP
,  	,  	 ,	O
mucolytics 	mucolytics 	 NN	B-NP
,  	,  	 ,	O
narcotic  	narcotic  	 JJ	B-NP
analgesics 	analgesics 	 NN	I-NP
,  	,  	 ,	O
small  	small  	 JJ	O
molecules 	molecules 	 NNS	O
,  	,  	 ,	O
tyrosine  	tyrosine  	 FW	B-NP
kinase  	kinase  	 FW	I-NP
inhibitors 	inhibitors 	 FW	I-NP
,  	,  	 ,	O
peptides 	peptides 	 NN	B-NP
,  	,  	 ,	O
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
nucleic  	nucleic  	 JJ	B-NP
acids 	acids 	 NNS	I-NP
,  	,  	 ,	O
vasoconstrictors 	vasoconstrictors 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
63 	63 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
62  	62  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
comprises  	comprises  	 VBZ	O
an  	an  	 DT	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
agent.  	agent.  	 CD	I-NP
64 	64 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
63  	63  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
agent  	agent  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent.  	agent.  	 CD	I-NP
65 	65 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
64  	64  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
steroidal  	steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agent  	agent  	 NN	I-NP
is  	is  	 VBZ	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
21-acetoxypregnenolone 	21-acetoxypregnenolone 	 NNP	O
,  	,  	 ,	O
alclometasone 	alclometasone 	 NN	B-NP
,  	,  	 ,	O
algestone 	algestone 	 NN	B-NP
,  	,  	 ,	O
amcinonide 	amcinonide 	 NN	B-NP
,  	,  	 ,	O
beclomethasone 	beclomethasone 	 NN	B-NP
,  	,  	 ,	O
betamethasone 	betamethasone 	 NN	B-NP
,  	,  	 ,	O
budesonide 	budesonide 	 NN	B-NP
,  	,  	 ,	O
chloroprednisone 	chloroprednisone 	 NN	B-NP
,  	,  	 ,	O
clobetasol 	clobetasol 	 NN	B-NP
,  	,  	 ,	O
clobetasone 	clobetasone 	 NN	B-NP
,  	,  	 ,	O
clocortolone 	clocortolone 	 NN	B-NP
,  	,  	 ,	O
cloprednol 	cloprednol 	 NN	B-NP
,  	,  	 ,	O
corticosterone 	corticosterone 	 NN	B-NP
,  	,  	 ,	O
cortisone 	cortisone 	 NN	B-NP
,  	,  	 ,	O
cortivazol 	cortivazol 	 NN	B-NP
,  	,  	 ,	O
deflazacort 	deflazacort 	 NN	B-NP
,  	,  	 ,	O
desonide 	desonide 	 NN	B-NP
,  	,  	 ,	O
desoximetasone 	desoximetasone 	 NN	B-NP
,  	,  	 ,	O
dexamethasone 	dexamethasone 	 NN	B-NP
,  	,  	 ,	O
diflorasone 	diflorasone 	 NN	B-NP
,  	,  	 ,	O
diflucortolone 	diflucortolone 	 NN	B-NP
,  	,  	 ,	O
difluprednate 	difluprednate 	 NN	B-NP
,  	,  	 ,	O
enoxolone 	enoxolone 	 NN	B-NP
,  	,  	 ,	O
fluazacort 	fluazacort 	 NN	B-NP
,  	,  	 ,	O
flucloronide 	flucloronide 	 NN	B-NP
,  	,  	 ,	O
flumethasone 	flumethasone 	 NN	B-NP
,  	,  	 ,	O
flunisolide 	flunisolide 	 NN	B-NP
,  	,  	 ,	O
fluocinolone  	fluocinolone  	 JJ	B-NP
acetonide 	acetonide 	 NN	I-NP
,  	,  	 ,	O
fluocinonide 	fluocinonide 	 NN	B-NP
,  	,  	 ,	O
fluocortin  	fluocortin  	 JJ	B-NP
butyl 	butyl 	 NN	I-NP
,  	,  	 ,	O
fluocortolone 	fluocortolone 	 NN	B-NP
,  	,  	 ,	O
fluorometholone 	fluorometholone 	 NN	B-NP
,  	,  	 ,	O
fluperolone  	fluperolone  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
fluprednidene  	fluprednidene  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
fluprednisolone 	fluprednisolone 	 NN	B-NP
,  	,  	 ,	O
flurandrenolide 	flurandrenolide 	 NN	B-NP
,  	,  	 ,	O
fluticasone  	fluticasone  	 JJ	B-NP
propionate 	propionate 	 NN	I-NP
,  	,  	 ,	O
formocortal 	formocortal 	 NN	B-NP
,  	,  	 ,	O
halcinonide 	halcinonide 	 NN	B-NP
,  	,  	 ,	O
halobetasol  	halobetasol  	 JJ	B-NP
propionate 	propionate 	 NN	I-NP
,  	,  	 ,	O
halometasone 	halometasone 	 NN	B-NP
,  	,  	 ,	O
halopredone  	halopredone  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
hydrocortamate 	hydrocortamate 	 NN	B-NP
,  	,  	 ,	O
hydrocortisone 	hydrocortisone 	 NN	B-NP
,  	,  	 ,	O
loteprednol  	loteprednol  	 JJ	B-NP
etabonate 	etabonate 	 NN	I-NP
,  	,  	 ,	O
mazipredone 	mazipredone 	 NN	B-NP
,  	,  	 ,	O
medrysone 	medrysone 	 NN	B-NP
,  	,  	 ,	O
meprednisone 	meprednisone 	 NN	B-NP
,  	,  	 ,	O
methylprednisolone 	methylprednisolone 	 NN	B-NP
,  	,  	 ,	O
mometasone  	mometasone  	 JJ	B-NP
furoate 	furoate 	 NN	I-NP
,  	,  	 ,	O
paramethasone 	paramethasone 	 NN	B-NP
,  	,  	 ,	O
prednicarbate 	prednicarbate 	 NN	B-NP
,  	,  	 ,	O
prednisolone 	prednisolone 	 NN	B-NP
,  	,  	 ,	O
prednisolone  	prednisolone  	 CD	O
25-diethylamino-acetate 	25-diethylamino-acetate 	 CD	O
,  	,  	 ,	O
prednisolone  	prednisolone  	 FW	B-NP
sodium  	sodium  	 FW	I-NP
phosphate 	phosphate 	 FW	I-NP
,  	,  	 ,	O
prednisone 	prednisone 	 NN	B-NP
,  	,  	 ,	O
prednival 	prednival 	 NN	B-NP
,  	,  	 ,	O
prednylidene 	prednylidene 	 NN	B-NP
,  	,  	 ,	O
rimexolone 	rimexolone 	 NN	B-NP
,  	,  	 ,	O
tixocortol 	tixocortol 	 NN	B-NP
,  	,  	 ,	O
triamcinolone 	triamcinolone 	 NN	B-NP
,  	,  	 ,	O
triamcinolone  	triamcinolone  	 JJ	B-NP
acetonide 	acetonide 	 NN	I-NP
,  	,  	 ,	O
triamcinolone  	triamcinolone  	 JJ	B-NP
benetonide 	benetonide 	 NN	I-NP
,  	,  	 ,	O
triamcinolone  	triamcinolone  	 JJ	B-NP
hexacetonide 	hexacetonide 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
derivatives  	derivatives  	 NNS	O
and  	and  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
66 	66 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
65  	65  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
comprises  	comprises  	 VBZ	O
mometasone  	mometasone  	 CD	B-NP
furoate.  	furoate.  	 CD	I-NP
67 	67 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
51  	51  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
has  	has  	 VBZ	O
a  	a  	 DT	O
first  	first  	 JJ	O
collapsed  	collapsed  	 JJ	O
configuration  	configuration  	 NN	B-NP
that  	that  	 WDT	O
permits  	permits  	 VBZ	O
it  	it  	 PRP	O
to  	to  	 TO	O
pass  	pass  	 VB	O
through  	through  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium  	ostium  	 NN	I-NP
or  	or  	 CC	O
surgically  	surgically  	 RB	O
created  	created  	 VBN	B-NP
fenestration 	fenestration 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
second  	second  	 JJ	O
expanded  	expanded  	 JJ	O
configuration  	configuration  	 NN	B-NP
after  	after  	 IN	O
placement  	placement  	 NN	O
into  	into  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity.  	cavity.  	 CD	I-NP
68 	68 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
67  	67  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
at  	at  	 IN	O
least  	least  	 JJS	O
partially  	partially  	 RB	O
conforms  	conforms  	 VBZ	O
to  	to  	 TO	O
the  	the  	 DT	O
shape  	shape  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
and  	and  	 CC	O
substantially  	substantially  	 RB	O
contacts  	contacts  	 VB	O
the  	the  	 DT	O
mucosal  	mucosal  	 JJ	B-NP
surface  	surface  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
sinus  	sinus  	 JJ	I-NP
cavity  	cavity  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
expanded  	expanded  	 JJ	O
configuration.  	configuration.  	 CD	B-NP
69 	69 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
51  	51  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member.  	member.  	 CD	I-NP
70 	70 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer 	polymer 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
metal 	metal 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
71 	71 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
70  	70  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer.  	polymer.  	 CD	B-NP
72 	72 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
71  	71  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
lactide 	lactide 	 JJ	B-NP
/ 	/ 	 CD	I-NP
glycolide  	glycolide  	 CD	I-NP
polymer.  	polymer.  	 CD	I-NP
73 	73 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
comprises  	comprises  	 VBZ	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
pliable  	pliable  	 JJ	O
filaments.  	filaments.  	 CD	O
74 	74 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
73  	73  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
one  	one  	 NN	O
or  	or  	 CC	O
more  	more  	 RBR	O
pliable  	pliable  	 JJ	O
filaments  	filaments  	 NNS	O
are  	are  	 VBP	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
a  	a  	 DT	O
multi-looped  	multi-looped  	 JJ	B-NP
structure.  	structure.  	 CD	I-NP
75 	75 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
74  	74  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
multiple  	multiple  	 JJ	O
loops  	loops  	 NNS	O
are  	are  	 VBP	O
concentric  	concentric  	 VBN	O
to  	to  	 TO	O
one  	one  	 CD	O
another.  	another.  	 CD	O
76 	76 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
self-expands.  	self-expands.  	 CD	O
77 	77 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
expands  	expands  	 VBZ	O
by  	by  	 IN	O
exertion  	exertion  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
expansive  	expansive  	 JJ	B-NP
force.  	force.  	 CD	I-NP
78 	78 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
77  	77  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
expansive  	expansive  	 JJ	B-NP
force  	force  	 NN	I-NP
is  	is  	 VBZ	O
provided  	provided  	 VBN	O
by  	by  	 IN	O
expansion  	expansion  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
balloon.  	balloon.  	 CD	O
79 	79 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
migration  	migration  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
out  	out  	 RP	O
of  	of  	 IN	O
a  	a  	 DT	O
sinus.  	sinus.  	 CD	B-NP
80 	80 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer 	polymer 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
metal 	metal 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
81 	81 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
80  	80  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer.  	polymer.  	 CD	B-NP
82 	82 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
81  	81  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 NN	B-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
lactide 	lactide 	 JJ	B-NP
/ 	/ 	 CD	I-NP
glycolide  	glycolide  	 CD	I-NP
polymer.  	polymer.  	 CD	I-NP
83 	83 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
form  	form  	 VB	O
a  	a  	 DT	O
tubular  	tubular  	 JJ	B-NP
structure.  	structure.  	 CD	I-NP
84 	84 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
migration  	migration  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
out  	out  	 RP	O
of  	of  	 IN	O
a  	a  	 DT	O
sinus.  	sinus.  	 CD	B-NP
85 	85 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
maintain  	maintain  	 VB	O
patency  	patency  	 VBN	O
of  	of  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium.  	ostium.  	 CD	I-NP
86 	86 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
released  	released  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion.  	portion.  	 CD	I-NP
87 	87 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer 	polymer 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
nonbiodegradable  	nonbiodegradable  	 JJ	B-NP
polymer 	polymer 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
metal 	metal 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
combinations  	combinations  	 CD	B-NP
thereof.  	thereof.  	 CD	O
88 	88 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
87  	87  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer.  	polymer.  	 CD	B-NP
89 	89 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
88  	88  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
lactide 	lactide 	 JJ	B-NP
/ 	/ 	 CD	I-NP
glycolide  	glycolide  	 CD	I-NP
polymer.  	polymer.  	 CD	I-NP
90 	90 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
plurality  	plurality  	 NN	O
of  	of  	 IN	O
spokes.  	spokes.  	 CD	O
91 	91 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
53  	53  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
migration  	migration  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
out  	out  	 RP	O
of  	of  	 IN	O
a  	a  	 DT	O
sinus.  	sinus.  	 CD	B-NP
92 	92 	 CD	O
.  	.  	 .	O
A  	A  	 DT	O
system  	system  	 NN	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
comprising 	comprising 	 NNS	O
:  	:  	 :	O
a 	a 	 LS	O
)  	)  	 -RRB-	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
inserter  	inserter  	 NNS	I-NP
comprising  	comprising  	 VBG	O
a  	a  	 DT	O
conduit  	conduit  	 NN	O
having  	having  	 VBG	O
a  	a  	 DT	O
lumen  	lumen  	 NN	B-NP
and  	and  	 CC	O
a  	a  	 DT	O
distal  	distal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
;  	;  	 :	O
b 	b 	 LS	O
)  	)  	 -RRB-	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
lumen  	lumen  	 NN	B-NP
or  	or  	 CC	O
releasably  	releasably  	 VB	O
secured  	secured  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
sinus  	sinus  	 JJ	I-NP
inserter 	inserter 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
comprising  	comprising  	 VBG	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
optionally  	optionally  	 VBG	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
wherein  	wherein  	 VBG	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
has  	has  	 VBZ	O
a  	a  	 DT	O
first  	first  	 JJ	O
collapsed  	collapsed  	 JJ	O
configuration  	configuration  	 NN	B-NP
that  	that  	 WDT	O
permits  	permits  	 VBZ	O
the  	the  	 DT	O
device  	device  	 NN	O
to  	to  	 TO	O
pass  	pass  	 VB	O
through  	through  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
ostium  	ostium  	 NN	I-NP
or  	or  	 CC	O
surgically  	surgically  	 RB	O
created  	created  	 VBN	B-NP
fenestration  	fenestration  	 NNS	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
second  	second  	 JJ	O
expanded  	expanded  	 JJ	O
configuration  	configuration  	 NN	B-NP
after  	after  	 IN	O
placement  	placement  	 NN	O
into  	into  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity.  	cavity.  	 CD	I-NP
93 	93 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
system  	system  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
92  	92  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
is  	is  	 VBZ	O
delivered  	delivered  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
by  	by  	 IN	O
advancing  	advancing  	 VBG	O
a  	a  	 DT	O
pusher  	pusher  	 NN	O
through  	through  	 IN	O
the  	the  	 DT	O
conduit  	conduit  	 NN	B-NP
lumen.  	lumen.  	 CD	I-NP
94 	94 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
system  	system  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
92  	92  	 CD	O
further  	further  	 JJ	O
comprising  	comprising  	 VBG	O
a  	a  	 DT	O
sheath.  	sheath.  	 CD	O
95 	95 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
system  	system  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
94  	94  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
is  	is  	 VBZ	O
delivered  	delivered  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
by  	by  	 IN	O
retracting  	retracting  	 VBG	O
the  	the  	 DT	O
sheath  	sheath  	 NN	O
to  	to  	 TO	O
deploy  	deploy  	 VB	O
the  	the  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
and  	and  	 CC	O
ostial  	ostial  	 JJ	B-NP
member  	member  	 NN	I-NP
and  	and  	 CC	O
expand  	expand  	 VB	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member.  	member.  	 CD	I-NP
96 	96 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
system  	system  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
92  	92  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
inserter  	inserter  	 NN	I-NP
is  	is  	 VBZ	O
preloaded  	preloaded  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 NN	I-NP
device.  	device.  	 CD	I-NP
97 	97 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
system  	system  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
92  	92  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
is  	is  	 VBZ	O
sinus  	sinus  	 JJ	B-NP
inflammation  	inflammation  	 JJ	I-NP
due  	due  	 JJ	O
to  	to  	 TO	O
functional  	functional  	 VB	B-NP
endoscopic  	endoscopic  	 JJ	I-NP
sinus  	sinus  	 JJ	I-NP
surgery  	surgery  	 NN	I-NP
( 	( 	 -LRB-	O
FESS 	FESS 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
98 	98 	 CD	O
.  	.  	 .	O
A  	A  	 DT	O
method  	method  	 NN	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
comprising 	comprising 	 NNS	O
:  	:  	 :	O
a 	a 	 LS	O
)  	)  	 -RRB-	O
providing  	providing  	 VBG	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
comprising  	comprising  	 VBG	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
optionally  	optionally  	 VBG	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion  	portion  	 NN	I-NP
within  	within  	 IN	O
or  	or  	 CC	O
on  	on  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
inserter 	inserter 	 NN	I-NP
;  	;  	 :	O
b 	b 	 LS	O
)  	)  	 -RRB-	O
accessing  	accessing  	 VBZ	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
inserter 	inserter 	 NN	I-NP
;  	;  	 :	O
c 	c 	 LS	O
)  	)  	 -RRB-	O
deploying  	deploying  	 VBZ	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
so  	so  	 RB	O
that  	that  	 IN	O
the  	the  	 DT	O
cavity  	cavity  	 JJ	B-NP
member  	member  	 NN	I-NP
substantially  	substantially  	 RB	O
contacts  	contacts  	 VB	O
the  	the  	 DT	O
mucosal  	mucosal  	 JJ	B-NP
surface  	surface  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
paranasal  	paranasal  	 JJ	I-NP
sinus  	sinus  	 NN	I-NP
after  	after  	 IN	O
expansion.  	expansion.  	 CD	O
99 	99 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
method  	method  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
98  	98  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
releases  	releases  	 VBZ	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
to  	to  	 TO	O
treat  	treat  	 VB	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
for  	for  	 IN	O
about  	about  	 IN	O
one  	one  	 CD	O
week.  	week.  	 CD	B-NP
100 	100 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
method  	method  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
98  	98  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
releases  	releases  	 VBZ	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
to  	to  	 TO	O
treat  	treat  	 VB	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
for  	for  	 IN	O
about  	about  	 IN	O
two  	two  	 CD	O
weeks.  	weeks.  	 CD	O
101 	101 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
method  	method  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
98  	98  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
releases  	releases  	 VBZ	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
to  	to  	 TO	O
treat  	treat  	 VB	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
for  	for  	 IN	O
about  	about  	 IN	O
three  	three  	 CD	O
weeks.  	weeks.  	 CD	O
102 	102 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
method  	method  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
98  	98  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
device  	device  	 NN	I-NP
releases  	releases  	 VBZ	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
to  	to  	 TO	O
treat  	treat  	 VB	O
the  	the  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
for  	for  	 IN	O
about  	about  	 IN	O
one  	one  	 CD	O
month.  	month.  	 CD	O
103 	103 	 CD	O
.  	.  	 .	O
A  	A  	 DT	O
device  	device  	 NN	B-NP
configured  	configured  	 NN	I-NP
to  	to  	 TO	O
deliver  	deliver  	 VB	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
and  	and  	 CC	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
lateralization  	lateralization  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
middle  	middle  	 JJ	B-NP
turbinate.  	turbinate.  	 CD	I-NP
104 	104 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
103  	103  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
device  	device  	 NN	O
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
deliver  	deliver  	 VB	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
sustained  	sustained  	 JJ	O
release  	release  	 NN	B-NP
fashion.  	fashion.  	 CD	I-NP
105 	105 	 CD	O
.  	.  	 .	O
A  	A  	 DT	O
device  	device  	 NN	B-NP
configured  	configured  	 NN	I-NP
to  	to  	 TO	O
deliver  	deliver  	 VB	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
and  	and  	 CC	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
tissue  	tissue  	 NN	O
adhesions  	adhesions  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
area  	area  	 NN	O
proximate  	proximate  	 VBD	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
or  	or  	 CC	O
proximate  	proximate  	 VBG	O
an  	an  	 DT	O
area  	area  	 NN	O
or  	or  	 CC	O
an  	an  	 DT	O
excised  	excised  	 JJ	O
sinus  	sinus  	 NN	B-NP
cavity.  	cavity.  	 CD	I-NP
106 	106 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
105  	105  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
device  	device  	 NN	O
is  	is  	 VBZ	O
configured  	configured  	 VBN	O
to  	to  	 TO	O
deliver  	deliver  	 VB	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
sustained  	sustained  	 JJ	O
release  	release  	 NN	B-NP
fashion.  	fashion.  	 CD	I-NP
107 	107 	 CD	O
.  	.  	 .	O
A  	A  	 DT	O
device  	device  	 NN	O
for  	for  	 IN	O
treating  	treating  	 VBG	O
a  	a  	 DT	O
paranasal  	paranasal  	 JJ	B-NP
sinus  	sinus  	 JJ	I-NP
condition  	condition  	 NN	I-NP
comprising  	comprising  	 VBG	O
an  	an  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
dispersed  	dispersed  	 NN	I-NP
within  	within  	 IN	O
a  	a  	 DT	O
biodegradable  	biodegradable  	 JJ	O
polymer  	polymer  	 JJ	B-NP
matrix 	matrix 	 NN	I-NP
,  	,  	 ,	O
wherein  	wherein  	 VBG	O
the  	the  	 DT	O
device  	device  	 NN	O
comprises  	comprises  	 VBZ	O
a  	a  	 DT	O
cavity  	cavity  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
an  	an  	 DT	O
ostial  	ostial  	 JJ	B-NP
member 	member 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
optionally  	optionally  	 VBG	O
a  	a  	 DT	O
nasal  	nasal  	 JJ	B-NP
portion 	portion 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
exhibits  	exhibits  	 VBZ	O
an  	an  	 DT	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
cumulative  	cumulative  	 JJ	I-NP
release  	release  	 NN	I-NP
profile  	profile  	 NN	I-NP
in  	in  	 IN	O
which  	which  	 WDT	O
a  	a  	 DT	O
therapeutically  	therapeutically  	 JJ	O
effective  	effective  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
said  	said  	 VBD	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
maintained  	maintained  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
sinus  	sinus  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
35  	35  	 CD	O
days  	days  	 NNS	O
after  	after  	 IN	O
implantation  	implantation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
device.  	device.  	 CD	O
108 	108 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
107  	107  	 CD	O
in  	in  	 IN	O
which  	which  	 WDT	O
a  	a  	 DT	O
therapeutically  	therapeutically  	 JJ	O
effective  	effective  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
maintained  	maintained  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
25  	25  	 CD	O
days  	days  	 NNS	O
after  	after  	 IN	O
implantation  	implantation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
device.  	device.  	 CD	O
109 	109 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
107  	107  	 CD	O
in  	in  	 IN	O
which  	which  	 WDT	O
a  	a  	 DT	O
therapeutically  	therapeutically  	 JJ	O
effective  	effective  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
maintained  	maintained  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
14  	14  	 CD	O
days  	days  	 NNS	O
after  	after  	 IN	O
implantation  	implantation  	 VBG	O
the  	the  	 DT	O
device.  	device.  	 CD	O
110 	110 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
107  	107  	 CD	O
in  	in  	 IN	O
which  	which  	 WDT	O
a  	a  	 DT	O
therapeutically  	therapeutically  	 JJ	O
effective  	effective  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
maintained  	maintained  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
for  	for  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
about  	about  	 IN	O
four  	four  	 CD	O
days  	days  	 NNS	O
after  	after  	 IN	O
implantation  	implantation  	 VBG	O
the  	the  	 DT	O
device.  	device.  	 CD	O
111 	111 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
107  	107  	 CD	O
with  	with  	 IN	O
a  	a  	 DT	O
drug  	drug  	 NN	B-NP
release  	release  	 NN	I-NP
kinetic  	kinetic  	 NN	I-NP
profile  	profile  	 NN	I-NP
which  	which  	 WDT	O
achieves  	achieves  	 VBZ	O
at  	at  	 IN	O
least  	least  	 JJS	O
a  	a  	 DT	O
therapeutically  	therapeutically  	 JJ	O
effective  	effective  	 JJ	O
level  	level  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
within  	within  	 IN	O
4  	4  	 CD	O
days  	days  	 NNS	O
after  	after  	 IN	O
implantation.  	implantation.  	 CD	B-NP
112 	112 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
107  	107  	 CD	O
with  	with  	 IN	O
a  	a  	 DT	O
drug  	drug  	 NN	B-NP
release  	release  	 NN	I-NP
kinetic  	kinetic  	 NN	I-NP
profile  	profile  	 NN	I-NP
which  	which  	 WDT	O
sustains  	sustains  	 VBZ	O
at  	at  	 IN	O
least  	least  	 JJS	O
a  	a  	 DT	O
therapeutically  	therapeutically  	 JJ	O
effective  	effective  	 JJ	O
level  	level  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
from  	from  	 IN	O
day  	day  	 NN	O
4  	4  	 CD	O
through  	through  	 IN	O
day  	day  	 NN	O
35  	35  	 CD	O
after  	after  	 IN	O
implantation.  	implantation.  	 CD	B-NP
113 	113 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
107  	107  	 CD	O
with  	with  	 IN	O
a  	a  	 DT	O
drug  	drug  	 NN	B-NP
release  	release  	 NN	I-NP
kinetic  	kinetic  	 NN	I-NP
profile  	profile  	 NN	I-NP
which  	which  	 WDT	O
is  	is  	 VBZ	O
substantially  	substantially  	 RB	O
proportional  	proportional  	 JJ	O
and  	and  	 CC	O
contemporaneous  	contemporaneous  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
biodegradation  	biodegradation  	 NN	B-NP
and  	and  	 CC	O
mass  	mass  	 JJ	B-NP
clearance  	clearance  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
device  	device  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
and  	and  	 CC	O
sustains  	sustains  	 VBZ	O
a  	a  	 DT	O
therapeutically  	therapeutically  	 JJ	O
effective  	effective  	 JJ	O
level  	level  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
sinus  	sinus  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
up  	up  	 RP	O
until  	until  	 IN	O
clearance  	clearance  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
device.  	device.  	 CD	O
114 	114 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
of  	of  	 IN	O
claim  	claim  	 NN	O
107  	107  	 CD	O
wherein  	wherein  	 CD	O
the  	the  	 DT	O
active  	active  	 JJ	O
agent  	agent  	 NN	B-NP
is  	is  	 VBZ	O
released  	released  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
drug  	drug  	 NN	B-NP
release  	release  	 NN	I-NP
kinetic  	kinetic  	 NN	I-NP
profile  	profile  	 NN	I-NP
combining  	combining  	 VBG	O
two  	two  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
of  	of  	 IN	O
the  	the  	 DT	O
profiles  	profiles  	 NN	O
of  	of  	 IN	O
claims  	claims  	 NNS	O
111 	111 	 CD	O
,  	,  	 ,	O
112 	112 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
113 	113 	 CD	O
.  	.  	 .	O
